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Abstract
This study was conducted to establish whether or not a set of factors from the model 
of the theory o f planned behaviour, and the composite attitude behaviour model, 
can predict the prescription behavioural intention of physicians, and to see whether 
prescription behaviour could be altered by external stimuli developed on the basis 
of the most and least influential elements of prescription behaviour.
The study was conducted in Greece using sales representatives from a 
pharmaceutical company. Two external stimuli were developed, based on the 
factors found to influence the prescription behaviour of physicians most and least.
In the main study, questionnaires were sent to 538 physicians to evaluate the 
determinants of their prescription behavioural intention in relation to cost-conscious 
drug prescribing. Physicians completed questionnaires at the beginning and end of 
a 6-months study period, during which they were visited monthly by the sales 
representative. The physicians were divided into three groups: one exposed to the 
stimulus with the greatest effect on behavioural intention, one to the stimulus with 
the least effect, and a control group. Information on the actual prescription 
behaviour of the physicians was collected for a week at the beginning and end of 
the study period. The data were analysed in accordance with the behavioural 
models mentioned above.
The composite attitude behaviour model was significantly superior to the model of 
the theory of planned behaviour in predicting prescription behavioural intention. 
This result demonstrates the usefulness of the former model in predicting non-fully- 
volitional behaviour. It is frequently thought that physicians are motivated to 
concentrate principally on the facts in a message. However, this research 
demonstrated that peripheral considerations are also important, and suggests that 
attempts to change physicians’ prescription behaviour should include elements of 
the attitudinal, normative and control constructs that have the most influence on 
behavioural intention.
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CHAPTER 1 Introduction
1.1. Background to the research
In the health sector, as in the economic system in general, the scarcity of resources 
means that it is frequently necessary to make choices. In the economy as a whole, 
the problem of compatibility between needs and resources is resolved by price: the 
consumers who are not able or willing to pay are thus unable to satisfy their needs, 
even though they may regard these as essential. In the public health system, pricing 
cannot be used as an instrument to achieve equilibrium between needs and 
resources, if we are to offer healthcare to all. Notwithstanding this principle, the 
problem remains as to how to meet the health needs of the population, which can be 
regarded as almost limitless, in ways which are compatible with the scarce 
resources available. This is a fundamental question of choice and priority that all 
public health systems have to address.
Rationing is an economic strategy which can be adopted when the demand for 
essential goods exceeds their supply and the mechanism of price competition cannot 
be used. This measure is introduced in extreme situations only, such as in a war or 
serious calamity, when the normal rules of the marketplace cannot operate. In the 
health sector, if services are free of charge at the moment of use, this will tend to 
create a situation of excess demand, with the risk that the services will be exhausted 
and health funds depleted. There is thus the potential for a situation which would 
require rationing of resources. Given that we cannot use pricing as an instrument of 
control, and in the absence of economic equilibrium and autoregulation in the health 
sector, it will be necessary to define rules in order to satisfy the health needs of the 
total population, and to ensure the optimal use of the available resources.
Even in the absence of such rules, rationing undoubtedly takes place in the health 
sector. It may take different forms, occur at different institutional levels, and be 
practised by many individuals (e.g., physicians, politicians, and local government 
officials), who may follow subjective criteria, not necessarily corresponding to the 
interest and welfare of the community.
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There exist three basic strategies of rationing in the health sector. The first, which at 
this moment is unique in its kind, is the one adopted by the US state of Oregon. It 
answers simultaneously two basic questions: what provisions, and at what cost, will 
health provisions be supplied by the state to its citizens, in the absence of pricing 
methods and within the limits of the budget. This is a clear form of rationing and 
one which has not previously been put into practice (Bariletti et al., 1999). The 
second strategy is that operated in both The Netherlands and Sweden, in which a 
limited rationing has been recognised. In The Netherlands, a number of principles 
have been defined in order to identify a base packet of health provisions, valid for 
all insured persons, while in Sweden, the principles define how health services 
should be prioritised. In neither of these countries is there an actual list of allowed 
services (Scrip, 2000a; 2000d). The third strategy is that practised in New Zealand 
and Great Britain, where the government has not concerned itself with the process 
for definition and verification of guidelines on resource distribution, but has left any 
rationing of resources to be carried out at a local and individual level (Kobelt, 1996; 
Bariletti et al., 1999).
Apart from the allocation of available supplies, rationing in the health sector is 
mainly achieved by price control of pharmaceutical products. The system of free 
pricing, with prices determined by the marketplace, has generally been abolished 
and prices are instead established by negotiations between pharmaceutical 
companies and public bodies. In the European Union (EU), several mechanisms are 
used to control the prices of pharmaceutical products. Italy and The Netherlands 
follow a system of reference pricing where the price is based on a weighted average 
price in several other countries. In Austria, price-setting is based on a product’s 
cost price for locally manufactured products and for products manufactured 
elsewhere as if the product were manufactured in Austria. Great Britain, Ireland 
and Sweden use a system where prices are negotiated on the basis of the objectives 
of the pharmaceutical industry and the public bodies (Scrip, 2000a). These 
objectives might be, for example, to create an incentive for the local pharmaceutical 
industry by allowing higher prices for products which are locally developed and 
manufactured. Countries where prices are fixed entirely by the authorities are
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France, Greece, Belgium and Portugal (Scrip, 1999a, 2000b, 2000c, 2000e, 2001a, 
2001b; Bariletti et al., 2000).
In recent years, Australia and the Canadian state Ontario have introduced 
pharmaco-economic studies as a method to control healthcare costs. These are 
economic analyses of the therapeutic characteristics of a pharmaceutical product, 
including cost-effectiveness, cost-utility and cost-benefits. These evaluations have 
become an important element in obtaining marketing authorisation for a product in 
several countries such as Great Britain (Kangis & Van der Geer, 1996).
These cost-containment measures have not been very successful in limiting or 
reducing the increase in the public health budget, however, and therefore in many 
countries a system of patient co-payment has been introduced. Co-payment exists 
in several forms, such as a fixed fee to be paid by the patient per prescription 
(prescription charge), or the reimbursement of only a percentage of the cost of a 
pharmaceutical product, the remaining part being paid by the patient. Co-payment 
for pharmaceutical products has increased dramatically in the past few years, 
particularly in countries where many pharmaceutical products are no longer 
reimbursed. In Italy in the period 1990-1998, for example, the total costs for 
pharmaceuticals paid by the patient went up from 31.4% to 49.5% (Bariletti et al.,
1999). Due to co-payment by the patient, the percentage of total healthcare costs 
for pharmaceuticals in the national health budget is, in many countries, not much 
above 10% (see Table 2).
Another system which has been adopted in one way or another by some members of 
the EU, is to set a ceiling for total public sector expenditure on reimbursement. 
Denmark has adopted this system. Individual pharmaceutical companies are 
obliged to assist by keeping within an overall price ceiling. This is done by 
assessing, on a monthly basis, whether total expenditure exceeded comparable 
expenditure in the preceding year. If government expenditure on drugs increases in 
a given month, the government checks to see whether particular companies have 
increased their turnover by a similar amount, compared to the turnover in the same
3
month of the preceding year. If this is the case, the company is assumed to be 
responsible for the increase in total expenditure. The company or companies 
concerned would then be obliged to reduce their prices until the excess expenditure 
has been eliminated. This agreement has given rise to a large number of questions 
of interpretation and discussion between the industry and the Danish Ministry of 
Health. One important topic of discussion has been whether companies have been 
obliged to cut prices to a level beneath the European average in order to comply 
with the government’s annual expenditure limits (Bariletti et al., 2000).
The Danish Ministry of Health imposed these regulations based on the consumption 
of medicine. However, consumption has since far exceeded that foreseen by the 
parties to the agreement. The result is that total National Health expenditure has 
been significantly greater than the level agreed. The Danish Ministry of Health’s 
interpretation of the agreement is that the ceiling should be observed, while the 
industry feels that the individual companies should not have to cut prices to below 
the European average. The European Commission has stated that the agreement 
quota system contravenes EU competition rules, specifically if prices are forced 
down below an European average level. The justification for this is that the 
agreement quota system freezes companies’ market share to the market share of the 
year before; companies are free to increase their market share but have to pay for 
this by way of price reductions. This tends to counter the rules of normal 
competition, for example, increased efficiency, marketing, etc. It also tends to 
militate against the introduction of new products, since companies would then have 
to maintain the price of their products or reduce their market share (Mefa 
Foreningen af danske medicinfabrikker, 1997).
However, health budgets in many countries remain seemingly out of control. This 
is clearly shown by the percentage increase, on top of inflation, of the sales value of 
pharmaceuticals in the most developed countries during the period 1989-1999 
(Table 1).
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Table 1 Percentage of increase, on top of inflation, of the sales value of 
pharmaceuticals in the most developed countries during 1989- 
1999.
Country Sales value o f Percentage o f variation Sales value o f
pharmaceuticals in 1999/1989 pharmaceuticals
billions o f local on top o f
currency inflation
1989 1999 Sales value of
pharmaceuticals
(a)
Inflation
(b)
(^
Belgium 37.866576 76.024177 100.8 23.7 62.3
France 51.749954 86.851 67.8 21.1 38.6
Germany 14.983566 23.607389 57.6 28.0 23.1
Japan 1929.700 2833.135 46.8 11.9 31.2
Greece 74.900 348.151 364.8 182.0 64.8
Italy 9844.000 17181.000 74.5 48.3 17.7
The Netherlands 2.299965 4.217524(97) 83.4(97) 22.4(97) 49.8(97)
Portugal 90.700 305.545 236.9 78.5 88.7
United Kingdom 2.222449 5.551548 149.8 43.6 74.0
Spain 336.68417 875.215959 160.0 51.0 72.2
U.S.A.
(pharmacists and 
foodstores
28.473 86.049157 202.2 34.2 125.2
(a): Source: Information Medical Statistics - I.M.S., 6330 Cham, Switzerland
(b): Source: Perspectives économiques de l’OCDE, n. 65, June 1999
(c): {( 100+a)/( 100+b)-1}xl 00
Another cost containment measure introduced in many European countries is an 
attempt to influence the prescribing habits of physicians. In Germany, for example, 
if the annual budget of the Statutory Health Insurance (SHI) for drugs and 
medicines were exceeded, the physicians would be held financially responsible. In 
order to limit their responsibility, the federal ministry of health, the leading 
association of the statutory Health Insurance Funds and the federal Association of 
SHI-accredited physicians worked out a common action plan in order to meet the 
drug and medicine budget for 1999. This plan was published on 17 September 
1999, and is not binding, but is only a recommendation addressed to the SHI- 
accredited physicians (Scrip, 1999b).
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In other European countries too, there have been attempts to alter the prescribing 
habits of physicians. The most common recommendations have been:
• to switch to prescription of less expensive generic drugs,
• to stop prescribing some minor drugs,
• to avoid prescription of some ‘debated’ drugs,
• to exclude private prescriptions from Statutory Health Insurance,
• to avoid the use of expensive innovate treatments without a proven added 
therapeutic value,
• to obtain a second opinion before prescribing an active substance with 
debatable or minor added therapeutic value.
The legality of these cost-cutting programmes, which have been adopted in several 
European countries in the light of the increasing costs of pharmaceuticals, is highly 
debatable. It has been claimed that these programmes could be considered to 
breach the anticartel laws. These programmes distort competition, preventing 
specific drugs from being prescribed, for the specific purpose of meeting the drug 
budget, without having in many cases a legal basis (1999, Conference Bleue).
However, even though the legal bases for these actions are often lacking, the 
introduction of new cost-containment measures that will restrict the prescription 
freedom of physicians must be expected as the costs of public health (as a 
percentage of gross national products) continue to rise in most countries. In the 
period 1963-99 this percentage rose from 0.63 to 0.67% in Italy, from 0.72 to 
1.05% in France, from 0.43 to 0.90% in Germany and from 0.36 to 0.76% in the 
UK. Pharmaceuticals, although representing only a limited percentage of the total 
health costs (see Table 2), remain vulnerable to cost-containment measures as other 
determinants of the public health expenses, such as salaries of specialists, are more 
difficult to influence.
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Table 2 Public health costs as a percentage of gross domestic product
Country As a percentage of gross Pharmaceuticals / public health costs
domestic product in percentage
1983 1997 Differenc
e
97/83
1983 1997 Difference
97/83
Austria 5.3 6.0 + 0.7 10.6 11.9 + 1.3
Belgium 6.2 6.7 + 0.5 11.0 13.2 + 2.2
Denmark 5.6 6.7 + 1.1 9.7 12.9 + 3.2
Finland 5.5 5.7 + 0.2 11.5 10.7 -0.8
France 6.4 7.1 + 0.7 12.5 13.2 + 0.7
Germany 6.2 8.3 + 2.1 12.6 16.8 + 4.2
Japan 5.0 5.7 + 0.7 13.9 16.2 + 2.3
Greece 4.1 5.0 + 0.9 12.1 11.9 -0.2
Ireland 6.4 4.9 -1.5 11.4 (‘86) 15.0 + 3.6
Italy 5.5 5.3 -0.2 12.4 10.5 -1.9
Norway 4.3 6.2 + 1.9 12.2 13.7 + 1.5
The Netherlands 6.2 6.2 + 0.0 9.7 (’84) 12.7 + 3.0
Portugal 3.0 4.7 + 1.7 6.8 10.8 + 4.0
United Kingdom 5.2 5.8 + 0.6 11.6 14.5 + 2.9
Spain 5.1 5.6 + 0.5 10.8 (’85) 13.3 + 2.5
Sweden 8.7 7.2 -1.5 13.9 11.5 -2.4
Switzerland 5.3 7.0 + 1.7 15.7 13.2 + 2.5
U.S.A. 9.4 6.5 -2.9 13.6 20.3 + 6.7
Average 5.9 6.1 + 0.2 12.0 13.5 + 1.5
Source: Indicator! farmaceutici, June 2000, Farmindustria, Largo del Nazareno 13,
00187 Rome, Italy, p. 419
The influence of cost-containment measures on the prescription behaviour of 
physicians is not yet well understood. There is concern that cost-saving 
programmes may limit the freedom of physicians to prescribe the products that they 
consider best for the treatment of their patients. For example, the best product 
might not be reimbursed and thus not available for the lower income patient. The 
influence of the patient on the prescription behaviour of the physician, arising from 
of the co-payment measures, has not been well analysed. The importance of the 
cost element, as an external stimulus in the hands of the pharmaceutical industry, in 
persuading physicians to prescribe a particular product, is also not yet clear. It 
would be interesting to understand if and how the prescription behaviour of 
physicians is responding to these cost-containment measures. Are physicians 
willing to respond to cost-containment measures? What is the influence of the co­
payment system on the physician’s prescription behaviour? Should, for instance.
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the pharmaceutical industry add an external stimulus based on the cost-effectiveness 
of their products to their promotional messages? Is physicians’ prescription 
behaviour intention and actual behaviour influenced by cost-containment measures?
The subjective expected utility theory of reasoned action, developed by Ajzen and 
Fishbein (1980), and the theory of planned behaviour, developed by Ajzen (1985), 
state that the customers’ actual behaviour is best predicted by their intentions. The 
attitudes and beliefs of people they respect will also influence customers’ 
behaviour. This was not the first time that customer behaviour had been found to be 
directly linked with attitudes and beliefs. The theory of Ernest Dichter (1964) 
related customers attitudes to their behaviour, while Allegrante et al. (1980) 
demonstrated that customers tend to give a different weighting to different attributes 
of a product, based on the customer’s attitudes towards those attributes. Thus, the 
impact of marketing stimuli on the buying decision process might be enhanced by 
influencing the right attitudes of customers.
The relationship between attitudes and behaviour has been extensively tested.
Many studies have confirmed the view that a customer's buying behaviour can be 
seen as reasoned action, that is, the pros and cons of the behaviour are weighed 
before a buying decision is made (Ajzen & Fishbein, 1980). These studies are 
based on the so-called "expectancy value or subjective expected utility theory" 
models. In addition to the customer’s basic attitudes, the expectancy of the extent 
to which the product will meet the customer’s needs will determine the choices 
made. Some normative factors may also be included, such as considerations of 
professional acceptability. Such models have been shown to predict customer's 
buying intentions correctly in approximately 70% of cases in different fields (Van 
derPutte, 1991).
Research has been undertaken in areas such as food choices (Freeman & Sheiham, 
1997), smoking (Hill et al., 1997) and low-risk AIDS-related behaviours (Bandawe 
& Foster, 1996). However, the view of Ajzen and Fishbein, that behaviours are 
best predicted by intentions, seems not to function under all circumstances. Barling
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and Moore (1996) proved that behavioural intentions are stronger than behaviours 
with 85% of the respondents intending on engaging in the behaviour but only 39% 
of the respondents actually performing the behaviour. Also, the correlation between 
attitudes alone and apparent behaviour turns out to be less strong. A review of the 
literature by Wicker (1969) reported a correlation of 0.20 between attitude and 
behaviour. The limited role of attitudes in guiding behaviour emphasises that a 
variety of factors other than attitudes, also influence behaviour. The influence of 
these factors on behaviour reduces and masks the extent to which attitudes guide 
behaviour. Therefore, in order to understand customer's behaviour, other relevant 
determinants of behaviour must also be considered.
The patient is the final consumer of pharmaceutical products. However, it is the 
physician who takes the final purchasing decision when he or she issues a 
prescription. The physicians are therefore viewed in this research as the customers 
or consumers and, as a consequence, the theoretical framework based on consumer 
behaviour may legitimately be used.
Research has shown that attitudes, normative beliefs, outcome evaluation, habits 
and perceived behavioural control are important determinants of physicians’ 
prescription behavioural intention and actual behaviour (Denig & Haaijer-Ruskamp, 
1995). Research into the possibilities of influencing the determinants of physicians’ 
prescription behaviour with promotional tools is scarce. The pharmaceutical 
industry has an increasing need to improve the success of their efforts to influence 
prescription behaviour (Brown & Srikanthan, 1998), however, because of 
increasing competition due to globalisation, decreased margins due to cost-saving 
measures introduced by government bodies, and the decrease in the number of new 
chemical entities launched. The low output of the worldwide pharmaceutical 
industry in terms of new products is particularly alarming; in 1998 only 38 new 
active substances were introduced worldwide, a five-year low (Shimmings, 1999).
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The unravelling of the human genome and derived functionality at the protein and 
cellular level will give rise to the identification of hundreds or even thousands of 
new drug targets relevant to a specific pathophysiological process. In addition, it 
will fractionate human disease into subclasses, potentially enhancing the specificity 
of drug treatment and make it more individualised. Huge numbers of new chemical 
entities will be identified as potential leads for new medicines. A new lead, 
however, is not yet a new therapeutic agent with proven efficacy and safety. 
Multidisciplinary approaches are required to link new targets with new chemicals 
and to develop innovative concepts and new technologies in drug design, in drug 
transport, delivery and targeting, in physiologically based drug disposition and 
metabolism, in efficacy and safety assessment by identifying and validating genetic, 
biomedical, pharmacological and clinical markers. The research and development 
costs of the pharmaceutical industry will therefore only increase and, in spite of 
decreasing development and drug registration time-periods, the need to reach a 
break-even point within a reasonable time frame will become even more important 
for the pharmaceutical industry than it is today.
Pharmaceutical marketing is the most important factor used to influence the 
customer or prescriber of pharmaceutical products. Marketing activities include the 
activities of sales representatives and all other aspects of sales promotion such as 
journal advertisement, direct mail, participation in conferences, samples, gifts, 
hospitality for the medical profession, seminars, etc. In order to be most effective 
those promotional tools should target those elements of physicians’ decision­
making process which can be influenced. Therefore governments, health insurance 
funds, and the pharmaceutical industry must first understand the decision process if 
they are to develop external stimuli to induce the desired alterations of prescription 
behaviour.
Subjective expected utility theories, such as the theory of reasoned action, of 
planned behaviour and of interpersonal behaviour (Ajzen & Fishbein, 1980; Ajzen, 
1985; Triandis, 1980) have been used to investigate the factors leading to 
prescription behavioural intention. It has been shown that the interaction and
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combination of many social and psychological factors must be considered when 
examining physicians’ decision-making processes. The predictive power of models 
of the subjective expected utility theory is less here, because it refers to a 
behavioural domain in which volitional control is thought to be incomplete.
Rentier and Speckart (1979) called the influence of incomplete control ‘Volitional 
deficiency” and indicated that the result is that only a fraction of those with the 
behavioural intention actually carry out the behaviour. Locke (1995) stresses that 
an objective, scientific approach to behaviourism must take volition as an obvious 
starting point. Furthermore, other research has confirmed that variables external to 
the models of the subjective expected utility theoiy indirectly influence behavioural 
intention and behaviour (Yang et al., 1994).
Pharmaceutical companies frequently use market research to gain a better 
understanding of the factors that influence the prescription behavioural intent and 
actual prescribing behaviour of physicians. These investigations frequently 
concentrate on the main elements of the subjective expected utility theories, such as 
attitudes, subjective norms, and perceived behavioural control. Promotional 
campaigns are developed, based on the results of this research, in order to diminish 
discrepancies between the encountered and wished attitudes. Pharmaceutical 
companies may also try to influence the normative beliefs of the physician by 
highlighting the prescription behaviour of leading specialists.
Representatives of pharmaceutical companies are trained to eliminate the obstacles 
which are caused by physicians’ feeling that prescribing a particular pharmaceutical 
product is not completely up to them, factors which the expectancy value theories 
describe as perceived behavioural control. These marketing activities cover the 
three main elements of the subjective expected utility theories, namely attitudes, 
normative beliefs and perceived behavioural control. However, the discrepancy 
between behavioural intention and actual behaviour seems to remain. Many 
pharmaceutical companies respond to this situation by increasing the number of 
representative visits to the physicians, or they may develop more material in order 
to convince the physician of the superior efficacy, safety, tolerance or convenience
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of their product. Pharmaceutical companies participate in or organise workshops, 
symposia and congresses where opinion leaders unveil their favourable stand on a 
particular medicine in order to influence the physicians normative beliefs.
However, the discrepancy between behavioural intention and actual behaviour 
frequently remains and it is clear that other determinants of behaviour play an active 
role with or without the mediation of behavioural intention.
In order to be allowed to join the common currency of the EU, Greece had to meet 
the Maastricht criteria. The Greek government was forced to take drastic measures 
to bring their finances under control. Cost-containment measures in the health 
sector were one of the steps taken. These measures are expected to influence the 
prescription behaviour of physicians because of the increased importance of the cost 
of therapy.
The high reimbursement levels of pharmaceutical products are an increasing 
financial burden for health insurance fimds and hospitals. Additional measures 
might therefore be expected from the health authorities and health insurers in order 
to reduce the costs of pharmaceuticals. For example, an extension of the list of 
pharmaceutical products for which the patient has to pay a part or the entire cost, or 
attempts to change the prescription behaviour of physicians by forcing them to 
prescribe lower-priced products, less frequently, and in smaller quantities. Greek 
physicians’ prescription behaviour is therefore expected to become increasingly less 
volitional.
The publication of a so-called positive list, enumerating those products which are 
reimbursed, and its regular revision is one of the first constraints. Other examples 
are the appearance of hospital formularies, indicating which products are available 
in the hospital’s pharmacy. The financial situation of the patient is another concern, 
the average income in Greece being approximately two-thirds of the average of the 
EU, making co-payment of the medication a huge obstacle. As the financial burden 
of public health costs becomes an increasing problem for the government, hospitals 
and sick fimds, it will be interesting to see how cost-containment measures
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influence the prescription behaviour of physicians. This will enable the 
pharmaceutical industry to decide how best to react to changing physician attitudes, 
beliefs and control factors.
1.2. Research problem and research questions
A variety of factors are described in literature as being responsible for influencing 
behaviour. Intention is viewed as one immediate antecedent of actual behaviour. 
According to Ajzen’s (1985) theory of planned behaviour there are three 
conceptually independent determinants of intention. The first is attitude toward the 
behaviour and refers to the degree to which the person has a favourable or 
unfavourable evaluation of the behaviour in question. The second predictor is a 
social factor termed the subjective norm, which refers to the perceived social 
pressure to perform or not to perform the behaviour. The third antecedent of 
intention is the degree of perceived behavioural control. This factor refers to the 
perceived ease or difficulty of performing the behaviour and it is assumed to reflect 
past experience as well as anticipated impediments and obstacles. The relation 
between attitudes, as one of the determinants of behavioural intention, and a 
behavioural change appeared early in the focus of research in social psychology. 
Kelman (1961, pp.57-78) identified three sources of attitude change: compliance, 
which arises when an attitude is adopted for ulterior motives, such as the desire to 
make a favourable impression on others; identification, which arises when an 
individual adopts an attitude in order to establish or maintain a satisfying 
relationship with others; and internalisation, which occurs when the new attitude is 
embraced as part of a cluster of attitudes because the individual feels comfortable 
subscribing to it.
Consistency theories have tried to determine how attitudes change. The key 
concept of those theories such as the balance theory, the congruity theoiy, and 
Festinger’s cognitive dissonance theory, is that balance and consistency must 
remain between a person's opinions, attitudes, knowledge and values. Inconsistency
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between what a person does and what he or she feels, leads, according to this 
theory, to a change of behaviour or a change of attitude in order to reduce this 
psychological discomfort. According to these theories, behavioural changes may be 
achieved by playing down the attractiveness of the current behaviour and providing 
supportive information for the attractiveness of a behavioural change. The validity 
of consistency theories, in particular the cognitive dissonance theory, has generally 
been supported by test results, although some doubt has been thrown on the 
findings (Brehm, 1966). More recent theoretical developments include emphasis on 
other organising principles in addition to balance as defined by Heider (Insko,
1984). Also more attention is being paid to the role of individual differences in 
cognitive style which may affect people's tolerance ofi or even desire for, imbalance 
and ambivalence.
The subjective expected utility theory of reasoned action (Ajzen & Fishbein, 1980), 
its extension of the theory of planned behaviour (Ajzen, 1985), and also the theory 
of goal pursuit (Warshaw et al., 1982; Bagozzi & Warshaw, 1990) and the theory of 
interpersonal behaviour (Triandis, 1977) have drawn most attention. Several 
strategies of persuasion have been proposed based on the findings of those theories. 
Probably the most significant strategy is that of Foxall and Goldsmith (1994), who 
combined the determinants of behavioural intention and actual behaviour defined in 
different theories. Considering the theory of goal pursuit they suggest associating 
the product with the key goals consumers have, i.e., that companies should 
demonstrate that their product provides the benefits that consumers seek. The belief 
element of the theories should be used to reduce dissonance. Thus, customers' 
beliefs about a product should be changed so that the customers see the product as 
being superior to competing products, and the weighting of the importance of the 
attributes should be influenced. The customer should be stimulated to believe that 
the attributes on which the product is strong, are actually more important than the 
consumer thought initially. Foxall and Goldsmith (1994) further suggest adding a 
new belief combination to the product to enhance its attractiveness and 
competitiveness. Also, the suggestion that others believe that the consumer should 
buy the product is important, and should influence the subjective norm as defined
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by the theory of planned behaviour. It should be suggested that the others even 
wish that the consumer would act according to their wishes. The addition of a new 
subjective normative component completes this strategy.
However, the success of these models depends not only on one’s desire or intention, 
but also on non-motivationai factors such as availability of requisite opportunities 
and resources. Ajzen (1985) describes these factors as representing people’s actual 
control over the behaviour. Other researchers of customer behaviour have also 
identified them. Triandis (1977) calls them the facilitating factors, Sarver (1983, 
pp. 155-163) the context of opportunity, Tisha (1984, pp. 61-74) the resources, and 
Kuhl (1985, pp. 101-129) action control.
Extensive research has been done in an effort to understand the relation between 
psychological conditions such as attitudes, beliefs, and subjective norms, and 
behavioural intention. Fewer empirical investigations, identifying the determinants 
of actual behaviour, have been reported. Most researchers accepted Ajzen and 
Fishbein's position that most behaviour is determined by behavioural intention.
This path does not always seem to be correct, however, as Bagozzi and Yi (1989, 
pp.266-279) have shown that people sometimes do not form intentions because they 
lack the motivation or opportunity to do so. Accurate prediction of behaviour 
cannot be ensured unless the extent to which a person has control over the 
behaviour in question is accurately assessed. Empirical studies have demonstrated 
that the subjective expected utility models of Fishbein and Ajzen (theory of 
reasoned action) and Ajzen (theory of planned behaviour), developed to predict 
behavioural intention and behaviour, are only partly successful where they concern 
behaviour that is under volitional control (Sutton, 1998, pp. 1317-1338). It is 
difficult to validate these models in areas in which the customer’s behaviour is only 
partly volitional.
The poor correlation between behavioural intention and actual behaviour suggests 
that there are other determinants of behaviour, which are not covered by the existing 
models. Ajzen suggests that the discrepancy between behavioural intention and
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actual behaviour may be caused by factors that are internal or external to the 
subject. Internal factors include locus or exact place of control (Rotter, 1966), 
action or state orientation (Kuhl, 1985, pp. 101-129) and information, skills, 
abilities, emotions and compulsions over which an individual is likely to have less 
than complete control. External factors such as time, opportunity, and dependence 
on others may prevent or delay the performance of the behaviour without altering 
the underlying determinants of behavioural intention. Reinecke et al. (1996, pp. 
749-772) speculated that delayed behaviour might be the cause of the low 
correlation between behavioural intention and behaviour because of changes of 
beliefs and attitudes over time. Research suggests that people frequently do not do 
what they intend to do, because of a lack of resources and opportunities. 
Behavioural intentions are unstable and frequently are not formed until immediately 
before behaving (Liska, 1984, p.72). Macey and Brown (1983, pp. 123-141) found 
that the predictive ability of intentions was better if individuals expressed stable 
intentions. They stress that it is important to measure intentions as closely as 
possible to the time of the behaviour. However, Fishbein and Jaccard (1973, pp.37- 
51) mention that it is not the passage of time per se that attenuates the link between 
intention and behaviour: exposure to new information or new events may also 
change intentions.
Somewhat stronger attitude-behaviour relations are reported when attitudes toward 
a particular behaviour are assessed instead of attitudes toward a general behaviour 
(Kothandapani, 1971, pp.321-333; Ostrom, 1969, pp. 12-30). Furthermore, most 
research into customer behaviour seems incorrectly ascribed to a one-way attitude 
to behaviour causal flow while it has been demonstrated that there exists a relevant 
feed back mechanism. There is an effect of attitudes on behaviour but also of 
behaviour on attitudes (Heise, 1977, pp.259-288; Andrews & Kandel, 1979, pp.298- 
310; Kahle & Berman, 1979, pp.315-321; Bentler & Speckart, 1981, pp.226-238). 
Thus, the measurement of behavioural intention alone seems to be insufficient to 
predict actual behaviour. It seems that more determinants of a particular 
comportment should be identified, as well as the different weightings of the factors 
which influence the behaviour, if we want to fully understand customers’ conduct.
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This should be done with the best possible control over the influence of time. There 
is thus a serious problem in this area which is not adequately treated in the 
literature: are there more factors which have a significant influence on behaviour in 
addition to behavioural intention?
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Figure 1 Schematic presentation of the customer decision process as 
presented in the subjective expected utility models
Customer decision making
Feed back:
Subjective NormPerceived behavioural 
control
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control
Influence of past 
behaviour on
Attitudes
Factors internal 
of the model:
Subjective norm
Perceived
behavioural
control
Compulsions
Information
Abilities
Emotions
Skills
Behavioural
intention
Behavioural 
intention and
BehaviourBehaviour
Factors external of the model: Influence of new information?
Time
Opportunity 
Dependence of others 
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 ► Not covered by the expectancy value model of planned behaviour
Schematic presentation based on comparisons made by present author between 
known subjective expected utility models and the representation of Ajzen’s theory 
of planned behaviour as presented by Ajzen (1991, Figure 1, p. 182)
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The application and testing of theoretical models, such as the model of the theory of 
planned behaviour, is almost exclusively focused on predicting behavioural 
intentions. In most behavioural studies, investigators do not observe actual 
behaviour but rely on respondents' self reports of behaviour or intentions to behave, 
and most data are collected from interviews. Most studies that claim to study 
behaviour itself have in reality studied the behaviour reported by the studied 
subjects. Strictly speaking, therefore, most tests of attitude, subjective norm, 
perceived relation between behavioural control and behaviour, would be better 
described as tests of the relation between verbal and non-verbal indicators of 
attitude, subjective norm and perceived behavioural control. These measures may 
suffer from the same response distortion and bias as other indicators measured by 
questionnaires. People may evade answering questions or distort their reports to 
protect their privacy, to avoid legal prosecution, to gain economical advantage, and 
to obtain social approval and avoid disapproval. Linn (1965, pp. 353-364) 
demonstrated as early as 1965 that biases occur in reports of behavioural intentions 
and behaviour, and reported intentions may not be true intentions.
This may well be the situation in the pharmaceutical industry, where sales 
representatives try to convince the physician of the features of a product without 
actually selling the product to the physician. The doctor may express a false 
intention in order to limit the time spent with the representative, or just to be nice to 
the representative, or there may be some economic benefits which the physician is 
not willing to reveal. Research on the efficacy of strategies for reducing response 
distortion suggests that these strategies are at best only partially successful (Sudman 
& Bradbum, 1974; Bradbum, 1983, pp. 289-328; Nederhof, 1985, pp. 263-280; 
Schuman & Kalton, 1985, pp. 635-697). The fact that answers generated by 
questionnaires may not always be valid has been demonstrated by the studies of 
Schuman and Presser (1996), and De Wit et al. (1995, pp. 50-58). The information 
processing approach to consumer decision-making also shows that the model 
components, such as attitudes, behavioural intentions, and actual behaviour, often 
do not correlate well with each other (Foxall, 1983; Denig & Haaijer-Ruskamp, 
1992, p.l 1; Mesters & Oostveen, 1994, pp.33-47).
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The managements of most pharmaceutical companies try to associate their products 
with the key goals of their customers, by emphasising in their promotional efforts 
that their products provide the benefits that customers seek. Thus, literature on 
efficacy, safety and tolerance are used to convince the physician of the superiority 
of the product, while daily treatment costs and user convenience may be added as 
extra stimuli, if relevant. The important gap between physicians' prescription 
behavioural intention and actual behaviour suggests that these strategies have been 
only partly successful.
Thus, the measurement of behavioural intentions alone seems insufficient to predict 
actual behaviour. More determinants of a particular behaviour must be identified, 
as well as the different weightings to be applied to the behaviour, if we are to hilly 
understand this relation. The influence o f time must also be taken into account.
It is necessary to understand the determinants of a customer's behaviour, as opposed 
to behavioural intention, before we investigate whether any verbal measures can be 
effective stimuli to change existing behaviour. This is particularly important in the 
pharmaceutical market, where the use and impact of marketing stimuli are limited 
by regulations and restrictions. Marketing is complicated by the frequently low 
levels of product differentiation, the regulation of the price and distribution 
channels, and the limitation of promotional possibilities, e.g. with respect to timing, 
message content, and/or target groups. Ajzen and Fishbein (1980) point out that 
behaviour should be volitional if the models of subjective expected utility theories 
are to function well, and they claim that most behaviour is volitional. However, the 
low correlation between behavioural intention and actual behaviour might be due to 
the fact that most behaviour is not fully volitional.
The prescription behaviour of physicians is clearly influenced by the existence of 
negative or positive lists, limited treatment durations and prescription size, and by 
patient co-payment, and is therefore not fully volitional. Non-volitional behaviour 
is not restricted to the pharmaceutical market. Banking in developing countries is 
another market in which non-volitional behaviour plays a role. The management of
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private banks is frequently restricted in the number of new offices they can open, 
and in the kind of services and conditions they can offer to their clients. Interest 
rates may be partly the result of market influences but they are primarily regulated 
and dictated by central banks. The behaviour of the customers of private banks is 
also not frilly volitional; for certain banking transactions they are forced to make use 
of the National Bank. As a result, the correlation between behavioural intention and 
actual behaviour for bank customers may also be low.
Another important limitation of research on customer behaviour is that researchers 
have not yet extensively examined the factors which can change individual non- 
volitional behaviour. Revealing these factors is very important for managers in 
regulated markets such as pharmaceuticals, as it may enable them to improve their 
market shares in the face of the limited possibilities for product differentiation, 
increasing competition, and decreasing margins. It might also explain why 
physicians' prescription behaviour is so resistant to change and thus provide the 
management of pharmaceutical companies with tools to allow them to maximise the 
effects of their marketing efforts. An understanding of these factors may also assist 
ministries of health, hospitals, and health insurance funds to reduce the total number 
of prescriptions written by physicians, and/or the quantities of pharmaceuticals 
prescribed, and/or the budget involved.
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The problem addressed in this research can be summarised as follows:
Expectancy value models have been substantially enlarged to be able to account for 
behaviours that are not wholly under volitional control. Their application has had 
mixed success, as there still exists an important discrepancy between stated 
behavioural intention and customer’s overt non-volitional behaviour. There seems 
to be a serious problem in measuring behavioural intentions or understanding the 
influences on actual non-volitional behaviour, in addition to intention. The reasons 
for the low correlation between behavioural intention and actual behaviour are not 
treated adequately in the literature. Disclosure o f all the determinants o f non- 
volitional behaviours is necessary i f  strategies to modify behaviour are to be 
developed.
Essentially, it is argued that customer behaviour is never completely volitional and 
that there are more determinants of behaviour than intention alone. The objective of 
this research was to find a model in which it is possible to identify the most 
important factors which influence customer behaviour, and to validate this model 
by showing that marketing stimuli aimed at those factors can change actual 
customer behaviour.
The overall research question is:
Can marketing strategies influence non-volitional customer’s behaviour?
The subsidiary research questions are:
Does a model exist to identify the most salient determinants of non-volitional 
customer behaviour?
Can manipulating the most salient determinants of such behaviour change non- 
volitional customer behaviour?
Does the impact of marketing stimuli improve in markets where customers' 
behaviour is not volitional when those stimuli are focused on changing the most 
salient determinants of such behaviour?
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The research questions are developed and discussed in Chapter 2 of this thesis. 
They are established in section 2.7 and shown on page 115.
1.3. Justification for the research
At the micro-economic level of healthcare economics, non-stop efforts are being 
made by politicians everywhere to contain healthcare costs in general, and 
pharmaceutical costs in particular. In November 1998 major pharmaceutical 
companies were having to recast their 1999 budgets to take into account the recent 
changes in Germany, Italy and France, which affect prices and thus company 
revenues. Around the world, pharmaceutical companies have become boxed in by 
the rising costs of research and development, by the regulations for bringing new 
products to market, by the lack or limitation of the period of patent protection, by 
national and international regulations on pricing, and by promotional rules, as well 
as by their shareholders and stock market analysts (Brown, 1999, p.73).
The response of the industry has been three-fold. More money has been put into 
research and development in order to improve productivity. The result has been a 
huge increase in the cost of bringing a new chemical entity to the market and no 
sign of increased productivity (Brown, 1999, p.73). To create growth, many 
companies have merged. This policy has not been conspicuously successful either 
(Beynon, 1999, p.49), and the merged companies have tended to grow more slowly 
than their smaller competitors, as the time required to overcome cultural differences 
between the merged partners and to define and focus on the adjusted core business, 
has had a negative effect on their overall development. There have also been 
attempts by industry to ease the external constraints on the business, by seeking 
faster registration for new products, more liberal pricing, and less restricted 
marketing, but these effects have had little success apart from a slight decline in the 
time taken to bring new products to market (Brown, 1999, p. 73).
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National pricing policies show no sign of becoming more liberal, and marketing 
activities are as tightly controlled as ever. On a global level, the promise of a flatter 
playing field for the larger companies through the GATT/TRIPs agreement is a long 
time coming. The major constraint on the growth of the pharmaceutical industry, 
however, remains the level of funding for the provision of healthcare. As long as 
governments and other authorities strictly ration this funding, the pharmaceutical 
industry cannot hope to do more than grow at the rate at which the funding is 
increased. In the light of this, anything that can be done to improve the output of 
promotional activities must be worthwhile. However, simply spending more money 
does not seem to be the answer, as the prescription behaviour of physicians seems 
resistant to change.
The prescription behaviour of physicians may be influenced by the promotional 
efforts of the pharmaceutical industry. Consumer awareness of specific prescription 
medicines, as a result of wide discussion of particular drugs in the media, may also 
influence prescribing. In the presence of these influences, the prescription 
behaviour of physicians may be considered to be quite volitional. However, within 
the framework of regulation of prescribing, as part of the overall healthcare policy 
of governments or reimbursements committees, it may become quite non-volitional.
Non-volitional behaviour is not limited to the prescription behaviour of doctors, of 
course. Any behaviour which is influenced by regulations, such as those arising 
from the protection of the environment, limitations of the use of natural resources, 
and restriction of available budgets, will also be far from fully volitional. Fishbein 
and Ajzen (1980) state that mainly fully volitional behaviour is important from a 
psychological point of view. This statement can thus be challenged, as most 
behaviour of interest for marketers is not fully volitional. Existing models to 
identify the determinants of behaviour concentrate mainly on the determinants of 
behavioural intention. This may be sufficient if the correlation between behavioural 
intention and behaviour is high, as with fully volitional behaviour. However, the 
correlation between behavioural intention and actual behaviour is low with non- 
fiilly volitional behaviour. Locke (1995, pp. 265-273) stresses therefore that
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objective scientific research into behaviourism should take volition as a self-evident 
starting point.
If  a model could be developed or applied to show the determinants of behaviour, in 
particular the elements that hamper the execution of that behaviour, it could be used 
to develop a persuasive marketing campaign. Better use could be made of 
marketing attributes if the real determinants of non-volitional behaviour were 
known. Improved allocation of marketing resources, focusing on influencing the 
most relevant determinants of customer behaviour, should lead to improved market 
shares.
1.4. General approaches
Recent approaches to understanding and predicting behaviour fall into three main 
categories. The first approach is a methodological one, exemplified by the work of 
Fishbein and Ajzen. This approach concentrates on the methods used to measure 
the observed relationship between attitudes and behaviour, and on developing and 
applying improved methods in order to improve prediction and understanding of 
behaviour. Fishbein and Ajzen found that consistency between attitude and 
behaviour is higher if the level of generality or specificity of the attitude measure 
matches that of the behaviour measure. Thus, to predict a broad collection of 
behaviours, one should use a global measure of attitude. However to predict a 
specific behaviour, one should use a very focused attitude measure (Fishbein & 
Ajzen, 1975; Ajzen & Fishbein, 1977, pp.888-918; Davidson & Jaccard, 1979, 
pp. 1364-1376). Most attitude measures have traditionally presented subjects with a 
set of fixed opinion statements. This should be avoided, however, as most 
attitudinal responses in naturalistic persuasion settings are spontaneously evoked 
(Ostrom, 1989, p.33).
In the current research project, it is important to determine what thoughts are 
activated in these settings and how they compare to the thoughts elicited just prior 
to writing a prescription. The use of structured instruments and devices to examine
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attitudinal thoughts in natural settings should therefore be avoided. Structural 
modelling techniques such as linear structural relationships or LISREL (Joereskog 
& Soerbom, 1984) also fit into this category (Bentler & Speckart, 1979, pp.452- 
464,1981; Bagozzi, 1981, pp.607-627; Fredricks & Dossett, 1983, pp.501-512). 
These statistical programs simultaneously estimate errors of measurement and 
relations among theoretical constructs such as behaviour and its predictors. The 
estimates of these relations are not biased by the presence of random measurement 
error and are often substantially higher than estimates from more traditional 
correlation and regression analysis. If attitude were the only determinant of 
behaviour this approach would provide a solid basis from which to solve the 
research problem.
A second approach to attitude behaviour relations focuses on understanding the 
cognitive processes relating attitudes to behaviour. For example, Fazio and 
Williams (1986, pp.505-514) predicted and have shown that the attitude-behaviour 
link is stronger if the attitude is cognitively accessible. Accessibility of an attitude 
is increased by personal experience with the attitude object and by repeated 
expression of the attitude. Thus, attitude-behaviour consistency will be high if the 
attitude were developed from direct interaction with the attitude object or if the 
individual has repeatedly discussed his or her attitude. However, attitude- 
behaviour consistency will be low under other conditions. Direct interaction with 
the attitude object is difficult in a marketplace dominated by non-fully volitional 
behaviour, as the customer will rarely show the determinants of non-volitional 
behaviour.
A third approach to improve understanding and prediction of behaviour and 
attitude-behaviour relations is to look for variables other than attitudes that 
influence behaviour and reduce the correlation between attitudes and behaviour. 
The inclusion of measures of these other variables in studies will improve the 
prediction and understanding of behaviour. The multiple correlation is optimal if 
all of the determinants of an action are included as predictors in a multiple 
regression analysis. This ‘other variable’ approach has been followed by a number
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of different researchers over the years. Fishbein and Ajzen (1975) emphasised the 
importance of subjective norms and also discussed unforeseen obstacles and lack of 
ability as factors influencing behaviour. Triandis (1980, pp. 195-259) suggested 
habits and the environment as additional determinants of behaviour, while both 
Rogers (1983) and Ajzen (1985) emphasised perceived self-efficacy (the belief that 
one is able to carry out the action; Bandura, 1977) as an important additional 
influence. They indicated that the attitude-behaviour correlation will be reduced to 
the extent that perceived self-efficacy influences behaviour independently of 
attitude or that attitude and perceived self-efficacy interact. The inclusion of 
perceived self-efficacy as a predictor variable will improve prediction and 
understanding. Ajzen considered self-efficacy to be part of the perceived 
behavioural control construct. However, Manstead and Van Eekelen (1998, 
pp. 1375-1392) demonstrated that perceived behavioural control and self-efficacy 
can be distinguished and that they make different contributions to the prediction of 
behavioural intention and actual behaviour. Their research shows that two sets of 
items are needed to measure the constructs of self-efficacy and perceived 
behavioural control, one set looking at one’s conviction that one is able to achieve 
the outcome and the other the belief that the outcome can be influenced by one’s 
efforts. Self-identity was found by Armitage and Connor (1999, pp.72-90) to be 
able to predict independently behavioural intention from perceived behavioural 
control.
Departing from the view of Locke (1995) that objective scientific research into 
behaviourism should take volition as an obvious starting point, it can be concluded 
that subjective expected utility theories do not entirely cover the determinants of 
behaviour. The literature research undertaken for this research project therefore 
concentrated first on discovering which determinants of non-fully volitional 
behaviour should be covered by the research model (see section 2.2 of this thesis), 
and secondly, which of the existing models best fulfils the purpose of this research 
(see section 2.3 of this thesis).
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The most salient behavioural and normative beliefs of physicians concerning cost- 
conscious prescribing were investigated during the first field study (see section 3.3 
of this thesis). Knowledge of these beliefs was necessary in order to examine the 
second research question which concerns resistance to change. These salient 
variables were included in the questionnaires used during the second and third field 
studies. The second field study (see Chapter 3 of this thesis) was performed to 
confirm the belief that physicians’ prescription behaviour is not fully volitional.
This is one of the critical points of the expectancy value models which were 
investigated. The third field study was divided into three parts. At baseline, the 
independent variables of prescription behavioural intention of the participating 
physicians were isolated by means of questionnaires. The actual prescription 
behaviour of the participating physicians was analysed by investigating the 
prescriptions dispensed by pharmacists. Prescriptions for selected products were 
counted without informing the issuing physician in order to prevent bias. (See 
Chapter 5 for details on the methodology and Figure 2 on page 30 for information 
on the key activities.) Two external stimuli were developed, based on the 
independent variables derived from the baseline data. One stimulus was based on 
the independent variable expected to influence physicians’ prescription most, while 
the second was based on the variable considered the least likely to influence 
behavioural intention.
During the second phase of the third field study three groups of physicians were 
visited at least six times within six months by their usual representative with the 
usual promotional message. The first external stimulus was added to message given 
to the first group of participating physicians, and the second stimulus to the second 
group. The third group acted as a reference group.
The baseline data were used to confirm the validity of the selected model. At the 
end of the study period the independent variables of the prescription behavioural 
intention of the physicians were analysed using the same questionnaires used at 
baseline. Actual prescription behaviour at the end of the study period was also 
analysed. Analysis of baseline and end-study data on the independent variables.
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together with the actual prescription behaviour should provide an answer to the 
third research question, which concerned whether or not there would be any 
changes due to the use of the external stimuli. During the study period other 
independent variables that might influence behavioural intention or actual 
behaviour, such as changes in the system of re-imbursement, price changes, 
launches of new products, etc., were monitored and their confounding influence on 
the research outcome estimated.
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Figure 2 Flowchart of field studies and interviews
June 1998:
Open ended elicitation 
questionnaire in order to 
determine the salient beliefs o f 
physicians
November 2 -14 ,1 9 9 8 :
Field study to determine which 
underlying normative and 
behavioural beliefs are salient
March 1999:
Final test o f questionnaire
November, December 1999:
Counting o f prescriptions at 
pharmacy level to reveal the 
actual prescription behaviour 
ofphysicians
March 27 -  November 17,2000:
Six visits to each o f the selected 
physicians with regular 
promotional message to which 
the first, second, or no extra 
stimulus was added.
June, July, August 1998:
Field study to verify that 
prescription behaviour o f 
physicians is volitional
January 1999:
Pre tests o f questionnaire
November, December 1999:
Questionnaires distributed to 
and collected from the selected 
physicians in order to 
determine the independent 
variables which influence their 
prescription behaviour.
January 14,2000:
Analysis o f data obtainedfrom 
the questionnaires distributed in 
November and December 1999. 
Nine physicians who did not 
participate in the study did the 
analysis.
October and November 2000:
Counting o f prescriptions at 
pharmacy level to reveal the 
actual prescription behaviour o f 
physicians
October and November 2000:
Questionnaires distributed to 
and collected from the selected 
physicians to determine the 
independent variables which 
influence their prescription 
behaviour
1.5. Outline of the report
This thesis consists of seven chapters:
In Chapter 1 the broad area of interest is outlined and the research problem 
described. The increases in healthcare costs seen in many developed countries and 
the resulting cost-containment measure taken by government bodies are reviewed, 
and our lack of insight as to the influence of these measures on prescription 
behaviour of physicians discussed. There is a general discussion of the prediction 
of and influences on customer behaviour. The principal results of previous 
investigations are discussed, in particular research on determinants of behavioural 
intention and actual behaviour and the models used to study them.
The research problem of this thesis concerns the low correlation found between 
behavioural intention and actual behaviour, in circumstances in which customer 
behaviour is only partly volitional. Existing models for prediction of behaviour do 
not cover all determinants of behaviour adequately. Most research concentrates on 
testing the relation between attitudes and behavioural intention. Exceptionally, 
research has tested the correlation between attitudes and actual behaviour, but most 
studies claiming to reveal the relation between determinants of behaviour and actual 
behaviour, have tested the behaviour reported by the investigated subjects, which 
may not reflect actual behaviour.
The basic research question. Can external stimuli influence non-wholly volitional 
customer behaviour? is of particular importance for those interested in modifying 
the prescription behaviour of physicians, such as the pharmaceutical industry, the 
health authorities, hospitals, and health insurance companies. The general approach 
to the research problem is described, including the definitions used, the limitations 
of scope and the key assumptions made.
Chapter 2 discusses the theoretical foundation upon which the research is based. 
The relevant literature on the decision-making process, and on determinants of
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behaviour in general, is reviewed, to determine how other researchers have treated 
this research problem. This is followed by a description of the nested models used 
to predict customer behaviour and a discussion of the results of empirical studies 
with these models. Finally, the usefulness of the nested theories and models for the 
research project are explored and discussed. Chapter 2 concludes with the 
formulation of the null hypotheses.
The aim of the research is to test the null hypotheses in an environment in which 
individuals have incomplete volitional control over their behaviour. Chapter 3 
describes the additional field research performed in order to define how volitional 
the behaviour of the selected population actually is, and thus how suitable the 
population is for this research. The procedures and methods used in the field work 
are described. The results are discussed and a conclusion drawn about the degree of 
volitional control which physicians have over their prescription behaviour.
Chapter 4 describes the environment within which this research was carried out. It 
provides essential information needed to assess the generalisability of the results. 
The restrictions which apply to the prescription and promotion of pharmaceutical 
products after marketing authorisation has been obtained are described. The pricing 
of pharmaceutical products within the EU is discussed and the legal implications of 
price-restrictive measures reviewed. The marketing practices of the pharmaceutical 
industry, including what is known about the influence of promotional activities on 
prescribing behaviour of physicians, are discussed. The major therapies for the 
indications chosen are presented and discussed. The chapter concludes with a 
discussion of the environment in which the research has taken place and considers 
the usefulness of the research project.
Chapter 5 describes the major methodologies used in the study, and provides details 
of the technique of analysis and subjects or sources of data (e.g. the population 
investigated, the sampling time-frame and the sample size). The procedures for 
data collection and analysis (e.g. how the variables will be measured, details of the 
pilot studies, when and where the data were collected, the response rates and
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possible non-response bias, dates and protocols of interviews, determination of 
internal and external validity, etc.) are discussed. The statistical methods used in 
the study are described (test for response bias, test of the assumptions of regression, 
etc.). The steps taken to control confounding variables are documented. The 
limitations of the methodology are considered, in as far as these were not covered in 
Chapter 1, section 6 of this thesis. Practical limitations on the study conduct are 
clarified and justified. Any special or unusual treatment of the data prior to analysis 
is discussed and the computer programs used to analyse the data, with justifications 
for their use, are described. Chapter 5 concludes with a discussion of ethical issues.
Chapter 6 presents the results of the field studies and analyses their relevance to the 
null hypotheses. This chapter is restricted to a presentation and analysis of the 
collected data, without drawing general conclusions or comparing the results to 
those of other researchers. Sensitivity analyses of findings of possible errors in data 
are included.
Chapter 7 summarises the findings for each hypothesis described in Chapter 6 and 
discusses them within the contexts of this and prior research examined in Chapter 2. 
The implications of the findings for the understanding of the null hypotheses is 
explored. Chapter 7 includes qualitative findings about the research problem 
developed during the research and concludes with a summary listing of the 
contributions of the research. The theoretical and practical implication of the study 
findings are discussed, both for private sector managers (section 7.5.1) and for 
public sector analysts and managers (section 7.5.2). Other limitations than the ones 
mentioned in Chapter 1, paragraph six, that became apparent during the study are 
presented. Chapter 7 concludes with a discussion of the implications of the findings 
for further research.
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1.6. Delimitations and key assumptions
This research will be restricted to areas in which actual behaviour can be measured 
objectively, rather than by subjective reports. It was assumed that the behaviour of 
the investigated subjects is partly volitional, and that the limiting elements of 
volitional behaviour are quite stable. Physicians are limited in their prescribing 
behaviour by, among others, reimbursement lists, negative or positive lists, hospital 
budgets, and co-payments of patients. These limiting elements are quite stable. 
Scrutiny of the prescriptions written allows us to measure the actual prescription 
behaviour of physicians. The influence of external stimuli on the relevant 
determinants of behaviour is therefore measurable, as other variables can be 
controlled. The conclusions of this research are only valid for the pharmaceutical 
market in the country in which the research took place. This is because the 
pharmaceutical markets of individual countries vary significantly due to national 
regulations and restrictions. No claim for generalisation will be made beyond these
1.7. Definitions
Definitions adopted by researchers are often not uniform, so key and controversial 
terms are defined here:
Attitude is described as a "predisposition to respond to some class of stimuli with 
certain classes of responses and designate the three major types of response as 
cognitive, affective, and behavioural" (Rosenberg & Ho viand, 1960, p. 3). Attitude 
is an overall evaluation that can range from extremely positive to extremely 
negative.
Attitude chame is a term used to characterise conditions under which a person 
holds a pre-existing attitude that is subsequently changed.
Attitude formation is a term used to characterised conditions under which a person 
has yet to develop an attitude.
Attitude object is any abstract or concrete entity that yields the stimuli that elicit the 
evaluative responses that are regarded as following from the attitude (Eagly & 
Chaiken, 1993, p. 2).
Attribute is a characteristic or property of a product generally referring to a 
characteristic that serves as an evaluative criterion during decision making. 
Behaviour is the manifest, observable response in a given situation with respect to a 
given target.
Behavioural Intention is the cognitive representation of a person’s readiness to 
perform a specific behaviour. It is an intention to try to perform a behaviour (Beale 
& Manstead, 1991, p. 410)
Beliefs are" the associations or linkages that people establish between the attitude 
object and various attributes" (Eagly & Chaiken, 1993, p. 103)
Control beliefs have to do with the perceived presence of factors that may facilitate 
or impede performance of a given behaviour.
Descriptive beliefs are beliefs that are formed on the basis of the acquisition of new 
information obtained by direct observation.
Formulary is a survey of pharmaceutical products available to be prescribed by 
hospital physicians. The list is usually issued by the hospital pharmacists and limits 
the number of products or product presentations.
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Inferential beliefs are beliefs that are formed on the basis of processing of new 
information obtained by direct observation (Fishbein & Ajzen, 1975, p. 213). 
Morbidity is: the state of being morbid or diseased.
Nesative list is a list of pharmaceutical products that are completely or partially 
excluded from reimbursement. These lists are usually issued by health insurance 
bodies.
Non volitional control represents the degree to which behaviour can not be 
performed at will.
Perceived behavioural control refers to people’s perceptions of their ability to 
perform a given behaviour.
Positive list is a list with pharmaceutical products that are completely or partially 
reimbursed. These lists are usually issued by health insurance bodies.
Sick fund is an insurance company, association, club or cooperative that ensures 
that the whole or part of medical expenditure of its members is covered by a pool of 
funds; such funds may be directly contributory or not and may belong to the private 
or public domain.
Subjective norm is "the subject's perception that most people who are important to 
him/her think he/she should or should not perform the behaviour in question"
(Ajzen & Fishbein, 1980, p. 57). It is the perceived social pressure to engage or not 
engage in a behaviour.
Value is "an enduring belief that a specific mode of conduct or end state of 
existence is personally and socially preferable to alternative modes of conduct or 
end states of existence" (Rokeach, 1968, p. 160).
Values are shared beliefs or group norms that have been internalised by individuals. 
Volition is: the exercise of, or power of using one’s own will; i.e., of choosing, 
making a decision etc.
Volitional control represents the degree to which a behaviour can be performed at 
will.
Volitional deficiency means that only a fraction of those with the intention actually 
carry out the behaviour. For the purpose of this research, the elements which might 
cause the volitional deficiency and which are not alterable by promotional 
expressions will be excluded (for example, age, job, or income).
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CHAPTER 2 Literature review
2.1. Introduction
This chapter aims to build a theoretical foundation upon which the research will be 
based by reviewing the existing relevant literature concerning the immediate 
discipline of decision making and its parent discipline, behaviour. The main target 
was to identify how others have treated this research problem and to evaluate their 
findings. In order to investigate the possibilities of influencing buying behaviour, 
all factors having a possible influence on such behaviour have to be determined.
We also have to analyse whether or not, to what extent, and in what way, these 
factors are susceptible to change. Fishbein and Ajzen (1975) argue that behavioural 
intentions predict behaviour which is under volitional control only. However, a 
wide variety of behaviour is not under volitional control, but requires special 
abilities, skills (for example, playing the saxophone), and the co-operation of others 
(for example, using public transport). Most behaviour is neither completely 
volitional nor non-volitional, but ranges from behaviour that requires little skill or 
co-operation of others, to behaviour that requires considerable skill or social co­
operation. Variations in resources or legal restrictions may also turn volitional 
behaviour into non-fully-volitional behaviour.
The behaviour under consideration seems partly non-fully-volitional, as physicians 
operate under a number of externally imposed limitations, e.g. re-imbursement lists, 
the availability of products in hospitals, and prescribing guidelines of sick funds. 
Liska (1984, p. 63), however, points out that dichotomising behaviour into volitio­
nal and non-volitional does not add much to the prediction of the behaviour, and 
suggests that models to measure behavioural intentions and actual behaviour should 
also take into account the consideration variation in intentions relative to the 
variation in resources. The literature research concerning the determinants of 
behaviour therefore covered all sorts of behaviour, without making any distinction 
between volitional or non-fully-volitional behaviour.
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This review is followed by an analysis of the available knowledge in the area of the 
research problem.
The second part of this chapter contains a description of the nested models used to 
predict customer behaviour, and a discussion of the results of the empirical studies 
with the existing models. The usefulness of the nested theories and models for the 
solution of the research problem are explored and discussed. Chapter 2 concludes 
with the formulation of the null hypotheses.
2.2. Major determinants of the buying behaviour
There are four major groups of factors which influence buying behaviour: cultural, 
social, personal, and psychological factors. Fishbein and Ajzen (1975, p. 16) state 
that only the social factor subjective norms, and the psychological factor attitude 
towards behaviour, are important, as all factors work through them. Godin et al. 
(1996, p. 1563) expressed the same view, stating that behaviour is not a direct result 
of cultural background, social position, personality traits, education, or interpersonal 
relationships, but that those factors influence beliefs, perceptions, and principles. 
However, Morrison et al. (1996, p. 1674), found that income and race both added to 
the prediction of behavioural intention, net of the prediction achieved with attitude 
and norm.
Past behaviour has also been shown to have a greater influence than attitude and 
norm on the prediction of behavioural intention (Fredricks & Dossett, 1983, pp. 501- 
512; Echebarria et al., 1988, pp.181-189; Eiser et al., 1989, pp. 193-202; Echebarria 
& Valencia-Garate, 1994, p.292). However, its influence on actual behaviour is not 
completely clear yet as the direct relationship between past behaviour and 
behavioural intention and between past behaviour and actual behaviour, 
independent of the variables defined by the theory of planned behaviour or self- 
identity, could not be attributed to common method variance (Conner et al., 1999, 
pp. 1676-1704).
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Conner (1993, pp.235-238) stated that it is important to consider demographic 
variables separately from attitudinal variables. Chan and Fishbein (1993, p. 1465) 
point out that attitude and norm are uni-dimensional and therefore are not correlated 
with each other. Morrison et al. (1996, p.675), however, found some support of 
multidimensionality of attitude and norm while Shepherd and O’Keefe (1984, 
pp.287-288) found evidence for substantial correlation between attitude and 
subjective norms. These findings mean that the literature review should cover all 
four groups of factors that might influence behavioural intentions and actual 
behaviour and not be restricted to norms and attitude as Fishbein and Ajzen 
suggested.
2.2.1. Cultural factors
Kotler (1997, p. 172) considers that culture exerts the broadest and deepest influence 
on consumer behaviour. Schiffinan and Kanuk (1987, pp.495-503) agree that the 
most fundamental determinant of a person's wants and behaviour is culture. Culture 
is reflected in shared cognitions, standard operating procedures, and unexamined 
assumptions (Triandis, 1996, pp.407-415). Children acquire a fiill set of values, 
perceptions, preferences and behaviours while growing up. Influences come mainly 
through family, friends, institutions such as schools and sport clubs, and through 
television programmes, video games, and advertisements. Each culture consists of 
smaller subcultures such as nationalities, religions, racial groups and geographical 
regions. Engel et al. (1995, p.97) suggest that value research will continue to 
increase due to the growing importance of cross-cultural issues and the need for 
more predictive segmentation tools. However, possibilities to change an existing 
culture are extremely limited as the cultural pattern is mainly formed during the first 
10 years of life (Keuning & Eppink, 1996, p.364).
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2.2.2. Social factors
Godin et. al. (1996, p. 1577) notice that social factors are represented by the sum of 
normative and role beliefs. The social factor can thus be divided in two sub­
components: normative belief and role belief.
• Normative beliefs and selective norms
Normative beliefs are described as the perception of normative expectations of 
specific social referents. Subjective norms or personal normative beliefs are seen as 
a result of normative beliefs, weighted by the individual's motivation to comply 
with each of those expectations (Krahe & Reiss, 1995, p.2119) which is usually 
measured using the formula: normative belief multiplied by the motivation to 
comply. Normative beliefs thus consist of an evaluation of the significance of a 
behaviour to oneself. It measures how obliged the individual feels to comply with 
the norm when faced with the decision of whether or not to perform the behaviour 
in question. Initially Fishbein and Ajzen made a distinction between the beliefs 
about the normative expectations of referent groups or a generalised other, and 
personal normative beliefs, i.e., the person’s own belief about what he or she should 
do. However, empirical findings have indicated that a subject’s report of his or her 
personal normative beliefs serves mainly as an alternative measure of behavioural 
intention (Fishbein & Ajzen, 1975, p.305). Schwartz and Tessler (1972, pp.225- 
236) used another definition of personal normative beliefs. Normative beliefs could 
find their roots in moral or social norms.
Moral norms differ from social norms in that the individual's final choice does not 
depend on the opinion of others (Godin et al., 1996, p. 1563). According to Schwarz 
and Tessler (1972) those beliefs that emphasise moral considerations should be 
called personal normative beliefs.
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Ajzen and Fishbein originally developed a model to predict behavioural intention 
based on three components, including a measure of moral obligation in addition to 
attitude and social norms. However, as mentioned earlier, they found that in many 
situations this component merely served as an alternate measure of behavioural 
intention (Ajzen & Fishbein, 1970). Accordingly, they dropped this component 
from the model. However, this issue had not been fully resolved, as discussion of 
the criteria for determining when a moral component is relevant, continued. 
Distinctions between social and moral norms were difficult to draw. Hart (1961) 
discussed the cardinal features that distinguish ‘moral situations’. The first relevant 
feature is how important the person considers the decision and its consequences to 
be. Second is ‘immunity from deliberate change’, meaning that, that unlike rules 
for a game, moral norms cannot be ‘made up’. A third feature Hart (1961, p. 175) 
called ‘form of moral pressure’, by which he meant that, appeals to obey moral 
rules are not made solely to utilitarian factors but rather to a respect for the rules, as 
things important in themselves. Studies using the Hart criteria were partially 
successful in distinguishing both variables.
Gorsuch and Ortberg (1983) suggested that the importance of attitude is taken over 
by personal moral obligations in moral situations. Their study results showed 
nevertheless that moral obligation remained a significant predictor of behavioural 
intention in a service situation, which is considered to be non-moral. In recent 
literature, the distinction between social and moral norms or personal normative 
beliefs has faded away, as it seemed difficult to develop a satisfactory 
operationalisation of the difference. Consequently, subjective norms involve 
evaluating the individual's perception of the significance of a given behaviour 
within the reference group (Godin et al., 1996, p. 1562). However, Kotler (1997, 
p. 175) has shown that a person's behaviour is not influenced by one reference 
group, but by all the groups that have a direct or indirect influence on that person’s 
attitude or behaviour. The most influential primary reference group consists of 
family members. Two kinds of families can be distinguished: the family of 
orientation (parents) and the family of procreation (spouse and children). 
Orientation towards religion, politics, economics, personal ambition, self-worth and
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love is acquired from the parents (Moschis, 1985, pp.898-913), while the family of 
procreation has a more direct influence on everyday buying behaviour (Spiro, 1983, 
pp.393-402; Wortzel, 1980, pp.212-215). There is no need to belong to a special 
reference group to be influenced by it, however. Groups to which a person wants to 
belong, the so-called aspirational groups, also exert an influence.
Normative beliefs towards relatively abstract goals are usually termed values, while 
evaluations of more concrete objects are called attitudes (Eagly & Chaiken, 1993, 
p.5). Rogers considers that values are the result of direct exposure to the 
environment and the relationship with others and that the importance of the opinion 
of others attains such importance that personal valuation of an experience can be 
denied (Kirschenbaum & Henderson, 1990). Given the early cognitive stage of 
young children, norms of family members are expected to have a more pronounced 
influence on children’s behaviour intention than attitude. Morrison et al. (1996), 
however, found that attitude and subjective norm had similar effects on smoking 
intentions, while for drinking the effect of attitude was stronger. Other studies have 
demonstrated the dominance of attitude over subjective norm (Fishbein, 1982, 
pp. 179-197; Norman & Tedeschi, 1989, pp.543-558; Perkins et al., 1992, pp.67-73). 
The influence of normative beliefs on behavioural intention and actual behaviour 
seems to vary. Its influence on behavioural intentions has been confirmed by 
several authors (Southern, 1980; Waldon, 1984; Yang et al., 1994, pp.83-96; Raats 
et al. 1995, pp.484-494), while others have failed to demonstrate a significant 
contribution of subjective norms to behavioural intention (Ray, 1981, pp.66-75; 
Pryor, 1990, pp. 146-157; Krahe & Reiss, 1995, p.2130).
Hendon showed that the influence of reference groups on buying behaviour varies 
among products and brands (Hendon, 1979, pp.752-761). Group influence is strong 
for products that are visible to others whom the buyer respects. The more cohesive 
the group, the more effective its communication process, and the higher the person 
esteems it, the more the group will shape the person's product and brand choices 
(Price & Feick, 1984, p.250; Brinberg & Plimpton, 1986, pp.297-300). Parker et al. 
(1995, p. 134) demonstrated the importance of subjective norms for the prediction of
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behavioural intention to commit driving violations when anticipated regret variables 
were added. Anticipated regret variables can also be seen as a part of the attitude 
construct when referring to behavioural rather than normative beliefs. The 
importance of normative beliefs alone on behavioural intention formation has been 
reported in research into the concept of impression-relevant involvement (Leippe & 
Elkin, 1987, pp.269-278; Johnson & Eagly, 1989, pp.290-314). This is a 
motivational state which occurs when people expect that their attitudes or 
behavioural intentions will be made known to an evaluative audience. Godin et al. 
(1993, pp.81-102) studied the prediction of exercising intentions and behaviour 
among pregnant women and found that normative beliefs influenced behaviour only 
through behavioural intention. Myeong and Crawley (1993, pp.381-400), however, 
found that subjective norms exert a direct influence on behaviour. This was 
confirmed by Millstein (1996, p.401), who showed that subjective norms, as well as 
attitudes, directly influenced behaviour, and not only via behavioural intention. The 
importance of subjective norms in research on resistance to behavioural change has 
been demonstrated by Baer et al. (1980, pp.416-422) while elaborating on 
impression management theory. Normative beliefs might be even more important 
than attitudes for a behavioural change, as changing attitudes are likely to fail if 
behavioural intentions are primarily determined by normative considerations (Krahe 
& Reiss, 1995, p.2120).
• Rolc-identity salience
Role belief, the second component of the social factor, is a person's position in the 
family, work, or organisation. It can be defined in terms of role and status. A role 
consists of the activities that a person is expected to perform. Each role carries 
status. People are used to choosing products that communicate their role and status 
in society (Kotler, 1997, p. 179). Norms and roles differ among societies, cultural 
subgroups, situations, and the consequences associated with breaching accepted 
norms (Godin et al., 1996, p. 1563). Chamg et al. (1988, p.304) stress that the more 
salient the role identity is, the higher the probability is that the individual will 
behave consistently with that identity. Studies have reported that role belief in
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particular, can make an important contribution to the prediction of behavioural 
intentions (Sparks & Shepherd 1992, pp.388-399).
2.2.3. Personal factors
Buying behaviour is influenced by personality (Mischel, 1986). Personality is 
usually described as the person's distinguishing psychological characteristics that 
lead to relatively consistent and enduring responses to his or her environment 
(Kassaijian & Sheffet, 1981, pp. 160-180). Those personal factors are shaped by the 
individual's life-cycle, life-style, and personal evaluation of the difficulty to perform 
the behaviour and habit. Many marketers use a concept related to personality.
They try to develop brand images that match the target market's self-image (Kotler, 
1997, p. 181). The use of almost 50 different personality traits in over 90 studies 
yielded disappointing results in predicting behaviour (Wells & Beard, 1973, pp. 141- 
199). Personality traits improve the ability to predict behaviour by 10% or less 
(Mischel, 1983, pp.252-283). The customer's actual self-concept might differ from 
the ideal self-concept. According to Sirgy (1982, pp.287-300), this might be the 
reason for the mixed record of success on predicting consumer responses to brand 
images.
• Life cycle
Adults experience certain passages or transformations from one life-cycle stage to 
the next as they go through life (Lepisto, 1985, p.47). People buy different goods 
and services depending on those stages. However, it is not their personal life-cycle 
stage alone which shapes their buying decision process but also their family life­
cycle (Kotler, 1997, p. 180). A person's occupation is another factor which 
influences his or her consumption pattern. Marketers try therefore to identify the 
occupational groups that have above-average interest in their products and services 
(Kotler, 1997, p. 179). Disposable income, savings, assets, debts, borrowing power, 
and attitude towards spending versus saving, greatly affects people's buying 
behaviour. Kotler (1997, p. 180) states that marketers of income-sensitive goods
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pay attention to trends in personal income, savings and interest rates. If economic 
indicators point to a recession, marketers take steps to redesign, reposition, and re­
price their services or products so they continue to try to offer value to target 
customers. Pratt (1992, pp.259-267) demonstrated the influence of age and income 
as significant predictors of self-reported beliefs and behaviours of public relations 
practitioners.
• Lifestyle
Adler was the first to describe the importance of a person's life-style on buying 
decisions (Ansbacher & Ansbacher, 1967). Wells and Tigert (1971, pp.27-34) 
describe a person's lifestyle as a pattern of living in the world as expressed in the 
person's activities, interests, and opinions. It can also be defined as a summary 
construct reflecting consumer's values. Consumers use constructs, such as life­
style, to generalise situational cues and reduce incompatibility or inconsistency in 
their values and personality. Life-style may change quite rapidly and research of 
behavioural intention and behaviour should consequently pay attention to possible 
changes during the period researched (Engel et al., 1995, p.449).
• Personal evaluation of the difficulty to perform the behavioural 
intention
Personal evaluation of the difficulty to perform the behavioural intention has been 
shown to have an important influence on behavioural intention (Boldero, 1995, 
pp.440-462). Perceived control over the intended behaviour has been shown to be 
the strongest predictor of road safety behaviour (Evans & Norman, 1998, pp.481- 
489). Sparks et al. (1997, pp.418-438) used principal component analysis to show 
that perceived difficulty in carrying out the behavioural intention should be assessed 
separately to perceived behavioural control, as they influence different components 
of the behavioural decision-making process. These authors demonstrated that 
perceived difficulty has an independent predictive effect on behavioural intention 
while perceived control does not. This is in contrast to the findings of Richard et al.
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(1994, pp. 1837-1847), who reported that perceived behavioural control was one of 
the two main determinants of behavioural intention, having an effect on both 
behavioural intention and actual behaviour. The effects of perceived behavioural 
control on target behaviour are clearest when the behaviour presents some problem 
with respect to control (Madden et al., 1992, pp.3-9). This highlights the fact that 
considerable care needs to be taken when constructing measures of personal 
evaluation of difficulty to perform the behaviour (Sparks et al., 1997, p.431).
e Habit
Evidence has accumulated to indicate that behavioural intentions are better 
predicted from a combination of attitudes, subjective norms, and previous 
behaviour than from attitudes and subjective norms alone (Bagozzi, 1981; Rentier 
& Speckart, 1981; Speckart & Rentier, 1982; Fredricks & Dossett, 1983; Rudd et 
al., 1984). However, despite the weight of the evidence, Ajzen has consistently 
argued that past behaviour should not be included in a causal model of behaviour 
change (Ajzen, 1987, p.41; Beck & Ajzen, 1991, pp.285-301). He does not argue 
that previous behaviour does not predict intentions to perform in the future, rather, 
that it has no explanatory value.
There are four documented lines of research that have shed more light on the 
correlation between past behaviour and friture intention. The first one is the trait 
hypothesis. Traits are conceptualised as underlying characteristics of a person that 
cause behavioural consistency across time and situations (Allport, 1967; Goldberg, 
1990; John, 1990). Thus, traits can be the causal agent of both past behaviour and 
behavioural intention in the future. According to the trait hypothesis, previous 
behaviour is not the cause of friture behavioural intention; rather traits are 
responsible for the correlation between past behaviour and future intentions to 
behave in a certain manner. A related concept, habit, which provides a similar 
explanation, is discussed in section 2.3.5, where we consider the subjective 
expected utility model of the theory of interpersonal behaviour (Triandis, 1980).
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The second research line concerns the consistency hypothesis. There is 
considerable evidence that people like to think of themselves as behaving 
consistently (Cialdini, 1988). Although this desire for consistency can be 
conceptualised as a trait, it does not, by itself, offer sufficient explanation for the 
correlation between past behaviour and intention. Instead, it is suggested that the 
combination of a past behaviour and a desire to remain consistent in the future 
causes predictable future behaviour. Thus, according to the trait hypothesis, a trait 
is a causal agent of past behaviour and future intention, but, according to the 
consistency hypothesis, it is not clear what causes past behaviour.
The third research line is the attitude change hypothesis. Several influential 
theories assume that the performance of a behaviour can lead to an attitude change. 
For example, Festinger (1957) argued that the performance of a behaviour that is 
inconsistent with a previously held attitude can lead to an unpleasant state of 
dissonance. One way of reducing such dissonance is to change the attitude so that it 
is more consistent with the behaviour. Thus, behaviour can cause attitude change 
through the mechanism of dissonance reduction. Bern’s (1972) self-perception 
theory provides another mechanism for attitude change. Specifically, the 
performance of a behaviour can cause people to assume that they must have a 
consistent attitude or they would not have performed the behaviour. Thus, attitude 
change results from the process by which people make attributions for their own 
behaviour.
The fourth line is the priming hypothesis. Increasing the accessibility of 
information in memory can affect a wide range of dependent variables such as 
recall and judgements (Markus & Zajonc, 1985). Furthermore, such effects are 
much easier to demonstrate when subjects are unaware of being primed (Martin, 
1985,1986). It is reasonable to suppose that performing a behaviour in the past, 
increases its accessibility in the memory, which in turn affects intentions to perform 
it again in the future. A review of the literature does not indicate that this is the 
result of a highly controlled reasoning process, but rather that it occurs relatively 
spontaneously and with little conscious effort or awareness. Thus, it can be argued
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that any variable that increases the cognitive accessibility of a behaviour has the 
potential to affect intention. Because priming occurs with little awareness, it is 
difficult to adjust for the course of the prime or for its relevance to the judgement at 
hand. Guessing another person’s intention, as well as deciding on one’s own, is a 
result of a judgement affected by whatever information that is accessible at the time. 
Therefore, a priming manipulation that increases the accessibility of a behaviour 
should affect both kinds of judgement.
There is an abundance of support in the literature for the trait hypothesis (Wiggens 
& Pincus, 1992), the consistency hypothesis (Cialdini, 1988; Pratkanis & Aronson, 
1992), the attitude change hypothesis (Knox & Inkster, 1968; Wicklund & Brehm, 
1976; Vaughan & Lanzetta, 1981; Axsom & Cooper, 1985, Axsom & Lawless, 
1992) and the priming hypothesis (Trafimow & Borrie, 1999).
With regard to the prediction of behavioural intention, many authors have reported 
that past behaviour has a greater influence than attitude and subjective norm 
(Fredricks & Dossett, 1983, pp.501-512; Echebarria et al., 1988, pp.181-189; Eiser 
et al., 1989, pp. 193-202; Echebarria & Valencia-Garate, 1994, p.292). For 
example. Pare and Elam (1995, pp.215-228) confirmed that past behaviour has a 
greater influence on actual behaviour than social and environmental factors in the 
field of discretionary use of computers, while Giles and Cairns (1996, pp.299-305) 
found that past behaviour is a better predictor of behaviour than attitudes and 
subjective norms for church-attending behaviour of Roman Catholics in Northern 
Ireland. Other investigators, however, have failed to demonstrate the importance of 
previous behaviour. For example, Yang et al. (1994, p.94) report that regression 
analysis of previous behaviour makes some but little contribution to future 
behaviour. This difficulty in demonstrating the influence of habit might be due to 
the difficulty of designing adequate measures of habit. Unfortunately, statistical 
associations between measures of past behaviour and subsequent behaviour are 
ambiguous as the influence of other factors blurs the influence of past behaviour. 
According to Eagly (1993, p. 181), the available literature suggests, that a number of 
everyday behaviours are controlled only partially by intentions and may be
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controlled in part by habit. Recognition of the influence of past behaviour on 
current behaviour seems important, as ‘habit’ derived from previous behaviour, 
unlike normal attitudes and beliefs, can be very resistant to change (McKenna,
1994, p.282). However, the cognitive processes underlying habitual behaviour are 
still unclear (Aarts et al, 1998, pp. 1355-1374).
2.2.4. Psychological factors
Motivation, perception, past experience, beliefs, values and attitudes are identified 
in the literature as relevant psychological factors which influence buying behaviour.
• Motivation and mood
The perceived difference between an ideal state and the present state is the central 
variable in motivation. The more significant the difference, or need, the more the 
power it has to activate behaviour. Havlena and Holbrook (1986, pp.394-404) 
illustrated that these needs can be classified into two broad categories based on the 
expected outcome of the behaviour, namely utilitarian and experiential needs. 
Utilitarian needs result in considering objective, functional, product features or 
expected benefits while experiential needs are the result of subjective responses, 
pleasures, irrational expectations and aesthetic considerations (Hirschman & 
Holbrook, 1982, pp.92-101). Strong needs are referred to as drives and those drives 
influenced by past experiences emerge as wants. Needs have to reach a certain 
level of intensity to become a motive or drive. Psychologists have developed 
various theories of human motivation. Freud sees the person as repressing many 
urges in the process of growing up. He assumes that the real psychological forces 
that shape people’s behaviour are largely unconscious. Based on Freud's theory of 
motivation, Ernest Dichter (1964) developed motivational research, using in-depth 
interviews to uncover the deeper motives triggered by the product. Frederick 
Herzberg developed the "two factor theory" of motivation. He distinguishes 
between factors that cause dissatisfaction and factors that cause satisfaction (Thierry 
& Koopman-Iwema, 1984, pp. 141-142). This theory of motivation has two
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implications. First, sellers should do their best to avoid dissatisfiers as they may 
‘unmake’ the buying decisions. Second, sellers should identify the major satisfiers 
or motivators of purchase and capitalise on them through skilful use of the 
marketing mix. Sales representatives should be competent to identify the 
dissatisfiers and be able to eliminate them, they should also be trained to identify 
the satisfiers and to be able to stimulate them. The low correlation between 
behavioural intention and prescription behaviour of the physician seems not to be 
due to the incompetence of the average representative, as all pharmaceutical 
companies are faced with the same phenomenon. The literature also provides 
support for a differential effect of mood conditions on information processing 
(Armitage et al., 1999, pp.419-433). Attitudes seem better predictors of behavioural 
intention than subjective norms in negative mood conditions while the opposite was 
found in positive mood conditions.
• Perception
Perception is defined as "the process by which an individual selects, organises and 
interprets information inputs to create a meaningful picture of the world” (Berelson 
& Steiner, 1964, p.88). A person, motivated to buy, does not always buy. Kotler 
(1997, p. 185) states that how the person actually acts is influenced by his or her 
perception of the situation. Perception depends not only on the physical stimuli but 
also on the relation of the stimuli to the surrounding field, and on conditions within 
the individual. People may have different perceptions of the same object due to one 
of three perceptual processes: selective attention, selective distortion, and selective 
retention. The general occurrence of the problem of low correlation between 
behavioural intention and actual behaviour indicates that this phenomenon is not 
due to the perception of an individual, but that it is a more general tendency.
• Learning
The literature on persuasive communication and advertising makes a distinction 
between communications that increase awareness and those that actually bring
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about a change in behaviour. The Effective Health Care Bulletin (February, 1999) 
gives an overview of more than 50 systematic reviews of different dissemination 
and implementation strategies and concludes that just publishing guidelines to 
promote healthcare effectiveness and improve healthcare quality is a relatively 
ineffective method of changing clinical practice. While knowledge of a prescribing 
or practice guideline may be important, it concludes that it seems rarely sufficient to 
change established behaviour by itself. There is also little evidence that the 
distribution of mail and other passive means of guideline dissemination are 
effective in changing behaviour. Behaviour is more likely to be changed if it is 
followed by positive reinforcement, such as audit and feedback. This process is 
part of learning, which describes changes in an individual's behaviour arising from 
experience. Engel et al. (1995, p.514) point out that there are two approaches to 
learning: the cognitive and the behaviourist approaches. The former considers 
changes in behaviour because of obtained new knowledge, while the latter 
examines the observable behaviour only and not the mental processes. Learning 
theorists say that learning is produced through the interplay of drives, stimuli, cues, 
responses, and reinforcement. Learning theory thus can teach marketers how to 
increase demand for a product by associating it with strong drives, using motivating 
cues, and providing positive reinforcement (Kotler, 1997, p. 186). Pharmaceutical 
companies use the learning theory; for example, by inviting physicians to 
participate in clinical trials. While prescribing the particular product for patients 
enrolled in clinical trials the physician acquires knowledge about the advantages 
and limitations of the product.
•  Behavioural beliefs
Beliefs are defined as associations or linkages that people establish between the 
attitude object and various attributes. Eagly and Chaiken (1993, p. 103) state that 
most attitude theorists believe that people have beliefs about attitude objects and 
that these beliefs are in some sense the basic building blocks of attitudes. Fishbein 
and Ajzen (1975, p.213) make a distinction between descriptive and inferential 
beliefs. A descriptive belief is a thought that a person holds about something based
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on direct observation and tends to be fairly veridical. Processing acquired 
information forms inferential beliefs. Personal factors do not play a role in the 
formation of descriptive beliefs but they do with inferential beliefs. According to 
Fishbein and Ajzen, individuals acquire relatively stable concepts of probabilistic 
relationships among sets of beliefs. This implies that a new item of information 
will have implications for many other beliefs about the object or event. When new 
information is obtained a process of elaboration starts, in which existing beliefs 
often become more complex and move towards higher levels, until a new 
equilibrium is achieved. This elaboration often involves more centrally held values, 
such as end-state values, defined by Rokeach as terminal values (Kahle, 1984). 
Studies to understand the influence of beliefs on behavioural intention should 
therefore also take into account the influence of new information on those beliefs.
It seems insufficient for an understanding of the inference process to compare prior 
and past beliefs only (Fishbein & Ajzen, 1975, p.214). Different beliefs underlie 
different kinds of behavioural intentions (Pancer et al., 1992, pp.211-222). The 
number of beliefs a person holds may be very large. It appears therefore impossible 
to measure all the beliefs that influence the behavioural intention. Fishbein and 
Ajzen (1975, p.219) recommend considering the first five to nine modal salient 
beliefs in a given population as the basic determinants of the behavioural intention. 
Non-salient beliefs can be left out, as salient beliefs predict behavioural intentions 
better than non-salient beliefs (Petkova et al., 1995, pp.463-483). Strong beliefs are 
said to be more stable than weak beliefs, (Doll & Ajzen, 1992, pp.754-765), and 
they are more readily accessible in memory (Ajzen et al., 1992).
Pancer et al. (1992, pp.211-222) found that the more pronounced the beliefs are, the 
more effective they are in changing behavioural intentions, and the better they could 
predict actual behaviour (Fazio et al., 1989, pp.280-288; Petkova et al., 1995, 
p.482). It is for the same reason that Elliott and Jobber (1995, pp. 143-158) suggest 
to incorporating a measure of personal belief salience in models to predict 
behavioural intention. Ajzen and Fishbein (1980, p.80) stress that beliefs only 
influence behaviour indirectly, as they influence attitudes and subjective norms that
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exert an influence on behaviour via behavioural intention. This is confirmed by 
Rosenberg (1968, p.84), who studied the degree of consistency between attitudes 
and beliefs. He realised that a person's evaluation of an attitude object tends to be 
consistent with his or her beliefs, when these beliefs are defined in terms of 
expectancy value products. He concludes that a person tries to change either the 
attitude, the belief, or both, when there is inconsistency between an attitude and 
associated belief. Based on Rosenberg's theory, research into behavioural intention 
should be focused on factors which influence beliefs rather than attitudes.
However, Chaiken and Yates (1985, pp. 1470-1481) state that consistent people 
organise their beliefs differently to inconsistent people. They differ in the handling 
of information discrepant from their attitudes. This indicates that beliefs and 
attitudes should be treated separately as factors influencing behavioural intention.
• Values
McKenna (1994, p.253) describes a value as an ideal to which the individual 
subscribes. Values can be either personal or social. They represent the basic 
conviction that a specific mode of conduct is preferable to any others. Contrary to 
attitude, values do not imply the existence of an object towards which the value is 
directed. Rokeach believes that values are concerned with efforts to obtain end- 
states, terminal elements, or final goals and developed a scale to measure them 
(Engel et al., 1995, p.445). He divided beliefs into three categories: the evaluative, 
the prescriptive, and proscriptive beliefs. Evaluative beliefs judge whether 
something is good or bad, while prescriptive and proscriptive beliefs judge the 
desirability of some means or end state. Rokeach classified values as specific 
beliefs of the third kind (Burgess, 1992, p.49). According to Rokeach, we should 
clearly differentiate between values and attitudes. Rokeach (1973, p. 18) defines 
attitudes as an organisation of several beliefs about an object or situation while 
values transcend objects and events. The main difference is that values act as 
standards while attitudes do not. Engel et al. (1995) highlight that attitudes have 
their main influence during the period of alternative evaluation of criteria, such as
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leading to the purchase of a product, while values come into play when the potential 
customer thinks whether the product in general fits with his or her standards.
Several theories have been developed in order to understand the influence of values 
on customer behaviour, such as the social adaptation theory, the means-end chain 
theory, the MECCA model, and the value attitude model. Burgess (1992, p.66) 
states that researchers need to know more about the influence of affect on personal 
value activation during the consumer decision process. This suggests that research 
into values should consider the role of mood and emotion on values and thus on 
customer behaviour. Family-oriented core values have been shown to shape buying 
behaviour (Vinson et al., 1977, pp.44-50), while Pitts and Woodside (1984, pp.55- 
67) have reported that it is possible to base effective market segmentation on values 
as a criterion.
• Attitude
Krech et al. (1962) portrayed an attitude as an element that describes a person's 
enduring favourable or unfavourable cognitive evaluations, emotional feelings, and 
action tendencies toward some object or idea. He also describes attitudes as 
enduring systems of positive or negative evaluations, emotional feelings, and action 
tendencies with respect to an individual's social world. An attitude is "an 
organisation of several beliefs about an object or situation (Rokeach, 1973, p. 18). 
Allport (1935, pp.798-844) says it differently: "Attitudes are mental states 
developed through experience, which are always ready to exert an active influence 
on an individual's response to any conditions and circumstances that the attitudes 
are directed towards". Attitudes can also be considered to be the consequence of 
adhering to a particular value (McKenna, 1994, p.253). Historically, three 
components of attitudes have been distinguished: cognitive, affective, and 
behaviourally based (Allport, 1935; Katz & Stotland, 1959, pp.423-475). 
Cognitive-based attitudes are based primarily on a person’s beliefs about the 
properties of the attitude object; their function is informational or utilitarian 
Affectively based attitudes are based more on people’s feelings and values than
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their beliefs. Their fonction may be value-expressive. Attitudes toward political 
candidates are generally more affectively than cognitively based. Other affectively 
based attitudes derive not from values but from past learning, through learning by 
association (classical conditioning) or learning based on the reinforcing properties 
of prior actions (instrumental conditioning). Behavioural-based attitudes are based 
on self-perceptions of behaviour when the initial attitude is weak or ambiguous. In 
1969, Ostrom (1969, pp. 12-30) showed that separate cognitive, affective and 
behavioural elements can be identified but that they are also interrelated. This 
finding was confirmed by Kothandapani (1971, pp.321-333), and has received other 
support (Breckler, 1984, pp. 1191-1205).
Attitudes are also determined by expectancy-value considerations, i.e., beliefs that 
the behaviour will lead to certain outcomes weighted by the evaluation of these 
outcomes as desirable or undesirable. This can be expressed by the formula: 
attitude = behavioural beliefs % outcome evaluation (Krahe & Reiss, 1995, p.2118- 
2122). Attitudes put people into a frame of mind of liking or disliking an object, 
moving toward or away from it. According to Ajzen and Fishbein (1975), in 
general, an individual will hold a favourable attitude towards a given behaviour if 
he or she believes that the performance of the behaviour will lead to mostly positive 
outcomes; on the other hand, if the individual believes that mostly negative 
outcomes will result from the behaviour, he or she will hold a negative attitude 
toward it (Mykytyn & Harrison, 1993).
Review of the literature indicates that attitudes lead people to behave in a fairly 
consistent way toward similar objects. Attitudes economise on energy and thought, 
as people do not have to interpret and react to every object in a fresh way. As 
mentioned before when discussing balance theory, attitudes change when they fail 
to maintain equilibrium in the face of new information. A person's attitude settles 
into a consistent pattern, and to change a single attitude may require major 
adjustments in other attitudes. For this reason, attitudes are very difficult to change. 
Attitude persistence has been explored systematically and embedded in themes such 
as associative interference and the sleeper effect, both of which invoke ideas about
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cognitive linkages in order to explain the persistence of attitude to change.
Attitudes change over time only. Eiser and Van der Pligt (1988, p.32) highlight the 
fact that studies to measure the influence of changes of attitudes on behaviour 
should include measurements at more than one point in time. The attitudinal 
component has a very pronounced role as predictor of behavioural intention (Krahe 
& Reiss, 1995, p.2130). However, behavioural intentions are not always formed 
and attitudes may be better predictors of behaviour than behavioural intention. The 
independent effect of attitudes on behaviour is frequently substantial, sometimes 
stronger than the indirect effect mediated by behavioural intentions, and sometimes 
even stronger than the independent effect of intentions (Liska, 1984, p.66). Broad 
attitude measures are found to have a low correlation with specific behaviours. In 
order to measure the influence of attitude on behaviour, the influence of specific 
actions directed at the attitude object should therefore be analysed (Ajzen, 1989, 
p.255).
Several approaches to the study of the dynamics of attitude change are known, such 
as message learning, and cognitive response approaches and the so-called “dual 
process” models. Approaches more based on the motivational factor are the 
cognitive consistency theories, of which the most important are cognitive 
dissonance, impression management, and the reactance theory. The self-perception 
theory has been used as well as an approach that emphasises the importance of 
social judgement processes. The number of different approaches to understanding 
attitude change emphasises the enduring concern with attitude change, as attitudes 
are thought to exercise a direct influence on behaviour. Theoretical activity in the 
domain of attitude change can hardly be used to study behavioural change, as this 
theorising seems to miss the social context (Manstead et al., 1995, p.39). Both 
theory and experimentation in the field of attitude change are typically concerned 
with the impact of persuasive messages, usually verbal, delivered by one 
communicator to a number of persons who are conceptualised as individuals. It is 
remarkable that there is as yet relatively little formal connection between the fields 
of attitude change and social influence. In the latter field careful consideration is 
given to norms, roles, identities and relationships.
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The multidimensional view of attitude holds that cognitive and affective response 
tendencies represent conceptually distinct components of attitude (McGuire, 1985). 
Specifically, the model presented by Rosenberg and Hovland (1960), which serves 
as the point of origin of most contemporary analyses, is a hierarchical model that 
includes cognition, affect, and conation (volition) as primary factors and attitude as 
a single secondary factor. In the model of Rosenberg and Hovland, the three 
components are defined independently and yet include, at a higher level of 
abstraction, the distinct construct of attitude. Each component is furthermore made 
up of verbal and non-verbal response categories, and each of these further contains 
a large number of very specific responses to the attitude object.
These responses can be classified into broader categories and different labels 
allocated to these categories, while still dealing with the same evaluative disposition 
called attitude (Ajzen, 1989, p.245). The shared evaluative character of the 
cognitive, affective, and conative attitudinal components has often been a source of 
perplexity. This is especially apparent when attempting to distinguish empirically 
between cognition and affect. Norman (1975), for example, has employed the 
evaluative semantic differential as a measure of affect, whereas Breckler (1984) has 
used it as a measure of cognition. Close examination of the semantic differential’s 
evaluative factor actually reveals a mixture of what appear to be cognitive (e.g. 
useful-useless) and affective (e.g. pleasant-unpleasant) adjective scales. These two 
types of scales are often highly correlated and thus tend to load on the same factor. 
Ajzen and Timko (1986), however, found that they could tap two different 
underlying constructs. It should therefore be possible, by carefully selecting 
appropriate scales, to use the semantic differential to assess an attitude’s cognitive 
or affective component.
Given that the three components reflect the same underlying attitude, they should 
correlate to some degree with each other, and a moderately good correlation has 
been found in measures of the three components. Yet, to the extent that the 
distinction between cognitive, affective, and conative response categories is of 
psychological significance, measures of the three separate components will still be
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useful. A number of attempts have been made over the years to confirm the 
discriminant validity of measures designed to assess the different components of 
attitude, first with the multitrait-multimethod matrices (Kothandapani, 1971) and 
later, by means of confirmatory factor analysis (Widaman, 1985). Depending on 
the method used and the assumptions made, the data have variously been 
interpreted either as supporting a tripartite model or a single-factor model. The 
major issue seems to revolve around whether differences between measures of the 
cognitive, affective, and conative components are to be interpreted as theoretically 
uninteresting method variance or as being due to true differences between 
conceptually independent components.
Chan and Fishbein (1993, pp. 1455-1470) have demonstrated that emotional 
reactions are significant predictors of behavioural intentions in the field of health 
prevention and condom use. At a general level, however, most reports suggest that 
a single factor is found to account for much of the variance in attitudinal responses, 
and the correlations between measures of the three components are typically of 
considerable magnitude. Emotional reactions may depend at least in part on 
cognition and, like cognition, may feed into the overall evaluative response to an 
attitude object. In addition, affect may be associated with the perceived attributes of 
an object and may thus be partly responsible for the evaluative direction and 
intensity of beliefs. The affect factor seems important for behavioural change. 
Positive affect has been proven to facilitate integration of information and shown to 
decrease anchoring in reasoning among physicians (Estrada et al., 1997, pp.l 17- 
135).
2.2.5. Cost as a decision criterion
Although most physicians recognise that the cost of prescription drugs is an 
important aspect of healthcare expenditure, many are seemingly unaware of actual 
drug costs (Miller & Blum, 1993, pp.33-36). As cost has been chosen as a decision 
criterion for this research project, it is important to know what relative value cost is 
assigned by physicians, compared with other decision criteria. An analysis of the 
literature on the decision criteria of physicians is presented in Table 3.
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Table 3: Cost as a prescribing decision criterion of physicians
Average values assigned to decision criteria by physicians. Study 1 : Denig et al., 
1988, pp.1381-1386; Study 2: Denig et al., 1993, pp.915-924. Data reported in 
study (2) were on a 10-point scale ranging from not important to very important, 
while data reported in study (1) were standardised on a 10-point scale as physicians 
were asked to report on a 7- and a 10-point scale.
Treatment (see abbreviation)
IBS (1) RC (1) PI (2) AH (2) PA (2) AC (2) OS (2) OC (2) AR(2) VH(2)
Biomedical aspects
Efficacy 7.7 8.3 9.6 9.3 9.6 9.6 9.6 9.8 9.8 9.9
Adverse events
Serious 8.1 7.3 8.5 8.7 9.4 8.5 7.7 7.3 7.4 8.1
Minor 5.3 3.0 4.0 5.2 5.2 4.0 4.7 6.0 4.7 4.3
Convenient dosage 5.3 ... 6.5 7.8 6.8 5.3 6.8 7.7 4.8 3.7
Economical aspects
Costs 5.4 2.6 4.1 6.0 5.3 2.8 5.3 2.3 4.5 3.1
Social environment
Opinion of colleague 5.0 5.1 6.4 7.1 6.7 5.7 6.6 5.3 7.8 5.8
Wishes o f patient .. . ... 3.6 5.2 5.3 7.3 4.8 7.8 3.0 2.1
Habit
Personal experience 6.7 7.4 7.9 8.0 8.3 8.6 8.6 9.3 8.3 8.9
Abbreviations: IBS= irritable bowel syndrome; RC= renal colic; PI= platelet inhibition after shunt or 
bypass; AH= anti-hypertensive therapy; PA= postoperative anti-emetics; AC= anti-emetics for patients 
on chemotherapy; OS= opioid analgesics for pain after surgery; OC= opioid analgesics for patients with 
cancer; AR= antibiotics for respiratory infections of unknown origin; VH= vasodilatation for 
haemodynamically unstable patients.
Costs seem to be an important criterion in the prescription decision process, 
particularly in non-life threatening situations and when therapy duration is long, 
such as with antihypertensive treatment. Recently, Lundin (1998) reported that 
physicians change their prescription behaviour because of the cost factor. Reports 
in the literature also indicate that physicians prescribe the trade name version of a 
medicine less frequently to patients who have to pay for it, compared with frilly 
insured patients.
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2.3. Models to measure behavioural influencing factors
It is important to ascertain whether a model which reveals the most significant 
factors that influence customer behaviour has already been developed and validated. 
The first research question is therefore:
Does a model exist to unveil the most salient determinants o f non-fullv volitional 
customer behaviour?
We will first review the most important theories to determine the factors that are 
influencing behaviour and the relevant models mentioned in the literature. 
Beginning in the 1970s, research into buying behaviour took a decidedly cognitive 
turn and focused primarily upon information processing. Even today, most research 
addresses the determinants of decision making and emphasises memory processes, 
human judgement and choice, attitudes, and intention formation. The multi­
attribute attitude models have emerged as the most dominant models to analyse 
information processing.
Multi-attribute attitude models take two forms. One form supposes that attitudes 
towards a product/service are a summation of consumers’ judgements of the 
likelihood that a product/service will exhibit certain attributes, multiplied by 
evaluations of those attributes. The second form supposes that attitudes toward an 
action can be represented as judgements of the likelihood that the action will result 
in particular consequences, multiplied by evaluations of those consequences. 
Evaluations are taken to reflect favourable-unfavourable, good-bad, or similar 
bipolar reactions indicative of a class of responses measured on semantic 
differential scales. Multi-attribute attitude models are examples of a class of 
expectancy-value and subjective expected utility models. Unlike the psychological 
theory of behaviourism, expectancy-value theories hold that consideration of the 
individual person is essential in understanding and predicting human actions. These 
theories form a special sub-unit of general decision making principles. Expectancy- 
value theories also hold that people are goal-oriented. In other words, the
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behaviours they perform in response to their beliefs and values are undertaken to 
achieve some end or goal.
These multi-attribute attitude models have been useful in predicting people’s 
attitudes, preferences, choices, etc., and have been the mainstay of economics, 
marketing, and various sub-areas of psychology for over 50 years. Nevertheless, 
they have also been criticised. Two problems seem conceptual. Firstly, existing 
multi-attribute attitude models are blamed for failing to represent the underlying 
structure among likelihood judgement, also called beliefs or cognitions. The 
models should ignore the possibility of a structure of likelihood judgements and 
hypothesise that a single point-form or number captures consumer response. 
Secondly, the multi-attribute attitude models are criticised for failing to account for 
relationships among likelihood judgements. To the extent that likelihood 
judgements are related in causal, inferential, or functional ways, the multi-attribute 
attitude models are blamed for being imperfect.
An alternative pattern, according to Bagozzi would be to model the cognitive 
scheme which consumers hold with respect to their motives, values and goals. The 
information represented in cognitive scheme can be shown to influence attitudes, 
intentions, decision making, and choice. A cognitive scheme is defined by Bagozzi 
as a consumer’s knowledge structure about an object, person, or situation and 
consists of thoughts, based on experience, and connections amongst those thoughts. 
The basic thoughts in a cognitive scheme covering motives, values, or goals 
constitute “declarative knowledge” and reflect accurate information and abstract 
concepts. The connections amongst thoughts are illustrations of “procedural 
knowledge” and resemble if-then propositions. Bagozzi and Edwards (2000) used 
an open-ended extraction procedure based on ideas from the philosophy of rhetoric 
to generate consumers’ hierarchical goal structures. By use of multiple regression 
analysis, they found that decisions were functions of certain goals, as well as 
connections of goals.
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Pieters et al. (1995) also investigated goal hierarchies concerning weight loss, 
Bagozzi and Dabholkar (1994) studied value hierarchies predicting consumer 
recycling behaviours and voting in the presidential elections, and Bagozzi et al. 
(1999) examined motivational hierarchies influencing decisions to join or remain in 
the army.
The literature is not consistent on which approach provides a more abundant 
representation of the basis of decision making. Both the multi-attribute attitude 
models and motivational-value/goal hierarchies address the antecedents of or 
reasons for acting but neither of them consider how consumer actions are executed. 
That is, they stop at the intention or decision to act and do not investigate the 
process following decision-making leading to actual behaviour.
As early as 1862 psychologists began developing theories showing how attitude 
impacted behaviour. Most of the current attitude-behaviour models emerge from 
theories which grew out of the 19th century when the field of psychology began to 
look at the term “attitude”. Those theories suggested that “attitudes could explain 
human actions” (Ajzen & Fishbein, 1980, p. 13). Thomas and Znaniecki were the 
first psychologists to regard attitude as individual mental processes that shape a 
person’s actual and possible responses, and this led to the review of attitudes and 
behavioural predictors by social scientists.
Thurstone and Chave (1929) first developed methods for measuring attitudes using 
interval scales. From this, emerged the well known, more specific and easier to use 
Likert scale, which is still used today. Allport theorised (1935) that the attitude- 
behaviour relationship was not uni-dimensional as had been thought, but rather 
multidimensional. Attitudes were viewed as complex systems comprising a 
person’s beliefs, feelings, and action tendencies with respect to an object. In the 
1950s this point of view about uni-dimensionality became commonly accepted.
The Gestalt psychologist Lewin, developed the field theory of decision-making in 
1936 (Lewin, 1938). In this theory, people are viewed as acting in a life space,
63
which is the sum of all the psychological factors infringing upon a person at any 
specified moment. This life space is separated into regions and fields, which 
correspond to one’s conceptual organisation of the world. Each of these fields has 
associated links with a valence (defined as the positive or negative attractiveness of 
some object or activity to that person). Lewin used the concept of subjective 
probability to describe the likelihood that a behaviour will result in the achievement 
of a particular goal. This measure of the probability of success or failure in 
reaching an objective is a pivotal idea in the expectancy value models developed 
later. When the subjective probability is multiplied by the valence a field has for a 
person, the result is a force or weighted valence which influences a person to move 
away from a negatively valenced field towards one more positively charged.
Lewin’s field theory described a process of decision making that had particular 
influence on later researchers (Feather, 1959). In 1944, the scalogram analysis to 
measure beliefs about the object was developed by Guttman. Von Neumann and 
Morgenstem’s book Theory o f Games and Economic Behavior (1944) dealt with 
risky decision making. Risky decision making occurs when the probability of an 
event’s occurrence can be determined. This objective probability is distinguished 
from subjective probability where there is uncertainty as to the probability of an 
event occurring. In the theory of games, profits and losses are measured in terms of 
an individual’s utility function or functions, that is, one’s relative values. This 
theory was the first to establish a set of axioms of rational behaviour that, if 
followed, would establish a unique, objective decision strategy for an individual to 
follow. However, in this objective view of probability, there is no room for 
individual judgements. It is assumed that a person knows what the objective 
chances are for various outcomes, that is, that the expected utility equals the actual 
utility of an outcome. There is no evidence that people are able to do this except 
under limited conditions (Edwards, 1954).
Doob in 1947 proposed that attitudes are not directly related to behaviour but enable 
us to understand the overall pattern of behaviour. Seven years later Savage (1954, 
p.3) took basic game theory and modified it by substituting subjective probability
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for objective probability. The subjective view held that “probability measures the 
confidence that a particular individual has in the truth of a particular proposition”. 
The magnitudes of these probabilities are, however, bound by some rules of 
consistency which are stated axiomatically. This personalistic, goal-oriented view 
is characteristic of the expectancy-value theories developed later.
One of the first expectancy value theories, although it is usually not recognised as 
such, is Rotter’s social learning theory, developed in 1954. It is concerned with 
three major antecedents of behaviour: expectations regarding the occurrence of 
specific outcomes or subjective probabilities, reinforcement values which are 
positively or negatively associated with events or subjective utilities, and the 
psychological situation which presents the possible directions of behaviour to a 
person. Taken together, the expectations and reinforcement values determine a 
parameter called the behaviour potential. The assumption in this theory is that a 
person will choose the action with the highest behavioural potential. The person 
will thus try to maximise his or her utility and this theory should therefore be seen 
as belonging to the subjective expected utility theories. This attempt to maximise 
utility supplies the motivation to act.
Atkinson’s motivational theory (1957) can also be seen as another early subjective 
expected utility theory. This theory deals with the effect of individual differences in 
motive strength on risk-taking behaviour. Motivation to achieve success, the 
subjective expected utility, is viewed as a product of the subjective probability of 
success and the incentive value of success. Similarly, motivation to avoid failure is 
a product of the subjective probability of failure and the negative incentive value of 
failure. Cognitive and affective components, reflecting these products, result in 
behaviour. While this theory was developed to deal with decision making in a 
social context, its similarity to expectancy-value theories is apparent. In 1961 
Homan introduced the social exchange theory, which states that rewards in a 
relationship minus costs are equal to profits or motivation to remain in a 
relationship. This is another example of an early expectancy value model, as 
rewards minus costs is similar to subjective probabilities of the success of actions
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combined with an assessment of the values of those actions while the motivation to 
remain in a relationship is similar to the subjective expected utility.
Thibaut and Kelly in 1959 and Blau in 1964 used similar ideas to deal with social 
influence and interactions. Thibaut and Kelly saw power as an exchange analysis in 
which gains for compliance are compared to costs or gains from alternative action. 
Blau used the rewards one partner gives to another in a love relationship as an 
example of the balance sought in an outcome-to-input ratio. Motivating objectives 
are not static but are subject to change over time. These changes can be sudden or 
barely register in an individual’s awareness. Objectives may be dropped or a person 
may lose sight of what his or her goals are. This variability in goals over time has 
important implications for any effort at persuasion which aims to influence goals.
In 1960, Rosenberg and Hovland theorised that a person’s attitude toward an object 
is filtered by his or her cognition, affect, and behaviour. Behavioural decision 
theory or subjective expected utility theory is one of the most fully developed of the 
expectancy value formulations (Edwards, 1961). The likelihood of an event, which 
is subject to human influence, occurring, the so-called expectancy variable, is seen 
as the subjective probability that the outcome will take place if a behaviour is 
undertaken. The value variable, the subjectively determined utility of the goal, is 
multiplied by the expectancy. The product is the subjective expected utility. In 
order to maximise one’s outcomes, the individual chooses the subjective expected 
utility with the highest score. Also included in the equation are terms for the 
probability of the outcome occurring if no action is taken and the utility of not 
achieving the wanted outcome, which occurs usually with negative scores. These 
terms are summed over all relevant outcomes and alternatives, both positive and 
negative, to arrive at the final subjective expected utility which will indicate 
whether or not a person will decide to perform a given behaviour.
Some modifications have been suggested for the basic subjective expected utility 
theory, including a focus on individual differences such as self-esteem (Pelc & 
Midlarsky, 1977), expectations of personal efficacy (Bandura et al., 1977), and
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focus of control (Bauman & Fischer, 1985). Situational factors to be considered in 
the model include locus of attribution and self-focus (Carver & Scheier, 1982), 
environmental situations which preclude the completion of an action, and the 
relationship between subjective and objective probabilities (Sutton, 1982).
Conceptual or methodological problems include whether subjective expected 
utility’s are additive or should be replaced by a weighted average rule (Lynch,
1979) and how similar subjective expected utility theories are to probability theories 
(Mitchell, 1977). The expectancy theory (Vroom, 1964) applies an expected value 
model to an organisational setting. As in Lewin’s field theory, Vroom utilised 
valences, defined as affective orientations toward particular outcomes, multiplied 
by the strength of the expectancies of the instrumentality or utility of those 
outcomes. This product yields an estimate of the force on a person to perform a 
particular act. In 1969, Wicker conducted an extensive survey and literature review 
on the subject and concluded “it is considerably more likely that attitudes will be 
unrelated or slightly related to overt behaviour than that attitudes will be closely 
related to actions” (Ajzen & Fishbein, 1980, p.25).
Fishbein and Ajzen (1980, p.5) assumed that individuals are usually quite rational 
and make systematic use of information available to them. They state that people 
consider the implications of their actions before they decide to engage or not to 
engage in a given behaviour. For Fishbein and Ajzen (1975), behaviour is a result 
of intentions. Intentions in turn, are functions of one’s attitudes to the behaviour in 
question and one’s normative norms. Attitudes result from one’s beliefs or 
expectations that a behaviour will lead to a particular outcome, its subjective 
probability and one’s evaluation of that outcome, its subjective utility. The 
subjective norms are a combination of a person’s beliefs of how significant others 
feel about the normative appropriateness of the anticipated behaviour and the 
individual’s decisioh as to the value of those predicted norms.
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The theory of reasoned action (TRA) was developed in 1967, which is a model of 
the psychological processes that mediate observed relations between attitudes and 
behaviour. The theory of reasoned action is composed of attitudinal, social 
influence, and intention variable to predict behaviour. The theory asserts that 
intention to perform behaviour is determined by the individual’s attitude toward 
performing the behaviour and subjective norm held by the individual. The model 
looks at behavioural intentions rather than attitudes as the main predictors of 
behaviours. Ajzen and Fishbein’s theory is ”a specialised summation of 
information integration focusing on beliefs as the basis building blocks of human 
cognitive schemes” (Smith, 1982, p. 259). In this theory, in order to effect 
persuasion, the persuader must focus on the content of the message and work to 
alter the target’s primary beliefs (Fishbein & Ajzen, 1981). By 1980 the theory was 
used to study human behaviour and develop appropriate interventions.
Research has suggested that Fishbein’s original theory needs to be expanded to 
consider the effects of the time interval between intention to act and actual 
behaviour, the influence of previous behaviour on subsequent behaviour, and the 
sequence of behaviour (Saltzer, 1981). There have been conflicting results as to 
whether attitudes directly affect intentions to behave as Fishbein and Ajzen 
predicted (Bagozzi, 1981) or in more indirect fashion, especially in people with an 
internal rather than external locus of control (Saltzer, 1981). The health belief 
model (Maiman & Becker, 1974) takes expected-value ideas into the medical realm. 
The value variable is the perception one has of one’s reduced susceptibility to and 
the severity of a disease, while the expectancy variable is the perception of benefits 
minus the costs of the recommended behaviour of treatment. The product of these 
two variables is a disposition to act, called the subjective expected utility or 
outcome variable.
Rogers’s protection motivation theory (1975) deals with cognitive appraisal 
processes, which mediate attitude change. These processes consist of three parts:
• the magnitude of the ‘noxiousness’ of a specified event or its appraisal 
severity or utility
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• the probability of the event’s occurrence or the expectancy one has of being 
exposed to that event
• the efficacy of the response or the belief one has in the efficacy of the 
coping response or its subjective expected utility.
Rogers views the protection motivation theory as a special case of expectancy-value 
theory. It is concerned primarily with the effects fear has on attitude change, 
defined as the intent to adopt the recommended action. Some shortcomings of the 
theory which Rogers acknowledges are its neglect of the duration of the noxious 
events, the interval between them, and the cost involved in any response to those 
events.
Triandis (1980) presented an extension of Fishbein’s basic model of behavioural 
choices in 1979, with his theory of social behaviour. While Fishbein started the 
decision process with a person’s primary beliefs as the ultimate determinants of 
behaviour, Triandis expanded this view by looking at how those beliefs originated 
and what factors influenced their expression in action. Intentions are still seen as 
leading to behaviour, but habit hierarchies or automatic situation-behaviour 
sequences, relevant or physiological arousal, and the presence of positively or 
negatively facilitating conditions such as environmental characteristics, are viewed 
as also having direct impacts on behaviour. Personality factors that influence this 
process result from past behaviour, culture, history, and ecology. In congruence 
with earlier theories, Triandis utilised the concept of perceived consequences or 
subjective expected utility or outcome evaluations, which consist of a summation of 
perceived probabilities that behaviours will have particular consequences or their 
subjective probabilities and the perceived value of those consequences or subjective 
value. Triandis viewed these subjective evaluations as being influenced by 
feedback from objective consequences of the actual behaviour and the 
interpretations the individual makes of those results.
In 1988 the theory of planned behaviour was added to the theory of reasoned action 
to address the inadequacies that Ajzen and Fishbein had identified in their research 
using the theory of reasoned action. The development of the theory of reasoned
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action assumes that people form their intentions by thinking about their attitudes 
and subjective norms. They form their attitudes by thinking about the consequences 
of their behaviour and form their subjective norms by thinking about the approval 
or disapproval of their behaviour by others important to them (Ajzen & Fishbein, 
1980). Fishbein and Ajzen suggested that the proximal cause of one's behaviour is 
one's intention to engage in the behaviour. They state that attitudes exert their 
influence on behaviour via behavioural intentions. Behavioural intention in this 
theory is defined as a function of beliefs about the behaviour itself and not about the 
object of the behaviour (Fredricks & Dossett, 1983, p. 501). The second 
determinant of behaviour, according to Fishbein and Ajzen is subjective norm. 
Hence, behavioural intention is a linear regression fimction of attitude toward the 
act or behaviour and subjective norm. The theory of reasoned action is a modified 
version of Dulany's (1968) theory of propositional control. As in the original theory 
this modified version assumes that most behaviour of interest to social psychology 
is under volitional control.
2.3.1. The theory of reasoned action
The theory of reasoned action (TRA) looks at behavioural intentions as being the 
immediate antecedents to behaviour. It is believed that the stronger a person’s 
intentions to perform a particular behaviour, the more successful they are expected 
to be. Intentions are seen as a function of salient beliefs and or information about 
the likelihood that performing a particular behaviour will lead to a specific 
outcome. It is theorised that intentions are a function of two basic determinants: 
attitude toward behaviour and subjective norm of behaviour.
• The model
The model can be stated algebraically as follows:
B ~ BI = wl ATT + w2SN
B = behaviour
BI = behavioural intention
ATT = attitude toward the behavioural act
SN = subjective norm
wl and w2 = empirical weights indicating the relative importance of the first and 
second term
Subjective Norm = Normative beliefs x Motivation to comply = which can be 
stated algebraically :
r
SN = E Nbj x Mcj
j=l
Nbj = normative belief ( i.e. subjective probability)
j = referent
Mcj = motivation to comply
r = number of referents
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ATT = attitude toward the behaviour which can be stated algebraically:
n
ATT= 2 BbixOei 
i=l
n = the number of salient consequences
Bbi = behavioural belief that the behaviour leads to some consequence i
Oei = evaluation of the consequence i
Figure 3: The model of the theory of reasoned action
BehaviourRelative
importance
Behavioural
intention
Subjective norm
Attitude toward 
the behaviour
Evaluative 
beliefs about 
the
consequences 
of the 
behaviour
Normative 
beliefs about 
the behaviour
motivation to 
comply
(Fishbein and Ajzen, 1975, p. 16)
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Coverage and limitations of the model
While empirical research shows that attitudes and subjective norms frequently 
influence intentions, a number of problems can be pointed out with the 
representation of the determinants of attitudes and subjective norms under the 
theory of reasoned action. One limitation of the classic approach is conceptual and 
has implications for predicting decisions. By modelling the determinants of 
attitudes and subjective norms as the summation of expectancy-value products, the 
classic approach assumes that each product (e.g. (Bbi) (Oei) and (Nbj)(Mcj)) 
contributes equally and the net effect of antecedents can be represented as singular 
summaries. This prevents one from determining the contribution of beliefs and 
normative expectations individually and their relative importance and makes the 
approach less diagnostic than required.
The second and connected issue concerns the content of behefs and normative 
expectations used in the classic approach. The standard elicitation procedure used 
to generate beliefs and normative expectations typically generates excessively 
hypothetical or intangible determinants that relate poorly to the actual subjective 
expectancies of decision-making. Furthermore, use of product terms as predictors 
of attitude and subjective norms poses methodological problems because self 
reports are not often ratio scales, as required in tests of hypotheses for the models as 
they stand. This is especially a problem when sums of product terms are applied. 
Fishbein limited the model to behaviours are under volitional control. He thus 
excluded behaviour that occurs independently of attitudes because it has become a 
habit, e.g. brushing teeth after each meal,.
The attitudes covered by the theoiy of reasoned action are attitudes toward 
behaviours, and not attitudes toward targets (Eagly & Chaiken, 1993, p. 169). 
Emotional outbursts, and performance of well-learned skills such as skating, cannot 
be explained by the theory of reasoned action (Ajzen & Fishbein, 1980, p.245).
Nor can the model of the theory of reasoned action be used when we want to 
distinguish between personal and normative reasons for engaging in a behaviour
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(Miniard & Cohen, 1981, p.317). The theory of reasoned action disallows the 
possibility that attitudes sometimes elicit behaviour with little or no intervening 
thought (Eagly & Chaiken, 1993, p. 169). Impulse buying is an example of little 
intervening thought. The distinction between attitudes toward the behaviour and 
subjective norms is somewhat arbitrary (Miniard & Cohen, 1981, pp.309-339). The 
perceived impact of one’s actions on other people can generally be stated equally 
well in terms of a behavioural belief, such as ‘going out to theatre with my wife 
tonight makes her happy’, or as a normative belief, such as ‘my wife thinks that we 
should go to theatre tonight’. There can be thus considerable confusion between 
attitudinal and normative aspects of the model, sometimes resulting in statistical 
problems when two predictors are simultaneously entered into the regression 
equation to predict behavioural intentions. Eagly & Chaiken (1993, p. 171) 
therefore propose to represent other people’s preferences for one’s behaviour in 
terms of behavioural beliefs and not as normative beliefs. Normative beliefs should 
be seen as a determinant of the attitude of others toward the behaviour.
•  Results of empirical tests of the theory of reasoned action
In a review of 10 studies of the theory of reasoned action, Ajzen and Fishbein 
(1973, pp.41-57) reported a mean R of 0.81 of the predictability of intention and 
behaviour. In a meta-analysis performed by Sheppard et al. (1988, pp.325-343), 87 
estimates of the predictability of intention and behaviour were found. They 
reported a mean R of 0.66 for the prediction from attitude and subjective norm. A 
later, even more extensive, meta-analysis of 113 articles showed that the mean R for 
predicting intention from attitude and subjective norm was 0.68 (Van der Putte, 
1991). However, the reported relation between behavioural intention and behaviour 
is rather weak. Sheppard et al. (1988, pp.325-343) reported a mean R of 0.53. This 
weak correlation between behavioural intention and behaviour was also confirmed 
by Van der Putte (1991), who found a mean R of 0.62. The variability across 
studies for the prediction of behaviour from intention is rather large. Fishbein and 
Ajzen (1975, pp.375-376) state that the delay between the assessment of the 
intention and the actual engagement in the behaviour might have reduced the
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behavioural intention-behaviour correlation. During the period of delay intentions 
might have changed. However, these weak correlations between behavioural 
intentions and behaviour could also reflect the determination of behaviour by 
processes not covered by the model of reasoned action (Eagly & Chaiken, 1993, 
p. 176).
The true strength of the relations between the terms of the model might however 
also be underestimated by the quantitative reviews of studies with the model of the 
theory of reasoned action. This is due to the fact that the theory of reasoned action 
applies only to volitional behaviour and that behavioural intention should be a 
weaker predictor of behaviour when behaviour is not fully volitional. More positive 
attitudes and stronger social norms significantly predicted more likely behavioural 
intention (Barling & Moore, 1996, pp. 77-78) as predicted by the theory of reasoned 
action. Godin et al. (1996, pp. 1556-1586) proved that the model of the theory of 
reasoned action has cross-cultural validity although less significant than the models 
of the theory of planned behaviour and the model of interpersonal behaviour. Herr 
(1995, pp. 371-380) evaluated the theory of reasoned action in the context of 
general attitude theory and raised concerns regarding its implementation, with 
particular respect to measurement, falsifiability, and testability issues. He suggests 
studying the affect or belief - based attitude mediation by attitudinal theories that 
build on and complement the theory of reasoned action.
The causal structure of the model is criticised by De Wit et al. (1995, pp.50-58). 
They suggest that response effects may influence the results of studies using 
questionnaires. In a comparison of the applicability of the model of the theory of 
reasoned action with the model of interpersonal behaviour, Yang et al. (1994, 
pp.83-96) found the latter to have greater predictive utility. Netemeyer and Bearden 
(1992, pp.49-59) showed that the model of the theory of reasoned action is only 
weakly able to reflect varying experimental conditions. The model of the theory of 
reasoned action does not cover all the variables which influence behaviour and 
Yang et al. (1994, pp.83-96) showed that variables external to the model indirectly 
influence behavioural intention and behaviour. The model has also been criticised
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for not taking into account perceived moral obligation, which represents a person’s 
personal belief about right and wrong. Studies have demonstrated that the addition 
of perceived moral obligation to the model improved its predictive ability (Gorsuch 
& Ortberg, 1983, pp. 1025-1028). Rentier and Speckart (1981, p.234) showed that 
attitudes also have a significant direct influence on subsequent behaviour and thus 
challenged the theory of reasoned action which advocates that the influence of 
attitude on behaviour is through behavioural intention only.
2.3.2. The theory of reasoned action, extended by Rentier and
Speckart
This heading is probably a bit misleading as the theory of Rentier and Speckart is 
not just an extension of, but actually differs from, the theory of reasoned action. 
Attitudes and subjective norms have, according to Fishbein and Ajzen (1975, 
p.372), only an indirect influence on behaviour via behavioural intention. In 
contrast, Rentier and Speckart (1979, p.461) proved that attitudes, or other factor(s) 
linearly related to attitude, contribute significantly to the occurrence of behaviour 
directly without the regulation of behavioural intentions, while they also confirmed 
that subjective norms mediate behaviour via behavioural intention only. Another 
difference is the role of past behaviour. The Fishbein and Ajzen viewpoint is that 
previous behaviour influences behavioural intention via attitudes and subjective 
norms and does not have a direct influence on behaviour. However, Rentier and 
Speckart’s theory includes previous behaviour as a predictor of behaviour. Rentier 
and Speckart (1979, p.461) claim that the addition of past behaviour measures to a 
model allows for a more precise prediction of behaviour compared with the model 
of the theory of reasoned behaviour.
Triandis, in his model of interpersonal behaviour, also included past behaviour and 
called it habit. The difference between the theory of Rentier and Speckart and that 
of Triandis is that the latter defined behaviour as a joint outcome of behavioural 
intention and habit while Rentier and Speckart state that there is a indirect influence 
of habit on behaviour through behavioural intention completed by past behaviour
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also having a direct influence on behaviour. Thus the theory of Bentler and 
Speckart tries to predict subsequent behaviour on the basis of prior behaviour, 
attitudes, subjective norms, and behavioural intentions.
• The model
The model can be stated algebraically:
B ^  BI = W1ATT + W2 SN + W3 HABIT
Figure 4 : The model of the theory of reasoned action, extended by Bentler
and Speckart.
Behavioural
intention
Behaviour
Past behaviour
Attitude
Subjective
norm
Source: Bentler & Speckart (1979) p. 455
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Bentler (1980, pp. 419-456) calculated a measurement model for each variable 
using confirmatory factor analysis in order to remove the effect of un-reliabilities in 
the measured variables from the regression coefficients that estimate the relations 
between the terms of the model. Causal relations in the models can be estimated 
without contaminations by unreliabilities in the real, measured variables.
• Coverage and limitation of the model
This model covers behaviour that may occur independently of attitudes because it is 
habitual. Bentler and Speckart (1979, p.462) claim that their model accounts for 
typical and atypical behaviours more fully and completely than the model of the 
theory of reasoned action. Bentler and Speckart did not restrict their model to 
volitional behaviours as Fishbein and Ajzen had, but it should be kept in mind that 
Bentler and Speckart’s model differs only in two places from the model of the 
theory of reasoned action and still does not include determinants of non-volitional 
behaviour. The role of habit per se remains indeterminate because of the difficulty 
of designing adequate measures of habit. Unfortunately, statistical associations 
between measures of past behaviour and later behaviour are ambiguous because 
they may represent the influence of many other factors that are present on both 
occasions. So any detailed consideration of the processes by which people plan 
their actions is missing from this extended theory of reasoned action.
• Results of empirical tests with the model
Bentler and Speckart (1981, pp.226-238) proved that the addition of habit to the 
model of the theory of reasoned action improved the rate of prediction of behaviour, 
with respect to studying and exercise. The model was tested and its ability to 
predict behaviour was confirmed with respect to voting for a particular political 
party (Echebarria et al., 1988, pp. 181-189) and blood donation (Chamg et al., 1988, 
pp.303-317). Denig et al. (1988) proved that there is a considerable overlap 
between the three determinants of behavioural intention in this model but that the 
addition of habit, in the form of weighted experiences, added predicted value. In a
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situation with a more significant non-volitional component, such as the prescription 
of drugs, they suggest that the model does not cover sufficiently all the determinants 
which may influence the behaviour. Denig et al. (1988, pp.1385-1386) showed that 
attitude, subjective norms and habits, measured as weighted experiences, explain 
approximately only half of the overall assessments of drug prescription.
2.3.3. The theory of goal pursuit
Many psychologists have examined the psychological processes which are directly 
relevant to planning and goal orientation (Kendzierski 1990, pp.27-45; Sternberg,
1990). Research has focused particularly on the regulation of behaviour in terms of 
the principles of feedback control, according to which people set standards for their 
behaviour, compare their behaviour with the standards, and attempt to reduce 
discrepancies between their behaviour and the standards (Powers, 1973; Scheier & 
Carver, 1988). According to this view, people are expected to set goals and to 
adjust their current behaviour in order to match these goals. Their goals are thus 
end states or outcomes toward which they hold positive attitudes. Based on this 
theory, Warshaw et al. (1982) and Bagozzi and Warshaw (1990, pp. 127-140) 
adapted the model of the theory of reasoned action to include the mental and 
physical processes that intervene between intention to achieve an outcome and 
actual realisation of it. Bagozzi and Warshaw called their theory the theory of 
trying. This theory differs from the theory of goal pursuit that it takes account of 
how recent the previous behaviour was and its frequency in the past. Both theories 
take into account some aspects of the planning that allows people to reach remote 
goals. The behaviour predicted is defined as trying to achieve a goal.
• The model
The model is the same as for the theory of reasoned action but behavioural intention 
is re-formulated as intention to try or attitude toward trying to attain a goal; the 
normative term is re-formulated as others' expectations of one's trying to achieve a 
goal.
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Figure 5 : The model of the theory of goal pursuit
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Specific Mermediate 
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attaining the outcome
Attitude toward 
unsuccessful attainment 
of the goal
Weighted by the 
perceived likelihood of  
failure
Source: Bagozzi & Warshaw (1990) p. 129
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Coverage and limitations of the model
Some behavioural researchers have specified that theories of behaviour should 
consider clearly how people conceptualise and then execute a set of actions required 
to obtain a particular goal or to engage in specific behaviour. Eagly and Chaiken 
(1993, p. 191) criticise the theory of reasoned action and related models, such as that 
of Bentler and Speckart, for not including the process by which people plan their 
actions. Even the theory of goal pursuit considers only limited aspects of planning, 
while most actions involve a plan of some complexity. Also missing from this 
attitude-behaviour theory, is the belief that goals are ordered in a hierarchy.
Neither this theory, nor the theories of reasoned action and related models, represent 
behaviours as being linked to one another in hierarchies that are structured in terms 
of more abstract intentions to reach goals (Eagly & Chaiken, 1993, p. 192).
Vallacher and Wegner (1987, pp.3-13) have demonstrated that attention to this 
hierarchy is important as the type of goal that is most important in relation to a 
particular action varies to a large extent depending on the situational framework and 
other factors.
• Empirical tests with the model
The concept of trying and its elaboration in terms of a function of a normative term 
and three additional determinants has so far received only limited experimental 
testing. Bagozzi and Warshaw (1990, p. 13 8) reported that the success-related and 
process-related paths from attitude toward trying, through the terms of beliefs 
multiplied by evaluations, were supported by the theory of trying,. They found that 
expectations of success multiplied by attitude toward success and attitude toward 
the process were both significant predictors of attitude toward trying. However, 
they were unable to confirm either the failure-related terms or the expectations of 
failure multiplied by attitude toward failure as expressed by the model.
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2.3.4. The theory of planned behaviour
Ajzen proposed the theory of planned behaviour for behaviours that are not folly 
under volitional control. The theory of planned behaviour can be seen as an 
extension of the theory of reasoned action by the addition of one's perception of 
how easy or difficult it is to perform the behaviour. This new variable is labelled 
perceived behavioural control.
e The model
Figure 6: The model of the theory of planned behaviour
Behaviour
Subjective norm
Attitude toward 
the behaviour
Behavioural
intention
Perceived
behavioural
control
Control beliefs x 
Perceived 
facilitation
Behavioural 
beliefs x  
Outcome 
evaluation
Normative 
beliefs x  
Motivation to 
comply
Source: this Figure was presented by Ajzen (1991, Figure 1, p. 182).
• Coverage and limitations of the model
Ajzen (1985, pp. 11-39) states that the theory of reasoned action is valid for non- 
habitual behaviours that are easily executed by almost everyone, without special 
conditions. He acknowledges, however, that the amount of control one has over
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one’s behaviour influences the extent to which one's intentions are carried out. For 
behaviours that are more difficult to execute, Ajzen proposes this improved version 
of the model of the theory of reasoned action.
Eagly and Chaiken (1993, p. 189) criticised the causal link between perceived 
behavioural control and behavioural intention as suggested by Ajzen. They state 
that the mere fact of controllability would not seem to encourage people to engage 
in negatively evaluated behaviours. They add that people perhaps take control into 
account only in conjunction with their desire to engage in behaviour or attain a goal. 
Another criticism is that Ajzen treats belief structures in the theory of planned 
behaviour, like Fishbein and Ajzen did in the theory of reasoned action, as uni- 
dimensional constructs (i.e. E Bbi x Oei, X Nbj x Mcj). This criticism is based on 
reports in the literature which indicates that monolithic belief sets may not be 
consistently related to attitude or subjective norm (Bagozzi, 1981, pp.607-627; 
Bagozzi, 1982, pp.562-583). The model might therefore not reveal the particular 
determinants of beliefs which influence behaviour most. Taylor and Todd (1995, 
p. 152) suggest, therefore, the use of the model of planned behaviour in which the 
belief structures are decomposed. In this way the specific factors that may 
influence behaviour, including their relationships, emerge more clearly.
• Empirical studies with the model
The importance of the addition of perceived behavioural control to the model in 
order to improve its predictive power has been confirmed by Lynne et al. (1995, 
pp.581-598) who looked at the adoption of water saving (conservation) technology 
and actual capital investment by the adopter. Also, Mathieson (1991, pp. 173-191) 
found support for the model in the domain of technology acceptation. The theory 
has also been tested in other settings such as leisure (Ajzen & Driver, 1992, pp.207- 
224), and medicine (Beale & Manstead, 1991, pp.409-431; Randall & Gibson,
1991, pp. 111 -122). Giles & Cairns (1995, pp. 173-188) used the model to predict 
behavioural intention on blood donation. However they also found some support 
for a multidimensional representation of the belief-based measure of attitude. In
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terms of predictive power, the theory of planned behaviour is comparable to the 
theory of reasoned action (Taylor & Todd, 1995, p. 147). Hill et al. (1997, pp. 107- 
115) found via discriminant function analysis that the contribution of subjective 
norms to the prediction of behaviour is much less fundamental than the 
contributions of attitude and behavioural control. This finding is in conflict with 
that of Taylor and Todd (1995, p. 152) who found attitude and subjective norm to be 
significantly related to behavioural intention, while perceived behavioural control is 
not. According to these authors, the addition of perceived behavioural control to 
the theory of planned behaviour did not improve the prediction rate of behavioural 
intention.
Giles and Cairns (1996, pp. 299-305) investigated the determinants behind the 
apparent discrepancies in the frequency of church attendance among Catholics and 
Protestants in Northern Ireland. They found that the omission of habit in the model 
might have caused the low-recorded predictive power for the Catholic group.
Godin et al. (1996, pp. 1556-1586) proved that the model of the theory of planned 
behaviour has cross-cultural validity.
2.3.5. The theory of interpersonal behaviour
In the theory of interpersonal behaviour, two additional factors are added to 
behavioural intention compared with the theory of reasoned action (Triandis, 1977, 
1980, pp. 195-259). The additional factors are the strength of established habits of 
behaviour and the presence of facilitating conditions or circumstances that hinder 
one from performing a particular behaviour. According to this theory, behavioural 
intention is influenced by four factors: cognition, (e.g., the personal evaluation of 
the consequences of carrying out the intended behaviour for the person him or 
herself), affect, (e.g., the feelings of pleasure or displeasure associated with the 
intended behaviour), social determinants such as community determined norms 
with respect to the intended behaviour, and personal normative beliefs. Comparing 
the expectancy value models of the theory of reasoned action and planned 
behaviour with the model of the theory of interpersonal behaviour it can be
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concluded that, in the first two models the influence of cognition on intention is 
mediated through its impact on the affect factor of the attitude construct, whereas in 
the last model cognition and affect are two parallel and direct causes of intention.
• The model
The model can be presented algebraically as two equations:
B = wl x (BI) + w 2 x (HABIT)
BI = w3 x (ATT) + w4x (XBbl x Oei) + w5 x (SSN) +W6 x
(SPN) + W7 x (SR)
B = a specific overt behaviour
BI = intention to perform that behaviour
ATT = attitude toward that behaviour
HABIT = habit of performing a behaviour
SSN = subjective social norm
SPN = personal norm
SR = social role
Bbl x Oei = perceived consequence people associate with the behaviour
and the evaluation of the consequences
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Figure 7: The model of the theory of interpersonal behaviour:
External variables:
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Behavioural
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Behaviour
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Affect
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belief
Cognitive
Source: Triandis (1977)
Previous behavioural habits are defined by Triandis (1977; 1980, pp. 195-259) as 
sequences of behaviour that have become relatively automatic in the sense that they 
occur without self-instruction. Affect refers to the feeling or emotions that people 
experience in relation to the thinking of the behaviour. Contemporary theories of 
emotion allow for both pro-positional and non-pro-positional representations of 
emotional experience. This was clearly demonstrated by Buck (1985), who made a 
distinction between analytic versus syncretic knowledge, or by Leventhal (1984),
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who indicated conceptual versus schematic memory systems. Affects can be 
negative or positive but provide, according to Eagly and Chaiken (1993, p. 666), 
only one source of experience from which attitudes are formed.
• Coverage and limitations of the model
Most research utilising the theory of interpersonal behaviour, has treated affect as 
equivalent to the attitude construct in the theory of reasoned action (Chan & 
Fishbein, 1993, p. 1459). Fishbein et al. (1992) disagree with this view. They state 
that affect in the theory of interpersonal behaviour is a much stronger, classically 
conditioned positive or negative reaction to the consideration of performing the 
behaviour in question than attitude in the theory of reasoned action. The addition of 
the emotional reaction component to the affective component of attitude is expected 
to be important for behaviours which have a strong emotional component.
• Empirical studies with the model
Several different theoretical orientations lead to the expectation that people’s 
affective reactions will generally be consistent with their behaviours. In dissonance 
theory, this expectation follows from the assumption that people have a need to 
reduce dissonance; in self-perception theory it is assumed that people gather their 
feelings from their actions; and in impression management theory it follows from the 
assumption that people want to appear consistent in front of others. Much of the 
research generated by these theories has been concerned with the effect of behaviour 
on attitudes, including the affect component, rather than with the reverse causal 
relation. Whatever mechanism is assumed to be responsible, people have been 
shown to try to bring their feelings in line with their past behaviour.
However, the theories of dissonance and impression management also imply that to 
maintain affective-cognitive consistence, people choose to behave in ways that are 
consistent with their affective tendencies. The model of interpersonal behaviour
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views the formation of behaviour in an identical way, i.e., as a result of attitudes, 
including the affect component.
The addition of emotional reaction proved to increase the predictive power of the 
behaviour model (Chan & Fishbein, 1993, p. 1465). The value of the model was 
confirmed in several settings such as driving behaviours (Parker et al., 1995, 
pp. 127-137), getting a mammogram (Baumann et al., 1993, pp. 1733-1756) and 
condom use (Godin et al., 1996, pp. 1556-1586). Although past behaviour as a 
independent variable in the model of the theory of interpersonal behaviour 
contributed to predicting behaviour in and above behavioural intention, its overall 
importance remains unclear (Eagly & Chaiken, 1993, p. 180).
2.3.6. The theory of spontaneous or automatic processing
An alternative view to the theories of the expectancy value models was put forward 
by Fazio (1986, pp. 204-243). According to this theory, attitude influences 
behaviour by selectively activating various thoughts stored in memory and hence 
producing a selective perception of the attitude object. Fazio (1986, pp. 204-243; 
1989, pp. 153-179) defined attitudes as a learned association between an attitude 
object and an evaluation. Like any construct based on associative learning, attitude 
strength varies. Fazio indexes strength using a reaction time paradigm. The more 
quickly an attitude can be expressed, the greater its strength. The stronger the 
attitude, the more accessible it is. The attitude object and its evaluation are linked 
together and stored as a proposition within long term memory. The attitude object 
is seen as a concept in an associative network and can result in a positive or 
negative evaluation. Fazio thus believes that activation of an attitude, because of 
the associative networks, allow strongly linked beliefs to come to mind. Thus, 
although attitude is dependent on previous positive or negative experiences, it 
influences, rather than is merely influenced by, the evaluative beliefs a person 
brings to mind when deciding on a course of action. Fishbein and Ajzen (1975) 
argue that people decide that something is good or bad because of the salient beliefs 
they hold. Thus, people with different attitudes may see different aspects of an
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issue as salient. Another possible explanation was given by Eiser and Van der Pligt 
(1988, p. 29) who proposed that a consequence of adopting a particular attitude 
might cause particular beliefs to become more or less salient. According to the 
theory of spontaneous or automatic processing, repeated activation of an evaluative 
response to an attitude object would strengthen the attitude - evaluation association. 
The frequency and recency of past activation of a construct is believed to make the 
attitude more accessible upon the presentation of attitude relevant cues (Higgins, 
1989, pp. 75-123). Fazio argues that the associative strength as indexed by 
accessibility has important consequences, such as the tendency to enhance the 
extent to which people engage in behaviour consistent with attitudes.
• The model
Figure 8: Model of the theory of spontaneous or automatic
processing
Selective
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Attitude
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Behaviour
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Immediate 
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attitude object
Definition 
of the 
event
Source: Fazio (1986), Figure 8.1, p 212
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Coverage and limitations of the model
Whether or not an attitude is accessible from memory is expected to have an impact 
upon the degree to which the attitude guides behaviour toward the objective object 
(Fazio, 1989, p. 168). A number of variables may be related to the classification of 
individuals as possessing attitudes of either high or low accessibility. The more 
accessible an attitude is from memory the greater the likelihood that the attitude will 
influence subsequent behaviour (Fazio, 1989, p. 171). Research on the selective 
processing of information indicates that accessible attitudes are less susceptible to 
change as a function of new information that is received about the attitude object, 
compared with less accessible attitudes (Fazio, 1989, p. 175). Strong attitudes create 
biases in information processing and these biases tend to maintain and even to 
polarise existing attitudes (Eagly & Chaiken, 1993, p.621). If only relatively 
inaccessible attitudes are modifiable via persuasion than the model of spontaneous 
or automatic processing may say more about attitude formation than about attitude 
change (Fazio, 1989, p. 175). Bargh et al. (1992) have claimed that variations in 
associative strength are more a function of word frequency and cultural norms than 
individual differences in experience with the attitude object.
• Empirical studies with the model
Empirical tests of Fazio's view of attitudes as object evaluation associations have 
yielded confirming results. In tests, subjects who were asked to express their 
attitudes repeatedly were found to be capable of responding relatively quickly to 
direct inquiries about their attitudes (Powell & Fazio, 1984, pp. 139-148). Fazio et 
al. (1986, pp. 229-238) proved that attitudes can be activated automatically and the 
likelihood of such activation depends on the strengths of the object-evaluation 
association. The stronger the association between object and evaluation, the more 
rapidly the subject was able to respond (Powell & Fazio, 1984, pp. 139-148).
90
2.3.7. Composite attitude behaviour model according to Eagly and
Chaiken
The composite attitude behaviour model takes both attitudes toward targets and 
attitudes toward behaviour into account. In this model, behaviour originates in the 
activation of habits, attitudes toward targets, and three classes of anticipated 
outcomes of behaviour: utilitarian, normative and self-identity (Eagly & Chaiken, 
1993, p.209). Attitude toward targets considers social, political, interpersonal and 
other attitudes that come to mind in everyday situations. Utilitarian outcomes 
embody those rewards and punishments that are anticipated to follow from 
engaging in the behaviour or behavioural beliefs. Self-identity outcomes refer to 
affirmations or rejections of the self-concept that are anticipated to follow from 
engaging in the behaviour (Eagly & Chaiken, 1993, p.210). The composite attitude 
behaviour model can be considered an integration of other expectancy value models. 
The theory places attitudes in the context of other psychological determinants of 
behaviour.
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The model
Figure 9: Representation of the composite attitude behaviour model
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Source: Eagly A.H., Chaiken S. (1993), p. 209 
• Coverage and limitations of the model
The composite attitude behaviour model, being an integrative framework of other 
subjective expected utility models, covers all the determinants of behaviour of those 
models. However, the composite attitude model identifies behaviour as being 
determined by both attitudes toward targets and attitudes toward behaviours. All 
other expectancy value models treat attitudes toward behaviour as antecedents of 
behaviour but do not include attitudes toward targets. It is important to explore also
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the causal relation between attitudes toward targets and behaviour as shown by 
research on direct experience and attitude accessibility (Eagly & Chaiken, 1993, p. 
202).
•  Empirical tests with the model
The composite attitude behaviour model, developed by Eagly and Chaiken in 1993, 
has not undergone empirical testing yet.
2.3.8. The drug choice model
The drug choice model attempts to extend the contribution of values and norms to 
the predictive power of the theory of reasoned action, extended by Bentler and 
Speckart (Denig et al.,1988, p. 1382). Norms concerning professional acceptability 
have been extended to measure independently, in addition to the advice and 
criticism of colleagues, also those of other specified groups. Besides treatment 
outcomes and norms, the experience gained from past experience forms part of the 
model. Although there is some correlation between experience and expectancies
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The model
Figure 10: Representation of the drug choice model
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•  Coverage and limitations of the model
It is debatable just how different this model is from the model of the theory of 
reasoned action, extended by Bentler and Speckart. Denig et al.(1988) define habit 
as personal experience influenced by the value of personal experience. However 
there is no reason to limit habit, which is defined in other expectancy value models
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as a simple repetition of behaviour. Habit may alo be considered to cover the 
influence of the experience obtained. Past behaviour with repeated negative 
experience is unlikely to be continued. The authors state that the predictive power 
of the drug choice model is superior to other expectancy value models, as norms, 
which are not limited to the advice and criticism of colleagues, have been measured 
independently for more specific groups. However, other expectancy value models 
also cover norms of others and do not limit themselves to the influence of 
colleagues.
• Empirical tests with the model
According to this model a drug choice results from the interaction of expectancies 
and values about treatment outcomes (attitudes, normative beliefs and personal 
experiences). Denig et al. (1988) found that the drug choice model could only 
partially predict a prescriber’s drug of first choice and that the predictive power of 
the model depends in part on the type of disorder in question. Literature suggests 
that in some fields of prescribing, physicians consciously weigh distinct pros and 
cons before choosing a drug, while in other fields the drug choice is less reasoned 
(Denig & Haaijer-Ruskamp, 1992, p. 14). In the latter case, other factors seem to 
influence prescription behaviour which are not covered by the drug choice model.
2.4. Discussion
It is unlikely that the effect of culture on the behavioural intention or on behaviour 
can be influenced (Keuning & Eppink, 1996, p.364). A model to test the influence 
of factors on the behavioural intention and actual behaviour should therefore have 
proven cross-cultural validity, or all existing cultures and subcultures should be 
represented in the target-group to be investigated. Of the social factors, personal 
normative beliefs, calculated as normative beliefs weighted with the motivation to 
comply, should also be included. Although the influence on behavioural intentions 
and actual behaviour did not appear to be significant in all studies, the influence 
remained important (Raats et al., 1995, pp.484-494; Krahe & Reiss, 1995, pp.2130;
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Bandawe & Foster, 1996, pp.223-232). Models should also include anticipated 
regret variables for behaviours which have a high expected influence of moral 
norms (Parker et al., 1995, p. 134). Although role belief has been proven to make a 
significant contribution to the prediction of behavioural intentions, it should not be 
included in the model. Role beliefs are difficult to change as they are based on the 
person's individual status in society. The existing diversity of role beliefs should 
therefore be well represented in the target population to be investigated.
The literature suggests that it is important to consider personal factors such as stage 
of one’s life-cycle, occupation, age, income and lifestyle, separately from attitudinal 
variables (Conner, 1993, pp.235-238). However, they should not be included in the 
model as they are not alterable (Kassatjian & Sheffet, 1981, pp. 160-180). They 
should, however, be taken into consideration when composing the target-group.
The perceived difficulty of performing the behaviour should be included as it has 
been proven that this has a direct influence on behavioural intention and is not 
covered by perceived behavioural control (Sparks et al., 1997, pp.418-438). 
Consumer personality may also shape responsiveness to persuasive 
communications. Persons scoring high in need for cognition display greater 
sensitivity to peripheral message cues such as source attractiveness (Haugvedt et al., 
1992, pp.239-260). Personality traits improve the ability to predict behaviour only 
marginally (Mischel, 1983, pp.252-283) and should therefore be left out in order not 
to complicate the model unnecessarily.
Most studies confirm that habit resting on previous behaviour is an important 
influential factor of behavioural intention and behaviour (Pare & Elam, 1995, 
pp.215-228; Echebarria-Echebe & Valencia-Garate, 1994, pp.285-293).
Specifically, it has been suggested that knowledge gained from past behaviour will 
help to shape behavioural intention (Eagly & Chaiken, 1993; Ajzen & Fishbein,
1980), partly because experience makes knowledge more accessible in memory 
(Fazio et al., 1982; Regan & Fazio, 1977) and also because past experience may 
make low probability events more salient, ensuring that they are accounted for in 
the formation of intentions (Ajzen & Fishbein, 1980). The model should therefore
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cover past behaviour even though it can be very resistant to change (McKenna,
1994, p.282).
Of the psychological factors there is no need to include motivation in the model if 
the target groups to be studied are comparable and are a true reflection of the entire 
population to be studied. The importance of motivation was clearly demonstrated 
by Petty et al. (1983, pp. 135-146). It might be argued therefore that differences in 
consumer’s motivational state during message processing might blur the study 
results. However, it is still believed that motivation can be omitted if, in addition to 
studying a properly representative group, the research questions attract comparable 
motivation from all investigated groups. Thus, indications which require treatment 
by the physician should be included in the questionnaire in order to guarantee a 
reasonable level of motivation.
Perception should be covered by performing the study in the real world or under 
experimental conditions which reflect reality. Learning may change the individual's 
behaviour because of new experiences. In our model it can be left out as long as the 
group studied and the reference group are not asked to participate in a clinical study 
and thus will not be directly involved in a process of learning. The influence of 
new information has to be taken into account as it might change beliefs. This item 
should be treated with special care during the study as the additional information, 
which will be offered to one of the groups, may contain new information. From the 
entire number of beliefs which an individual holds, the model should cover the first 
five to nine modal salient beliefs (Fishbein & Ajzen, 1975, p.219). All other beliefs 
can be ignored as an individual is able to treat up to nine beliefs only and because 
the most salient ones have been proven to have the most pronounced influence on 
behavioural intention (Petkova et al., 1995, pp.463-483).
There are differences in the literature about the place of values in behavioural 
science. Fishbein and Ajzen’s theory of reasoned action (1975) and Rokeach’s 
belief system theory (1973) recognise attitudes as a function of values. However, 
Fishbein places no importance on attitudes toward objects but directs his attitude
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concept toward behaviour. Rokeach maintains that objects and events should be the 
sole focus of attitudes. However, as values are the consequences of encounters with 
cultural, institutional, and personal forces, they change only gradually over time. 
Therefore the groups studied should be analysed as to their values and the velocity 
by which the values change (Vinson et al., 1977, pp.44-50). The model should 
measure the influence if those changes are expected to become significant over 
time. Attitudes should be treated as behavioural beliefs combined with outcome 
evaluation (Krahe & Reiss, 1995, p.2122). Attitudes are difficult to change but they 
should be taken into consideration as they have a pronounced role as predictor of 
behavioural intention (Krahe & Reiss, 1995, p.2130).
It can thus be concluded that the model best suited to test the influence of 
determinants of behaviour should include the following seven factors:
• attitudes,
• anticipated regret variables,
• behavioural beliefs, together with outcome evaluation,
• normative beliefs, together with motivation to comply,
• anticipated regret variables,
• habit, and
• perceived behavioural control covering the perceived ease or difficulty of 
performing the intended behaviour.
The influence of culture, new information and time should be well controlled during 
the study.
The model of the theory of reasoned action, developed by Fishbein and Ajzen 
(1975), has proven cultural validity although less significantly than the model of 
planned behaviour or interpersonal behaviour (Godin et al., 1996, pp. 1556-1586). 
Furthermore it covers subjective norms that are the outcome of normative beliefs 
multiplied by the motivation to comply with the norms. The criticism that the 
model lacks a measurement about a person's beliefs about right and wrong seems 
invalid, as this should be adequately covered by subjective norms. The model 
covers five to nine most salient beliefs, which Fishbein and Ajzen define as those
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attitudes which are the product of the multiplication of behavioural beliefs with 
outcome evaluation.
The model covers attitudes toward the behaviour only and not attitudes toward 
targets. Attitudes toward targets, according to Fishbein and Ajzen (1975), as well 
as other variables, affect behaviour only through the more proximal determinants of 
behaviour specified in the model. This position has been challenged frequently as 
the majority of the variables that social scientists have regarded as important to 
behaviour are not covered by the model (Eagly & Chaiken, 1993, p. 169). Yang et 
al. (1994, p.83) proved that variables external to the model indirectly influence 
behavioural intention and behaviour.
Past behaviour has a significant influence on current behaviour. Its omission from 
the model of the theory of reasoned action makes the model less appropriate for the 
current research problem. Past behaviour should therefore be added to the model if 
it is to be used for this research. Perceived difficulty to perform the behaviour is 
also lacking and this factor is expected to have an important influence when 
behaviour is only partly volitional. As the aim of this research is to study partly 
non-volitional behaviour, a high expected influence of moral norms could be 
expected. The omission of anticipated regret variables therefore makes the model 
of the theory of reasoned action inappropriate for this research.
The cross-validity of the model of reasoned action as extended by Bentler and 
Speckart, has not yet been proven. However, this should not prevent the use of this 
model during this research as long as different cultures are well represented by the 
subjects studied. The model includes the influence of normative beliefs on actual 
behaviour via behavioural intention. This seems appropriate, as no direct influence 
of normative beliefs on behaviour has been demonstrated. There is no difference 
with respect to the inclusion of beliefs between the model of reasoned action and 
the model of Bentler and Speckart. Thus the influence of normative beliefs on 
behaviour should be sufficiently covered. Past behaviour or habit can have a direct 
influence on behaviour, as well as an indirect influence via behavioural intention.
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Both tracks are included in the model of Bentler and Speckart. The addition of 
habit increases the predictive power of the model (Bentler & Speckart, 1981, 
pp.226-238).
Attention should be paid to measurement of the influence of past behaviour. 
Difficulties are reported in the design of adequate measures of habit as the outcome 
is frequently blurred by the inclusion of other factors that influence behaviour. An 
improvement has been the addition of a measurement model for each variable using 
confirmatory factor analysis (Bentler, 1980, pp.419-456). The effect of 
unreliabilities in the measured variables from the regression coefficients that 
estimate the relations between the terms of the model could be reduced. The model 
of Bentler and Speckart lacks two other important determinants of behaviour, 
perceived difficulty to perform the behaviour and anticipated regret variables. This 
may be the reason that the model of Bentler and Speckart has been demonstrated to 
explain only approximately half of the behaviour in markets where behaviour is 
only partly volitional (Denig et al., 1988, pp. 1385-1386).
A relatively neglected area of consumer behaviour, the pursuit of goals, is addressed 
by Bagozzi and Warshaw (1990, p. 127). Their model of the theory of goal pursuit, 
based on Fishbein’s theory of planned behaviour, includes a specification of three 
dimensions of attitude: attitude towards success, failure, and the process of trying.
It covers the inclusion of self-efficacy judgements as expectations of success and 
failure. The third component acknowledges people’s expectations that achieving 
desired outcomes requires certain instrumental actions, which are positively or 
negatively evaluated. Its approach to the searched expectancy value model is 
therefore better than either the model of the theory of reasoned action or the related 
model of Bentler and Speckart. Although its validity in different cultural settings 
has not been estimated, this should not be a limitation if the correct subject selection 
is made. Subjective norms are partly covered in the model by a determinant that 
measures the other's expectations concerning one's trying to attain a goal.
Normative beliefs, one of the two determinants of subjective norms, are expected to 
determine the outcome of the evaluation of the others’ expectations. However,
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what is lacking in the model is the impact of the person's motivation to comply with 
these norms. The attitude toward the process involved in trying covers the 
perceived difficulty of performing the behaviour. Anticipated regret variables are 
covered by the measurement of the attitude toward (unsuccessful attainment of the 
goal weighted by the perceived likelihood of failure or success and the assumed 
consequences. Direct measurement of the influence of past behaviour is also 
lacking in this model. Habit is expected to influence the attitude towards 
(unsuccessful attainment of the goal but knowledge of its direct influence on 
behaviour is important when searching for the best way to influence behaviour.
The fact that the model lacks any determination of a hierarchy of goals seems less 
important for the current research problem (Eagly & Chaiken, 1993, p. 192), as it is 
not the aim to meet the customer's goal but to change the behaviour of the customer 
to accept the goal offered. Attitudes should be sufficiently covered by the 
determinant attitude toward trying to attain the goal. More difficult is the 
measurement of the five to nine most salient beliefs. It can be argued that these are 
covered partly by the normative beliefs, being part of subjective norms, and partly 
by behavioural beliefs, being part of attitudes. Because the most salient beliefs are 
not measured directly, strategies to change behaviour cannot be focused on these 
most salient beliefs with this model.
The model of the theory of planned behaviour, developed by Ajzen (1985, pp.ll- 
39) has proven cross-cultural validity (Godin et al., 1996, pp. 1556-1586). The 
model covers both attitudes towards the behaviour and subjective norms, defined as 
the outcome of the product of normative beliefs and motivation to comply. The five 
to nine most salient beliefs are not included individually but are expected to exert 
their influence on behaviour via perceived behavioural control and attitudes towards 
the behaviour. This does not meet the needs of the current research, where 
knowledge of the importance of the individual beliefs is needed in order to 
determine the best strategy to change behaviour (Taylor & Todd, 1995, p. 152). In 
the theory of planned behaviour one's perception of how easy or difficult it is to 
perform a behaviour is called perceived behavioural control. Ajzen states that 
perceived behavioural control influences behaviour via behavioural intention only.
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This model thus departs from the premise that there is no direct influence of 
perceived behavioural control on behaviour. This seems correct for positively 
evaluated behaviours but may not be true for behaviours which are negatively 
evaluated. Millstein (1996, pp.398-402) demonstrated such a direct effect of 
perceived behavioural control on behaviour. Perceived difficulty to perform the 
behaviour is not measured directly by the model but is expected to act via perceived 
behavioural control. This is a weak point of this model as knowledge about the 
perceived difficulties can assist in the development of tactics to overcome this 
hurdle. Past behaviour is also not covered directly by the model which may account 
for the low correlation which is found between behavioural intention and overt 
behaviour (Giles & Cairns, 1996, pp.299-305).
Ajzen claims that the model of the theory of planned behaviour should predict 
adequately non-fiilly-volitional behaviour. When behaviours violate the assumption 
of volitional control, the model of the theory of planned behaviour has been shown 
to be superior to the model of the theory of reasoned action (Madden et al., 1992, 
pp.2-9). Behaviour which is not fully volitional is relatively strongly influenced by 
moral norms, which themselves influence anticipated regret variables. The 
omission of the latter determinant from the model of the theory of planned 
behaviour makes the model less useful in research of non-volitional behaviour.
The theory of interpersonal behaviour, developed by Triandis (1977; 1980, pp. 195- 
259), has proven intercultural validity (Godin et al., 1996, pp. 1556-1586). The 
model includes the influence of past experience on behaviour. Personal normative 
beliefs are expected to cover attitudes. Norms are embedded by subjective norms 
or normative beliefs multiplied by the motivation to comply. Perceived difficulty to 
perform the behaviour is also included and called facilitating conditions. The model 
only indirectly covers the most salient beliefs. Their influence is measured partly 
via cognition, which measures the subject’s personal evaluation of the 
consequences of performing the behaviour, partly via affect (feelings of pleasure or 
displeasure) and partly via personal normative beliefs. The importance of the 
addition of the affect component has been demonstrated in several studies (Bamum,
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1993; Chan & Fishbein, 1993, pp. 1455-1470). The contribution of the individual 
salient beliefs to the behaviour is not determined. This is a disadvantage of the 
model when developing a strategy for behavioural change.
The model of the theory of spontaneous or automatic processing (Fazio, 1986, 
pp.204-243; Fazio et al., 1983) has not been tested for cross-cultural validity. 
Therefore, in addition to a rigid control of the influence of new information and 
time on the outcome of the research, the influence of culture would need to be well 
monitored during the study if this model were used. Norms are measured by the 
model as an influence on behaviour via definition of the situation. Measurement of 
the accessibility of attitudes gives only some indirect information about the 
influence of the most salient beliefs on behaviour. This is considered a weak point 
of the model if the results are to be used to develop strategies to change overt 
behaviour. Perceived difficulty to perform the behaviour is included in the model 
as definition of the situation. However, this is also influenced by norms and 
therefore the significance of facilitating conditions on the behaviour remains 
unclear. Anticipated regret variables are also mediated via definition of the 
situation. Thus any feeling of regret that might hamper engagement in the 
behaviour cannot be measured directly. The model measures the rate of 
accessibility of the attitude and thus it does not reveal directly the influence of habit 
on actual behaviour.
The composite attitude behaviour model developed in 1993 by Eagly and Chaiken, 
although not yet validated, seems to be the most appropriate for this research 
project. The model sees attitudes toward the intended behaviour as a product of 
habit, attitude toward the target, beliefs, subjective norms and perceived 
behavioural control. The model also accepts a direct influence of habits on 
behaviour, and of subjective norms and perceived behavioural control on 
behavioural intention. The attitude toward target variable is meant to encompass 
beliefs associated with such attitudes (Eagly & Chaiken, 1993, p.218). The model 
includes Triandis’s description of past behaviour as sequences of behaviour that 
have become relatively automatic and which do not need any self-instruction
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(Triandis, 1977; 1980, pp. 195-259). Beliefs in the composite attitude model are 
called utilitarian outcomes which cover the most salient beliefs related to the target 
and which can be measured individually. Knowledge of the strengths of the 
individual’s most salient beliefs is needed in order to develop strategies for attitude 
change, although the evaluative content of people’s beliefs about attitude objects are 
usually moderately consistent with their attitudes. Perceived behavioural control is 
covered by the model and is called self-identity outcomes. The particular 
configuration of emotions that becomes activated at the thought of the behaviour, 
defined by Triandis as affective term (Triandis, 1977, p. 16), is not included in the 
composite model. Eagly and Chaiken defended this position with the argument that 
the inclusion of emotional reactions has not been proven to predict intentions and 
behaviours consistently better than the Fishbein and Ajzen models (Eagly & 
Chaiken, 1993, p. 180). Although most data in literature suggest that a single factor 
can account for variances in attitude and affect, the conclusion is not uniform. In 
order to be able to measure its significance, affect should consequently be added to 
the composite attitude behaviour model if it is to be used for this research.
The expectancy value models are not the only known combinational theories of 
attitude formation and change. There is also the probabilogical model and models 
of the information integration theory (Anderson, 1991). The probabilogical model 
predicts changes in beliefs that occur when people hold certain logically related 
beliefs. It examines the general proposition that the relations among beliefs obey 
the laws of mathematical probability theory. The main idea of the model is that 
people align conclusions in a logical fashion with premises that come to mind, 
when logic is defined mathematically according to the principles of probability. 
Although conditional inferences play an important role in persuasion, they should 
be regarded as only one of a variety of inference processes that have been 
postulated to underlie belief change and therefore this model is less appropriate for 
the resolution of this research problem. The information integration theory 
presumes that attitudes and beliefs are formed and modified as people receive and 
interpret new information and integrate it with prior attitudes and beliefs. As this 
research will investigate the possibilities to influence customer behaviour without
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providing new information, the models of the information integration theory are less 
appropriate than the expectancy value models.
Models of change can be used both to understand the prescription behaviour of 
physicians and to guide the development and implementation of interventions 
intended to influence behaviour. Some models are concerned purely with 
behaviour, illuminating individual reactions to changing circumstances (e.g., the 
learning theory), while some focus on beliefs and attitudes, and others map a variety 
of social and economic influences in the environment. Perceived benefits weighed 
against perceived barriers, perceptions about the attitudes of important others to the 
behaviour and self-efficacy, or the belief in one’s ability to perform a particular 
behaviour are sets of beliefs that have been reported in the literature as being 
important in determining behaviour. Modification of these factors represents an 
important route for influencing the behaviour of physicians. The models of social 
cognition theory see factors such as beliefs, attitudes, and intentions, as central 
influences in shaping behaviour and thus seem to cover these three sets of beliefs. 
These models, known as the expectancy value models, have met difficulties in 
achieving validation for behaviours which are characterised by a lack of control. 
Expectancy value models have been extended in an attempt to encompass non- 
fiilly-volitional control. Literature suggests that this has been only partly successful.
The composite attitude behaviour model developed by Eagly and Chaiken in 1993, 
seems to encompass non-fiilly-volitional behaviour as it includes factors which are 
considered to influence control over behaviour. Based on the above-mentioned 
argumentation, it was decided to use the composite attitude behaviour model to 
explore the research problem. The construct of attitude toward targets of the model 
was, for the purpose of this research, further subdivided into anticipated regret 
variables and emotional reactions or Triandis’ affective term, as the literature 
suggests that the latter might on its own be a significant determinant of the rate of 
anchoring of physicians beliefs.
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2.5. Research model
The model used to study the research problem is based on the argumentation, 
mentioned in 2.4., and the model described in section 2.3.7. of this thesis, namely 
the composite attitude behaviour model as developed by Eagly and Chaiken, 
extended by the inclusion of Triandis affective term. It can be argued that the 
separate inclusion of emotional reaction is not a real extension but a separation of 
this affective term from Eagly and Chaiken’s attitude toward target. Ostrom (1969, 
pp. 12-30) and Kothandapani (1971, pp. 321-333) both concluded that the affective 
and cognitive factors, although distinguishable from each other, were interrelated.
In this research model the division will be used in order to measure more adequately 
the influence of the affective term on its own, as the associations between affect and 
cognition might be overestimated by relying on self-report measures of the different 
components in cases where the attitude object is physically absent (Breckler, 1984, 
pp. 1191-1205). Past behaviour is regarded as sequences of behaviours that have 
become relatively automatic so that they occur without self-instruction (Triandis, 
1977; 1980, pp. 195-259). The anticipated outcomes, divided by Eagly and 
Chaiken into utilitarian, normative and self-identity outcomes, were further broken 
down to their basic determinants in this research model. Utilitarian outcomes are 
sub-divided into behavioural beliefs and outcome evaluation, and normative 
outcomes into normative beliefs and motivation to comply. Self-identity is not 
further broken down but labelled anticipated regret variables. This research model 
also encompasses Fazio’s steps of selective perception and immediate perceptions 
of the attitude object (1986, pp. 204-243) by defining attitude toward the target as 
the evaluative content of people’s beliefs about attitude objects, which is usually at 
least moderately consistent with their attitudes (Eagly & Chaiken, 1993, p. 218). 
Ajzen’s concept of perceived behavioural control (1988) or perceived difficulty to 
perform the behaviour is frilly covered by attitude toward the behaviour. This 
determinant also covers Bandura’s concept of self-efficacy, which is characterised 
by the conviction that a person is able to perform a certain behaviour successfully 
(Bandura,1977, p.193; Bandura, 1982, pp. 122-147; Bandura et al.,1977, pp. 125- 
139; Bandura et al., 1980, pp. 39-66; McCaul et al., 1988, pp. 114-128). Beliefs
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about the likelihood that one has enough resources to control the behaviour are 
believed to influence perceived behavioural control. Thus, the attitude toward the 
behaviour is defined by Eagly and Chaiken as salient beliefs concerning the degree 
of control over the behaviour. Attitudes toward behaviour include the idea that 
people orient their behaviours to goals as described in the theory of goal pursuit 
(Eagly & Chaiken, 1993, p.211). Attitudes toward behaviour thus represent goals 
toward which the individual has a positive attitude. Eagly and Chaiken’s view that 
attitudes toward targets do not have a direct impact on behaviour but only influence 
behaviour indirectly via attitudes will be followed. This is because behavioural 
choices require the person to use some cognitive process to convert his or her 
evaluation of a target into attitude toward the behaviour.
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Figure 11 : Representation of the model of the theory of planned behaviour
and the decomposed composite attitude behaviour model:
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2.6. Conclusion
The model of the theory of planned behaviour, which includes the perceived 
behavioural control term, has been proven to predict behaviour better than the 
model of the theory of reasoned action in situations of non-fiilly-volitional 
behaviour. The theory of planned behaviour is clearly more successful in predicting 
behaviours in domains where skills and resources are required and the behaviour 
does not occur merely because people decide to act. However, scrutiny of study 
results shows that, although the addition of perceived behavioural control results in 
a more comprehensive model, its predictive power for overt behaviour is still 
relatively low. The model of the theory of spontaneous and automatic processing is 
not an alternative to the theory of reasoned action and related models, as Fazio 
suggested, because the model elaborates some of the more distal determinants of 
behaviour. It concentrates on attitudes towards targets, which are distal or external 
to the attitudes toward behaviour, as they are included in the theory of reasoned 
action and related models. The model of the theory of goal pursuit approaches the 
prediction of behaviour as mental and physical processes that intervene between 
intention to attain an outcome and the actual attainment of it. This model, like all 
nested models of the expectancy value theory, discloses only some of the relevant 
factors leading to the formation of behaviour and does not inform us of their 
individual weight. The development of a strategy for behavioural change will be 
impossible if some of the most salient factors of behaviour formation remain 
unclear.
The composite attitude behaviour model, developed by Eagly and Chaiken, seemed 
the best suited for this research. It includes all the important determinants of non- 
fiilly volitional behaviour mentioned in the literature, such as habit, attitude towards 
the target, perceived behavioural control, normative beliefs and motivation to 
comply, and behavioural beliefs and outcome evaluation. Emotional reactions were 
added in order to cover also the affective term, as described by Triandis. During the 
pilot study to prove that the prescription behaviour of physicians is not fully
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volitional, these emotional reactions proved to be important (for more details see 
Chapter 3 of this thesis).
The composite attitude behaviour model has not been validated yet. However the 
model is a composite of the models of the theories of reasoned action, planned 
behaviour and interpersonal behaviour which have been validated individually. A 
pilot study confirmed that physicians display non-fiilly volitional behaviour when 
they intend to change their prescription habit concerning anti-depressants and anti­
hypertensives., see chapter three of this thesis. This field study confirmed that 
physicians could be used as subjects to be studied as they demonstrate non-fiilly 
volitional behaviour while considering changing their prescription habit. The 
research can consequently move on to the next stage as planned
2.7. Immediate discipline, research questions and hypotheses
This research addresses a marketplace in which the customer shows non-fiilly- 
volitional behaviour. The buying decision process is influenced by, among others, 
subjective norms, environmental factors, and/or a limited availability of resources 
(e.g., budget). Some limiting factors can be easily revealed while others remain 
hidden. Those hidden determinants of a customer's behaviour can undo most of the 
projected impact of the presentation of external stimuli. Revealing the critical 
determinants factors of customer behaviour becomes even more important in a 
marketplace where the influence of marketing activities can only be measured 
indirectly or after some time. Thus, in the pharmaceutical prescription market, it is 
the physician who prescribes but the pharmacist who dispenses. The physician may 
express to the sales representative of the pharmaceutical company a product- 
favourable behavioural intention, but this may be in conflict with the subsequent 
prescription behaviour recorded by the dispensing pharmacists.
The influence of promotional activities of a sales representative in the 
pharmaceutical industry can only be measured after a significant time lag, by 
analysis of the sales of dispensing pharmacists. Sales representatives need to
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highlight those product features that influence the actual prescribing behaviour of 
the physician in order not to lose precious time. This research project set out to 
investigate the determinants of the physician’s actual prescription behaviour and the 
elements able to trigger prescribing behavioural change. The days of companies 
concentrating on their product’s features in their promotional messages, might be 
behind us. However, the low relation between behavioural intention and actual 
behaviour highlights the fact that not all the factors which influence the decision 
process are covered adequately by existing expectancy value models. The low 
correlation between behavioural intention and actual behaviour might trigger a 
process of decreasing motivation of pharmaceutical sales representatives, may make 
it difficult for sick funds to obtain the desired cost-savings and for hospitals to stay 
within their budget for pharmaceuticals.
The relevant contemporary theories in the customer behaviour area, that were 
reviewed in the first part of this chapter, describe variables that play a central role in 
the process of formation of actual behaviour. There are considerable conceptual 
differences in the ways that these variables interact and play a role in the formation 
of behaviour. These differences in conceptual framework were ignored during the 
first part of the research, as the first objective was to identify all the factors that 
influence customer behaviour. Thus, the view of Fishbein and Ajzen (1975, p. 16), 
that specific behaviour is only determined by the person's intention to perform that 
behaviour, was rejected, as it would not allow us to disclose all relevant factors that 
could be manipulated in order to change non-fully-volitional behaviour.
Several theories can be classified at the conceptual level as dealing with the 
formation of behaviour. Most of them deal with only some determinants of 
behaviour, such as the dissonance and attribution theories that deal with beliefs 
only. Other theories specify causal relations such as the theory behind the 
expectancy value models and the attribution theory or specify dynamic 
interrelations among variables such as the balance and dissonance theories. No 
specific theory has been followed here, so as not to limit the scope of the search for 
determinants of behaviour. Descriptive beliefs were not taken into consideration as
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there is little evidence that personal factors such as beliefs, desires, attitudes, or 
personal characteristics have any systematic effect on the formation of descriptive 
beliefs (Fishbein & Ajzen, 1975, p.213). Inferential beliefs were included, as 
individuals are known to form new beliefs through some judgement process on the 
basis of new information such as beliefs about an object, person, or action. 
Attitudes are formed on the basis of beliefs. Attitude formation, and thus the 
process of formation of behaviour, cannot be followed when its informational base, 
such as beliefs, is not understood (Fishbein & Ajzen, 1975, p.284). Therefore, 
Fishbein and Ajzen suggest to measure five to nine most salient beliefs in order to 
understand the attitude construct. Anticipated regret variables should be measured 
if the behaviours to be investigated have a high expected influence of moral norms. 
Non-fiilly-volitional behaviours are expected to be frequently influenced by 
normative beliefs. The model to be used to analyse the influence of the individual 
factors on behaviour should therefore include, in addition to attitude, the most 
salient behavioural beliefs and outcome evaluation.
The first research question is therefore:
Does a model exist to unveil the most salient determinants o f non-fullv volitional 
customer behaviour?
Conditional inferences, although playing an important role in persuasion, should be 
regarded as one of the many inference processes that have been postulated to 
underlie belief change. The probabilogical model was therefore rejected as proper 
for this research. The models of the information integration theory were rejected as 
they try to identify the influence of new information on attitudes and beliefs; this is 
beyond the scope of this research. The seven most nested models of the expectancy 
value theory were evaluated in Chapter 2. The composite attitude behaviour model 
which is a combination of the expectancy value models of the theories of reasoned 
action extended by Bentler and Speckart, planned behaviour and interpersonal 
behaviour, seems most suited for this research as it includes subjective norms, past 
behaviour, attitudes, perceived behavioural control, and behavioural beliefs which 
cover as well anticipated regret variables. An affective element will be added to the
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model. Eagly and Chaiken (1993, p.211) highlighted several times that the 
integrative framework of their composite attitude behavioural model emphasises 
that the relation between attitudes and behaviour is best understood by placing 
attitudes in the context o f ‘other’ psychological factors that also determine 
behaviour. Habits, norms, and also emotional reactions can be considered such 
‘other’ psychological factors. The composite attitude behaviour model is thus 
expected to be able to reveal the major determinants of non-fully-volitional 
behaviour.
Choice o f the market
A market which is appropriate for the validation of the model must be determined 
as the next step.
A search for possibilities to change non-fully volitional customer behaviour is the 
purpose of this research. Change can only be measured over time. This means that 
the conditions in the market-segment to be investigated should be stable. Items 
such as the influence of the availability of new information about the products to be 
investigated, the launch of new products, changes of customer's needs or purchasing 
power over time, and of product availability during the period of the study, should 
be well controlled and neutralised.
The industrial market and the market for specialty goods are two examples of 
suitable markets for this research. Conditions in these markets change less rapidly 
than in the market for convenience goods. The pharmaceutical market seems 
therefore a good research ground as new product launches in the medical field are 
not so frequent and their influence is gradual and measurable. Change of market 
conditions such as the introduction or changes of a reimbursement list can also be 
measured adequately.
The market to be investigated should also be characterised by non-fully volitional 
behaviour. Again, the pharmaceutical market satisfies those conditions. Physicians
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are limited in their choice of products to be prescribed by negative or positive lists 
of sick funds, hospital formularies, or purchase policy of the supplying pharmacist.
Non-fully-volitional behaviour is characterised by a rather strong influence of 
normative beliefs on customer behaviour. The influence of normative beliefs on the 
prescription habits of physicians is unknown. Another characteristic of non-fully- 
volitional behaviour is that the inclusion of perceived behavioural control in an 
expectancy value model adds to the prediction of behavioural intention. 
Furthermore, the correlation between behavioural intention and behaviour is rather 
low. A small study was performed in order to ensure that the market segment, 
selected for this research, is characterised by these phenomena. The results of this 
study are presented in Chapter 3 of this thesis.
It should be possible to measure the results of the manipulation of determinants of 
customer behaviour. Overt behaviour before and after manipulation of the factor 
should be measured while excluding the influence of other factors that might blur 
the outcome. The pharmaceutical market meets those requirements. The 
prescription pattern of a physician can be measured by analysing, via the dispensing 
pharmacist, the prescriptions issued for treatment of a certain indication. Changes 
in morbidity can be eliminated when concentrating on one or two indications only. 
A change in morbidity will influence the total number of prescriptions issued for a 
certain indication but will not influence the market share of a certain product.
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The corresponding research question is:
Can manipulating the most salient determinants o f such behaviour chanee non-fullv 
volitional customer behaviour?
Marketing stimuli, such as promotional messages, aim to change non-favourable 
customer behaviour. They will not be very successful if those marketing stimuli 
focus on non-salient determinants of customer behaviour. The marketer who uses 
marketing stimuli that aim to changing the most salient determinants of non-fully 
volitional behaviour may be more successful than colleagues who do not.
Therefore, the third research question is:
Does the impact o f marketing stimuli in markets where customers' behaviour is only 
vartlv volitional improve when those stimuli are focused on changing the most 
salient determinants o f such behaviour?
To summarise, the three research questions are:
1. Does a model exist to unveil the most salient determinants o f non-fullv 
volitional customer behaviour?
2. Can manipulating the most salient determinants o f such behaviour chanee non- 
fullv volitional customer behaviour?
3. Does the impact o f marketing stimuli in markets where customers' behaviour is 
only vartlv volitional improve when those stimuli are focused on changing the 
most salient determinants o f such behaviour?
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The corresponding null hypotheses are:
Hoa If the composite attitude behaviour model** according to Eagly and
Chaiken is not used instead of the model of the theory of planned 
behaviour*, according to Ajzen. then not a greater number of determinants 
of non volitional behaviour will be reveiled.
Hia If the composite attitude behaviour model** according to Eagly and
Chaiken is used instead of the model of the theory of planned behaviour*, 
according to Aizen. then a greater number of determinants of non volitional 
behaviour will be reveiled.
H ob if the most salient determinants of non-volitional behaviour are not exposed
to promotional expressions then they will not alter in magnitude
H ib if the most salient determinants of non-volitional behaviour are exposed to
promotional expressions then they will alter in magnitude
Hoc If promotional tools do not influence the most salient determinant of non-
volitional behaviour then they do not change overt customer behaviour
H ic if  promotional tools influence the most salient determinant of non-volitional
behaviour then they also change overt customer behaviour
* Ajzen (1985)
** Eagly and Chaiken (1993)
116
2.8. The expected findings and their implications
This research is expected to lead to a better understanding of the determinants of 
customers’ buying behaviour in a market segment dominated by regulations and 
restrictions. It will demonstrate that external stimuli can be developed and used 
with success to diminish the rigidity of non-volitional behaviour towards change if 
those stimuli are focused on the most salient determinant of that behaviour.
This research aims to contribute to the body of knowledge about the determinants of 
non-volitional behaviour and its rigidity to change. If the composite attitude 
behaviour model, developed by Eagly and Chaiken, can be validated, it can become 
a preferred alternative to the expectancy model of the theory of planned behaviour 
where non-volitional behaviour is concerned. It might lead to a better 
understanding of the rigidity to change of non-volitional behaviour.
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3.1. Introduction
This research on the prescribing behaviour of physicians can only be carried out if it 
can be confirmed that this behaviour is non-fully-volitional. Non-fully-volitional 
behaviour is characterised by a rather strong influence of normative beliefs on 
customer behaviour. The available literature in this area is rather limited. Denig et 
al. (1993, p.920), in a study carried out in a university hospital in the Netherlands, 
found that the views of colleagues were rather important for physicians when 
prescribing medicines. Few other studies have reported the importance of 
normative beliefs in other settings in the prescription medicine field (Segal & 
Hepler, 1985, pp.967-976; Chinburapa & Larson, 1988, pp.3-18; Denig et al., 1988, 
pp. 1381-1386) but due to the limitations of these studies it is not clear whether the 
results can be generalised.
In addition to normative beliefs, perceived behavioural control is a second 
determinant of the degree of behavioural volition. Recent research suggests that 
the addition of perceived behavioural control to expectancy value models will 
improve the prediction of behaviour if that behaviour is not folly volitional (Schiffer 
& Ajzen, 1985, pp.843-851; Ajzen & Madden 1986, pp.453-474; Ajzen, 1988; 
Jurgens, 1998). Any incremental accuracy in predicting behaviour provided by 
perceived behavioural control depends on the degree of volitional control one has 
over the behaviour (Madden et al.,1992, pp.3-9). Perceived behavioural control 
obtains a low rating when people believe that they lack the resources or 
opportunities to perform a behaviour. They are unlikely to form strong intentions to 
perform the behaviour as perceived behavioural control is thought to directly 
influence behavioural intention. However, perceived behavioural control is also 
directly related to behaviour if the behaviour is not under folly volitional control 
(Engel et al., 1995, pp.389-390).
119
Behaviour that is not fully under the volitional control of the physician is thus 
characterised by four factors:
• a rather strong influence of normative beliefs on behavioural intention.
• an improvement in the prediction of the intention to behave in a particular way 
when a perceived behavioural control is added to the variables.
• perceived behavioural control yields low ratings when people believe that they 
lack the resources or opportunities to behave in a particular way.
• perceived behavioural control is also linked to behaviour if the behaviour itself 
is not fully volitional, as stated above (Engel et al., 1995, pp.389-390). Non- 
fully-volitional behaviour is thus characterised by a considerable influence of 
perceived behavioural control on behavioural intention and, because of the 
direct influence of perceived behavioural control on behaviour, also by a low 
correlation between stated and observed behaviour.
Since the literature is not clear about the volition of prescription behaviour of 
physicians and since the absence of foil volition might influence the nature and 
impact of external stimuli, it is important to examine the extent to which the 
influence of this non-folly-volitional behaviour can be supported empirically. It is 
thus hypothesised that the prediction of the intention to prescribe in a particular way 
will be improved significantly when factors such as assumed peer group pressure 
and other external norms are taken into account. As a result, prescription behaviour 
will prove not to be folly volitional.
3.2. Organisation of the study of volition
The study was divided into a pre-test study to determine the salient beliefs of the 
physician population, carried out with 30 physicians in Athens, and a small-scale 
exploratory pilot study to examine the volitional nature of prescribing behaviour in 
a sample of 40 physicians throughout Greece.
It was decided that a questionnaire-based survey would best serve the purposes of 
this pilot study. There are about 21,200 physicians in Greece who work in a
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practice and prescribe pharmaceutical products. Of these, some 57% are specialists. 
For the pilot study, a stratified random sample of 18 general practitioners and 22 
specialists was drawn from the database of Solvay Pharma M.E.P.E., the Greek 
subsidiary of a major pharmaceutical company. The specialists included in the 
study were from two of the main specialisations: 13 cardiologists and nine 
neurologists/psychiatrists. The sample of general practitioners represented the main 
conurbations of the country. The physicians were visited personally by the 
investigator in order to explain the purpose of the study and to leave behind the 
questionnaire. They were asked to return the completed questionnaire to the 
investigator. The questionnaires were returned in June, July and August 1998. Co­
operation from target participants was exemplary, except for two physicians. One 
general practitioner refused to participate while one physician did not return the 
questionnaire. Analysis of the data was done on a SPSS 8.0 package for Windows.
3.3. Materials
e The pre-test study
An open-ended elicitation questionnaire based on the work of Ajzen and Fishbein 
(1980, pp.63-64) was administered in June 1998 to à sample of 15 specialists and 
15 general practitioners in Athens. Respondents were asked to list the advantages, 
disadvantages, and anything else associated with the costs of medicines that they 
considered when prescribing pharmaceutical products. To be included as a salient 
belief, an item had to be mentioned by at least 75 % of the sample. The researcher 
set this benchmark after peer group discussion, but it had no other methodological 
foundation. Five salient beliefs emerged and were included in the questionnaire 
used during the pilot study. During the same pre-test the participants were asked to 
list all possible anticipated outcomes of their considering the costs of medicines 
when prescribing. The five anticipated outcomes that were the most highly rated 
during the pre-test were included in the pilot study.
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• The pilot study
The questionnaire used in the pilot study comprised specific measures of the various
theoretical constructs as follows:
1. Behavioural Intention (BI) Respondents rated the statement "I estimate the daily 
therapy cost of a treatment every time I believe that I have to change the 
medicine that I prescribe" on a seven point Almost always -  Almost never 
scale.
2. Attitude toward the act (ATT): " The estimate of the daily therapy cost of a 
treatment every time I believe that I have to change the medicine that I 
prescribe, is to me: Amusing - Boring; Wise - Silly; Proper - Wrong; Pleasant - 
Unpleasant; Good - Bad; Useful - Damaging; and Moral -  Immoral”, was rated 
on a seven (7) point semantic differential scale. These items for inclusion in the 
attitude scale were identified during the pre-test. The internal consistency of 
this scale was high (Cronbach's alpha = 0.9083) and the sum of the seven items 
was taken as a proxy for attitude.
3. NORM. This variable was composed of the sum of the replies to two questions. 
"Many of the people whose opinion I value think that I (Should -Should not) 
estimate the daily therapy cost of a treatment every time I believe that I have to 
change the medicine that I prescribe" and “ I feel that it is my social duty to 
reduce the cost of a treatment that I will prescribe from now on”. Both questions 
were rated on seven (7) point Should - Should not and Agree - Disagree scales. 
This item was used as a proxy for normative and peer group pressure.
Subjective Norm (SN) was the multiplication of NORM and Motivation to 
comply (Me).
4. Evaluation of the anticipated outcomes (Oei), see evaluation of the consequence 
i (p. 72). Five outcomes of an "evaluation of the daily treatment costs of a 
medication before prescribing" were obtained from the pre-test. These were:
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reduce the cost for the sick funds, reduce the expenses of the patients, help me 
to take therapy costs into account in my clinical practice, improve my patients’ 
opinion about me, improve the sick fund’s opinion about me. Respondents in 
were asked to judge each of the outcomes on a seven (7) point Significant - 
Insignificant scale. The sum of the responses to the five items was adopted as 
the proxy for evaluation.
5. Behavioural belief strength (Bbi), see p. 72. The five items measured were the 
same as for the evaluation of outcomes (Oe): reduce the cost for the sick funds, 
reduce the expenses of the patients, help me to take therapy costs into account in 
my clinical practice, improve my patients’ opinion about me, improve the sick 
fund’s opinion about me. Respondents were asked to indicate the strengths of 
their belief that performing the behaviour would lead to each of these outcomes 
on a seven (7) point Almost always -  Almost never scale. The sum of the five 
items was taken to represent the strength of belief.
The sum of the cross products of the ten behavioural beliefs and their 
corresponding evaluations was also treated as an indirect measure of attitude 
and was denoted as EBbiOei. According to the theory of reasoned action 
(TRA), EBbiOei should be significantly correlated with ATT.
6. Normative beliefs (Nbj), see p. 71. Five important reference individuals and 
groups were identified from the pre-test. These were the pharmacists, 
colleagues, sick funds, patients, and opinion leaders. Respondents were asked 
to score what they thought each of these reference groups would wish them to 
do on a seven (7) point Almost always - Almost never scale. The sum of the 
five answers represents this belief.
7. Motivation to comply (Mcj), see p. 71. Respondents were also asked to indicate 
on a seven (7) point Almost always -  Almost never scale the likelihood that 
they would comply with the assumed wishes of each one of the same reference 
group. The sum of the five responses is used as the value for this variable.
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The cross products of the five normative beliefs and their corresponding 
motivations to comply was treated as an indirect measure of normative pressure 
and was denoted as ENbjMcj. According to the theory of reasoned action, 
ENbjMcj should be significantly correlated with NORM.
8. Perceived behavioural control (PBC). Respondents were asked to evaluate the 
extend to which taking into account the cost of treatment was within their own 
discretion. The three items (“Easy - Difficult”; “Is my choice -  Is not my 
choice”; “Depends on me - Depends on other people or incidents” measured on 
a seven (7) point scale, are in line with Ajzen and Madden (1986, pp. 453-474). 
The internal consistency of responses to this scale was acceptable (Cronbach’s 
alpha = 0.6977). The sum of the responses to the three items gave the value of 
Perceived Behavioural Control (PBC).
9. Emotional reaction (ER). Although no standardised set of items has been 
developed to assess ER, three items were used to capture Triandis idea of 
emotional reaction toward a behaviour. Respondents were asked to rate how 
they felt having to take account of costs in their prescriptions. The seven (7) 
point semantic differential scales were “Free - Oppressed”; “Comfortably - 
Abhorrence”; and “Pleasantly - Unpleasantly”. The internal consistency of this 
scale was high (Cronbach's alpha = 0.9119), and the sum of the responses of the 
three items was taken as a measure of emotional reaction. See Appendix A for 
a copy of the original Greek questionnaire and Appendix B for a translation of 
the questions into the English language.
3.4. The results of the pilot study
All individual measures making up the variables were re-coded onto a -3 to +3 
bipolar scale, before analysis. Table 4 shows the descriptive statistics for the 
variables measured. ATT, PBC and ER are totals of their components, while SN is 
the multiplication of the sum of the variables of norm (NORM) and the sum of the
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variables of motivation to comply (Me); Appendix C shows the full range of 
measurements before aggregation.
Table 4: Outline descriptive statistics
Variable Mean s.d
BI (Behavioural Intention)
ATT (Attitude)
SN (Subjective Norm)
PBC (Perceived Behavioural Control) 
ER (Emotional Reaction)
0.1316
5.6579
4.2895
3.6053
-0.8421
1.8912
8.5401
13.7839
3.9833
4.8520
Source: field work
Table 5: Pearson correlation coefficients between variables
BI ATT SN PBC
BI (Behavioural Intention)
ATT (Attitude) 0.704**
SN (Subjective Norm) -0.283 -0.483**
PBC (Perceived Behavioural Control) 0.685** 0.657** -0.345*
ER (Emotional Reaction) 0.840** 0.551** -0.054 0.676**
Notes: N = 38; *p <0.05; **p <0.01
Source: field work
It will be noted that Behavioural Intention (BI) is strongly correlated with 
Emotional Reaction (ER), Perceived Behavioural Control (PBC) and with Attitude 
(ATT) and is negatively related with Subjective Norm (SN).
To explore further the extent to which external influences contributed to explaining 
Behavioural Intention (BI), a series of regressions was carried out, singling out 
several variables; these regressions were hierarchical, using the "enter" method. 
Two sets of regressions were estimated. First, Behavioural Intention (BI) was 
regressed without the variable Emotional Reaction (ER) and then with it included.
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Table 6: Regression of Behavioural Intention (BI)
Dependent variable: 
Explanatory variables: Behavioural Intention (BI)
R F P<
Attitude (ATT) 0.704 35.373 0.001
Attitude, Perceived Behavioural Control 
(ATT, PBC)
0.763 24.449 0.001
Attitude, Perceived Behavioural Control and 
Subjective Norm (ATT, PBC, SN)
0.767 16.226 0.001
Source: field work Notes: N=38; sign =2-tail
It will be noted from Table 6 that all the coefficients of regression with Behavioural 
Intention (BI) are high, positive and statistically significant (p < 0.001). The 
contribution of Attitude (ATT), Perceived Behavioural Control (PBC) and 
Subjective Norm (SN) to the explanation of the variance is about 50%. The 
estimated R is in line with Ajzen’s (1991) review of twelve studies that predicted a 
variety of behaviours in other decision areas (playing video games, election 
participation, performing cognitive tasks, and shoplifting). A further regression was 
run, this time including Emotional Reaction (ER) among the independent variables, 
yielding the results presented in Table 7.
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Table 7: Regression of Behavioural Intention (BI), including Emotional
Reaction (ER)
Explanatory variables:
Dependent variable: 
Behavioural Intention (BI)
R F P<
0.001Attitude and Emotional Reaction 
(ATT, ER)
Attitude, Emotional Reaction and Perceived 
Behavioural Control (ATT, ER, PBC) 
Attitude, Emotional Reaction, Perceived
0.888
0.894 32.684
0.889 42.609
65.463
0.001
0.001
Behavioural Control and Subjective Norm 
(ATT, PBC, ER, SN)
Source: field work
It can be seen that the inclusion of the variable Emotional Reaction (ER) to the 
regression has made an important contribution to increasing the explanation of the 
variance by at least 20%, with R2 being almost 80%. As with the previous 
regression, all the coefficients were positive and statistically significant (p < 0.001).
3.5. Discussion
Thus, the evidence leads to the conclusion that the inclusion of the physicians' 
emotional reaction or affect toward the act (operationalised through the variable 
ER) makes an important contribution to the prediction of whether or not a physician 
will consider costs when writing a prescription. This configuration of emotions that 
becomes activated at the thought of a particular behaviour, was described by 
Triandis (1977, p. 16). Given that little has been written on the emotional 
determinants of attitude change in the health care sector, the findings of the present 
study open the door to further work, scaleable in size and in different settings. The 
inclusion of Subjective Norm (NORM x Motivation to comply) in the regression 
resulted in an increase in the explanatory power of the variables to 83 % of the 
variance (p < 0.001).
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If behaviour is not fully volitional there should be, according to Schifter and Ajzen 
(1985), Ajzen and Madden (1986) and to Ajzen (1988), an improvement in the 
prediction of behavioural intentions when perceived behavioural control is added to 
the expectancy value model. The evidence collected supported this expectation 
(see: Table 6 of this thesis) with an improvement in the explanation of the variance 
by about 10% (from 49.6 to 58.2 %). The inclusion of subjective norm (SN) made 
only a minor contribution to the explanation (less than 1%) of the variance. This 
confirms the findings of Bunce and Birdi (1998), who concluded that in 
circumstances of high behavioural control the theory of planned behaviour (ATT, 
PBC, SN) collapses to the theory of reasoned action (ATT, SN). It can therefore be 
concluded that the sample responded in accordance with the second characteristic of 
non-fully volitional behaviour.
Recent literature confirms that the intentions of physicians in terms of prescriptions 
are significantly associated with both attitudes and subjective norms but that these 
attitudes, subjective norms and behavioural intentions were not predictive of actual 
prescribing behaviour (Lambert et al., 1997).
Although it was the aim of this part of the study to confirm that physicians’ 
prescription behaviour is not fully volitional and thus to confirm the suitability of 
the research subjects, some other elements were discovered that are important for 
the research project.
The mean of one of the five items, comprising the normative beliefs index, differs 
importantly from the other factors. Physicians believe that they are under some 
pressure from the sick funds to take cost of medicines into consideration when 
prescribing drugs (M = 2.368). However, the motivation to comply with that 
pressure from sick funds is negative (M = - 0.105). It is therefore important to 
break down Subjective Norm not only into its two constituent elements but also 
further, as important differences might be discovered.
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The sum of the cross products of the five behavioural beliefs and their 
corresponding evaluations (£ = 8.071) could not be used as an indirect measure of 
attitude (M = 0.808) as the theory of reasoned action predicts. Also, the sum of the 
cross products of the five normative beliefs and their corresponding motivations to 
comply (E = 0.571) could not be treated as an indirect measure of normative 
pressure (M = 1.51). However, this equivalence of Subjective Norm (SN) and the 
sum of the cross products of normative beliefs and their corresponding motivations 
to comply (ENbMc), as Fishbein advocated, has been questioned already by 
Miniard and Cohen (1981, p. 319). They state that the two approaches to 
operationalising the normative component will not show corresponding results 
when the motivation to comply is negative for one or more referents. This was the 
case in this pilot study as the physicians showed a negative motivation to comply 
with the pressure of the sick funds to prescribe at lower costs. The non-equivalence 
found means that, during this research, no indirect measurements for attitude and 
subjective norm may be used.
3.6. Conclusion
The evidence examined leads to the conclusion that the physicians in the sample, 
although claiming that they are not willing to succumb to pressure from sick funds, 
are willing to be cost conscious when the patients ask them to do so and when 
patients pay for the medicine themselves. This study has therefore shown that if an 
analysis of behavioural intention and behaviour is to be undertaken, it is important 
to separate normative beliefs and the physician’s motivation to comply with the 
assumed wishes of a number of reference groups.
As in the case of attitudes and subjective norms, it was found that perceived 
behavioural control was related to an underlying set of salient beliefs. Although all 
beliefs scored positively, there could be important differences between them. 
Further, although not considered in detail here, they provide useful information 
about important contributors to determining behaviour that is not completely under 
volitional control.
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The influence of norms on behavioural intention; the improvement in prediction of 
this intention by adding perceived behavioural control and the significant influence 
of the control factor, lead to the conclusion that the prescribing behaviour of 
physicians is not fully volitional.
It was therefore concluded that the selected specialisation of physicians met the 
characteristics needed for this research and that this study could proceed to the next 
step, defining the methodology.
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CHAPTER 4 Context or research environment
4.1. Introduction
Chapter 4 describes the environment in which this research was conducted. It 
provides the information needed to evaluate the generalisability of the findings.
The restrictions which apply to prescribing and promoting pharmaceutical products 
after marketing authorisation has been obtained from the Greek regulatory 
authorities are described. The pricing of pharmaceutical products is discussed in 
the context of European Community law. The marketing practices of the 
pharmaceutical industry are discussed and the effects of promotional practices 
enumerated, in particular, what is known about the influence of promotional 
activities on prescribing behaviour of physicians. The most widely adopted 
therapies for the indications chosen are reviewed. This chapter concludes with a 
discussion of the environment in which the research has taken place.
4.2. The pharmaceutical market place
The market for pharmaceutical products is heavily controlled in Greece, with 
pharmaceutical companies requiring marketing and price approval from the Greek 
health authorities before a product can be released on to the market. This ensures 
that pharmaceutical products have been evaluated for efficacy, quality and relative 
safety before they are marketed. The price application, containing information 
about the prices of the product concerned in other countries of the European Union, 
ensures that prices are among the lowest in Europe. The Code for Good 
Manufacturing Practices ensures continued quality of manufactured products once 
marketing approval has been granted.
Further restrictions apply to pharmaceutical products after marketing approval has 
been granted. It is considered that consumers generally do not have sufficient 
knowledge to make informed decisions regarding the use of pharmaceuticals, thus, 
the promotion and marketing of pharmaceutical products is restricted to physicians
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and pharmacists. The market for self-medication or over-the-counter (OTC) 
products is very small in Greece.
Further restrictions on the market of pharmaceutical products have evolved with the 
development of a "positive list", which is a list of products which are fully or 
partially re-imbursed by the sick funds. The Greek ministry of development has 
developed this list of products to ensure that all consumers have equal access to 
essential medicines. Sick funds subsidise pharmaceutical products which are on the 
list for between 70% and 100%, depending on how life-saving a product is. A sa 
result, the Greek sick funds have a direct interest in keeping the costs of 
pharmaceutical products low and in restricting the number of prescriptions written 
by physicians.
It is within this environment that pharmaceutical products are marketed and that this 
research will be performed.
The Greek pharmaceutical market is mainly primary-care driven. This sector 
accounts for approximately 85% of the total market (Dogramatzis, 1998, pp. 12-13). 
The vast majority of the Greek population (95%) is reimbursed by state 
reimbursement funds, which provide their members with free primary and hospital 
care and subsidised medicines. Reimbursement levels vary according to disease 
groups: 75% for most prescription pharmaceuticals; 90% for products to treat 
selected chronic diseases (for example, Parkinson’s disease & osteoporosis); and 
100% for severe and chronic diseases such as multiple sclerosis, diabetes, cancer 
and AIDS. Some medicines are excluded from the reimbursement list and have to 
be paid for in full by the patient.
Despite the harmonisation with EU legislation, the Greek over-the-counter (OTC) 
market has not yet developed to the same extent as its European partners 
(Dogramatzis, 1998, p. 13). One of the main reasons for this reticence is the strong 
influence of the pharmacists’ association in pressing the Greek government not to 
allow the sale of OTC products outside the traditional retail pharmacy setting. A
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second important reason is that most pharmaceutical products are reimbursed. 
Combined with the relatively low average income in Greece, this discourages the 
development of an OTC market.
4.3. The pricing of pharmaceutical products
Greece’s pharmaceutical pricing rules have posed problems for many years. 
Successive measures taken by the Greek authorities have deeply eroded its, already 
low, pharmaceutical prices. Furthermore, the Greek Drachma’s depreciation 
against other currencies renders the pricing situation all the more difficult for the 
marketing of imported products. The pharmaceutical pricing and reimbursement 
measures successively imposed by the Greek authorities almost invariably infringe 
European Community law. Over the past ten years, the European Commission has 
repeatedly invited the Greek authorities to try to resolve the pharmaceutical pricing 
issue. Successive criticisms have produced some very partial corrections. In some 
cases, the Greek authorities have limited themselves to correcting the most flagrant 
incompatibilities without producing any improvement in practice. Contrary to the 
provisions of directive 89/105/CEE, the competent authorities do not take their 
decisions within the 90-day time limit for setting up the prices of pharmaceutical 
products.
Furthermore, pricing decisions are not communicated to the applicant and are not 
supported by any statement of rationale to support the decisions reached. As well 
as the absence of pricing decisions, which constitute a prerequisite for inclusion of a 
product to the positive list, the competent authorities suspended any additions of 
pharmaceutical products to the reimbursement list during the period May 1995 to 
September 1997. Since that date, new pharmaceutical products have been added to 
a new reimbursement list, which entered into force on 1 April 1998, at which time 
the competent authorities issued a framework decree amending the existing pricing 
system and introducing pricing by reference to the lowest prices in the European 
Union. (Until that time, the Greek authorities had always set their prices by 
reference to the average of the three lowest prices in Europe.)
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The spiral of price depression has cut the earnings of some pharmaceutical 
companies to the point at which it has become impossible to put certain 
pharmaceutical products on the Greek market. Following that, in October 1997 and 
in December of the same year the Greek ministry of development issued two 
decrees laying down arrangements for implementation of a system of pricing by 
reference to the lowest price in Europe. Both decrees provided the framework for 
the final decree of April 1998 on reference pricing. However, with the new 
arrangements the Greek authorities introduced further obstacles to the marketing 
and sale of pharmaceutical products on the Greek market, by requiring that the price 
of a product may only be approved by the Greek authorities if it has already been 
placed on the market in at least two other European countries, one of which 
operates a pharmaceutical price control system. The Greek ministry of 
development, which is responsible for implementing the decree, has breached 
several of these provisions in order to enforce prices that are below the lowest 
charged in Europe.
For example, to determine the price of an "effervescent" form of a pharmaceutical 
product, the pricing committee used the lowest price charged for the basic form of 
this product, despite the fact that in the reference country, the price of the 
effervescent form was higher than that of the basic form, and in most cases, the 
pricing committee did not take into account the number of tablets in a pack, thus the 
pack size, when determining prices: it referred to the lowest prices of the smallest 
pack size available in the reference price country, even though packs sold on the 
Greek market were generally larger.
In the light of the above, the European Commission reintroduced in December 1997 
the complaint no P 95 - 4580 against the Greek government, which had initially 
been made in 1995 for infringements of Directive 89/105. It had not been resolved 
due to on-going discussions between the European Commission and the Greek 
government.
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The pharmaceutical industry in Greece, with the assistance ofEFPIA, also 
pressured the European Commission to adopt more active measures against the 
Greek government, with partial success.
In October 1999 the Greek Government received a reasoned opinion by which the 
European Commission required them:
• To abolish from the relevant legislation the regulation concerning special 
production costs for domestically manufactured products since its criteria are 
not clear.
• To abolish the provision of the legislation which requires that, for imported 
pharmaceutical products, the competent authority check each year for three 
years following the pricing decision, whether prices in the country of origin or 
in the reference price country have been reduced. According to this provision if 
these checks find any price that is lower than the original Greek price, then the 
Greek price for imported products is automatically reduced to match it. By 
contrast if the price in the country of origin or in the reference country is higher 
than the original Greek price, upward adjustment of the latter is not automatic.
• To abolish the provision from the relevant legislation for the pricing of imported 
products according to which the price of an imported pharmaceutical product is 
not approved unless it has already been placed on the market in at least two 
other countries of the European Union, one of which operates a pharmaceutical 
price control system. This provision, according to the European Commission, 
infringes directly article 30 of the Treaty of Rome, the actual article 28 of the 
Treaty of Amsterdam, and constitutes the main reason for introducing the case 
to the European court of justice.
• To respect the response-time requirements of the Transparency Directive in 
relation to the pricing of pharmaceutical products and reimbursement.
It should be noted at this point that, despite the insistence of the pharmaceutical 
industry to include in the reasoned opinion that the requirement for pharmaceutical 
products in Greece to have a price equal to the lowest price in the European Union 
is contrary to community law, the Greek ministry of development insisted this
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requirement should stay. Only if companies could prove that, due to the existing 
system of applying a price in Greece equal to the lowest price in the European 
Union, they are forced to sell their products at a loss, could they claim that the 
regulation in question violates the former article 30 of the treaty of Rome and article 
28 of the Treaty of Amsterdam.
The pharmaceutical companies were not prepared to submit data to support the 
above-mentioned claim and therefore the issue of the lowest price in the European 
Union is included in the reasoned opinion, although it does not constitute its 
principal reason. The Greek government failed to reply to the reasoned opinion by 
the deadline of 24 August 2000. The complaint will now be discussed at the 
European Commissioners board: “College des Commissaires”. This board will 
make the final decision concerning referral of Greece to the European Court of 
Justice.
The prescription behaviour of physicians may well be influenced by the product 
concerned being on the reimbursement list. For this reason an analysis of the Greek 
reimbursement situation is needed. The “positive” list of pharmaceutical products 
approved for reimbursement by health insurance funds issued by the Greek 
authorities on 1 April 1998, took into consideration the daily treatment costs of 
various pharmaceutical products. Products with higher than average daily treatment 
costs (in their class) were excluded from the positive list. The criteria used to draw 
up the positive list frequently set the reference costs of daily treatment below the 
lowest price fixed for a certain pharmaceutical product in the European Union. 
Consequently, if a pharmaceutical company does not wish to see its product 
excluded from reimbursement, which covers approximately 80% of the Greek 
pharmaceutical market, then it must reduce its price, often substantially, to match 
the reference costs of daily treatments. In practice, many pharmaceutical 
companies have been forced to reduce their prices below the lowest in the European 
Union, just to keep their products on the list.
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Following the issue of the positive list a complaint has been deposited by the Greek 
Association of Pharmaceutical Companies before the Council of State, the High 
Administrative Court, seeking the annulment of the Ministerial decision introducing 
the positive list in question. The main reason for the annulment request is the fact 
that the criteria for inclusion of pharmaceutical products on the list are 
unconstitutional. The hearing of the Court was fixed for 19 September 2000 but has 
been postponed. However, in the meantime the competent authority is developing 
new criteria for inclusion of the pharmaceutical products on the reimbursement list. 
The European Commission, on the other hand, after an initiative of the European 
Federation of Pharmaceutical Industry Associations (EFPIA), has included in the 
above-mentioned complaint P 95/4580 all infringements of the provisions of article 
6 of the Directive 89/105 with regard to deadlines for inclusion of pharmaceutical 
products in the reimbursement list (which have never been respected by the Greek 
government), as well as the failure to inform interested parties of the reasons for 
rejection or exclusion of a pharmaceutical product from the list.
Under the threat of these legal actions, the competent Greek authorities have 
expressed a desire to discuss all pending problems with the industry, although the 
outcome of such discussions is rather uncertain. It seems likely that pharmaceutical 
prices in Greece in the future will no longer be required to reflect the lowest prices 
in the European Union. This may result in higher prices for pharmaceutical 
products, but it will also cause higher healthcare costs and inevitably new cost- 
containment measures will be aimed at influencing the prescription behaviour of 
physicians. These measures will make improved knowledge about physicians’ 
prescription behaviour in a cost-conscious environment even more valuable.
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4.4. Marketing practices of the pharmaceutical industry
The word promotion originates from the Latin promovere, meaning to push 
onwards (Collins, 1991). In marketing terms, promotion is understood to comprise 
the activities undertaken to encourage the sale of a product (Collins, 1991). Burnett 
(1984) describes promotion as any communicative activity whose sole purpose is to 
move forward a product, service or idea in a channel of distribution. The World 
Health Organisation defines pharmaceutical promotion as:
"All informational and persuasive activities by manufacturers and distributors, the 
effect of which is to induce the prescription, supply, purchase and/or use of 
medicinal products" (WHO, 1988: 5).
Marketing practices of the pharmaceutical industry may be divided into four areas: 
advertising, sales promotion, medical relations, and personal selling. Advertising 
includes medical journal advertisements, in addition to direct mailings to 
physicians. Medical relations exercises include symposia or workshops sponsored 
by the pharmaceutical industry, clinical trials, and post marketing surveillance 
studies. They can also include public and professional services, news releases and 
editorials (Lidstone, 1987). Advertorials are promotional articles published in 
medical journals. However, unlike advertisements, they appear similar to feature 
articles. They are supplied by the pharmaceutical company, which is marketing the 
product and is considered as promotional material within the terms of this research. 
Personal selling in the pharmaceutical sector is characterised by the pharmaceutical 
representative who visits physicians in their own practices to promote the 
prescription of his or her company’s pharmaceutical products.
Marketing methods used by the pharmaceutical industry vary at different times 
during promotional campaigns and product life-cycles. Different promotional 
methods are useful for different purposes. Lidstone (1987) suggests that the 
pharmaceutical representative, meetings of physicians and post-marketing 
surveillance studies are the only promotional methods which can affect all stages of
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the promotion process, from product unawareness to reminders for repeated product 
use. Advertising can alert physicians to a pharmaceutical product’s existence; it can 
also create a climate that may predispose individuals to attitude change. However, 
interpersonal influence is usually required for trial to occur. Once trial has been 
achieved, advertising can help maintain usage (Lidstone, 1987). Direct mail is 
useful for targeted audiences and as follow-up promotional activity after a visit by a 
representative of the pharmaceutical industry (Greenwood, 1991).
Pharmacists may influence the prescription behaviour of physicians through 
Pharmacy and Therapeutics Committees, the formulary system, clinical 
consultations, and drug-use evaluations. The influence of the marketing practices 
of the pharmaceutical industry on the attitudes of clinical decision-makers involved 
in the Pharmacy and Therapeutics Committees (directors of pharmacies, physician 
chairpersons, and pharmacists who participate in formulary evaluations) has not 
been documented substantially. In one study in 1994 physicians emerged as being 
more satisfied with the marketing practices of the pharmaceutical industry than 
pharmacists (Poirier et al., 1994, p.380-381). It was suggested that this difference 
was due to critical evaluation of scientific data on drugs being more specific to the 
role of the pharmacist than the physician. However, the study was more concerned 
with the code of ethics than the influence of marketing activities on the attitude or 
behaviour of pharmacists and physicians. An earlier study in 1992 indicated that 
prescriptions and quantities prescribed of some third-generation cephalosporins 
increased because of direct detailing activities of representatives (Cleary, 1992, 
p.29). However, the study was too small a level to draw general conclusions.
Pharmaceutical companies try to have results of clinical studies with their products 
published in medical journals. Most respected medical journals use a method of 
“peer review” to select articles for publication. Under this system, papers submitted 
for publication are sent to experts in the subject in question who review the study 
design, methods, and conclusions drawn from the data presented. The final 
decision on whether to publish or reject belongs to the editor, but the opinion of 
reviewers is a major factor in this decision. With this strategy, the major medical
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journals maintain high standards for material published and sustain their objectivity 
and impartiality. Studies published by these medical journals may influence the 
prescription behaviour of physicians directly while reprints of the articles may be a 
useful promotional tool for a sales representative.
Some advertising or direct mail for pharmaceutical products tries to influence 
individuals at an emotional level whereas other advertising tries to rationally lead 
physicians to the decision to prescribe a product. On the assumption that physicians 
are active processors of information, product information is presented to the 
physician, with the expectation that it will be evaluated and integrated with other 
information. It is anticipated that a decision is made through systematically 
comparing the benefits of the various products available for prescribing.
Advertising tries therefore to persuade by providing information for a physician to 
make rational decision. The persuasion process moves from attention, to 
comprehension, to evaluation, to changes in product beliefs and attitudes, forming 
intention and finally, to over behavioural changes. A personal evaluative response 
or attitude toward the product’s attributes and a subjective estimation of the 
probability that the product actually has the attribute, determine an individual’s 
attitude toward the pharmaceutical product (Pechmann & Steward, 1989).
Medical relations exercises are being used increasingly by the pharmaceutical 
industry. These exercises can access large audiences and have been used to access 
physicians directly.
Direct marketing of pharmaceutical products to the general public is illegal in 
Greece at the present time. However, the promotion of health and health-related 
matters through the mass media is becoming increasingly common.
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4.5. The effect of promotional practices
For physicians in general, and for general practitioners in particular, obtaining 
information about pharmaceutical advances relevant to their field may be difficult. 
In Greece, the government has not seen its role as being a provider of independent 
prescribing advice, as in other countries of the European Union. Most general 
practitioners receive medical journals containing information on drugs; however, 
because they are frequently research based, they are not always perceived as being 
relevant to everyday practice (Thomson et al., 1994, p.220). The sales 
representative is seen by many physicians as a potentially useful source of 
information on new and existing therapies (Kawachi & Lexchin, 1992).
4.6. The influence of promotional activities on prescribing behaviour
of physicians.
Many studies have examined the influence of promotional activities by the 
pharmaceutical industry on beliefs of physicians. These studies have shown that the 
messages contained in the promotional material produced by the pharmaceutical 
industry may become the dominant beliefs of medical practitioners with regard to 
product prescribing practices.
Studies using promotional techniques as an intervention have demonstrated that 
these techniques are effective in achieving changes in prescription behaviour 
(Harvey et al., 1986; Bingle et al., 1991).
Harvey et al. (1986) ordered a commercial advertising agent to design a direct mail 
and advertising campaign to improve the correct prescribing of amoxycillin in a 
hospital in Melbourne. Audits of prescriptions within the hospital before the 
campaign proved that persistent inappropriate prescribing of antibiotics existed 
when judged against existing antibiotic guidelines. It was noted that problems with 
amoxycillin prescribing existed despite educational campaigns stressing prescribing 
guidelines and despite physicians being provided with feedback, including audits of
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their own prescribing practices. The campaign made use of a direct mailing to all 
staff members of the hospital and included a gift such as a pen and a note pad 
carrying a slogan. Around the hospital displays were installed in areas frequently 
used by physicians and free copies of the guidelines for antibiotic prescribing, were 
distributed. Posters were placed in various locations as a reminder for the 
physicians and to stimulate the use of the guidelines.
Audits of prescription behaviour concerning antibiotics were recorded at the start of 
the study, after six and after 18 months. More appropriate use of amoxycillin was 
recorded immediately after the start of the campaign, although the effect diminished 
over time, probably because of the absence of follow-up campaigns.
The effect of advertising combined with peer influences in order to improve the 
prescribing of analgesics in hospitalised patients was analysed by Bingle et aL 
(1991). The basis for this research was the conclusion of previous studies that most 
hospitalised patients do not receive adequate pain relief. Educational programmes 
consisting of conferences with a lecture format for physicians, used to improve 
adequate prescribing of analgesics but proved unsuccessful. An alternative 
promotional campaign in the form of an advertising campaign combined with a 
direct exchange of peer physician prescribing experience concerning analgesics was 
developed. The interventions were repeated three times after intervals of six weeks.
The results of this study showed an improvement in prescribing practices with 30 % 
(n = 149) of therapies meeting the criteria for appropriate therapy before the study 
and 43 % (n = 147) after the intervention. This difference was statistically 
significant. However, the investigators expressed concern that the promotional 
programme had failed to improve prescribing by the majority of prescribers.
There is some concern about adverse effects of the marketing practices of 
pharmaceutical companies on the prescription behaviour of physicians (Lichstein et 
al., 1992, p. 1011). Wazana (2000, pp.373-380) reviewed 29 studies that addressed 
the interaction between physicians and the pharmaceutical industry. She concludes
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that those interactions result more frequently in physicians prescribing a 
pharmaceutical product manufactured by the sponsor of a medical education 
programme, that hospitals increased their prescribing of a product supplied by a 
company sponsoring conference travel, and that resident physicians increased non- 
rational prescribing decisions. However, this last conclusion is open to some doubt 
as Wazana considered a change of prescription in favour of the promoted 
pharmaceutical products to be non-rational even when the promoted product was 
therapeutically and financially almost identical to the previously prescribed product. 
Furthermore, in the medical press, commentaries regularly express concern that 
perceived indebtedness of the physician to the pharmaceutical industry, resulting 
from marketing activities, might induce improper prescribing. Yet it may also be 
that physicians alter their prescribing habits because they have become more 
knowledgeable about the product and more comfortable with its use.
In response to these concerns, several professional societies such as the American 
College of Physicians (ACP; 1990), and the American Medical Association (AMA; 
1986) have proposed guidelines for the relationships between physicians and the 
pharmaceutical industry. The World Health Organisation (WHO; 1988) has also 
developed guidelines for promotional practices and has promulgated the "Ethical 
criteria for medical drug promotion". The main objective of this document is to 
improve healthcare through the rational use of pharmaceutical products. The WHO 
advocate that all member states and the pharmaceutical industry adopt or 
incorporate these criteria when developing their own ethical standards on drug use 
and monitor and enforce this once it has been established. The WHO ethical 
criteria for medical drug promotion practices, require that they should be reliable, 
accurate, balanced, truthful, and not misleading. It also advocates that promotion 
should support rational drug use and be in line with national health and drug 
policies.
The pharmaceutical industry has developed its own marketing standards and has 
installed in many countries self-regulatory bodies in order to eliminate these 
concerns and discourage code breaches. Examples are the Australian
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Pharmaceutical Manufacturers Association Code of Conduct (APMA, 1993) and 
the Codice Deontologico of the Italian Association of Pharmaceutical Industry 
(Farmindustria, 2000). On top of those self-regulating codes of conduct, the Greek 
ministry of health controls promotional material used by the pharmaceutical 
industry in Greece. Both elements guarantee that information about pharmaceutical 
products, dispensed by the industry in Greece, is a reliable source of information 
and should contribute to appropriate prescribing.
4.7. The influence of representatives of the pharmaceutical industry
on prescribing behaviour of physicians
While promotional campaigns have been shown to influence the prescribing 
behaviour of physicians, it is the representative of the pharmaceutical industry who 
has been identified as the most influential (Greenwood, 1991; Peay & Peay, 1988). 
Self-reports of physicians on the influential nature of promotional mediums on their 
prescription behaviour indicated that 3 % thought that advertising had a very 
prominent impact, whilst 68 % described it as minimal. The same sample of 
physicians described the representative of the pharmaceutical industry to be most 
influencial (20 %) while 54 % rated them as minimally influential (Avom et al., 
1982). Those findings were confirmed by an Australian study of Peay and Peay in 
1988 who found that the highest rated commercial source of perceived influence on 
physicians’ prescription behaviour was the representative of the pharmaceutical 
industry.
This Australian study in 1988 was performed among 124 physicians, both 
specialists and general practitioners in private practice. The representative of the 
pharmaceutical industry was found to be the most influential source of information 
for physicians in both product awareness and product use for a product containing 
temazepam as active ingredient (Peay & Peay, 1988). Over 70 % o f  the physicians 
reported being familiar with temazepam, which was a new pharmaceutical product 
at the time the study was conducted; 68 % (n = 68) indicated their first awareness of 
temazepam was from a source managed by the pharmaceutical industry. The
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representative of the pharmaceutical industry was reported as the most influential 
source in their first decision to prescribe temazepam by 42.6 % (n = 54) of the 
respondents. Sixty one percent of the physicians had had contact with a 
representative of the pharmaceutical industry regarding the pharmaceutical product 
and "this contact was the most consistent predictor of favourable reception to 
temazepam at the various points in the adoption process". Physicians who received 
visits from representatives of the pharmaceutical industry were aware of the product 
sooner than those who had not and were more likely to rate it as a moderate, rather 
than minor, advance over existing therapies. They were more likely to have 
prescribed it and more likely to have begun prescribing it at an earlier date. They 
were also more likely to prescribe it routinely in preference to alternative therapies 
(Peay & Peay, 1988).
The above findings were confirmed in a 1991 study into the prescription behaviour 
of physicians with respect to Pulmicort, and Lasipressin, two products launched in 
the past 12 months, and a control product. The control product was a product for 
hospital use only, which should not have been prescribed by general practitioners. 
The objective of the study was to determine the source from which physicians first 
learned of the product. The majority of the physicians 48% (n = 147), cited the 
representatives of the pharmaceutical industry as their first source of information 
regarding Pulmicort, while 31% mentioned advertisements and 6% indicated 
journals. Peer physicians, advertisements and journals were all rated lower than 
sales representatives, as sources of first information.
The results for the second product, Lasipressin, were similar with 65% (n = 128) of 
physicians reporting that representatives of the pharmaceutical industry were the 
most important first source of information, while 23% reported it to be 
advertisements and 14% peer physicians. The source of influence that encouraged 
physicians to first use a product was also established. For Pulmicort 48% (n = 27) 
of physicians indicated the representative of the pharmaceutical industry had been 
their source of influence to use the product. The use of Lasipressin was also 
influenced by the sales representatives, although 31% (n = 42) of physicians rated
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peer physicians as their primary influence to initiate product use, compared to 29% 
reporting the representative (Greenwood, 1991).
Other sources have confirmed the importance of face-to-face visits from 
representatives as the most powerful promotional tool available to the 
pharmaceutical industry (Walsh, 1992; Irving, 1991, Lilien et al., 1992). New 
products are an area in which representatives have particular influence (Bell, 1993). 
No consistent evidence was found in the literature to indicate that other sources of 
commercial promotion were as influential on prescribing practices as the 
representative of the pharmaceutical industry (Greenwood, 1991). Thus, this 
medium seems the best one to use in this research project in which we are looking 
at ways to influence the behavioural intention and prescription behaviour of 
physicians.
4.8. Treatment of the selected indications
General practitioners and cardiologists were evaluated for their prescription 
behaviour in the treatment of hypertension, psychiatrists for prescriptions in the 
treatment of depression, and gynaecologists for the treatment of the symptoms of 
menopause, at the beginning and at the end of the study period. In order to be able 
to analyse the changes in the prescription behaviour of the participating physicians, 
an analysis of the treatments used in the above-mentioned indications was carried 
out.
Treatment of the indications studied:
Hypertension:
Hypertension is generally not associated with other major symptoms. Therefore 
many patients are only found to be hypertensive during a routine check-up or 
when presenting with other disorders. Therefore, the main purpose of 
antihypertensive treatment is to reduce the risk of death/morbidity from stroke and 
ischaemic heart disease (heart attacks, heart failure, etc.) (McMahon, 2000; Van
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den Hoogen et al, 2000). Numerous intervention studies have demonstrated that 
reducing blood pressure has a significant impact in reducing the incidence of these 
problems, especially stroke (Staessen et aL, 2000; He & Whelton, 1999).
Many patients will be prescribed antihypertensive drugs, although most 
physicians will first of all urge them to reduce the risk factors associated with the 
development of high blood pressure, such as smoking, drinking alcohol, lack of 
regular exercise, excess salt in the diet, obesity and high cholesterol levels.
Unless blood pressure is very high or there are obvious complications, this ‘life­
style’ advice is often all that will be prescribed during the initial period of perhaps 
several months. During this time, the patient will make several visits to the 
physician for repeated blood pressure measurements to confirm that the blood 
pressure is constantely elevated (Carretero & Oparil, 2000). Thereafter the patient 
is likely to be prescribed an antihypertensive agent, which will have to be 
continued for life, with perhaps fine tuning of the dosage or switching to other 
antihypertensives if there is inadequate response or troublesome side-effects.
There are six main classes of antihypertensives in common usage for patients with 
mild to moderate hypertension, with a few other types being occasionally used. 
The six main types are: diuretics, e.g. hydrochlorothiazide; beta-blockers, e.g. 
propranolol, atenolol; ACE inhibitors, e.g. captopril, enalapril; calcium 
antagonists, e.g. nefedipine, diltiazem; angiotensin II antagonists, e.g. losartan, 
and eprosartan; and selective imidazoline I  receptor agonists, e.g. moxonidine. 
Diuretics and beta-blockers have been available as antihypertensive treatments for 
more than 30 years and it follows that many physicians are familiar with their 
advantages and disadvantages. They were frequently used as first-line treatments 
in the past, although nowadays ACE inhibitors or calcium antagonists are also 
prescribed as first-line treatment. The decision to use the newer therapies may be 
influenced by co-existing cardiovascular disorders, such as angina, for which the 
physician may prefer to use drugs which are active against both disorders (WHO, 
1999).
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The decision may also be influenced by contra-indications to some 
antihypertensive agents. For example, beta-blockers would not generally be used 
for a patient with asthma, and diuretics would not be used for patients with non­
insulin-dependent diabetes. For these reasons, we decided to analyse prescription 
behaviour concerning moxonidine, a centrally acting drug, and the majority of its 
relevant competitors in all the five classes of antihypertensives. The number of 
prescriptions for hypertension at the end of September 1999 in the whole of 
Greece was analysed and the most important products in all classes of 
antihypertensives were selected for inclusion in this research project so as to cover 
at least 75% of all prescriptions issued for this indication. This percentage was set 
for practical reasons after peer group discussion, but it had no other 
methodological foundation. Lists of these products were given to the participating 
sales representatives, who counted prescriptions for them at the pharmacy level.
Depression.
Depression can be thought of as «low mood» -  an emotional state of dejection and 
sadness, ranging from mild discouragement and downheartedness to feelings of 
utter helpnessness and despair. Unhappiness becomes depression when a person 
has past the stage of being able to «snap out of it», and it pervades the individual’s 
thinking and emotions, and interferes significantly with his or her psychological, 
social or occupational functioning. In addition, depression is often accompagnied 
by certain physical symptoms which are completely absent in cases of simple 
unhappiness (American Psychiatric Association, 1994).
In Europe about 6% of the population can expect to experience clinical depression 
within a given six-month period and 30-40% of these will have more than one 
episode. In general practice, about 5% of new consultations, and 20% of follow-up 
appointments will be for psychiatric, psychological, or emotional problems. The 
figures may well be underestimated since there are many missed diagnoses. The 
clinical features of depressive disorders are very varied. In recent years, a number 
of reference scales have been developed to help in the diagnosis of mood disorders. 
Two of the most widely used are the Diagnostic and Statistical Manual of Mental
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Disorders (DSMIV), issued by the American Psychiatric Association (1994) and 
the Feighner Criteria.
If untreated, depression can last from between a few weeks to several years.
Almost all young and middle-aged patients eventually make a complete recovery, 
but incomplete recovery is more frequent in elderly patients. All cases require 
simple psychological management, and most cases of moderate to severe depressive 
disorders also require an antidepressant drug (Spigset & Martensson, 1999; 
American Psychiatric Association, 2000).
Antidepressants such as the tricyclic agents have been widely used throughout the 
world since the 1950s. The pharmacological activity of tricyclics includes blocking 
the re-uptake of a wide range of neurotransmitters, including noradrenaline, 
serotonin, dopamine, histamine and acetylcholine. They may effect the sensitivity 
of receptor sites on presynaptic and/or postsynaptic membranes. The problem with 
having such a broad range of pharmaceutical activity is that some of these 
pharmacological effects can give rise to unpleasant or potentially dangerous side- 
effects. The main side-effects of tricyclic antidepressants are due to blockade of 
acetylcholine receptors (Moller & Volz, 1996; Frazer, 1997; Spigset & Martensson,
1999).
In the early 1980s, drugs with a highly selective effect on serotonergic 
neurotransmission were discovered (Moller & Volz, 1996; Frazer, 1997; Spigset & 
Martensson, 1999). These selective serotinin re-uptake inhibitors (SSRIs) are 
nowadays the main treatment of depression and related indications such as 
obsessive-compulsive disorders. Other categories of products such as anxiolytics 
and benzodiazepines are also sometimes used for the treatment of depression. 
However their use is more addressed to those patients whose depression is 
combined with anxiety. The SSRIs have all more or less an identical product 
profile and are thus useful for the purpose of this research. The number of 
prescriptions for SSRIs at the end of September 1999 in Greece was analysed, the 
most important products selected to be included in this research in order to cover at
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least 75% of the prescription issued for this kind of products. This percentage was 
again set by the researcher for practical reasons after peer group discussion, but it 
had no other methodological foundation. Lists of these products were given to the 
participating representatives of the pharmaceutical industry, who counted 
prescriptions for them at the pharmacy level.
Symptoms o f menopause.
The menopause is defined as the last menstruation. It can only be established 
retrospectively. The menopause, most commonly, occurs between the ages of 45 -  
55 , although it can occasionally occur much earlier. The time around the 
menopause, when the physiological changes associated with the gradual cessation 
of ovarian fimction occur, is called the climacteric, also known as perimenopause. 
The Auctioning and declining levels of circulating estrogen at this time are 
associated with a variety of unpleasant acute symptoms in many women. The 
climacteric period may last up to 10 years or even longer. The postmenopause is 
the period more than 12 months after the last menstruation (Greendale et aL, 1999). 
In postmenopausal women, hormone levels are greatly reduced and although the 
acute climacteric symptoms may now be diminishing, the women is instead at risk 
of a number of long-term problems resulting from estrogen insufficiency, including 
osteoporosis and cardiovascular disorders (Genazzani et al., 1996,2000).
About two-thirds of all women experience acute menopausal symptoms and in 
approximately half of these, symptoms will be severe. Occurence of symptoms is 
dependent on climacteric status. According to Oldenhave and Netelenbos (1994) 
vasomotor complaints are present in 41 % of women aged 39 and over with regular 
cycles, reach a maximum of 85 % of women around the menopause and decline 
slowly to 57 % at 10 years or more after the menopause. However, around one- 
third of women experience no menopausal symptoms, possibly because sufficient 
estrogen, in the form of estrone, is still produced by the adipose tissue to prevent 
problems. Indeed, obese women appear to be more likely to remain free of 
symptoms (Greendale & Judd, 1993).
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Various treatment options are available for the symptoms associated with 
perimenopause -  both acute conditions and potential chronic conditions -  including 
lifestyle changes, prescription and non prescription therapies, and 
alternative/complementary approaches (NAMS, 2000, p.8). Behavioural changes, 
such as moderate exercise and avoidance of potential triggers (e.g. caffeine, spicy 
foods, alcohol, warm room) may prevent some hot-flushes. However, evidence for 
the success of these measures is poor (Kronenberg, 1990). Various alternative 
therapies, such as botanicals, acupuncture, massage, meditation, and some soy 
products, may also provide benefits, although efficacy has not been documented in 
clinical trials, except for moderate quantities of soy products (Wyon et al., 1995; 
Hirata et al., 1997; Washburn et al., 1999). Treatment with exogenous estrogens is 
reported to be effective in relieving menopausal symptoms and also in providing 
protection from osteoporosis and cardiovascular disorders (Genazzani et al., 1996,
2000). For almost all women with an intact uterus, gynaecologists should add 
progesterone to estrogen replacement therapy to guard against an increased risk of 
endometrial carcinoma from unopposed estrogen (Heaps, 1997). Poor therapy 
compliance is common, even among women who elect to begin hormone 
replacement therapy (HRT), and presumably have derived some benefit from such 
therapy. There is evidence of poor adherence to recommended therapy: 20 to 30 % 
of women never fill their first prescription, 20 to 30 % discontinue HRT within 6 to 
8 months, and only 30 % of all menopausal women are regular users of HRT at any 
one time (Ravnikar, 1992). The cause of this problem may be manifold, but 
probably the chief reasons are that women are unconvinced about the need, 
benefits, efficacy, and safety of HRT. They are concerned about bleeding, cancer 
risks, and the inconvenience of permanent (usually daily) medication. The 
overriding principle in counselling the patient is the preventive medicine aspects of 
HRT -  such as preventing osteoporosis, preventing death from arteriosclerotic 
cardiovascular disease- in addition to ameliorating existing symptoms as hot 
flushes, vaginal dryness, and emotional symptoms (AACE, 1999). It is thought that 
the specialists, compared with the general practitioners, may convey more easily the 
proper balance of risk-versus-benefit information to the patient and reduce as a 
consequence the risk of non-compliance to therapy. This element was taken into
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account when selecting the specialists for the study. No consensus exists about 
when HRT should be instituted. Waiting for symptoms to appear seems 
unacceptable: bone loss and cardiovascular disease, for example, are initially 
asymptomatic. Menstrual irregularity or luteal-phase deficiency may signal a loss of 
production of sex hormones. In some women, hot-flushes may occur even before 
menstrual irregularity. In other women, changes of mood and affect may be the first 
indication of hormonal irregularities. The absence of consensus about the best 
moment for the start of a HRT therapy should not be a problem for this research as 
it is a general problem and not restricted to, in the study participating, 
gynaecologists.
4.9. Discussion
Knowledge and understanding of the phenomena under investigation is crucial to 
arrive at a proper basis for drawing conclusions. The primary aim of this chapter 
was therefore to describe the environment in which the research was conducted and 
to verify that all possible variables which may influence the research problem, both 
controlled and uncontrolled, are taken account of in this research. In particular, 
uncontrolled and un-controllable variables must be recognised in order to neutralise 
their possible confounding influence on the study results. Uncontrolled variables 
might have a hidden influence of unknown size on the research results (Oppenheim, 
1997).
A secondary aim was to verify the generalisability of the study results. It is 
important to understand the extent to which we can form conclusions about the 
relation between prescription behavioural intention and prescription behaviour of 
physicians in any cost-conscious environment, when this research was performed in 
Greece. While the characteristics of the sample are representative of the population 
from which the sample was drawn (see section 5.4), Gummesson (1991) argues that 
using statistics to generalise from a sample to a population is just one type of 
generalisation. In a phenomenological study we may generalise from one setting to 
another if the study characteristics have captured the interactions and characteristics
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of the phenomena to be studied. In many countries the cost-curbing decisions taken 
by governments or sick funds have created a prescription environment for the 
prescribing physicians which resembles the situation in Greece. Pharmaceutical 
companies in many countries have to deal with comparable situations concerning 
marketing and price approval. These environments are tending to become even 
more similar due to the integration of European law making. However, although 
less important than before, there still are important differences between the 
pharmaceutical markets of individual countries, due to national regulations and 
restrictions, and differences in culture and product availability. Knowledge of the 
context in which this research has taken place should enable other researchers to 
verify the generalisability of these study results to other environments.
4.10. Conclusion
A review of the research environment revealed no further factors which could be 
expected to influence the research project and which had not already been taken 
into account. It was concluded that no further elements were missing and that we 
could proceed to the presentation of the final research data.
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CHAPTER 5 Methodology
5.1. Introduction
This chapter starts with a justification of the methodology used in the study and a 
description of the subjects and/or sources of data (e.g. the population to be 
investigated, the sampling frame and sample size). Details of the instruments 
used, procedures for collecting data, and measurement of the dependent variable 
are given. Details of the pilot study are included, together with procedures for 
demonstrating internal and external validity. Possible non-response bias, the 
response rates, tests for response bias, tests of the assumptions of regression or 
similar statistical procedures, are described, together with methods used to control 
other variables which might influence results. The limitations of the methodology 
used are discussed, as far as these were not considered in section 1.6, as well as 
practical limitations on the sampling frame and the size of the questionnaire. The 
timing of and protocols for the physician interviews are described. Any special or 
unusual treatment of data before analysis is discussed and a description of the 
computer programs used to analyse the data, with justification for their use, is 
given. The chapter concludes with a discussion of ethical issues.
5.2. Justification of the paradigm and methodology
This research is expected to contribute to the body of knowledge about customer 
behaviour. A review of the literature indicates that we have insufficient 
understanding of behaviour that shows a lack of control. The well-documented 
expectancy value models, such as the model of the theory of planned behaviour, are 
not suitable for the evaluation of non-fully-yolitional behaviour. Eagly and Chaiken 
presented in 1993 their composite attitude behaviour model, which is believed to 
encompass such behaviour. Although this model has not yet been validated, this 
research should allow the necessary validation of its use when investigating 
prescription behaviour of physicians. In addition, this research is expected to reveal 
determinants of non-fully-volitional behaviour, which cannot be adequately
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determined using the model of the theory of planned behaviour. Ultimately this 
research should contribute to our knowledge of the possibilities to change non- 
fully-volitional behaviour.
The research project was divided into two parts. In the first part, the determinants 
of non-volitional behaviour were defined via the retrospective method. The 
composite attitude model, developed by Eagly and Chaiken (1993, p.209), which is 
based on the works of Fishbein and Ajzen, Triandis, and Rentier and Speckart, was 
used with the modification that the attitude towards targets construct was 
subdivided further into attitude, anticipated regret variables, and emotional 
reactions. For the afiFect factor of attitude the definition described by Triandis 
(1977) was used. The emotional element was added as, during a pilot study, 
emotional reactions were found to have an important influence on behavioural 
intention (see section 3.4). Confirmation of actual behaviour was obtained by 
analysis of prescriptions issued. In the second part of the study, marketing stimuli 
were used to manipulate one or more determinants of customer behaviour in order 
to observe its efifect on behaviour. Both parts of the study were conducted 
systematically in a natural setting.
The positivistic approach seeks the causal relationship between variables by 
uncovering causal laws and links them to a deductive or integrated theory (Hussey 
et al., 1997, p.52). A positivistic research method was chosen for this research 
project as this seeks the facts or causes of social phenomena such as non-fully- 
volitional behaviour, with little regard to the subjective state of the individual. This 
approach is open to criticism, however, as the highly structured research design 
imposes certain constraints on the results and/or may ignore more relevant or 
additional findings. This may be a slight disadvantage but the alternative, the 
phenomenological paradigm, focuses on the meaning of social phenomena and not 
on the frequency of certain, more-or-less naturally occurring, events in the social 
world (Van Maanen, 1983, p.9). As we needed to understand the frequency of 
certain non-fully-volitional behaviours and the intensity of the factors influencing 
this behaviour, the phenomenological approach was rejected.
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A pilot study was performed in 41 specialists and 40 general practitioners between 
Monday 2 November 1998 and Saturday 14 November 1998. The physicians were 
asked to complete a questionnaire with open-ended questions to elicit their most 
salient underlying normative and behavioural beliefs when prescribing 
pharmaceutical products. These beliefs were incorporated into the questionnaire 
that was used during the main study. (Two kinds of questionnaires would have been 
developed, one for specialists and one for general practitioners, if significant 
differences between salient beliefs per group studied had been found.) Closed 
questions were used in the questionnaire for the main study, in line with the 
positivistic methodology chosen.
A questionnaire with the specific measures of the various theoretical constructs as 
discussed in the conclusion of the literature research was developed. Subjective 
norms, anticipated regret variables, past behaviour, perceived difficulty to perform 
the behaviour and attitude were covered, in addition to Triandis’ concept of 
emotional reaction as described in the theory of interpersonal behaviour.
Emotional reaction was included, as an earlier pilot study had confirmed its 
importance for the prescription habit of doctors (see Table 7 in section 3.5).
At the start of the study (baseline visit), the doctors were visited by their usual 
medical sales representative and asked to fill in the questionnaire. In the same 
week, the doctors’ prescription habits were determined via an analysis of the 
prescriptions issued by the doctors and dispensed by local pharmacists. The 
completed questionnaires were analysed and the most and least important factors 
influencing prescription behaviour were determined. External stimuli were 
developed, based on these two factors. For the following six months, the sales 
representatives visited all selected physicians once a month with the company’s 
regular promotional message. For one-third of the selected doctors, an external 
stimulus in the form of a claim intended to influence the most important factor of 
prescription behaviour, was added to the regular promotional message at each visit. 
Another third of the selected doctors was confronted with the regular promotional 
message to which a claim focused on the least important determinant of behaviour
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was added. The remaining third acted as a control group. After the sixth visit, the 
physicians were asked to fill in the questionnaire again. In the week following the 
week of the sixth visit, the prescription habits of all selected physicians was 
analysed again. Comparisons between the initial or baseline and final prescription 
behaviours of the treated and untreated groups were expected to reveal any 
influence of the developed external stimuli which were intended to modify factors 
which influence non-fully-volitional behaviour. Analysis of actual prescription 
behaviour was done without the selected physicians being informed.
Cacioppo and Petty (1979) investigated the persuasive effects of message repetition 
on cognitive response, based on the assumption that repetition of a high-quality 
persuasive message would give people more opportunities to think about the 
message and increase attitude change and favourability. Experimental data show 
that favourable thoughts increased at a certain level of repetition. A frequency of 
six repetitions has been fixed for this research to increase the opportunity for the 
physicians to consider the argument in the message. Furthermore, this frequency 
was considered necessary in order to be able to create, in addition to an attitude’s 
accessibility in memory, also a temporal stability. This is important as an improved 
prediction of behaviour was proven to be mediated by the temporal stabilities of the 
predictor variables (Doll & Ajzen, 1992, pp.754-765). The number six was fixed 
after consultations with peer researchers of behavioural sciences, as a theoretical 
basis could not be found in literature.
Persuasive communication or promotion can be seen as a conscious attempt to 
change the behaviour of another through the transmission of a message designed to 
change attitudes, beliefs or behaviour (Engel et al., 1994). The ultimate goal of 
promotional practices is to change behaviour towards continued or increased 
product use. The effectiveness of communication depends on the dynamic 
interaction between the communicator, audience, message, and medium used to 
deliver the message (McGuire, 1985). Effective communication is dependent on 
the characteristics of the communicator of the message. Increasing the 
communicators’ attractiveness (De Bono, 1992), expertise (De Bono & Hamish,
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1988) and similarity to the audience (Berscheid, 1966) have all been shown to 
increase message persuasiveness. The attractiveness of the communicator can also 
affect the perception of the message. The message of a more attractive 
communicator will be comprehended more positively than the same message from 
one considered less attractive (Kelman & Eagly, 1965). Prior knowledge of the 
expertise of the communicator also increases the persuasiveness of the message 
(Mills & Harvey, 1972).
Sales representatives of the pharmaceutical industry can exploit these behavioural 
traits and thereby increase the likelihood that they will be persuasive.
Attractiveness can be exploited through attention to general preparation and through 
the establishment of relationship as a result of many visits. The latter also enables 
the representative and medical practitioner to identify similarities between 
themselves. Representatives can also improve their credibility, particularly if they 
have qualifications in the medical or pharmaceutical sciences, by alerting medical 
practitioners to their qualifications through the use of business cards.
Several studies have indicated that medical practitioners are reliant on the 
pharmaceutical industry for much of their drug information. Gambrill and Bridges- 
Webb (1980) studied the sources of therapeutic and prescribing information used by 
general practitioners in Australia. They interviewed 104 general practitioners 
regarding their drug information sources. The most recently recalled source of 
prescribing information was reported as journal reports by 46% of medical 
practitioners, whilst 22% reported pharmaceutical representatives and 10% drug 
company publications. Pharmaceutical representatives were considered a regular 
source of prescribing information by 56% of the sample, compared with 50% who 
considered journals a regular source of prescribing information. The representative 
was rated the most useful information source by 17% of the sample, while 13% 
considered consultants to be the most useful source.
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A study by Greenwood (1991) indicated that 90% of respondents saw 
pharmaceutical representatives and that 73% of these thought they would lose an 
important source of information if they stopped seeing them. The results of another 
survey o f200 medical practitioners in the UK indicated that 96% saw 
pharmaceutical representatives. On average, medical practitioners receive three 
visits by pharmaceutical industry representatives each week. In this survey, 21% 
indicated they were very satisfied with the industry’s promotional material and 49% 
were modestly satisfied (Anon, 1990/1991).
The medical representative has been shown to be important in persuasive 
undertakings, which justifies our using representatives to disseminate the external 
stimulus in the research project.
Table 8 Representation of the research design
Before
exposure
After
exposure
Group exposed to regular promotional message and 
additional message covering the most salient determinant 
of non fully volitional behaviour
SI R1
Group exposed to regular promotional message and 
additional message covering the least salient determinant 
of non fully volitional behaviour
S2 R2
Group exposed to regular promotional message Sc Rc
Source: present author
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5.2.1. Analytical methodology
A pre-test-post-test control group design was chosen. The determinants of the 
prescription behaviour of physicians were recorded at the beginning and the end 
of the study period via questionnaires. The most and least important common 
determinants of physicians’ behaviour at the beginning of the study period 
(baseline), were selected and their influence on prescription behaviour 
investigated. For six months the entire group of doctors studied was exposed to 
the same promotional message during monthly visits by the representative. A 
promotional claim based on the most important determinant of behaviour was 
added to the promotional message given to one third of the doctors, while another 
third was confronted with a claim based on the least important determinant of 
behaviour. The remaining third acted as a control group. The prescription habits 
of all the physicians was recorded at the start and the end of the study by analysis 
of the prescriptions of the physician dispensed via pharmacists during the weeks 
following the first and last promotional visit.
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Figure 12 Representation of the research design over time
Questionnaire Adjusted promotional message SI | Questionnaire
3*
Adjusted promotional message S2 | Questionnaire)
.171*V 1 r i r i r v
Promotional message Sc ~] Questionnaire)
171'
Prescription analysis Prescription analysis
* 513 and 171 are number of physicians 
Source: present author
This method was expected to avoid any contrived observations, as the intervention 
by the investigator at the pharmacist level was not expected to impact on the 
physician. Several elements might influence non-volitional behaviour almost 
equally. To be able to investigate two or more independent variables 
simultaneously, a factorial design was used as it allows us to measure the 
interaction effect (Zikmund, 1997, p.318). Alternative research designs have been 
considered such as in-depth interviews and focus groups. In-depth interviews 
seemed less appropriate for this research as well-skilled interviewers are needed to 
elicit both the superficial reactions and the subconscious motivations of the 
physician when prescribing. This research method is thus expensive, while the 
analysis and interpretation of the data has a tendency to be subjective (Zikmund, 
1997, p. 122). Focus group interviews, because they are unstructured, and group 
dynamic sessions, might trigger a synergistic and spontaneous interaction among
164
respondents. It was expected that individuals might be reluctant to express their 
non-biased feelings concerning perceived behavioural control in the rather artificial 
environment of group interviews. This research method was therefore also rejected.
A respondent who is not allowed to remain anonymous may be reluctant to provide 
confidential information. This might, to a certain extent, also be a problem with the 
self-administered questionnaire selected for this research. The alternative of using 
postal questionnaires was rejected, however, as the response rate would be expected 
to be low due to the length of the questionnaire.
The sales representative left the questionnaire with the physician and collected it 
after a few days. It was hoped that the absence of the interviewer during 
completion of the questionnaire would induce respondents to reveal even sensitive 
or socially undesirable information. Furthermore, bias should have been low, as the 
questionnaire did not ask the physicians to disclose their opinion concerning any 
particular product.
5.2.2. Scales
The summated rating method developed by Likert (1932, pp.44-53) is frequently 
used for measuring attitudes because it is simple to administer. The Likert scale 
usually includes several scale items to form an index. Each statement is assumed 
to represent an aspect of a common attitudinal domain. However, many patterns 
of response to the various statements can produce the same total score. Thus, 
identical scores may reflect different "attitudes" because of the different 
combinations of statements endorsed. The criticism is therefore that it is difficult 
to analyse the individual factors which influence attitudes.
The semantic differential, a series of attitude scales, might seem more appropriate, 
as the sensitivity of seven-point bipolar rating scales is higher than the five-point 
Libretto scales. The seven-point bipolar rating scale allows the strengths of the 
attitude toward the object to be clarified to a larger extent, although it does not 
give the absolute strength of the attribute. However, research indicates that a five-
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point scale is just as good and that an increase from five to seven or nine points on 
a rating scale does not improve the reliability of the ratings (Elmore & Beggs, 
1975). Moreover, the seven-point scale is less appropriate when sample sizes are 
small. It seemed therefore more appropriate to use a five-point scale. Many 
researchers assume that the semantic differential provides interval data. The scale 
has also been criticised for having only ordinal scaling properties because the 
weights given are arbitrary (Zikmund, 1997, p.359). Depending on whether or not 
the data are assumed to be interval or ordinal, the arithmetic average or the 
median is utilised to plot the importance of the elements that influence non- 
volitional behaviour and the effect of their manipulation on the resulting 
behaviour. Ostrom (1989, p.30) argues that it is technically inappropriate to use 
means and variances as measures of central tendency and dispersion with an 
ordinal scale.
Whether the semantic differential has an ordinal or interval scale was important 
for this research as the ordinal scale allows us only to rank-order the preferences 
while the interval scale allows us to measure the magnitude of the differences in 
the preferences of individuals (Sekaran, 1992, p. 161). To describe the 
relationship between modifications of communication and behavioural intention 
change accurately, it was therefore necessary to employ a scale with interval 
properties. Otherwise, one would not know whether a non-linear, e.g. negatively 
accelerated, function was due to some distortion in the underlying metric of the 
scale or due to the discrepancy phenomenon itself (Ostrom, 1989, p.30). It was 
decided to treat the scale as an interval scale and thus the data as quantitative data 
if their distribution allowed, i.e., if the variable being scaled was normally 
distributed in the individuals tested. Units of the scale were not manipulated until 
the assumed normal distribution was recovered from the individuals’ scores, as 
this procedure might have influenced the results.
The data would be considered ordinal data if the correct arithmetical interpretation 
could not be given to the assignments. In that case, the use of means and standard 
deviation would be abandoned, as they might be in error or misleading to the
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extent that the successive intervals (distances between answers) on the scale are 
not equal and do not have substantial meaning (Siegel & Castellan, 1988, p.33). 
The use of the Ridge regression would be considered, or the association would be 
measured using categorical data analysis, if the distribution were found to be 
abnormal. In this longitudinal research the same scale was used throughout the 
study to allow changes in concepts over time to be measured.
5.3. Choice of the intervening attribute
Promotional practices are designed to encourage attitude change through the 
transmission of persuasive communication. The effectiveness of the 
communication depends on the dynamic interaction between the communicator, 
audience, message, and medium used to deliver the message (McGuire, 1985). It 
is therefore necessary to understand the environment in which the research will 
take place, not only in terms of the pharmaceutical marketplace, but also by a 
thorough analysis of the pricing situation of pharmaceutical products, the 
marketing practices used by pharmaceutical companies in that marketplace, and 
their potential influences on the prescription behaviour of physicians. The context 
or research environment of this research was described in Chapter 4. Other 
considerations will be discussed here.
5.3.1. Selection of the indications
It was important that the prescriptions issued by the selected physicians and 
analysed during this research should concern treatments of illnesses that are well 
defined and will not be easily blurred by other related indications. The conditions 
must also be seen quite frequently by the physicians in order to ensure that an 
adequate number of prescriptions is available for analysis. The interest of the 
physicians in treating the indications must also be high.
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Hypertension is one of the most frequent illnesses seen by general practitioners and 
cardiologists (IMS, 2000). Its definition, issued by the World Health Organisation 
and the International Society of Hypertension (1999), is clear and well known to 
physicians. Because of the ageing of the population in most industrialised 
countries, hypertension is not only seen frequently but its morbidity is increasing. 
More detailed information about this indication and its treatment is given in section 
4.8.
Depression was chosen for the psychiatrists as it is also very well defined by the 
DSM-DI-R criteria issued by the American Psychiatric Association (1987) and is 
well known to physicians. More information about the indication and its treatment 
can be found in section 4.8.
Women with menopausal symptoms are frequently seen by gynaecologists. Interest 
in the treatment of the symptoms of menopause is increasing for two main reasons. 
Firstly, because women in the peri-menopause are no longer prepared to accept, as 
their ancestors did, the appearance of complaints during this phase of their fives. 
Secondly because osteoporosis, one of the risks of an untreated menopause, is 
causing annually a large number of hip fractures among elderly women 
(Campagnol! et al., 1984; Campagnol!, 1997). More detailed information about this 
indication and its treatment is given in section 4.8.
5.3.2. Products researched
A fist of products was provided in order to ensure that the sales representatives 
counted the products on the prescriptions in an identical way. The total number of 
prescriptions written for products was used to determine which products were 
included in the study. The products chosen are fisted in Tables 9-11.
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Table 9 The antidepressants included in the research
IMS classification Trademark Active ingredient
Researched product
1 N06A Dumyrox fluvoxamine
Competing products
2 N06A Ladose fluoxetine
3 N06A Seroxat paroxetine
4 N06A Seropram citalopram
5 N06A Efexor venlafaxine
6 N06A Remeron mirtazapine
7 N06A Analapril clomipramine
8 N06A Zoloft sertraline
Source: present author
Table 10 The products for the treatment of symptoms of menopause 
included in the research
IMS Trademark Active ingredient
_____________ classification__________________________________
Researched product
1 G03F Femaston 17 beta estradiol and 
dydrogesterone
Competing products
2 G03F Premelle estrogen and 
medroxyprogesterone
3 G03F Cyclacur estradiol and norgestel
4 G03F Premelle cycle estrogen and 
medroxyprogesterone
5 G03F Trisequens estradiol and noretisterone
6 G03F Divina estradiol valerate and 
medroxyprogesterone
7 G03F Kliogest estradiol and noretisterone
8 G03F Trisequens forte estradiol and noretisterone
9 G03F Estracomb TTS estradiol and noretisterone
Source: present author
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Table 11 The antihypertensives included in the research
IMS classification Trademark Active ingredient
Researched product
1 C02A Fisiotens moxonodine
Competing products : Selective imidazoline I receptor agonists
2 C02A Cynt moxonidine
3 C02A Aldomet a -  methyldopa
4 C02A Catapressan clonidine
5 C02A Loniten minoxidil
6 C02A Minipress prasocin
Competing products : Diuretics
7 C03A Lasix furosemide
8 C03A Fludex indapamide
9 C03A Moduretic amiloride
10 C03A Frumil furosemide and 
amiloride
11 C03A Hygroton chlorthalidone
12 C03A Aldactone spironolactone
13 C03A Tiaden tiadenol
Competing products: Beta blocking agents
14 C07A Tenormin atenolol
15 C07A Lopressor metoprolol
16 C07A Selectol seloprole
17 C07A Neocardon atenolol
18 C07A Inderal propanolol
19 C07A Kerlone betaxolol
20 C07A Pactens bisoprolol
Competing products : Calcium antagonists
21 C08A Norvasc amlodipine
22 C08A Tildiem diltiazem
23 C08A Plendil felodipine
24 C08A Adalat nifedipine
25 C08A Motens lacidipine
26 C08A Lacipil lacidipine
27 C08A Glopir nifedipine
Competing products: ACE inhibitors
28 C09A Coversyl perindopril
29 C09A Renitec enalapril
30 C09A Accupron quinapril
31 C09A Monopril fosinopril
32 C09A Vascace cilazopril
33 C09A Triatec ramipril
34 C09A Z Bee lisinopril
35 C09A Capoten captopril
Competing products : Angiotensin-II antagonists
36 C09C Cozaar losartan
37 C09C Diovan valsartan
38 C09C Karvea irbesartan
39 C09C Aprovel irbesartan
40 C09C Atacand candisartan
Source: present author
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5.4. Population investigated
5.4.1. Characteristics of the group studied
A small-scale study of 18 general practitioners and 22 specialists was carried out in 
June, July and August 1998 in an attempt to understand the determinants of 
physicians’ prescription behaviour and how volitional it is (see Chapter 3 of this 
thesis for more details). The study demonstrated the importance to decompose 
normative beliefs and motivation to comply in order to understand the decision­
making process. It was concluded, with a credible level of significance, that 
normative beliefs multiplied by the motivation to comply are significant 
determinants of physicians’ prescription behavioural intention. It was demonstrated 
that the prediction of behaviour increases when perceived behavioural control is 
added to the expectancy value model of the theory of reasoned action. The study 
results showed a low correlation between behavioural intention and actual 
prescription behaviour of physicians. It was therefore concluded that the 
prescription behaviour of the physicians is not fully volitional because of the 
significant influence of subjective norms, the influence of the addition of perceived 
behavioural control to the expectancy model, and the low correlation found between 
behavioural intention and behaviour. The findings supported the understanding that 
the model of the theory of planned behaviour does not function well when 
behaviour is characterised by a lack of control (Van der Geer & Kangis, 2000).
The study demonstrated that Greek physicians show non-fully volitional behaviour 
while prescribing antidepressants or antihypertensives. Limitations due to the 
existence of formularies for hospital medicines, pressure from sick funds and 
governmental bodies, such as regulatory affairs, influence norms, which are one of 
the determinants of the prescription behaviour of physicians. The characteristics of 
the group to be studied therefore fulfilled the requirements of this research (see 
section 3.6 for more details). However, there is also a second reason for selecting 
physicians as the target group. Their prescribing environment is not changing 
rapidly and if changes appear they are quite obvious. The annual number of new
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product launches is limited, modifications of re-imbursement lists rare, and changes 
in the registration status of existing products even less common. The control of 
other variables is therefore possible if physicians are selected as the target group to 
be studied.
It is the aim of this research to allow generalisation of the findings and to 
understand the resistance to change of non-volitional behaviour in general. A 
good relationship between the members of the sample and the target population of 
physicians should allow the generalisation of our findings to all specialisations. 
Therefore specialists as well as general practitioners were included in the group to 
be studied. In a study looking at grocery purchases and physician prescribing. 
Stem (1994, p.332) found that a whole range of differences in market structure 
were not reflected in dissimilar patterns of purchasing and prescribing. This 
suggests that the findings of this research might also be valid beyond the borders 
of the medical profession. Further confirmation will be sought in the literature by 
comparing the findings of this research with literature reports on non-volitional 
behaviour.
5.4.2. Selection of the specialists
There are about 41,000 registered physicians in Greece, according to data published 
by the EOvucq ETanoTncrj YTrrjpsaia EÀMôoç (National Statistical Services of 
Greece). However, this figure includes many specialisations which are not relevant 
for the present research because they generally do not prescribe pharmaceutical 
products (for example, anaesthetists, pathologists, radiologists, dentists and 
microbiologists). Furthermore, there are a number of non-practising physicians, 
such as doctors working in the pharmaceutical industry or retired physicians. It was 
therefore deemed more appropriate to refer to the list of practising physicians used 
by International Medical Statistics (IMS Hellas Ltd.). According to IMS, there 
were 21,233 physicians in practice in Greece in 1997 who prescribed 
pharmaceutical products.
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Table 12 The geographical distribution of specialists in Greece.
Speciality Athens/
Piraeus
Sterea Pelopo-
nissos
Epirus Thessaly Mace­
donia
Aegean Total
Paediatrics 1,865 122 134 89 144 599 188 3,141
Cardiology 961 67 137 64 92 372 124 1,817
Gynaecology 1,089 59 125 61 76 473 109 1,992
Neurology/ 796 25 57 53 56 401 58 1,476
Psychiatry
Oto-rhino- 365 31 58 29 42 263 58 846
laringology
Urology 363 21 41 23 35 149 38 670
Dermatology 249 21 53 28 31 120 43 545
Orthopaedics 525 41 54 38 48 255 96 1,058
Pulmonology 329 27 26 22 24 127 45 600
Others 1,103 89 133 88 101 503 184 2,201
Total 12,143
Source: International Medical Statistics, IMS Hellas Ltd (1997)
Three main specialisations were selected, namely cardiologists, gynaecologists and 
neurologists/psychiatrists, together accounting for approximately 43.5% of the total 
number of specialists. The three main specialties were chosen because they form 
together almost half of the total physician population, generate more than 40% of 
the total number of prescriptions (according to 1998 figures released by IMS Hellas 
Ltd.) and because these groups are expected to form a rather homogenous sub­
population. Other specialisations were rejected for one of three main reasons. 
Firstly because their numbers are too limited (e.g., urologists, pulmonologists and 
dermatologists), secondly because they prescribe pharmaceutical products 
infrequently (e.g., surgeons and endocrinologists), and thirdly because of the 
seriousness of the treated indications, which might nullify the influence of 
economics when prescribing (e.g., rheumatologists, eye specialists, oncologists and 
paediatricians, the largest single group of specialists).
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In order to keep the questionnaires as simple as possible, it was decided that the 
questions would concern only one indication per specialisation. Thus the 
requirement that the specialisation should also be characterised by the fact that one 
indication is very dominant in the spectrum of illnesses that the physicians treat.
The selected specialisations meet this target as symptoms of menopause is the 
indication seen most by the gynaecologists, essential hypertension by cardiologists, 
and depression by the psychiatrists while the two last mentioned indications are 
frequently seen by the general practitioners. It would be difficult for the other 
specialisations to meet this objective.
The distribution of the prescriptions over the three specialisations was also taken 
into account. A stratified sample technique has been used to ensure that the sample 
reflects the contribution of the different specialisations to the total number of 
prescriptions issued. The total sample had to be at least three groups of at least 171 
physicians (see section 5.5.1 for the calculation of sample size). The sample of 320 
specialists consisted of 110 cardiologists, 110 gynaecologists and 100 neurologists/ 
psychiatrists. The stratified sample was drawn from the database of Solvay Pharma 
M.E.P.E., the Greek subsidiary of Solvay Pharmaceuticals G.m.b.H. of Hanover in 
Germany, the pharmaceutical branch of Solvay S. A. of Brussels in Belgium.
A stratified sample technique was used to ensure that the sample also reflects the 
contribution of the number of prescriptions issued per geographical area to the total 
number of prescriptions issued (Table 13).
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Table 13 The geographical distribution of the prescriptions, issued for the 
selected indications in 1998.
Prescriptions x 1000
Speciality Athens/
Piraeus
Sterea Pelopo-
nissos
Epirus Thessaly Mace­
donia
Aegean Total
Cardiology 4,560.2 317.9 650.1 303.7 436.6 1,765.2 588.4 8,622.1
Gynaecology 4,330.4 234.6 497.1 242.6 302.2 1,880.9 433.4 7,921.1
Neurology/
Psychiatry
Total
4,271.8 134.2 305.9 284.4 300.5 2,152.0 311.3 7,179.3
23,722.6
Source: IMS Medical index, moving annual total September 1998
The stratified sample per cluster resulted in the following schedule of selected
physicians:
Table 14 The geographical distribution of the selected specialists.
Speciality Athens/ Sterea Pelopo- Epirus Thessaly Mace­ Aegean Total
Piraeus nissos donia
Cardiology 53 4 8 4 5 21 7 110
Gynaecology 60 3 7 3 4 26 6 110
Neurology/ 45 1 3 3 3 23 3 100
Psychiatry
Total 158 8 18 10 12 70 16 320
Source: present author
A systemic sample technique was used to select the individual physicians within 
the above clusters.
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5.4.3. Selection of the general practitioners
There were approximately 9.090 practising general practitioners in Greece in 
1997.
Table 15 The geographical distribution of general practitioners in Greece:
Speciality Athens/
Piraeus
Sterea Pelopo-
nissos
Epirus Thessaly Mace­
donia
Aegean Total
General
Practitioners
4940 438 718 261 446 1771 516 9090
Source: International Medical Statistics, IMS Hellas Ltd (1997)
This geographical distribution was taken into account when selecting the study 
subjects. The stratified sample of 218 general practitioners was drawn from the 
database of Solvay Pharma M.E.P.E., the Greek subsidiary of Solvay 
Pharmaceuticals G.m.b.H. of Hanover in Germany, the pharmaceutical branch of 
Solvay S. A. of Brussels in Belgium.
Table 16 Survey of the geographical distribution of the selected general 
practitioners over Greece:
Speciality A thens/ Sterea  
Piraeus
Pelopo-
nissos
Epirus Thessaly M ace­
donia
Aegean Total
General
practitioners
118 11 17 6 11 43 12 218
Source: present author
A systemic sample was drawn from the above shown stratified sample.
5.5. Sampling frame
In order to control as many extraneous variables as possible while manipulating a 
single independent variable or some independent variables, a completely 
randomised design (CRD) was used. Random number tables from Fisher and Yate
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(1953), developed as statistical tables for biological, agricultural and medical 
research, were used to select the target group. A stratified sample technique was 
also considered for the specialists and general practitioners, in order to obtain 
clusters in different geographical areas. Inside those clusters a systemic sampling 
technique was foreseen. The main advantage of this technique was that it would 
provide a good representation of the total population, although its complexity 
would be a disadvantage. A systematic sampling technique seemed therefore 
more practical and has been used.
Special attention was paid to the need to measure the actual prescription habits of 
the studied subjects. This would be easier in areas where prescriptions of certain 
physicians are dispensed by pharmacists of the area only. In urban areas, 
however, the dispersion of prescriptions might be very broad. Doctors whose 
prescription habits could not be controlled were therefore not included in the 
study.
5.5.1. Sample size
The sample size had to be as large as possible within the timetable and 
circumstances given. However, the sample size could not be less than 513, based 
on the following calculation:
ZS 2
N
E
where
Z standardisation level indicating the confidence level 
estimate of the population standard deviation 
acceptable magnitude of error
S
E
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For estimating the value of the standard deviation, one sixth of the range was used 
(Wentz, 1972, p. 145). The range of error was set at 2.5%, which is half of the 
total confidence interval (Zigmund, 1997, p.473). With a confidence level of 
95%, a range of error of 2.5% and an estimated standard deviation of 1.166667, 
the required sample size could be calculated:
N =
(1.96) x (1.16667)'
= 171 
0.175
The total sample size will be approximately three times 171 in order to construct 
the experimental and control groups.
5.6. Research procedures
The schedule for the research procedures is presented in section 5.2.1, Figure 12. 
The questionnaires at the beginning and end of the study period were distributed 
and collected by the representatives who usually visit the selected physicians. The 
actual prescriptions for the researched products, issued by the selected physicians at 
the beginning and at the end of the study period, were counted by the same 
representatives in the relevant pharmacies. As this checking of prescription 
behaviour is a rather common practice in Greece, it should not have led to the 
selected physicians being informed that this was part of the study. The external 
stimuli were presented to the physicians six times over the six-month period, 
together with the regular promotional message of the company. The dates of the 
visits were reported by the representatives on special forms in order to control the 
correct execution of the study (see section 5.13, Table 26 of this thesis).
5.7. Collection of data
The study subjects were visited at the beginning and the end of the study period 
by the usual medical representative and asked to fill in a questionnaire concerning 
the determinants of his or her prescription behaviour. No mention of any product
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was made in the questionnaire in order to avoid any response bias due to social 
desirability. This was considered an adequate method for the purposes of the 
study. The use of a mail questionnaire issued by an independent party, such as the 
faculty of pharmaco-economics of the University of Athens, was rejected as it was 
not expected to increase the reliability of the answers. In the same week as the 
first questionnaire was completed, the prescription habits of the physician with 
respect to antidepressants, antihypertensives, or hormone replacement therapies 
were analysed via the prescriptions issued by the doctor and dispersed by 
pharmacists in the area during the past week. The characteristics of the 
pharmacists contacted and alternative measurements considered, described in 
section 5.5, are Anther discussed in section 5.8 of this thesis. It was expected that 
the physician would be unaware that his or her prescription habits were being 
recorded. This observation technique has been chosen as the resulting data will 
not have any distortions, inaccuracies, or other response biases due to memory 
error, social desirability, etc. as would be possible with self-reported data. In the 
week after the sixth promotional visit the physician was asked to fill in the second 
questionnaire while his or her prescription habits of the past week were recorded, 
again via examination of prescriptions issued.
5.8. Measure of the dependent variable
It is the aim of this study to investigate the relationship between behavioural 
intention and actual behaviour. Therefore the actual number of prescriptions issued 
by the selected physicians and dispersed by pharmacists, was counted. This was 
done in the first and last week of the study period (see section 5.2.1, Figure 12, and 
5.13, Table 25 of this thesis). Differences between the prescription patterns of the 
intervention groups and the control group should be a measure of the dependent 
variable if all other variables are well controlled.
The sales representatives know by experience which pharmacies dispense most of 
the prescriptions of each physician. During the selection period confirmation of this 
was sought by direct questioning of the pharmacists. Physicians were excluded
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from the study if the medical representative had any doubt that at least two-thirds of 
their prescriptions could be covered. The same pharmacies were visited at the end 
as at the beginning of the study period. Only the number of prescriptions was taken 
into consideration, not the length of the therapy nor the daily dosage prescribed.
This is because the research was focussed on the event of prescription of a certain 
drug and not on the number of packs prescribed. If more than one of the products 
included on one of the lists of drugs (Tables 9-11) was mentioned on a single 
prescription, each product was counted separately.
In order to be able to analyse the influence of a change in morbidity, the number of 
prescriptions for competing products was also counted. A list of competing 
products had been determined before the start of the study, based on the most 
frequently prescribed products for that particular indication in Greece during the 
past half year as published by the International Medical Statistics, IMS Hellas (see 
section 5.3.2. of this thesis).
For various reasons, patients do not always follow their doctor’s instructions. Non- 
compliance means not taking the correct amount of the prescribed medicine at the 
proper time. Studies have shown that more than 50% of patients show some degree 
of non-compliance with prescribed medication, with about one third not taking any 
at all (Hayes, 1989). Thus, there is a possibility that an important percentage of the 
total number of prescriptions issued by physicians is not seen by pharmacists as 
they are never presented. In order to keep non-compliance to a minimum, the 
products investigated were products for which non-compliance is generally 
assumed to be less important.
The pharmacist keeps the written prescriptions after having supplied the medicines, 
so apart from possible errors due to non-presentation of the prescription by the 
patient, the written prescriptions give a real impression of what has been prescribed 
by the physician. There are three additional safeguards in this respect. Firstly,
Greek pharmacists are not allowed to change a prescription without the written 
consent of the prescribing physician. Secondly, they are only allowed to supply
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entire packs of medicine. Thirdly, each pack of a pharmaceutical product has a self- 
adhesive tear-off sticker which the pharmacists have to attach to the original 
prescription when supplying the product. This sticker on the prescription is an extra 
guarantee that the product has not only been prescribed but also dispensed to the 
patient.
A number of alternative methods of measuring the dependent variable were 
considered but rejected for various reasons, such as difficulty in collecting the data 
from the source or possible contamination of the collected data. Alternative sources 
considered were the prescribing physician him or herself, the major Greek sick 
fund, IKA, real unit sales data of the major distributor/wholesaler of pharmaceutical 
products in Greece, and the Greek branch of IMS AG. Social desirability bias and 
refusal to supply the data were the main reasons for not using the physician as a 
source; the sick fund was not expected to give permission to have the prescriptions 
issued and re-imbursed analysed, while data from the wholesaler might easily be 
distorted by stock changes at the level of the pharmacy or prescription alterations 
concerning treatment duration or quantities prescribed. The Greek branch of IMS 
could not be used, as they were not able to disclose the panel of doctors they use to 
obtain their statistical data.
5.9. Development of the questionnaire
Existing pharmaceutical promotional campaigns were used during this research as 
a bandwagon on which to study the influence of a new promotional claim based 
on the most important determinant of prescription behaviour. It might be 
expected that physicians’ behaviour is more or less volitional depending on how 
life-threatening the indication to be treated is. In order to eliminate this influence 
as much as possible, three common but specific indications were chosen. The 
rationale for the choice of essential hypertension and depression is that they are 
usually chronic conditions which require long-term treatment, while the treatment 
of menopausal complaints is a preventive treatment. Other factors which 
favoured the selection of these three indications, were the frequency of their
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occurrence, and the clarity of the definition of the indication. Also, all three 
indications fulfil the requirement that patient non-compliance is expected to be 
low. Heart patients who take drugs daily to lower their cholesterol, reduce blood 
pressure, or prevent a first heart attack, should know that compliance is critical to 
decrease risk. Similarly, patients suffering from depression should be motivated, 
as they know that non-compliance will reduce the quality of their social life or 
increase the risk of suicidal ideation. Women taking hormonal treatment for 
menopausal complaints are considered to know that non-compliance may induce 
complaints due to disturbances of their hormone balance. Only gynaecologists 
were included in the survey of hormone replacement therapy, as the literature 
indicates that patient non-compliance is lower when hormone replacement therapy 
is initially prescribed by a gynaecologist than by a general practitioner (Faulkner, 
1998). This should limit patient non-compliance in the present study.
Patients suffering from one of the three above-mentioned indications are 
frequently seen by the physicians for follow-up visits, thus further reducing the 
risk of patient non-compliance.
5.9.1. Physicians’ aspects of attitudinal domain, the claims of perceived
behavioural control, and the selection of the five most salient 
normative and behavioural beliefs
The method described by Fishbein and Ajzen (1975, p.218) was used to identify the 
most salient beliefs. This procedure advocates that a person’s beliefs about a given 
object or action can be elicited in a free-response format by asking the individual to 
list the characteristics, qualities, and attributes of the object or the consequences of 
performing the behaviour. There are some limitations to this method. All the 
beliefs elicited may not be salient beliefs; only the first two or three may be salient 
for a given individual and additional beliefs may not be primary determinants of 
self-identity, utilitarian, or normative outcomes. Unfortunately, no methods are 
described in the literature to determine the point at which a person starts giving non­
salient beliefs. Another problem is that the procedure of elicitation itself may
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produce changes in a person’s beliefs hierarchy. For example, previously non­
salient beliefs might become salient once they have been elicited. The alternative, 
to present a standard set of belief statements, might result in similar problems. The 
confrontation with pre-stated beliefs may change the respondents’ salient beliefs 
and thus affect the outcome. It thus appears impossible to obtain a precise measure 
of beliefs that determine an individual’s attitude towards behaviour. Fishbein and 
Ajzen therefore recommend asking a representative sample of the population to 
elicit their beliefs about the product or behaviour. The most frequently elicited 
beliefs could be considered the modal salient beliefs for the population. This 
method has been followed for this research.
Between Monday 2 November and Saturday 14 November 1998, both dates 
inclusive, 40 general practitioners and 41 specialists were visited with an open- 
ended questionnaire in order to determine their most salient beliefs. Physicians 
were selected at random from the greater Athens area and Crete using the database 
of Solvay Pharma M.E.P.E.. The participation was exemplary.
A multivariate test was performed to determine whether the two groups differed in 
underlying salient beliefs. No significant differences could be found and thus there 
was no need to develop different questionnaires for the general practitioners and 
specialists.
• Physicians’ attitude statements
In order to understand the expressions used by the physicians to express their 
attitude feelings, all 81 physicians were asked to answer the following question 
(one of the indications was shown to each doctor):
Consideration of the daily therapy cost o f an antihypertension 
(antidepressant/laxative for non-chronic constipation/antispasmodicfor irritable 
bowel syndrome) treatment every time I believe that I  have to change the medicine 
that I  prescribe, is to me:
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Table 17 Expressions used by physicians concerning their attitude
towards cost-conscious prescribing:
Specialists General
practitioners
Important Unimportant 11 3
Good ^ ^ Bad 8 19
Positive ^ ^ Negative 5 3
Necessary Unnecessary 3 2
Proper Wrong 1 0
Obligatory Not obligatory 1 3
Real Unreal 1 0
Bothersome Not bothersome 0 3
Logical Not logical 0 1
Usual Unusual 0 1
Correct <r-> Not correct 0 1
Source: field research
• Physicians’ claims of perceived behavioural control
Physicians disclosed their feelings of control while answering the following 
question:
which factors help or hamper me to be cost conscious while prescribing an anti­
hypertensive (antidepressant/laxative for non-chronic constipation/antispasmodic 
for irritable bowel syndrome):
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Table 18 Expressions used by physicians concerning their feelings of
control over the behaviour (PBC):
Specialists General
practitioners
Efficacy of the product 23 13
The financial situation of the patient 14 8
Side effects of the product 7 10
The financial situation of the insurance fund 5 7
Seriousness of the disease 3 0
Company’s profile 2 1
Reliability of the product 2 0
Long term efficacy 2 0
Nothing 2 9
Onset of action 1 0
By patient’s impression that high price means 
a better product 1 0
Pack size 1 1
Experience with the product 0 1
Source: field research
• Normative beliefs
Who or what is determining physicians’ prescription norms was unveiled by the 
following question:
who influences how cost conscious you are when prescribing an antihypertensive 
(antidepressant/laxativefor non-chronic constipation/antispasmodicfor irritable 
bowel syndrome):
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Table 19 Expressions used by physicians concerning their normative 
beliefs (Nb):
Specialists General practitioners
Patient 14 10
Insurance fund 12 9
Medical representative 11 13
Reliability of the product 7 4
Scientific literature 6 2
Nobody 5 8
Company’s image 2 1
Pharmacist 2 3
Many factors 0 3
Some factors 0 1
General situation 0 1
Source: field research
• Behavioural beliefs
If I  consider the daily treatment costs of a medicine before I  prescribe an anti­
hypertensive (antidepressant/laxative for non-chronic constipation/antispasmodic 
for irritable bowel syndrome), this will result in:
Table 20 Expressions used by physicians concerning their behavioural 
beliefs (Bb):
Specialists General
practitioners
Prescribing less effective products 17 14
Financial benefit for the patient 7 1
Financial benefit for the insurance fund 3 4
Financial benefit 3 0
Having doubts about the treatment 
Increased cost due to products with reduced
3 0
efficacy 2 1
Better compliance due to lower costs 1 2
Prescribing a better but more expensive product 1 0
Better cost/benefit ratio 1 7
Improved relation patient/physician 1 0
Endanger the safety of the patients 1 0
Increased fear for the insurance funds 1 0
Increased treatment duration 0 1
Source: field research
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The opinion that cost reductions have a negative impact on the quality of care is in 
line with what has been reported already by Wetchler (1992, pp. 20-24).
5.10. Preparation and testing of the questionnaire
Although various response effects have been demonstrated by survey researchers, 
the conditions under which they occur and their relation to seemingly relevant 
moderator variables such as attitude strength are not well understood (Schuman & 
Kalton, 1985, pp.635-697). However, it is apparent that different wording of the 
same question might lead to different answers. This is because questions 
concerning attitudes, norms, and beliefs are more sensitive than factual questions 
to changes in wording, context, or emphasis being given to individual elements of 
the question. Special attention was therefore paid to words or phrases that are 
ostensibly irrelevant to the main issue posed in the questions but that might have a 
substantial impact on the responses. For example, repetition of phrases in a 
number of subsequent questions was allowed in order to avoid misinterpretation.
Sets of questions are more reliable than single opinion items. As the best possible 
measurement of real attitudes, norms, and beliefs was required, sets of questions 
or attitude scales were used for measurement of the individual factors. This seems 
particularly important for the measurement of attitude structure. For proper 
analysis it is necessary to distinguish between the negative and positive 
constituents of the final attitude score. The multi-item measurement also has the 
advantage of greater reliability (Himmelfarb, 1993).
5.10.1. Preparation of the questionnaire
Based on the outcome of the pilot research into physicians’ aspects of attitudinal 
domain, the claims of perceived behavioural control, and the selection of the five 
most salient normative and behavioural beliefs (see section 5.9.1 of this thesis), a 
questionnaire was prepared. The structure of the questionnaire followed the 
elements of the composite model of the attitude behaviour relation developed by
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Eagly and Chaiken (1993, p.209). Contrary to the recommendations of Denig et al. 
(1988, p. 1382) the pharmacist was not included under normative beliefs as 
pharmacists were not found to be very influential in the pilot study (see Table 19).
The questionnaire was prepared by the investigator in the English language and 
translated into Greek by a Greek gastro-enterologist together with a statistician from 
the University of Athens. The resulting Greek questionnaire was translated back 
into English by the British Council in Athens and the resulting English 
questionnaire compared with the original. Differences were discussed with all 
translators involved in order to obtain complete agreement about the text.
The questionnaire is expected to allow an analysis of the determinants of 
physicians’ expressed prescription behaviour and the additional predictive power of 
the composite attitude behaviour model compared with the model of the theory of 
planned behaviour. How the questions are expected to contribute to the 
determination of the elements leading to certain prescription behaviour is discussed 
in sections 5.11 and 5.12.
It had to be decided whether, for the preparation of the questionnaire, the expressed 
determinants of the two independent samples, one from the specialists and the other 
from the general practitioners, could be regarded as having come from the same 
population. It had also to be decided whether the observed sample differences of 
perceived behavioural control determinants, normative and behavioural beliefs, 
between specialists and general practitioners signify real differences between the 
two groups or whether they are merely the type of differences that are to be 
expected among random samples of the population. Since the reported perceived 
behavioural control, and normative and behavioural beliefs are categorical variables 
and because there are two groups, namely the specialists and general practitioners, 
and because the categories are mutually exclusive and exhaustive, the chi-square 
test for independent groups seemed appropriate to test whether the differences 
exceed those expected by chance or random deviation from proportionality. The 
significance level should be low for two reasons. Firstly because of the limited
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number of answers, and secondly because it will form the basis for decisions about 
important investments. The means needed to change physicians’ prescribing 
behaviour might turn out to be costly. If the null hypotheses were wrongly rejected 
it might be a costly mistake. Therefore the significance level was set at 0.01.
The obtained behavioural beliefs were arranged in a contingency table in which the 
columns represented the two groups and each row represented the three combined 
categories of the measured variables. The categories created were:
• problems with the efficacy of the product (prescribing less effective 
products, having doubts about the treatment, increased cost due to less 
effective products, increased treatment duration, endangering the safety of 
the patient),
• financial aspects (financial benefit for the patient or insurance funds, 
increased fear for the insurance fund, financial benefit),
• better efficacy (prescribing a better but more expensive product, better 
cost/benefit ratio, better compliance, improved doctor/patient relation).
Combining adjacent classifications and, thereby, reducing the number of cells of the 
contingency table is allowed if such combining does not rob the date of their 
meaning (Siegel & Castellan, 1988, p. 123). The chosen classification is believed 
not to violate this requirement. The null hypothesis is that behavioural beliefs are 
independent of being specialist or general practitioner.
Table 21 Contingency table of the behavioural beliefs of specialists and 
general practitioners:
 Specialists________ General practitioners Total
Real Expected Real value Expected
value value value
Reduced efficacy 23 22.52 16 16.48 39
Financial aspect 14 10.97 5 8.03 19
Improved efficacy 4 7.51 9 5.49 19
Total 41 30 71
Source: present author
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With df= (n-1) = 2, the value of X2 is not significant beyond the 0.01 level (6.01 
versus 9.21, see for the calculation Appendix AD) according table IV of Fisher and 
Yates (1963). Therefore the null hypothesis of no difference between the 
behavioural beliefs of the two groups can be accepted at a = 0.01. Thus the same 
questionnaire could be used for both groups concerning the behavioural beliefs.
The obtained normative beliefs were also arranged in a contingency table in which 
the columns represented the two groups and each row represented the three most 
frequently mentioned variables.
Table 22 Contingency table of the normative beliefs of specialists and 
general practitioners:
Specialists_______ General practitioners Total
Real expected Real Expected
value value value value
Patient 14 12.87 10 11.13 24
Insurance fund 12 11.26 9 9.74 21
Medical representative 11 12.87 13 11.13 24
Total 37 32 69
Source: present author
With df = 2, the value of X2 is not significant beyond the 0.01 level (0.90 versus
9.21, see for the calculation Appendix AE) according table IV of Fisher and Yates 
(1963). Therefore the null hypothesis of no difference between the normative 
beliefs of the two groups can be accepted at a = 0.01. Thus the same questionnaire 
could be used for both groups concerning the normative beliefs.
Some factors mentioned by the physicians, such as reliability of the product and the 
scientific literature, were not included in the questionnaire as those factors are 
already used extensively by the pharmaceutical industry in their promotional 
messages.
When the physicians disclosed their feelings of control, they also mentioned factors 
which hamper the doctor’s cost-consciousness when prescribing. Most had to do 
with the fear of prescribing less effective products or products with a lower safety
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profile. Both elements were therefore included in the questionnaire. The financial 
situation of the patient or sick fund, although frequently mentioned, was omitted 
from perceived behavioural control as both were covered by normative beliefs and 
the motivation to comply. The seriousness of the disease and the patient’s 
impression that highly priced products are better products were mentioned by 
specialists only. Based on their frequency they should not be included at all or only 
in the questionnaires for the specialists. However, it would be interesting to see 
whether the seriousness of the indication treated is also important for the general 
practitioner and whether there is a significant difference between the two groups of 
prescribers concerning this factor. If so, the seriousness of the disease to be treated 
may need to be given a different weighting in promotional campaigns.
5.10.2. Testing of the questionnaire
The pre-test of the questionnaire was conducted in several phases. The first pre-test 
took place between 11 and 14 January 1999 with 21 cardiologists and gastro­
enterologists from Athens, while the second and final pre-testing was executed in 
March 1999 with 51 Greek cardiologists participating at a medical congress in 
Mexico and 39 Greek psychiatrists participating at a medical congress in Jordan. 
The specialists originated from all over Greece. The pre-testing process allowed us 
to determine whether the respondents had any difficulty understanding the 
questions or whether there were any ambiguous or biased questions. The layout of 
the questions concerning the determinants of attitude had to be changed from one 
combined question into five separate questions in order to guarantee complete 
answering. The wording of several questions had to be adjusted in order to be 
understood in full by all respondents without additional explanation. The pilot test 
showed that, in order to reduce the non-response rates, an endorsement of the study 
by a prestigious independent source, such as a letter of introduction from a 
university, was needed. Different layouts of the questionnaire were tested, for 
example, the answer-ticking boxes were reversed. This was done by a split-ballot 
type of pilot study in which half of the sample received questionnaires in which the 
positive or confirmative expressions were changed from the left side to the right
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side of the answer-ticking box. This change did not cause any noticeable 
differences in the answers.
5.11. Linkage between the questionnaire and the hypotheses
Table 23 The links between the hypotheses and the questionnaire
Description  Hypothesis 1______ Hypothesis Hypothesis
Measurement of actual 
prescription behaviour at the 
beginning of the study period 
Measurement of actual 
prescription behaviour at the end 
of the study period
Model of
planned
behaviour
Composite
attitude
model
2
Question 1 X X
Question 2 X X
Question 3 X X
Question 4 X X
Question 5 X X
Question 6 X X
Question 7 X X
Question 8 X X
Question 9 X X
Question 10 X X
Question 11 X X
Question 12 X X
Question 13 X X
Question 14 X X
Question 15 X X
Question 16 X X
Question 17 X X
Question 18 X X
Question 19 X X
Question 20 X X
Question 21 X X
Question 22 X X
Question 23 X X
Question 24 X X
Question 25 X X
Question 26 X X
Question 27 X X
Question 28 X X
Question 29 X X
Question 30 X X X
Source: present author
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5.12. Coverage of the expectancy value models by the questionnaire
Table 24 The coverage of the questionnaire and the expectancy value
models:
Description according to expectancy 
value models
Description according 
to the composite 
attitude model
Question
1 Behavioural intention Behavioural intention 1,
2 Past behaviour Habit 8,
3 Attitude Attitudes toward target 2,3,4,5,6
4 Anticipated regret variables Attitudes toward target 29
5 Emotional reaction Attitudes toward target 7
6 Perceived difficulty to perform the 
behavioural intention or 
perceived behavioural control
Self identity outcomes 14,15,16,17,
7 Behavioural beliefs Utilitarian outcomes 9,10,11,12,13,
8 Outcome evaluation Utilitarian outcomes 24,25,26,27,28,
9 Normative beliefs Normative outcomes 18,19,20,
1
0
Motivation to comply Normative outcomes 21,22,23,
1
1
General information General information 30
Source: present author
5.13. Administration of the instruments
The general practitioner and cardiologists:
In the period March -  September 2000, the external stimulus was added to the 
messages included in the so-called «detail aid», see Appendix F, which was used by 
the sales representatives as the basis for a discussion of the advantages of a certain 
antihypertensive therapy with general practitioners and cardiologists.
The detail aid consisted of eight pages. The first page was designed to draw the 
physician’s attention to the dangers of hypertension and metabolic syndrome for the 
cardiovascular system. The second page explains the role of the sympathie nervous
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system in the morbidity and mortality due to cardiovascular and metabolic 
disorders. The message of this page was that the centrally acting antihypertensives 
are crucial to the treatment of the hypertensive syndrome as overactivity of the 
sympathetic nervous system plays an important role in the pathogenesis of 
hypertension. The third page explains how Fisiotens (moxonidine) regulates the 
sympathetic overactivity. It was explained that Fisiotens’ selective binding to 1 1- 
imidazoline receptors reduces effectively blood pressure, whereas its limited 
binding to a 2-receptors limits its adverse events and explains its tolerance. The 
fourth page shows clinical evidence such as increases coronary reserve, reduced left 
ventricular mass and the amelioration of the contractility of the aorta. The fifth 
page gives data from the literature about the beneficial effect on the activity of the 
endothelium and the renal function. The sixth page shows the reducing effect on 
insulin resistance and increased glucose absorption at tissue level. According to 
available data, moxonidine is a reasonable choice for overweight hypertensive 
patients with concomitant disorders in metabolism of glucose and lipids. The 
seventh page discusses the low rate of adverse events of moxonidine and explains 
that the drug does not interact with other drugs. The eighth page shows the entire 
text of the package insert and stresses the once-daily dosage and that the product is 
reimbursed.
The first external stimulus, which was developed for this study, was added when 
discussing the eighth page with the first third of selected physicians. The second 
external stimulus was added in the same manner when discussing the eighth page 
with the second group of physicians participating in the study. To the third group 
no extra external stimulus was added to the basic promotional message.
The psychiatrists:
The "detail aid”, see Appendix G, used by the sales representatives when visiting 
psychiatrists also consisted of eight pages. The message «The Selective) 
S(erotonin) R(e-uptake) I(nhibitor)s to treat depression and subsequent anxiety» on 
the first page aims to direct the attention immediately to the group of products to
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which Dumyrox belongs. Pages two and three show comparisons of clinical data 
about the efficacy of fluvoxamine (Dumyrox) and its main competitors fluoxetine, 
paroxetine and sertraline in the treatment of depression. On page four clinical data 
on the treatment of social phobia with fluvoxamine is shown, while on page five the 
use of fluvoxamine with sexually active patients is discussed. The page concludes 
with the statement that fluvoxamine does not affect sexual function. Excessive food 
intake and its treatment with fluvoxamine is discussed on page six while 
pathological gambling as an increasing social problem is discussed on page seven. 
Clinical data are displayed which show that fluvoxamine reduces the thoughts about 
and willingness to gamble. On page eight the package insert is printed, the daily 
dosage highlighted and the fact that the product is re-imbursed.
The first external stimulus, which was developed for this study, was added when 
discussing the eighth page with the first third of the physicians selected. The 
second external stimulus was added in the same manner when discussing the eighth 
page with the second group of physicians participating in the study. The third 
group acted again as control group and were confronted with the normal 
promotional message only.
The gynaecologists:
An eight-page “detail aid”, see Appendix H, was also used with the gynaecologists. 
The attention of the physicians was drawn to the treatment of the symptoms of 
menopause by the expression «harmony in menopause» on the first page. The 
second page enumerates the symptoms of the menopausal syndrome. The third 
page presents the characteristics of 17 p estradiol and dydrogesterone, while clinical 
data on combined therapy with both active ingredients in the treatment of 
climacteric symptoms are shown on the fourth page. On page five, Femaston, a 
combination product of 17 p estradiol and dydrogesterone, is highlighted.
Femaston protects women from osteoporosis; treated women have a higher bone 
mass and a reduction in the incidence of bone fractures. On page six, it is 
mentioned that Femaston gives cardiovascular protection to women as it increases
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the level of high-density lipids and reduces the level of low-density lipids. Page 
seven gives an overview of the product characteristics and its daily dosage. Page 
eight concludes with the text of the package insert and stresses that the product is 
new and brings harmony in the menopause.
The first external stimulus developed for this study, was added when discussing the 
eighth page with the first third of the selected physicians. The second external 
stimulus was added in the same manner when discussing the eighth page with the 
second group of participating physicians. The remaining third of the selected 
gynaecologists acted again as control group.
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Table 25 The timetable of the study
Week Activity Details
1 First visit to one quarter o f the target group and 
the pharmacists o f the area
Filling in o f questionnaire and 
analysis o f prescription habits
2
3
4 ”
5 Analysis o f data, selection of most salient 
determinant o f prescription behaviour
6
7
8 Preparation o f promotional material
9
10 First detailing to a quarter of the target group
11
12
13
14 Second detailing to a quarter o f the target group
15
16
17
18 Third detailing to a quarter o f the target group
19
20
21
22 Fourth detailing to a quarter of the target group
23
24
25
26 Fifth detailing to a quarter o f the target group
27
28
29
30 Sixth detailing to a quarter o f the target group
31
32
33
32 First visit to the one quarter of the target group 
and the pharmacists o f the area
filling in o f questionnaire and 
analysis o f prescription habits
33
34
35
36_________ Start of the analysis o f the data
Source: present author
Study administration was reported by the representatives on the following 
schedule:
Table 26 Reporting of the administration of the external stimulus:
C o d e Name o f  the 
physician
Spec. Representative D ate o f  visit Product
i 2 3 4 5 6
Source: present author.
5.14. Use of the external stimuli
Physicians were asked for their opinions on the phrase (external stimulus) which 
had been developed on the basis of the pilot study in order to start a discussion 
about the subject. This “two-sided” communication structure was chosen for two 
reasons. Firstly, because previous research on persuasion has tended to characterise 
attitude change as resulting either from a thoughtful consideration of issue-relevant 
arguments or from associating various positive or negative cues with the attitude 
object. The general neglect of information contained in a message is according to 
Fishbein and Ajzen (1981, p.359) probably the most serious problem in 
communication and persuasion research. They state that paying careful attention to 
content should increase the persuasiveness of a communication more easily and 
dramatically than the manipulation of credibility, attractiveness, or any of the 
innumerable other factors that have caught the attention of investigators. Secondly 
because an argument contained in a two-sided communication is considered more 
effective than in a one-sided one if the initial attitude of the receiver is at variance 
with the attitude embedded in the message. The phrase used was furnishing a goal 
intention with an implementation intention. This is a common “selling technique” 
used by sales representatives as it has been demonstrated to significantly increase 
the probability of enacting the goal intention (Bamberg, 2000, pp.1903-1922).
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Reports in the literature suggest that implementation of intentions are effective 
because they allow participants to pass control of behaviour to the environmental 
cues contained in the implementation intention (Sheeran & Orbell, 1999, pp.349- 
369). Diminishing the influence of perceived behavioural control on real behaviour 
via the mediation of behavioural intention was not the only reason that the above- 
mentioned communication technique was selected for this research.
Encouragement of the formation of implementation intentions for specific action 
opportunities is expected to lead to more rapid changes of behaviour. Orbell and 
Sheeran (2000, pp.780-797) proved that the fact that intentions are formed does not 
relate to the speed with which they are translated into action. Supporting the 
formation of those intentions should increase the likelihood of observing significant 
changes of real behaviour in the limited time-span of this research. The above- 
mentioned communication technique was used by all participating representatives.
5.15. Non response bias
The pattern of the missing data at baseline and at the end of the study were analysed 
in order to identify an eventual non-response bias. The results are included in 
sections 6.4.2 and 6.7.2.
5.16. Non response rates
The possibility of bias was the primary concern, rather than the number or 
proportion of non-participators. Therefore the geographical distribution of the 
general practitioners who refused to participate in the first part of the study was 
compared with the distribution of the selected physicians. In total, 74 general 
practitioners (33.9% of the total selected) refused to participate in the study. These 
non-participators turned out to be quite equally distributed over the country, with 
Athens/Piraeus and Macedonia (Thessaloniki) having the highest percentage 
(34.7% and 39.5%, respectively), and Sterea having the lowest (18.2%). For more 
details see section 6.4.1 of this thesis. The geographical distribution of the non­
participating specialists was low (about 10%) and all the chosen specialties were
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well represented (see section 6.4.1, Table 44). There seems thus to be no risk of 
bias due to an unequal distribution of non-responders over the country and/or a low 
rate of participation in any one of the geographical areas.
The reasons for non-participation were also analysed in order to investigate whether 
the reasons for non-participation were somehow connected with the topic of the 
research (see section 6.4.1, Table 42). The main reason given by the general 
practitioners was that the questionnaire was too long, while other important reasons 
indicated were: no reason, no time, or wanted to be paid to answer. For specialists, 
insufficient time was the main reason given, with the length of the questionnaire 
being mentioned as a second reason (quite similar to the first reason). As the 
indicated reasons had nothing to do with the topic of the research, it was concluded 
that the topic of the research was not a cause of non-participation.
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5.17. Dates and protocols of interviews
Table 27 Survey of the field studies and interviews:
Time Description Sample size
June 1998 An open ended elicitation questionnaire to 30 physicians:
determine the salient beliefs of physicians 15 specialists and 15 
general practitioners
June, July, Field study to investigate how volitional 40 physicians:
Augusts 1998 prescription behaviour of physicians is in a 22 specialists and 18
cost conscious environment general practitioners
November 2- Field study to determine which specific 81 physicians:
14, 1998 underlying normative and behavioural 41 specialists and 40
beliefs are salient with physicians when 
prescribing pharmaceutical products
general practitioners
Jan 11-14 1999 Pre-test of questionnaire which will be used 21 physicians:
during the research cardiologists and 
gastro-enterologists
March 1999 Pilot study of the questionnaire which will 90 physicians:
be used during the research 51 cardiologists and 
39 psychiatrists
November, • Questionnaires distributed among the 538 physicians:
December selected physicians in order to 218 general
1999 understand the independent variables practitioners, 100
influencing their prescription behaviour psychiatrists, 110
• Analysis of the actual prescribing cardiologists and 110
behaviour of the selected physicians by 
counting prescriptions at pharmacy level
gynaecologists.
January 14, Analysis of data obtained from 9 physicians:
2000 questionnaires which were distributed in 2 cardiologists, 3
November and December 1999 by 9 general practitioners,
specialists who did not participate in the 2 gynaecologists and
study 2 psychiatrist
March 27 until 6 visits to each of the selected physicians Group 1 :134
November 17 with regular promotional message on which physicians
2000 the first or second or no extra external Group 2:131
stimulus is added. physicians 
Control group: 
131 physicians
October and • Questionnaires distributed among the 396 physicians:
November selected physicians in order to 140 general
2000 understand the independent variables practitioners, 77
influencing their prescription behaviour psychiatrist, 90
• Analysis of the actual prescribing cardiologists and 89
behaviour of the selected physicians by 
counting prescriptions at pharmacy level
gynaecologists
Source: present author
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5.18. Tests used
Statistical analysis was performed with the SPSS Base 8.0 for Windows in all cases 
except one. The exception was the use of Hotelling’s /-test to validate the 
superiority of the decomposed composite attitude behaviour model over the model 
of the theory of planned behaviour as the coefficients of correlations were 
correlated. In this particular case, the entire formula is presented, as well as the 
steps of the calculation in Appendix AA.
5.18.1. Test for response bias
There are five specific categories of response bias: acquiescence bias, extremity 
bias, interviewer bias, auspices bias, and social desirability bias.
The risk o f acquiescence bias, which is a response bias due to respondents’ 
tendency to concur with a particular situation, seems not to exist, as the 
questionnaire is anonymous.
Some individuals tend to use extremes when responding to questions, others always 
avoid extreme positions and tend to respond neutrally. Responding styles vary 
from person to person, and may cause an extremity bias. The social desirability 
scale can be employed in two ways to cope with this bias: reject the high-scoring 
subjects, and correct the data of high scorers. Because there is no clear-cut 
distinction between contaminated and uncontaminated data, rejection of the data of 
high-scoring subjects is imbued with arbitrariness. Moreover, this approach impairs 
the representativeness of the sample (Nederhof, 1985, p. 268). Correction rather 
than the rejection of contaminated data is another way to treat contaminated data.
An estimation is made of the degree of contamination by social desirability bias, 
e.g. by using the scores of a reference group, and the contaminated data are 
adjusted. Sometimes, those of low- or medium-scoring subjects replace data of 
high-scoring subjects. However, this method was also rejected as Stocking (1979) 
has shown that high-scoring subjects may differ, not only with regard to their 
susceptibility to social desirability bias, but also in many other ways from lower-
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scoring subjects. Therefore, no data were excluded or adjusted in order not to 
influence its representativeness. Theoretically, this type of bias might therefore 
have occurred in and influenced this research, however its effect should be 
considered low due to the large sample size.
Interviewers are not used in this study and therefore interviewer bias is non 
existent.
Auspices bias is caused by the influence of the image of the organisation searching 
for the information. The physicians were informed that the study was being done 
by a researcher from the University of Surrey, UK. The link of the researcher with 
the pharmaceutical industry was not known to the physicians and could thus not 
lead to any bias. The University of Surrey, being a academic institute, should not 
have influenced the answers of the physicians.
Social desirability bias is treated in section 5.19.1
5.18.2. Test for assumption of regression
The independent variables of the two research groups and the control group were 
measured by questionnaires completed by the physicians. This means that while 
real prescription behaviour, the dependent variable, is a random variable, the 
independent variables do not vaiy at random, but are under the control of the 
researcher. The influence of a possible variation over time, which is not controlled 
by the researcher, should have had a comparable influence on all three groups of 
physicians and should therefore not have disturbed the results of the regression 
analysis when groups were compared (Sokal & Rohlf, 1997, p.436).
5.18.3. Reliability of the measuring instrument
Reliability is expressed in the form of a correlation coefficient. It can be measured 
by making use of the internal consistency method, usually associated with 
Cronbach’s Alpha coefficient. The intemal-consistency method rests entirely on
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classical scaling theory. If the scale is expected to measure a single underlying 
continuum, then the items should have strong relationships both with the continuum 
and with each other. Since coefficient Alpha is a measure of squared correlation 
between detected scores and the true scores, it shows consequently an estimate of 
the dimensions of the total variance that is not due to error, and hence represents the 
reliability of the scale (Oppenheim, 1997, p. 160). The square of correlation 
coefficient expresses the percentage of shared true variance, and therefore a reliable 
coefficient of 0.90 means that the two measures have 0.81 or 81 % in common 
(Oppenheim, 1997, p. 159). Usually reliabilities of 0.70 and above, thus a 
percentage of 50 and above, is acceptable in studies of social and behavioural 
sciences as it is rare to find reliabilities much above 0.90 in this field (Robinson et 
al., 1991; Robinson & Shaver, 1973).
Two alternative internal consistency tests were considered but rejected. The 
Kunder Richardson (KR) formula was rejected as it can be applied to 
dichotomously scored data only while in this research large scale data had to be 
treated. The split-half reliability coefficient can be viewed as a one-test equivalence 
to alternate and test-retest. One single test is treated as two tests by dividing the 
items into two groups. The way the tested group is divided might influence the 
outcome and is therefore not appropriate. Cronbach’s Alpha does not have those 
limitations. The test can be used for both binary-type and large-scale data while the 
Cronbach is the mean of all possible split-half coefficients that are computed by the 
Rulon method.
5.18.4. Validity of the measuring instrument
The intention was to measure the strength and influence of the determinants of 
behaviour on behaviour. As this is an abstraction there does not exist a ‘true’ 
criterion measure (Oppenheim, 1997, p. 161), and thus measurement must take 
place indirectly. For this research this means that actual behaviour should reveil 
the magnitude of the individual determinants of non-fully volitional behaviour.
An achievement test in arithmetic may give a valid measure. In order to be able
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to determine whether the outcome can be used to generalise from the investigated 
medical specialisations to the entire medical profession, construct validity was 
used. There should be no significant difference between the score of the entire 
group of studied subjects and the four independent subgroups of medical 
specialisations as all medical specialisations displayed non-fully volitional 
behaviour (see section 3.5. of this thesis).
5.19. Control of variables
5.19.1. Social desirability distortion
One of the most common sources of bias is social desirability, which affects the 
validity of experimental and survey research findings. Social desirability can be 
seen as a result of self-deception and other-deception. No single method is able to 
cope completely with both other-deceptive and self-deceptive social desirability 
(Nederhof, 1985, p.263). A combination of prevention and detection methods is 
therefore advisable. From the two methods aimed at the detection and 
measurement of social desirability bias, the Marlowe-Crowne social desirability 
scales was chosen as it seems easier to apply than the rating of item desirability. 
With the latter method, the length of the questionnaire is doubled since the 
desirability rating is added to each item. It should be mentioned that there are 
some doubts about the validity of the Marlowe-Crowne scale as a measure of the 
need for social approval. However, the scale may be used to give an indication of 
the extent to which people distort their answers about a particular behaviour in a 
socially desirable direction, although it will not predict the exact frequency of that 
behaviour (Nederhof, 1985, p.266).
In addition to methods which aim primarily at detection and measurement of 
social desirability bias, attention has also been focused upon methods intended to 
prevent or reduce the effects of social distortion. Three methods were considered 
which deal with the mode of presentation of items to subjects (the forced-choice 
items, the neutral questions, and the randomised response technique), one method
205
dealing with the selection of interviewers and one with the choice of subjects 
studied. Finally, two methods which focus on the situation in which data 
collection takes place, such as the self-administered questionnaires and the bogus 
pipeline, were taken into consideration. All methods for reducing or preventing 
social desirability bias are only partially effective (Nederhof, 1985, p.275). 
However, in general, there seems to be less social desirability bias when subjects 
are offered some anonymity by self-administration of the questionnaires in the 
absence of the interviewer (Hillman, 1978). This method was therefore chosen 
for this research.
5.19.2. New product launches
During the study period new products might have been launched which might 
have competed with the products followed in this research. Any new launches 
were therefore recorded and reported. However, it was not expected that any 
newly launched products would distort the outcome of this study. The number of 
prescriptions for the three investigated products might have diminished or might 
have showed a lower growth trend due to new products but the effect would be 
expected to be equal for both the experimental and control groups.
5.19.3. Changes of reimbursement or prices of products
Changes in the re-imbursement list, or prices of pharmaceuticals published by the 
Greek ministry of commerce might have influenced the number of prescriptions 
written for the products investigated. Although the influence of any price change 
or change in re-imbursement status should have had an identical influence on all 
subjects studied and thus should not have disturbed this research, it might have 
altered the degree of volitional of the prescription behaviour. For this reason, had 
the price or re-imbursement status changed during the study for any product on 
the list of relevant products about which (a group of) the physicians were 
questioned, these physicians would have been excluded from the study.
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5.19.4. Changes in morbidity
During the analysis of the prescriptions written by the physicians, all prescriptions 
issued for the indication investigated were also counted in order to exclude the 
influence of an alteration of the rate of morbidity.
5.20. Limitations
5.20.1. Limitation of the methodology used
A specific issue is the limitation of the research to four groups of physicians (three 
specialisations and general practitioners) and three diagnoses. This means that, 
strictly speaking, any results and conclusions should be confined to these areas. 
However, Stem (1994) showed that the patterns of pharmaceutical prescribing are 
largely similar to those of grocery purchasing, i.e., a whole range of differences in 
market structure is not reflected in the patterns of buying of groceries and 
physicians’ prescribing. Thus, the conclusions of this research might be applicable 
outside the research area itself. However, the results derived from the current 
research are inherently interesting and so an eventual restriction of applicability is 
not a significant limitation.
5.21. Practical problems of the sampling frame or size of
questionnaires
No particular problems were encountered with the selected sampling frame. The 
length of the questionnaires was for some physicians a reason not to complete the 
questionnaire. An analysis of non-response rates and missing data at baseline and 
at the end of the study period can be found in sections 6.4.1, 6.4.2, 6.7.1 & 6.7.2.
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5.22. Unusual treatment of the data
Twenty-six of the 392 physicians who completed the study indicated belonging to 
an older age bracket at the end of the study than the one they indicated at the start of 
the study. This change of age group has not been taken into consideration when 
evaluating the data, in order to obtain the best comparable groups between baseline 
and the end of the study period.
In order to define how representative the prescription data of the participating 
physicians were, their prescription behaviour at baseline and at the end of the study 
period were compared with data from the entire pharmaceutical market.
Prescription data of the entire market were available at baseline and at the end of the 
study period of the antihypertensives and antidepressants only. Similar data were 
not available for products for the treatment of the symptoms of menopause as the 
total number of prescriptions was too small and therefore information about those 
prescriptions not bought by Solvay Pharma M.E.P.E. However, the total number of 
packs distributed in Greece was available. In order to be able to compare the real 
behaviour with behavioural intentions and to investigate the changes of prescription 
behaviour over time the total number of packs distributed by pharmacists were used 
as a measurement and not the number of prescriptions. The disadvantage of this 
approach is that all prescriptions might not be identical with respect to the length of 
treatment, but it was the most accurate measurement available. Units mentioned on 
the prescriptions counted by the sales representatives were thus compared with the 
total unit sales in Greece.
5.23. Ethical considerations
Many ethical issues apply to survey research. Such research must take into 
consideration the respondent's right to privacy, the use of deception, the 
respondent's right to be informed of the purpose of the research, the need for 
confidentiality, the need for honesty in collecting data, and the need for 
objectivity in reporting data. The use of hidden observation techniques, such as
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those used during this research, raises the issue of the respondent's right of 
privacy. This item is of particular interest, as not only were the prescription habits 
of the physicians analysed without their knowledge, but also the treatment of 
individual patients could be seen. In Greece, it is normal practice for pharmacists 
to allow well-known and respected representatives of the pharmaceutical industry 
to go through the prescriptions written by doctors. The physicians are expected to 
be aware of this general habit. Representatives who do not treat the obtained 
information with the appropriate confidentiality will not be allowed to examine 
the prescriptions again. During this research, the representatives gave information 
about the prescription habit of the participating physician to the researcher, 
although without disclosing the names of the doctor or patient. It was considered 
that the privacy of neither the physician nor patient was infringed by this research 
activity.
5.24. Discussion
The way the external stimuli are presented is important in allowing attitude, 
behavioural beliefs and other independent variables of physicians to change. 
Pharmaceutical industry representatives are a major source of drug information for 
physicians and most physicians allow them to visit their medical practices. 
Representatives are therefore in a position to establish the preconditions for 
behavioural change in the target group, and can raise the awareness of a product and 
encourage favourable attitudes towards it. It was therefore decided to use the 
representatives to present the external stimuli to the physicians in this study. 
According to De Bono and Telesca (1990) the strength of the arguments delivered 
also affects the persuasiveness of the communication. Therefore three similar 
groups were constructed, each of whom receives the normal promotional message, 
but one of which is also presented with a claim based on an independent variable 
which has been demonstrated to have a strong influence on behavioural intention. 
The second group receives, in addition to the normal promotional message, a claim 
based on a weak independent variable, while the third group acts as the control 
group. The chosen method minimises possible social desirability distortion, as the
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representative who delivers the external stimulus is known to the physician. It does 
allow us to study the influence of an external stimulus based on the independent 
variable that we have shown to have the greatest influence on behavioural intention. 
Repetition of the message seems to be important in improving its accessibility to the 
physicians when deciding on the product to be prescribed. It was decided to use six 
repetitions of the message to maximise accessibility from memory while at the 
same time keeping the representatives highly motivated to execute the field study as 
planned, although a sound theoretical basis for the choice of this number is lacking. 
Counting the actual prescriptions issued by the participating physicians should 
result in accurate data. The collection of actual prescription data at pharmacy level 
was not expected to create major problems, as this practice is quite common in 
Greece.
Although the length of the questionnaire might lead to a low response rate, this can 
be minimised with the help of the representatives, who encourage their physicians 
to complete the questionnaires.
5.25. Conclusion
This chapter started with a justification for the methodology used in the study, and 
a discussion of variables such as the population to be investigated, the sampling 
frame, and the sample size. Details of the instruments used to collect data, in 
particular, how data on the independent variables were collected via questionnaires 
at baseline and at the end of the study period. The basis on which the questionnaire 
was created was outlined, and the method used to evaluate actual prescription 
behaviour, the dependent variable, described. Details of the pilot study were given, 
including procedures to demonstrate internal and external validity. The study 
procedures for administering the questionnaires and for the promotional visits were 
outlined, with details about when and where the data collection took place.
The analytical methods used to analyse possible non-response bias, response rates, 
response bias or test of the assumptions of regression and other statistical 
procedures were discussed. The methods used to control other variables, which 
might influence the results, are documented. The limitations of the methodology
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used, in as much as these were not described in section 1.7, were discussed, as well 
as practical problems encountered during the distribution and collection of the 
questionnaires and the analysis of the collected data. Any special or unusual 
treatment of data prior to analysis were discussed and the computer programs used 
to analyse the data given, together with a justification for their use. The chapter 
concluded with a discussion of the ethical issues involved.
No major problems were encountered with the chosen methodology and it seemed 
therefore adequate for this research. It was therefore concluded that the study 
seemed sound from a methodological point of view.
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CHAFER 6 Analysis of data and development of the external stimuli
6.1. Introduction
This chapter presents the results of the studies conducted and analyses them for 
their relevance to the hypotheses. This chapter is restricted to a presentation and 
analysis of the collected data, without drawing general conclusions or comparing 
the results to those of other researchers, discussed in Chapter 2. After the 
introduction, descriptive data about the prescription behaviour of the physicians is 
presented, the characteristics of the products prescribed are described, and an 
analysis made of the independent variables leading to prescription behavioural 
intention. The data dealing with each of the study hypotheses are presented and a 
sensitivity analysis made of possible errors in the data.
6.2. Prescription data
The total number of prescriptions for the selected antidepressants, antihypertensives 
and products for the treatment of the symptoms of menopause (hormone 
replacement therapy (HRT) products) are presented per specialism iin Tables 28- 
32.
The percentage of prescriptions for the three researched products is compared with 
the total number of prescriptions issued for each indication in Tables 33 and 34.
The average weekly number of prescriptions for the selected products in the 
indications and for the researched products, issued by all physicians and by the 
selected physicians only, are calculated (Tables 35 & 36) and the numbers 
compared in order to validate the generalisability of the findings.
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Table 28 Annual number of prescriptions for the selected anti­
depressants written by general practitioners (GPs) in Greece:
MAT* Sept 1999 MAT Sept 2000 +/- %
Anafranil 16.248 9.770 -39.9
Dumyrox 14.345 12.039 -16.1
Efexor 37.766 48.301 +27.9
Ladose 105.588 145.824 +38.1
Remeron 14.345 28.983 +102.0
Seropram 86.511 104.326 +20.6
Seroxat 44.451 86.581 +94.8
Zoloft 0 2.414 n.a
Source: Information Medical Statistics -  I.M.S., 6330 Cham, Switzerland,
prescription index September 1999 and September 2000.
MAT = moving annual total
Table 29 Annual number of prescriptions for the selected anti­
depressants written by psychiatrists in Greece:
MAT Sept 1999 MAT Sept 2000 +/- %
Anafranil 111.065 78.834 -29.0
Dumyrox 91.866 118.136 +28.6
Efexor 211.781 154.819 -26.9
Ladose 191.636 214.669 +12.0
Remeron 129.516 184.525 +35.1
Seropram 181.595 214.551 +18.1
Seroxat 223.508 263.545 +17.9
Zoloft 0 29.133 n.a.
Source: Information Medical Statistics -  I.M.S., 6330 Cham, Switzerland,
prescription index September 1999 and September 2000.
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Table 30 Annual number of prescriptions for the selected anti -
hypertensives written by general practitioners in Greece.
MAT Sept 1999 MAT Sept 2000 +/- %
Accupron 319.571 234.905 -26.5
Adalat 259.238 262.980 +1.4
Aldactone 32.252 37.836 +17.3
Aldomet 32.740 26.859 -18.0
Aprovel 9.564 90.096 +842.0
Atacand 0 82.324 n.a
Capoten 102.149 83.937 -17.8
Coversyl 444.458 393.423 -11.5
Cozaar 198.345 283.949 +43.2
Cynt 125.325 125.190 -0.0
Catapressan 4.782 7.173 +50.0
Diovan 27.714 333.577 +1103.6
Fisiotens 79.948 136.516 70.8
Fludex 489.324 460.502 -5.9
Frumil 141.085 106.809 -24.3
Glopir 90.926 99.393 +9.3
Hygroton 143.232 136.448 -4.7
Inderal 74.068 103.371 +39.6
Karvea 7.051 89.565 +1170.2
Kerlone 21.152 48.523 +129.4
Lacipil 137.280 171.618 +25.0
Lasix 313.668 424.848 +35.4
Loniten 0 0 n.a.
Lopresor 116.860 207.446 +77.5
Minipress 2.391 0 n.a
Moduretic 245.747 255.798 +4.1
Monopril 295.834 257.351 -13.0
Motens 179.218 247.146 +37.9
Neocardon 67.505 60.533 -10.3
Norvasc 646.631 770.620 +19.2
Pactens 37.644 58.081 +54.3
Plendil 371.244 381.470 +2.8
Renitec 286.464 281.432 -1.8
Selectol 149.234 170.799 +14.5
Tenormin 387.809 358.020 -7.7
Tiaden 28.203 26.347 -6.6
Tildiem 263.948 298.113 +12.9
Triatec 92.829 200.893 +116.4
Vascace 185.780 185.610 -0.1
Z Bee 94.488 90.676 -4.0
Source: Information Medical Statistics -  I.M.S., 6330 Cham, Switzerland,
prescription index September 1999 and September 2000.
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Table 31 Annual number of prescriptions for the selected anti -
hypertensives written by cardiologists in Greece.
MAT Sept 1999 MAT Sept 2000 +/- %
Accupron 144.729 108.963 -24.7
Adalat 154.341 136.250 -11.7
Aldactone 30.573 19.123 -37.5
Aldomet 1.328 7.418 +458.6
Aprovel 2.655 34.121 +1185.2
Atacand 2.225 34.041 +1429.9
Capoten 76.796 81.762 +6.5
Coversyl 238.822 205.813 -13.8
Cozaar 129.302 142.007 +9.8
Cynt 92.839 82.505 -11.1
Catapressan 2.225 8.901 +300.0
Diovan 2.225 64.950 +2819.1
Fisiotens 39.511 52.090 +31.8
Fludex 114.045 161.058 +41.2
Frumil 237.345 212.499 -10.5
Glopir 98.113 73.602 -25.0
Hygroton 45.251 31.156 -31.1
Inderal 101.161 90.176 -10.9
Karvea 1.328 39.811 +2897.8
Kerlone 43.531 67.091 +54.1
Lacipil 23.074 31.402 +36.1
Lasix 387.815 422.586 +9.0
Loniten 2.225 0 n.a.
Lopresor 263.187 233.259 -11.4
Minipress 0 0 n.a.
Moduretic 108.192 102.289 -5.5
Monopril 82.144 81.351 -1.0
Motens 12.416 23.904 +92.5
Neocardon 87.099 144.243 +65.6
Norvasc 246.788 321.781 +30.4
Pactens 24.402 21.184 -13.2
Plendil 123.954 167.974 +35.5
Renitec 107.369 101.711 -5.3
Selectol 132.350 130.399 -1.5
Tenormin 187.251 199.137 +6.3
Tiaden 16.829 20.195 +20.0
Tildiem 233.399 269.432 +15.4
Triatec 28.889 45.414 +57.2
Vascace 63.483 81.845 +28.9
Z Bee 45.682 94.215 +106.2
Source: Information Medical Statistics -  I.M.S., 6330 Cham, Switzerland,
prescription index September 1999 and September 2000.
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Table 32 Annual number of packs of the selected products for the
treatment of the symptoms of menopause prescribed by
gynaecologists in Greece.
MAT Sept 1999 MAT Sept 2000 +/- %
Cyclacur 77.900 82.400 +5.8
Divina 24.000 31.300 +30.4
Estracomb ITS 2.400 2.700 +12.5
Femaston 11.300 11.800 +4.4
Kliogest 20.300 23.900 +17.7
Premelle 79.900 99.800 +24.9
Premelle cycle 67.400 82.200 +22.0
Trisequens 28.800 37.800 +31.3
Trisequens forte 5.100 6.200 +21.6
Source: Information Medical Statistics -  I.M.S., 6330 Cham, Switzerland,
pharmaceutical index September 1999 and September 2000.
Table 33 Number of prescriptions written per specialty for products
covered by this research:
Number ofprescriptions written p e r  specialty f o r  products covered  by this research
M .A.T  (moving annual total) Septem ber 1999*
Anti-hypertensives Anti-depressants H.R.T**
General practitioner 6.412.872 319.254 0
Specialist 3.756.004 1.126.622 329.953
Total o f the selected 
products
10.168.876 1.445.876 329.953
Total o f all products 11.588.973 1.827.926 329.952
% covered by this 
research
87.7 79.1 100.0
*Source: Information Medical Statistics -  I.M.S., 6330 Cham, Switzerland,
medical index September 1999.
** H.R.T. = hormone replacement treatment
Table 34 Total number of prescriptions written for the researched
products by all physicians:
Num ber ofprescriptions issued p e r  specialism  f o r  Fisiotens, Dumyrox, and Femaston. 
M.A.T. (moving annual total) Septem ber 1999*
Fisiotens Dumyrox Femaston
General practitioner 79.948 14.345 0
Specialist 39.511 91.866 11.866
Total covered by this research 119.459 106.211 11.866
Source : Greek pharmaceutical index and medical index, LM .S., September
1999
Table 35 Average weekly number of prescriptions issued by all and by the 
selected physicians:
average number o f  prescriptions p e r  week p e r  specialty in G reece 
M.A.T. September 1999
Antihypertensives Antidepressants HRT
all selected all Selected all selected
General
practitioner
13.57 13.66 0.68 1.90 0.00 0.00
Specialist 39.75 35.19 14.68 11.53 3.19 3.13
Total 53.32 48.85 15.35 13.43 3.19 3.13
(annual number of prescriptions divided by the number of specialists divided by 52) 
Source: present author
Table 36 Average weekly number of prescriptions for the researched 
products issued by all and by the selected physicians:
average number o f  prescriptions p e r  week p e r  specialty in Greece 
M.A.T. Septem ber 1999
Fisiotens Dumyrox Femaston
All Selected All Selected All Selected
General
practitioner
0.17 0.14 0.03 0.00 0.00 0.00
Specialist 0.42 0.38 1.20 1.13 0.12 0.08
(annual number of prescriptions divided by the number of specialists divided by 52) 
Source: present author
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The weekly average number of prescriptions issued for antihypertensives by the 
physicians participating in this research was 48.85, almost 8.4% lower than the 
weekly average issued by all general practitioners (GPs) and specialists together 
(see Table 35). For antidepressants and HRT products, the averages were 12.5% 
and 1.9% lower, respectively (see Table 35). The antihypertensives selected for this 
research, generate approximately 87.7% of the total number of prescriptions for 
antihypertensives; for antidepressants the percentage was 79.1%, and for HRT 
products, 100% (see Table 33). It was concluded that these percentages are 
sufficient to allow the use of the obtained data to draw general conclusions about 
the entire market. Analysis of data obtained via the analysis of the prescriptions in 
pharmacies, proved that the prescriptions written for the inividual products did not 
show important differences between the average of all and the selected physicians 
(see Table 36). The weekly average of prescriptions for Femaston was somewhat 
lower with the selected physicians, but it was considered that this might be due to 
the overall low number of prescriptions issued for this product. Sixteen per cent of 
the GPs (21 of 129) turned out to be high prescribers of antihypertensives with an 
average number of over 20 prescriptions per week. Analysis of their age and 
gender did not reveal any significant differences. High prescribers were on an 
average 42 years old (mean 2.1905; s.d. 0.5118) against an average of 41 years for 
all general practitioners (mean 2.1008; s.d. 0.6355,/? 0.741) while there were 
slightly more women in the high prescriber group (mean 1.238; s.d. 0.4364 against 
1.1667; s.d. 0.3744; p  0.320). It seems that prescribing cannot be categorised 
according to demographic variables.
6.3. Product prices
Prices to pharmacy of the investigated products were compared at baseline and at 
the end of the study period in order to reveal any changes in price. The daily 
treatment costs of the products were compared, in order to discover whether there 
were any financial advantages or disadvantages associated with any product.
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Table 37 Prices to pharmacy of the selected products for the treatment of
the symptoms of menopause:
Trademark Presentation Price to pharmacy in GDR
Start of study End of study Daily
treatment costs
Cyclacur 21 tablets 342 342 n.a.
Divina 21 tablets 1,064 1,064 n.a.
Femaston 28 tablets 1,910 1,910 68.21
Kliogest 28 tablets 1,777 1,777 63.46
Premelle 28 tablets 2,814 2,814 100.50
Premelle cycle 28 tablets 2,096 2,096 74.86
Trisequens 28 tablets 1,344 1.344 48.00
Trisequens forte 28 tablets 1,990 1.990 71.07
Source: AsAxio Ayopovopiog = Bulletin o f the economic control service or Market
inspection bulletin published in Ecpr^pepiSa tt|ç Rup£pvf|oea)ç= 
Government Gazette.
The therapeutic characteristics of Femaston can be best compared with Premelle, 
Premelle forte, Trisequens, and Trisequens forte, as all these products are specially 
developed and promoted for the treatment of the symptoms of menopause. Divina 
and Cyclacur, although prescribed for the same indication, have a therapeutic 
disadvantage compared with Femaston as treatment with these products requires 
patients to have a 7-day therapy-free-period after every 21 days of treatment which 
might induce a recurrence of symptoms. Cyclacur has a much wider indication 
profile and is prescribed also for the symptomatic treatment of oligo- and poly- 
menorrhoea, amenorrhoea, inter-cycle and pre- and post-menstrual bleeding. 
Kliogest has a different patient profile as it should be prescribed for women in late 
post-menopause only. The daily treatment costs of Femaston are 68.21 Greek 
Drachma (GDr) lower than its main competitors Premelle at 100.5 GDr, Premelle 
cycle at 74.86 GDr and Trisequens forte at 71.07 GDr. However, the daily 
treatment cost of Femaston is higher than the competing product Trisequens at 
48.00 GDr. A survey of the daily treatment costs of Femaston and its competitors is 
therefore a rather weak promotional tool in the hands of the representative 
promoting Femaston. The survey might help convince gynaecologists to switch 
from Premelle, Premelle cycle or Trisequens forte to Femaston because of
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economical reasons; however the real cost conscious gynaecologist might prefer 
Trisequens because of its low treatment cost.
Table 38 Prices to pharmacy of the selected products for the treatment of 
depression:
Trademark Presentation Price to pharmacy in GDR
Start of study End of study Daily therapy 
costs
Anafranil 20 X 75 mg 919 919 n.a.
Efexor 28 x 37.5 mg 4,165 4,165 148.75
Dumyrox 30 x 100 mg 3,124 3,124 104.13
Ladose 12x20 mg 2,869 2,869 239.08
Remeron 30 x 30 mg 10,539 10,539 351.30
Seropram 12 x 20 mg 3,022 3,022 251.83
Seroxat 14 x20 mg 3,548 3,548 253.43
Zoloft 14 x 100 mg - 5,660 404.29
Source: ÀEATIO AFOPONOMIAS = Bulletin o f the economic control service or
Market inspection bulletin published in EOHMEPIAA THE 
KYBEPNHEEŒ = Government Gazette.
All products for the treatment of depression included in this research, except 
Anafranil, belong to one of the newer classes of antidepressants: serotonin re-uptake 
inhibitors, noradrenaline re-uptake inhibitors, or noradrenaline-serotonin re-uptake 
inhibitors. They have all a quite similar efficacy and safety profile. Anafranil, a 
tricyclic, although much cheaper than the other products, has a more limited 
therapeutic ratio because of the risk of serious anticholinergic side-effects . 
Comparison of the daily treatment costs was therefore made on the newer 
antidepressants only. The daily treatment costs were calculated at the daily 
maintenance dosage as registered by the EOF, the health authorities in Greece. 
Dumyrox proved to offer a clear economic advantage, as shown in Table 38.
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Table 39 Prices to pharmacy of the selected products for the treatment of
hypertension:
Trademark Presentation Price to pharmacy in GDR
Accupron 14x20 mg
Start of study End of study 
1,842 1,842
Adalat 50 x 10 mg 1,033 1,033
Aldactone 20 x 100 mg 788 788
Aldomet 30 x 500 mg 813 813
Aprovel 28 x 300 mg 8,807 8,092
Atacand 28 x 4 mg - 3,365
Capoten 14 x 50 mg 1,784 1,784
Catapressan 30 x 0.15 mg 321 321
Coversyl 30 x 4 mg 4,053 4,053
Cozaar 10 x 50 mg 2,124 2,124
Cynt 20 X 0.3 mg 2,974 2,974
Diovan 14 x 60 mg 2,973 2,973
Fisiotens 28 x 0.4 mg 4,773 4,773
Fludex 30 x 2.5 mg 793 793
Frumil 28 x (40+5) mg 1,422 1,422
Glopir 50 x 10 mg 826 826
Hygroton 20 x 50 mg 322 322
Inderal 30 x 40 mg 309 309
Karvea 28 x 300 mg 8,807 8,092
Kerlone 28 x 20 mg 1,747 1,747
Lacipil 14 x 4 mg 1,915 1,915
Lasix 20 x 500 mg 2,301 2,301
Loniten 100 x 10 mg 4,481 4,481
Lopressor 40 x 100 mg 1,006 1,006
Minipress 30 x 0.2 mg 478 478
Moduretic 30 x (50+5) mg 717 717
Monopril 14 x20 mg 2,419 2,419
Motens 14 x 4 mg 1,915 1,915
Neocardon 21 x 100 mg 818 818
Norvasc 14 x 10 mg 3,084 3,084
Pactens 30 x 10 mg 2.006 2,006
Plendil 28 x 10 mg 4,473 4,473
Renitec 10x20 mg 1,403 1,403
Selectol 20 x 200 mg 2,008 2,008
Tenormin 28 x 50 mg 880 880
Tiaden 20 x (50+5) mg 428 428
Tildiem 30 x 60 mg 1,189 1,189
Vascase 28 x 5 mg 4,694 4,694
Z Bee 28 x 5 mg 1,060 1,060
Source: AEATIO ATOPONOMIAE = Bulletin of the economic control service or
Market inspection bulletin published in EOHMEPIAA THE 
KYBEPNHEEQE = Government Gazette.
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Many products for the treatment of hypertension are available in several strengths to 
enable the physicians to individualise the prescribed dosage according to the needs 
of each patient. Price comparison was based on the most prescribed presentation 
and strength of each product and average recommended daily dosage registered by 
the competent health authorities. The daily treatment cost calculated for Fisiotens 
was 170.46 GDr. Price comparison with diuretics was not made as these products 
are mostly co-prescribed with other pharmaceutical products for the treatment of 
hypertension. The following price comparisons between Fisiotens and the nine 
most important angiotensin II antagonists, ACE inhibitors, calcium antagonists and 
beta-blockers were used during the promotional campaign by the representatives of 
the pharmaceutical industry.
Table 40 Daily treatment costs of the most prescribed products for the 
treatment of hypertension:
Category Product Presentation Daily dosage Daily treatment 
costs in GDR
Centrally Fisiotens 28 x 0.4 mg 0.4 mg 170.50
acting agent
ACE inhibitor Coversyl 30 x 4 mg 4 mg 135.10
ACE inhibitor Renitec 10 x20 mg 20 mg 140.30
Angiotensin II Aprovel 28 x 300 mg 300 mg 289.00
antagonists
Angiotensin II Atacand 28 x 4 mg 16 mg 480.71
antagonists
Angiotensin II Cozaar 10 x 50 mg 50 mg 212.40
antagonists
Beta-blocking Tenormin 28 x 50 mg 100 mg 62.86
agent
Ca antagonist Norvasc 14 x 10 mg 10 mg 220.29
Ca antagonist Plendil 28 x 10 mg 10 mg 159.75
Ca antagonists Tildiem 30 x 60 mg 240 mg 158.50
Sources: prices: AEATIO ATOPONOMIAE = Bulletin o f the economic control
service or Market inspection bulletin published in EOHMEPIAA 
THE KYBEPNHEEOE = Government Gazette.
daily dosage: package inserts o f the products
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Of the ACE inhibitors Coversyl was chosen, not only because of the large number 
of prescriptions written for this product but also because renitec, its active 
ingredient, is seen as a reference product for measuring the efficacy of 
antihypertensives. Of the Ca antagonists, three products were included, Norvasc, 
the most prescribed antihypertensive, and Plendil and Tildiem which are also 
frequently prescribed products. Of the beta-blockers, Tenormin was included 
because of its large number of prescriptions, while Aprovel, Atacand and Cozaar, 
three recently launched angiotensin II agonists, were included because of their rapid 
growth. ACE inhibitors Coversyl (135.10 GDr), and Renitec (140.30 GDr), and the 
Ca antagonists Plendil (159.75 GDr) and Tildiem (158.50 GDr) have lower daily 
treatment costs than Fisiotens (170.50 GDr), but the price difference is relatively 
small and Fisiotens was launched more recently than the lower-priced products.
The price difference between Fisiotens and the beta-blocker Tenormin (170.50 vs 
62.86 GDr) is not important, as the beta-blockers have a low price profile and 
therapeutic limitations. The price advantage of Fisiotens with respect to the Ca- 
antagonist Norvasc is more important, as Norvasc is market leader in prescriptions 
of antihypertensives, diuretics excluded. With the recent introductions of the more 
expensive angiotensin II agonists Aprovel, Atacand and Cozaar, this price 
advantage of Fisiotens should be an important selling point.
6.4. Baseline data
6.4.1. Return rates
In total, 538 questionnaires were distributed personally by the sales 
representatives to the selected physicians, who were asked to complete them 
within one week. The completed questionnaires were collected by the same sales 
representative.
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Table 41 Return rates of completed questionnaires at baseline:
Distributed Completed questionnaires 
Returned
% returns
General practitioner 218 144 66.1
Psych/neurologist 100 89 89.0
Cardiologist 110 101 91.8
Gynaecologist 110 99 90.0
Total 538 433 80.5
Source: field work
The response rates were analysed in order to determine whether the causes or 
reasons for non-response were connected with the topics of the questionnaire and 
thus whether any bias might exist.
Table 42 Reasons for not returning the questionnaires at baseline:
General
practitioner
Psychiatrist/
neurologist
Cardiologist Gynaecologist Total
Questionnaire too 
long
26 3 2 4 35
No reason 21 3 3 1 28
No time 13 4 3 6 26
Want to be paid to 
answer
13 1 1 - 15
Disagrees with 
questions
1 - - - 1
Total 74 11 9 11 105
Source: field work
Only one general practitioner refused to complete the questionnaire because of 
disagreement with the nature of the questions. Although this reason would be a 
concern for biased results it can be disregarded in this study because of the low 
number. The other reasons for non-completion of the questionnaire could be 
disregarded, as they were not related to the subject treated in the questionnaire.
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Table 43 Geographical distribution of non-responding general 
practitioners at baseline:
Speciality A thens/ Sterea Pelopo- 
Piraeus nissos
Epirus Thessaly M ace­
donia
Aegean Total
Non 41 2 5 2 3 17 4 74
responding 
Gen. pract.
% 34.7 18.2 29.4 33.3 27.3 39.5 33.3 33.9
Source: Field work
Table 44 Geographical distribution of non-responding specialists at
baseline:
Speciality Athens/
Piraeus
Sterea Pelopo-
nissos
Epirus Thessaly Mace­
donia
Aegean Total
Cardiologists
%
6
11.3
0
0.0
0
0.0
1
25.0
0
0.0
2
9.5
0
0.0
9
8.2
Gynaecologists 5 
8.3
1
33.3
1
14.3
0
0.0
1
25.0
2
7.7
1
16.7
11
10.0
Neurologists/
psychiatrists
5
11.1
0
0.0
1
33.3
0
0.0
1
33.3
3
13.0
1
33.3
11
10.0
Source: field work
No particular pattern in the geographical distribution of the non-responders could be 
discovered. For this reason, together with the fact that no particular reasons for 
non-responding could be traced, it was decided that further analysis into the reasons 
for non-responding was unnecessary.
In addition to the collection of information about the dependent and independent 
variables of prescription behavioural intention of physicians via questionnaires, 
information about their actual prescription behaviour was collected by 
representatives visiting pharmacies and counting the prescriptions for the selected 
products.
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Table 45 Results of prescription analysis via pharmacists at baseline:
Total Physicians o f whom Physicians o f whom
physicians prescriptions could be prescriptions could not
selected counted be counted
General 218 152 66
practitioners
Psychiatrist/ 100 78 22
neurologist
Cardiologist 110 92 18
Gynaecologist 110 89 21
Total 538 411 127
source: field work
Table 46 Reasons why prescriptions of some physicians were not counted:
Not counted Pharmacist 
refused to 
give
information
Pharmacist could Unknown 
not guarantee that
prescriptions was 
covered
General 66 35 28 3
practitioner
Psychiatrist/ 22 11 11
neurologist
Cardiologist 18 10 8
Gynaecologist 21 13 8
Total 127 69 55 3
Source: field work
To be included in the study, at least 70% of the prescriptions written by the selected 
physicians had to be filled in the selected local pharmacy. This was important for 
this research in order to get a clear picture of the prescription pattern of the doctor. 
The percentage of the physicians from whom the prescriptions could not be counted 
for this reason, was well distributed over the specialties and was 12.8% for the GPs 
and around or below 10% for the other physicians. It was therefore assumed that 
this omission will not influence the study results.
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The percentage of the physicians of whom the prescriptions could not be counted 
because the pharmacist refused to disclose information was somewhat higher, being 
16.1% for GPs, 11.8% for gynaecologists, 11% for psychiatrists and 9.1% for the 
cardiologists. The low percentages and almost equal distribution over the 
specialties did not prevent the data being used for further analysis because of 
possible bias.
Table 47 Number of physicians who completed the questionnaires and 
from whom the prescriptions were counted:
Completed Total Completed
questionnaires prescriptions questionnaires received
_____________ counted______ + prescriptions counted
General 144 152 140
practitioner
Psychiatrist/ 89 78 77
neurologist
Cardiologist 101 92 90
Gynaecologist 99 89 89
Total 433 411 396
Source: field work
Completed questionnaires were received and prescriptions were counted from 334 
male and 62 female physicians. This ratio of 84.3 : 15.7 between males and 
females is in line with the Greek norm for physicians.
6.4.2. Missing data
Some collected completed questionnaires missed an answer on one or more 
questions. The missing data were analysed in order to verify possible bias.
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Table 48 Missing data on returned questionnaires at baseline:
Questions BI ATT1 ATT2 ATT3 ATT4 ATT5 ER HABIT
Completed 396 395 395 395 395 393 392 392
N ot completed 0 1 1 1 1 3 4 4
%  not com pleted 0.0 0.3 0.3 0.3 0.3 0.8 1.0 1.0
Questions Bbl Bb2 Bb3 Bb4 Bb5 PBC1 PBC2 PBC3
completed 392 390 389 389 392 389 387 394
not completed 4 6 7 7 4 7 9 2
% not com pleted 1.0 1.5 1.8 1.8 1.0 1.8 2.3 0.5
Questions PBC4 Nbl Nb2 Nb3 Mcl Mc2 Mc3 Oel
Completed 393 394 387 392 393 391 394 392
Not completed 3 2 9 4 3 5 2 4
% not completed 0.8 0.5 2.3 1.0 0.8 1.3 0.5 1.0
Questions Oe2 Oe3 Oe4 Oe5 ARV
Completed 390 392 390 390 392
Not completed 6 4 6 6 4
% not completed 1.5 1.0 1.5 1.5 1.0
Source: field work
The completed questionnaires showed a low percentage of missing data. No 
important differences between the individual questions could be noted. It was 
therefore decided to reject list-wise deletion and to use pair-wise deletion where 
possible. Discarding incomplete cases altogether was not done to prevent 
inadvertent creation of possible bias.
6.4.3. Statistical evaluation of baseline data
The preference is to use a parametric technique as its outcome is more reliable 
than that of non-parametric techniques (Oakshott, 1994). The skewness of the 
data was therefore analysed to determine which method of analysis should be 
used. Normal probability and detrended normal probability plots were used to
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verify the normal distribution of the data. The non-parametric Kolmogorov- 
Smirnov statistic was used, with a Lilliefors significance level for testing 
normality, as the number of observations was more than 50. This test should not 
be too sensitive when used for this research sample as it does not exceed 1000 
observations. The alternative Shapiro-Wilk statistic was rejected, as this test is 
more useful for samples with 50 or fewer observations. The Komogorov- 
Smirnov test is more powerful than the chi-square test when adjacent categories 
must be combined as in this analysis (Siegal & Castellan, 1988, p.54). Our 
research sample is well above 200, which is another reason not to use the chi- 
square test as it is less reliable with sample sizes outside the range 100-200 (Hair 
et al., 1998, p.655).
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Table 49 One sample Kolmogorov-Smirnov test of normality:
z D f Sig.
BI 5.661 396 0.000
ATT 1 4.643 395 0.000
ATT 2 4.843 395 0.000
ATT 3 4.452 395 0.000
ATT 4 4.474 395 0.000
ATT 5 3.502 393 0.000
ER 3.510 392 0.000
HABIT 4.688 392 0.000
Bbl 6.268 392 0.000
Bb2 5.055 390 0.000
Bb3 4.372 389 0.000
Bb4 5.020 389 0.000
Bb5 5.538 392 0.000
PBC1 4.635 389 0.000
PBC2 4.961 387 0.000
PBC3 5.907 394 0.000
PBC4 7.234 393 0.000
Nbl 6.764 394 0.000
Nb2 5.589 387 0.000
Nb3 6.472 392 0.000
Mcl 5.657 393 0.000
Mc2 5.408 391 0.000
Mc3 6.092 394 0.000
Oel 5.448 392 0.000
Oe2 5.696 390 0.000
Oe3 4.737 392 0.000
Oe4 5.175 390 0.000
Oe5 5.321 390 0.000
ARV 6.517 392 0.000
Source: field work
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The descriptive statistics of the baseline data (see Appendix Y) showed that 
subjective norm is positively skewed (1.018) as well as perceived behavioural 
control (PBC)4 (1.5929) while anticipated regret variables (ARV) are negatively 
skewed (-2.261). The other variables did not show very skewed curves. ARV and 
PBC4 showed peaked curves (kurtoses o f5.064 and 3.150, respectively) while ER, 
PBC1, PBC2, and HABIT showed a flat curve (kurtoses of-1.074, -1.610, -1.482, 
and -1.196, respectively). Because of their skewness or peak of the data, the 
normal probability and detrended normal probability plots of ARV, ER, SN, PBC1, 
PBC2, PBC4, and HABIT were also analysed (see Appendix Z). The results of the 
descriptive statistics, the detrended normal probability plots, and the Kolmogorov- 
Smirnov test of normality (Table 49) did not reveal abnormalities to such a level 
that data transformations to accommodate non-normal distributions were needed. It 
was therefore concluded that parametric methods could be used for data analysis.
Descriptive statistical data at baseline were analysed in order to obtain a first 
impression of the differences between the independent variables. The variables 
were analysed first for the entire group (Table 50), followed by an analysis per 
specialty or gender (Table 51).
Table 50 Descriptive statistics of the answers of all physicians at 
baseline:
N Minimum Maximum Mean Std. dev.
BI (behavioural Intention) 396 1.00 5.00 3.3157 1.1513
ATT (attitude) 393 5.00 25.00 17.1705 4.4423
HABIT 392 1.00 5.00 2.2415 1.4061
ER (emotional reaction) 392 1.00 5.00 3.4005 1.2264
PBC(perceived behavioural 386 4.00 20.00 11.6917 4.1599
control)
SN (subjective norm) 385 9.00 225.00 65.9766 44.128
ARV (anticipated regret 392 1.00 5.00 4.4056 0.9839
variables).
UTILOUTC (Utilitarian 383 30.00 525.00 227.0601 106.5620
outcomes)
Marketshare 396 0.00 1.00 0.1651 0.2301
Valid N  (listwise) 365
Source: field work
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Table 51 Descriptive statistics of the answers concerning behavioural
intention per specialty at baseline:
Variable Specialty Gender Age
Entire General Psych. Card. Gyn. Male Female <40 41- 51- >60
sample pract. 50 60
BI 3.32 3.43 3.25 3.31 3.20 3.33 3.20 3.45 3.30 3.09 3.56
(mean)
Source: field work
The descriptive statistics for all responses showed that physicians intend to be 
cost-conscious when prescribing (mean 3.3157; s.d. 1.1513; < 0.001). Cost- 
consciousness could also be demonstrated for specialists and general practitioners 
(p 0.006 andp  < 0.001). The general practitioners claim to be more cost-conscious 
while prescribing, when compared with the specialists, although this difference 
was not statistically significant (means 3.34 and 3.21;p  0.143). It was expected 
that the general practitioners would be less cost-conscious than the specialists as 
the latter are thought to have more serious conditions to treat which often need 
more expensive or longer treatments. As shown in Table 51 of this thesis, of the 
individual specialisations the cardiologists are the only specialists with a 
significant intention to prescribe in a cost-conscious manner (p 0.004). This 
behavioural intention was not significant in gynaecologists and psychiatrists (p 
0.069 and p  0.081). Physicians of all age groups have the intention to prescribe in 
a cost-conscious manner, except the age group of 51 up to and including 60 (p < 
0.005 andp  0.538). Male physicians expressed a behavioural intention to 
prescribe in a cost-conscious manner (p 0.002) while this could not be 
significantly demonstrated for their female colleagues (p 0.099).
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Table 52 Descriptive statistics of the answers concerning attitude per
specialty at baseline:
Variable Specialty Gender Age
Entire Gen. Psych. Card. Gyn. Male Female <40 41- 51- >60
ATT1
sample
3.19
pract.
3.16 3.38 3.18 3.08 3.20 3.11 3.31
50
3.17
60
2.94 3.60
(mean)
ATT2 3.86 3.78 3.96 3.89 3.85 3.88 3.76 3.97 3.75 3.81 4.36
(mean)
ATT3 3,83 3.96 3.77 3.73 3.75 3.87 3.58 3.90 3.78 3.73 4.12
(mean)
ATT4 3.44 3.42 3.45 3.51 3.38 3.46 3.35 3.47 3.43 3.40 3.56
(mean)
ATT5 2.87 2.81 3.04 2.89 2.81 2.88 2.85 3.12 2.85 2.62 2.84
(mean)
ER 3.40 3.37 3.13 3.64 3.43 3.49 2.94 3.40 3.34 3.42 3.84
(mean)
ARV 4.41 4.20 4.43 4.64 4.46 4.46 4.11 4.49 4.49 4.26 3.88
(mean) __________________________________________________________________
Source: field work
Of the attitudinal constructs ATT1, ATT2, ATT3, ATT4, ATT5, ER, and ARV, 
the latter showed the highest mean (Table 52). All subgroups of practitioners 
reported comparable positive data for ARV except the age group over 60 years 
who judged ARV much lower. The fifth attitude question, which included a 
perceived behavioural construct in the form of an obligation to prescribe in a cost- 
conscious manner, scored much lower than the other questions. This element 
might have blurred the measurement of the real attitude construct. The emotional 
reaction (ER) determinant had approximately the same score as the average of the 
other attitude determinants, except with female physicians where it had a much 
lower score. This difference could not be explained by a different distribution of 
female physicians over the specialties or age groups (paired sample correlation 
analysis = ER: specialty + females, p  0.055; ER: specialty + males, 0.162; ER: 
age females, p  0.252; ER: age males, p  0.695).
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Table 53 Descriptive statistics of the answers concerning habit per
specialty at baseline
Variable Specialty Gender Age
Entire Gen. Psych. Card. Gyn. Male Female <40 41- 51- >60
sample pract. 50 60
HABIT 2.45 2.44 2.53 2.46 2.39 2.52 2.11 2.63 2.44 2.04 3.00
(mean)
Source: field work
The influence of past experience seems to diminish with age except for physicians 
over 60 years of age where it increases (Table 53). Female doctors have a 
remarkably low rating for habit forming which could not be explained by a 
different age distribution over both sexes. No significant correlation between age 
and habit could be demonstrated ip 0.278 and p  0.096).
Table 54 Descriptive statistics of answers concerning behavioural beliefs 
(Bb) and outcome evaluation (Oe) per specialty at baseline:
Variable_____________________Specialty______________Gender______________ Age
Entire General Psych. Card. Gyn. Male Female <40 41- 51- >60
UITLOUT1
sample
3.09
pract.
3.30 2.31 4.03 2.49 2.98 3.69 3.41
50
3.30
60
2.30 2.60
(mean)
UITLOUT2 12.18 10.46 13.32 13.80 12.26 12.65 9.62 14.17 10.80 12.11 14.36
(mean)
UITLOUT3 12.40 11.45 13.52 13.52 11.80 12.71 10.77 15.56 12.24 8.35 12.56
(mean)
UITLOUT4 12.82 12.51 14.34 12.97 11.80 12.95 12.10 14.67 11.92 11.72 15.42
(mean)
UITLOUT5 724 6.47 7.82 6.98 8.22 7.30 6.94 8.13 7.33 5.55 8.04
(mean)
Source: field work
The first question about behavioural beliefs and outcome evaluation concerned a 
statement that less expensive drugs are also less effective. This observation had 
emerged from the pilot study performed to draft the questions of the questionnaire, 
and was confirmed by the answers to the question about the problem that the 
physician has with the assumed lower efficacy of low-priced products, when 
intending to prescribe in a cost-conscious manner.
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The baseline data on behavioural beliefs and outcome evaluation revealed that 
cardiologists do not believe that this will lead them to prescribe less effectively (p 
0.67). Gynaecologists and psychiatrists believe that they will not prescribe less 
effective products when they prescribe less costly products (p 0.008 and p  < 0.001). 
No important differences of opinion were noticed between the different age groups. 
Physicians also seem not to believe that prescribing less expensive products will 
lead to a better patient compliance, in other words the patient respecting the 
prescribed dosage recommendation (p < 0.001). General practitioners and 
specialists of all ages accept that cost-conscious prescribing results in a better 
costbenefit ratio or a financial benefit for patients or sick fimds. That cost- 
conscious prescribing results in a financial benefit for the patient obtained a much 
lower rating from female physicians than their male colleagues. This might be due 
to the fact that, compared with male physicians, a much higher percentage of female 
physicians are general practitioners and it is this specialty which shows a low belief. 
The behavioural belief and outcome evaluation that cost-conscious prescribing 
leads to a financial benefit for the sick funds is much lower in the age group of 51 to 
60 than elsewhere. This phenomenon was apparent with females as well as males 
while the standard deviation of responses among females was remarkably lower 
than among males.
Table 55 Descriptive statistics of the answers concerning perceived
behavioural control per specialty at baseline:
Variable______________ Specialty_________ Gender__________Age
Entire General Psych. Card. Gyn. Male Female <40 41- 51- >60
1 sample pract. 50 60
PBC1 (mean) 3.10 3.14 2.78 2.99 3.42 3.15 2.84 2.60 3.10 3.65 3.42
PBC2 (mean) 3.21 3.24 3.18 2.86 3.52 3.21 3.23 2.72 3.31 3.52 3.54
PBC3 (mean) 3.81 3.74 3.64 4.28 3.60 3.86 3.52 3.80 3.82 3.97 3.28
PBC4 (mean) 1.59 1.69 1.42 1.60 1.60 1.56 1.76 1.30 1.74 1.68 1.40
Source: field work
The first question of perceived behavioural control (PBC1, see Table 55) measures 
the constraints perceived because of the presumed low efficacy of low-priced 
products. The mean indicates that physicians consider themselves to be hampered
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from prescribing economically by low efficacy. This feeling, although less strong 
with the age group below 40, is notable among all specialties and age groups 
(p < 0.001). This seems to be in conflict with the conclusion deriving from analysis 
of the mean of behavioural beliefs (Bb) and outcome evaluation (Oe), indicating 
that the physician does not believe that the presumed lower efficacy of low-priced 
products will result in the physician prescribing a less effective treatment. It seems 
also not to correspond with the correlation ofPBCl with BI (0.027, p  0.592).
The significant feeling of being hampered from prescribing low-priced products and 
the non-significant low correlation between PBC1 and BI indicate that physicians 
no longer prescribe in a cost-conscious manner when they consider low-priced 
products to have a low efficacy. The side-effect profile of low-priced products 
(PBC2) is mainly deterring younger physicians to be cost-conscious while 
prescribing. The assumption that the patients' impression that higher-priced 
products are more effective or have less side-effects than lower-priced products 
(PBC4), has a mediocre negative influence on the prescription behavioural intention 
of physicians (-0.130 and p  0.001).
Table 56 Descriptive statistics of the answers concerning subjective norm 
(SN) (normative beliefs x motivation to comply) per specialty at 
baseline:
Variable Specialty Gender Age
Entire General Psych. Card. Gyn. Male Female <40 41- 51- >60
sample pract. 50 60
SN1 (mean) 4.90 4.27 5.66 4.29 5.86 4.70 5.97 6.25 4.67 4.24 3.12
SN2 (mean) 9.77 8.91 9.43 11.30 9.79 9.42 11.64 13.29 9.63 6.12 7.48
SN3 (mean) 8.15 7.22 8.50 8.13 9.34 7.92 9.37 9.38 8.55 6.58 4.75
Source: field work
The first item of Subjective Norm (SN1; see Table 56) measures physicians’ 
assumptions of the desire of the patient to have the physician take cost into 
consideration while prescribing and the willingness of the doctor to comply with 
this desire. The baseline study results show that the physicians’ assumption of the
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desire of the patient concerning the price of the medication has a low influence on 
the expressed behavioural intention of the physician (p < 0.001). The sick hind 
(SN2) has a more pronounced influence, in particular on physicians below 40 
years of age. The influence of pharmaceutical industry representatives (SN3) on 
the cost consciousness of the physician is not impressive, in particular for 
physicians of over 60 years of age.
In order to gain better understanding of the influence of the sick funds on the 
prescription behaviour of the physicians the two elements of subjective norm were 
also analysed separately.
Table 57 Descriptive statistics of the answers concerning normative
beliefs (Nb) and motivation to comply (Me) with the wishes of 
the sick funds per specialty at baseline:
Variable Specialty Gender Age
entire general psych. card. gyn. male female <40 41- 51-60 >60
sample pract. 50
Nb2 (mean) 3.79 3.40 3.71 4.36 3.87 3.78 3.82 4.44 3.76 2.90 4.08
Me 2 (mean) 2.36 2.35 2.22 2.56 2.27 2.28 2.76 2.82 2.41 1.77 1.78
Source: field work
The pressure of the sick fimds on physicians to prescribe economically is strong 
for all specialties (p 0.001), particularly cardiologists. In particular, physicians 
under 40 years admitted to feeling the pressure of the sick funds. This pressure 
decreased with age except for the oldest group. Motivation to comply with the 
norm is moderate, or low for age groups over 50 years. Cardiologists, the 
specialty reporting feeling the pressure of the sick funds most, were less willing to 
comply with the norm than the other groups.
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• Characteristics of the physicians and the determinants of
behavioural intention.
The physicians with a positive behavioural intention (BI = 4 or 5), were compared 
with the physicians who indicated that they did not take cost into consideration 
when prescribing pharmaceutical products (BI = 1 or 2). (See Appendix AB and 
Appendix AC for more details.) The means of two of the three variables of the 
attitude construct, attitude and emotional reaction, displayed a remarkable variance 
with the positive group much more pronounced than the negative group (4.01 and 
19.77 vs 2.65 and 13.37). Nevertheless, the correlation between behavioural 
intention and attitude and emotional reaction did not show a different pattern 
between both groups. There was no substantial difference between the means of 
anticipated regret variables (4.43 and 4.25). However, the correlation between 
behavioural intention and anticipated regret variables showed a considerable 
difference with ARV having a significant negative influence on BI in the positive 
group and a significant positive influence in the negative group (-0.163,/? 0.016, 
and +0.220, p  0.023, respectively). It can be concluded that both groups equally 
anticipate regretting prescribing what are assumed to be less-effective products, but 
that this has a negative impact on behavioural intention in the positive group only. 
This finding is not surprising as the negative group is not, or almost not, willing to 
take cost into account and thus the regret factor should have less influence on the 
negative influence of being cost-conscious.
No differences were registered between the groups concerning age or gender. An 
important contrast of means exists with regard to habit (3.31 and 1.47). Correlation 
analysis proved that the stronger the habit forming, the stronger its influence on 
behavioural intention (0.372,/? < 0.001, in the positive group vs 0.226,/? < 0.019, in 
the negative group).
The mean of SN of the two groups also shows a substantial difference with 26.37 in 
the positive group and 16.49 in the negative group. Subdividing this into the three 
normative referents (the patient, the sick fund and the representative of the
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pharmaceutical industry) indicates that the trend is identical for all three normative 
referents. Correlation analysis of the subjective norm factors on behavioural 
intention shows that the pharmaceutical industry representative is the only factor, 
which does not have a significant influence on the normative beliefs of the 
physician (p 0.3). Significant influences were noted for the patient or sick fund (p < 
0.001). It is interesting to note that the physicians expressed themselves as being 
willing to comply with the wishes of the pharmaceutical industry representatives 
with respect to cost-conscious prescribing (p < 0.001). This could be an interesting 
selling point for companies offering products with a financial benefit.
• Actual prescribing behaviour
The analysis of the actual prescription behaviour on the basis of the evidence 
collected from pharmacists, showed that physicians who were less cost-conscious 
prescribed, on average, approximately three times more of the three investigated 
products than their colleagues who were more cost-conscious, see Table 58. The 
cost-conscious physicians tended to prescribe fewer antihypertensives in general, 
although the difference was not statistically significant. The cost-conscious 
physicians prescribed significantly less of the selected antihypertensive (p 0.031) 
compared with their less cost-conscious colleagues. The less cost-conscious 
physicians prescribed significantly fewer antidepressants, while their cost- 
conscious colleagues prescribed significantly less of the selected antidepressant (p 
0.05 and p  0.04, respectively). Analysis of the daily treatment costs or the rate of 
re-imbursement did not reveal any important difference among the products. A 
study of the promotional material used for the relevant products by the 
pharmaceutical companies did not provide any explanation for this. Further 
research is needed in order to understand the reason for this important difference 
in behaviour. For the gynaecologists, no significant differences could be 
demonstrated.
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Table 58 Comparison of real prescription behaviour at baseline between
cost-conscious and not-cost-conscious physicians:
Antihypertensives Antidepressants Hormone replacement
__________ therapy______
Market Selected Market Selected Market Selected
product product product
cost-conscious 16.03 0.20* 15.14* 0.23* 14.95 0.23
not-cost- 18.32 0.61* 10.87* 0.60* 14.66 1.85
conscious 
P < 0.05
Source: field work
The strength of association between behavioural intention (BI) and the independent 
variables of prescription behaviour was measured by correlation analysis. If 
correlations could be established, this would permit elucidation of causal 
relationships between behavioural intention and the independent variables. This 
correlation analysis was seen as a preliminary descriptive technique to estimate the 
degrees of association among the variables involved.
241
Table 59 Bivariate correlation table of the dependent and independent 
variables:
Variable Variable
BI ATT HABIT ER UTILOUTC SN PBC ARV
BI 1.000 .698 .646 .515 .481 .299 -,129 .065
.000 .000 .000 .000 .000 .011 .199
396 393 392 392 383 385 386 392
ATT .698 1.000 .790 .659 .612 .410 -.141 .214
.000 . . . .000 .000 .000 .000 .006 .000
393 393 392 390 381 382 385 389
HABIT .646 .790 1.000 .628 .680 .413 -.149 .151
.000 .000 .000 .000 .000 .003 .003
392 392 392 389 380 381 384 389
ER .515 .659 .628 1.000 .500 .322 -.110 .074
.000 .000 .000 .000 .000 .031 .148
392 390 389 392 381 381 383 388
UTILOUTC .481 .612 .680 .500 1.000 .632 -.148 .095
.000 .000 .000 .000 .000 .004 .063
383 381 380 381 383 375 377 380
SN .299 .410 .413 .322 .632 1.000 -.148 .131
.000 .000 .000 .000 .000 .004 .010
385 382 381 381 375 385 377 382
PBC -.129 -.141 -.149 -.110 -.148 -.148 1.000 -.003
.011 .006 .003 .031 .004 .004 .960
386 385 384 383 377 377 386 383
ARV .065 .214 .151 .074 .095 .131 -.003 1.000
.199 .000 .003 .148 .063 .010 .960 • • •
392 389 389 388 380 382 383 392
N ote : data in each cell represent: correlation coefficient, significance and sample size. 
Source : field work
• Analysis of the correlation of HABIT with the dependent and other
independent variables.
Past behaviour has a significant correlation with behavioural intention (BI). Thus, 
physicians’ behavioural intention is related to their past experience (p < 0.001). 
The highest correlation was recorded with ATT and UTILOUTC (behavioural 
beliefs multiplied by outcome evaluation). No important differences were noted 
between the different specialties.
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• Analysis of the correlation of Subjective Norm (SN) with the 
dependent and other independent variables.
Subjective norm (normative beliefs multiplied by motivation to comply) has a much 
lower but still significant correlation with behavioural intention than attitude (ATT) 
and emotional reaction (ER), see Table 59. The decomposed subjective norm 
indicates that the correlation between the patient’s pressure on the physician to 
prescribe in a cost-conscious manner and behavioural intention is stronger than the 
pressure of the sick funds and the pharmaceutical industry representative (0.306,/? < 
0.001; 0.258,/? < 0.001; 0.152,/? 0.002, respectively). The internal consistency of 
subjective norm was acceptable as the reliability analysis showed a Cronbach alpha 
o f0.7000.
* Analysis of the correlation of perceived behavioural control (PBC)
with the dependent and other independent variables.
The PBC construct has a negative significant correlation with behavioural intention, 
see Table 59. Decomposed perceived behavioural control indicates that the 
assumed low efficacy of low priced products (PBC1) does not have a high 
correlation with behavioural intention (0.027; p  0.592). However, the side-effect 
profile of low-priced products (PBC2), the seriousness of the indication to be 
treated (PBC3) and the patient’s impression that high-priced products are better 
(PBC4), are negatively and significantly correlated with behavioural intention (BI) 
(-0.139;/? 0.006; -0.159;p  0.002; -0.130;p  0.010 respectively). The internal 
consistency of the PBC construct showed a Cronbach Alpha o f0.729. However, 
low alphas were found when the seriousness of the indication or the patient’s 
impression were omitted.
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• Analysis of the differences between the subgroups of the correlation
between dependent and independent variables.
There is no important difference in the subgroups. The correlation between 
behavioural intention and habit forming is the highest with psychiatrists (0.771 ; p  < 
0.001) and seems less important with general practitioners (0.568;p  < 0.001). This 
might be due to the fact that specialists have more patients with long term 
treatments. The treatment costs might be less important when treatment duration is 
short. The same reasoning might be valid for anticipated regret variables and 
behavioural intention, which is significant with cardiologists only (-0.222; p  0.036). 
The average treatment duration of cardiology patients may be longer than with 
patients of the other specialties. The influence of others (Subjective Norm) on the 
control factor (Perceived Behavioural Control) is negative with cardiologists and 
psychiatrists only (-0.280; p  0.009 and -0.233; p  0.047, respectively). This might 
also be caused by the severity of the indication.
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Table 60 Bivariate correlation table of the independent variables of the 
attitude construct (ATTITUDE):
Variable
BI ATT1 ATT2 ATT3 ATT4 ATT5 ER ARV
BI 1.000 .747** .564** .584** .664** .387** .515** .065
. . . .000 .000 .000 .000 .000 .000 .199
396 395 395 395 395 393 392 392
ATT1 .747** 1.000 .724** .711** .725** .446** .552** .175**
.000 .000 .000 .000 .000 .000 .001
395 395 395 395 395 393 392 391
ATT2 .564** .724** 1.000 .818** .685** .339** .632** .185**
.000 .000 .000 .000 .000 .000 .000
395 395 395 395 395 393 392 391
ATT3 .584** .711** .818** 1.000 .739** .450** .648**
**00
.000 .000 .000 .000 .000 .000 .000
395 395 395 395 395 393 392 391
ATT4 .664** .725** .685** .739** 1.000 .607** .548** .201**
.000 .000 .000 .000 .000 .000 .000
395 395 395 395 395 393 392 391
ATT5 .387** .446** .339** .450** .607** 1.000 .394** .160**
.000 .000 .000 .000 .000 .000 .002
393 393 393 393 393 393 390 389
ER .515** .552** .632** .648** .548** .394** 1.000 .074
.000 .000 .000 .000 .000 .000 .148
392 392 392 392 392 390 392 388
ARV .065 .175** .185** .181** .201** .160** .074 1.000
.199 .001 .000 .000 .000 .002 .148
392 391 391 391 391 389 388 392
** Correlation is significant at the 0.01 level (2-tailed).
N ote : data in each cell represent: correlation coefficient, significance and sample size.
Source : field work
* Analysis of the correlation of the elements of the ATTITUDE construct.
The determinants ATT1, ATT2, ATT3, ATT4, ATT5 and ER of the attitude 
construct (see Table 60) are highly correlated with each other and with behavioural 
intention. ARV (anticipated regret variables) has a low and non-significant 
correlation with behavioural intention and a low but significant correlation with ER
245
(emotional reaction). This different pattern might be due to the fact that many 
doctors seem to disagree with the statement that they will prescribe less effective 
products when they prescribe in a cost-conscious manner (see: behavioural beliefs 
and outcome evaluation). The internal consistency was high with a Cronbach alpha 
o f0.8839 for ATT1, ATT2, ATT3, ATT4, and ATT5 and 0.8922 when emotional 
reaction was added and 0.8615 when both ER and ARV were included. Utilitarian 
outcomes, which is behavioural beliefs (Bb) multiplied by outcomes evaluation 
(Oe), has a comparable correlation pattern as ATT, except for its correlation with 
subjective norm, which is higher for utilitarian outcomes. The internal consistency 
of utilitarian outcomes was 0.7669, which is also acceptable.
6.4.4. Analysis of baseline data by non-participating physicians
On Saturday January 14, 2000 a group of two cardiologists, three general 
practitioners, two gynaecologists and two psychiatrists met in Athens to discuss 
the outcome of the baseline questionnaire. Among the physicians were three 
female doctors: one general practitioner, one gynaecologist and one psychiatrist. 
The objective of the meeting was to get more understanding of the data produced 
by the baseline questionnaire concerning the prescription behavioural intention of 
396 physicians. A copy of the questionnaire and a survey with the means of all 
the answers to the baseline questionnaire (see Appendix I) were presented to the 
group of physicians and used as a basis for discussions.
It was concluded that Greek physicians have a positive attitude towards taking 
costs into consideration when prescribing medicines. No important differences 
were noticed between the different specialisations or sexes. However, a 
difference was noticed between the age groups. The willingness to take cost into 
consideration decreases with age, except for the group above 60 years of age. The 
age of the patient population of the latter physicians is thought to be above 
average and, as co-payment of prescribed pharmaceutical products might be 
problematic for the elderly, the physician might be forced to be more cost 
conscious. Although information about the characteristics of the physician’s
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patient population might be difficult to collect, it seems worthwhile considering
these characteristics when evaluating doctor’s prescription behavioural intention.
The specialists seemed to be less cost conscious than the general practitioners. 
However, this might be misleading, as many of the specialists filled in the 
questionnaire in their own private practices where they receive patients who are 
well insured. For these patients, price is less important, even for a therapy of 
longer duration, as the costs of pharmaceutical products are re-imbursed by their 
insurance.
The affect variable, which forms, together with attitude towards the act and 
anticipated regret variables, the attitude construct, turned out to be quite important 
for all specialists. However a remarkable difference was found between the sexes, 
with males having a more pronounced emotional reaction (see Appendix I). The 
group could not explain this phenomenon, which is in line with reports in the 
literature which indicate that male general practitioners are more vulnerable to 
advertisements in medical journals and magazines (R2 = 3.65, p  < 0.1) than their 
female colleagues (Pitt & Nel, 1988, pp.7-14).
Male physicians indicated that being cost-conscious while prescribing did not 
bother them much. The emotional reaction might be of a different magnitude, 
however, when physicians feel under pressure to prescribe more economically.
The pressure to search for low-priced treatments might bring them into conflict 
with their desire to prescribe the optimal treatment. The fact that cost-conscious 
prescribing is not a great concern to most physicians might be due to the fact that 
pressure to prescribe economically is quite a recent phenomenon.
Contrary to what had been anticipated, it was not younger doctors who were most 
influenced by habit but the subgroup of physicians between 51 and 60 years, in 
particular, the gynaecologists and to a lesser extent the psychiatrists. The desired
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safety of the product prescribed was thought to be the reason for this. The fact 
that cardiologists in this age group are habitually cost-conscious is probably due 
to the fact that antihypertensives are frequently prescribed life-long. The 
characteristics of the patient population and thus the seriousness of the indications 
to be treated might have caused the group of specialists from 51 to 60 years to be 
less used to being cost-conscious. The habit of prescribing economically is also 
more pronounced with males than with females (see Appendix I). Analysis 
showed that the female group had a lower average age (1.79 = 49 years versus 
2.11 = 52 years ) than the male physicians. This difference in habit forming might 
therefore not be related to gender but to the average age, as physicians tend to 
become more cost-conscious over 60 years.
From the behavioural beliefs it became clear that the average Greek physician 
does not believe that less expensive products are less effective compared with the 
more expensive ones. This might be different in other countries where copies of 
innovative products such as generic products have acquired an important part of 
the pharmaceutical market. The interchange of original with copy products is 
frequently criticised as the bio-availability of those copy products is often 
challenged. According to the members of the discussion group, patient 
compliance is not considered to have any importance for behavioural intention. 
They believe that patient compliance with the prescribed therapy does not depend 
on the cost of the product. Patient compliance is considered to be more influenced 
by the persistence of the symptoms of the illness.
While discussing the data relating to perceived behavioural control, the physicians 
indicated that they were hampered in prescribing when cost conscious, as the 
newer more effective products are frequently more expensive than the 
conservative treatments. They agree with the general statement that lower priced 
products are less effective than more expensive ones but disagree with the 
statement that frequently the low efficacy of low priced products hampers them in 
prescribing economically. The seriousness of the disease is a strong determinant
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of perceived behavioural control as the physicians frequently feel forced to 
prescribe more advanced and thus frequently more expensive treatments when life 
threatening diseases have to be treated. The physicians of the discussion group 
indicated that choosing the best treatment is more important than economic 
prescribing. It is quite rare that a patient expresses his or her opinion about the 
efficacy and price of a treatment. Its influence as a part of the perceived 
behavioural control construct is thus limited.
Of the normative beliefs, it is mainly the sick fimd which forces the physician to 
be cost-conscious when prescribing. The influence of the medical representative 
in this respect is, according to the discussion group, just an indirect result of the 
pressure of the sick funds, as price is used by them, if relevant, as an external 
stimulus to promote their product. The desire of the patient that the prescribing 
physician is cost-conscious is more pronounced with the specialists as the 
duration of treatment they prescribe is generally longer than the duration 
prescribed by the general practitioner. The influence of the sick fund on 
prescription behaviour is the strongest with cardiologists. It is thought that the 
long average treatment duration of antihypertensives, frequently for the rest of a 
patient’s life, is the main cause of this.
The motivation to comply with the desire of the patient to prescribe economically 
is low. This might be due to the fact that, currently, patient co-payment accounts 
for a maximum of 30% of the price of the product. This might change 
dramatically if the percentage of co-payment of the patient increases as a result of 
the deficits of the Greek sick funds. Female doctors seem to be more motivated to 
comply with normative beliefs than their male colleagues. The cardiologists are 
most motivated to comply with the desire of the sick funds to be cost conscious. 
However the physicians’ motivation to comply is only strong in the age group 
below 40 and is much lower in the older groups (2.82 vs 1.78). This may be 
because younger doctors are more open to change or it might be a reflection of the 
attention paid to daily treatment costs during their training.
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The results of outcome evaluation (Oe) indicate that the efficacy of a product is 
much more important than the daily treatment costs for the physicians. The 
expected financial benefit is important for all physicians but mostly for the group 
above 60 years. It is thought that the financial situation of the elderly is causing 
this phenomenon. It is therefore most significant with the group of doctors over 
60 years of age, as the age of their patient population is expected to be above 
average.
Concerning the anticipated regret variables, there was a strong feeling that it 
would be bad to prescribe less-effective products for reasons of cost.
6.5. Selection of the determinants of prescription behavioural
intention
The initial un-rotated factor matrix was computed to assist in exploring the 
structure among the set of predictor variables and to discover the most 
representative variable of the set of predictor variables. The component analysis 
model was chosen as it is widely used, although it is noticed that there remains 
considerable debate over which model, the common or component analysis 
model, is the most appropriate. In this application both models should arrive at 
essentially identical results as the communalities exceed 0.60 for most of the 
variables (Hair et al., 1998, p. 103). An exploratory approach in the form of 
common factor analysis is also often criticised for being easily associated with 
ambiguities inherent in the subjective, post hoc interpretation of factors (Rummel, 
1970). However, common factor analysis is only one of the methods used to 
understand the underlying structure of the predictive variables and thus the risk of 
making subjective conclusions marginal.
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Table 61 Initial un-rotated factor matrix of the baseline data:
Initial Extraction
Habit 1.000 0.759
ATT1 1.000 0.759
ATT2 1.000 0.729
ATT3 1.000 0.772
ATT4 1.000 0.748
ATT5 1.000 0.545
ER 1.000 0.580
ARV 1.000 0.691
PBC1 1.000 0.783
PBC2 1.000 0.801
PBC3 1.000 0.542
PBC4 1.000 0.434
SN1 1.000 0.685
SN2 1.000 0.699
SN3 1.000 0.582
UTILOUT1 1.000 0.780
UTILOUT2 1.000 0.617
UTILOUT3 1.000 0.617
UTILOUT4 1.000 0.602
UTILOUT5 1.000 0.710
Source: field work
The appropriateness of factor analysis was confirmed by the Barlett test of 
spheriticy, which reported an approximately Chi-Square o f4098.817, df 190 with 
a significance level of p< 0.0001. The Kaiser-Meyer-Olkin measure of sampling 
which reported 0.844 was used to confirm the outcome of the Barlett test as the 
latter has the disadvantage of being more sensitive to detecting correlations 
among variables when the sample size is large.
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Table 62 Principal components correlation matrix of the baseline data:
Component Initial Eigenvalues__________________Extraction Sums o f Squared Loadings
Total % of 
Variance
Cumulative
%
HABIT 7.280 36.401 36.401 7.280 36.401 36.401
ATT1 2.218 11.089 47.489 2.218 11.089 47.489
ATT2 1.651 8.255 55.744 1.561 8.255 55.744
ATT3 1.182 5.910 61.654 1.182 5.910 61.654
ATT4 1.103 5.516 67.170 1.103 5.516 67.170
UTILOUT3 0.881 4.404 71.574
7 0.823 4.117 75.691
8 0.774 3.872 79.563
9 0.670 3.349 82.913
10 0.562 2.810 85.723
11 0.487 2.437 88.159
12 0.449 2.244 90.404
13 0.400 1.999 92.402
14 0.317 1.587 93.989
15 0.262 1.311 95.300
16 0.250 1.250 96.550
17 0.232 1.160 97.710
18 0.194 0.972 98.682
19 0.155 0.774 99.456
20 0.109 0.544 100.00
(extraction method: principal component analysis, total variance explained)
Source: field work
The Scree test was used to identify the optimum number of factors that can be 
extracted before the amount of unique variance begins to dominate the common 
variance structure. The latest roots were plotted against the twenty factors in their 
order of extraction, and the resulting shape of the resulting curve analysed.
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Figure 13 Eigenvalue plot for Scree test criterion of the baseline data:
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The first five predictor variables are the minimum number of factors needed to 
account for the maximum portion of variance represented in the original set of 
variables. The Scree test for component analysis indicates that the sixth variable 
UTILOUT3 could be ignored.
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The component matrix gives the following picture:
Table 63 Principal components correlation matrix of the baseline data:
Component
Habit Attl Att2 Att3 Att4
Habit 0.844 0.09025 -0.182 0.04492 -0.05785
ATT1 0.839 0.178 -0.143 -0.03591 -0.03361
ATT2 0.820 -0.05675 -0.226 -0.05363 0.00178
ATT3 0.811 0.148 -0.303 0.02536 -0.00936
ATT4 0.802 0.110 -0.255 0.06492 0.155
UHLOUT3 0.741 -0.110 0.142 0.135 -0.130
UTILOUT2 0.738 0.03084 0.203 -0.138 -0.102
UHLOUT4 0.726 0.202 -0.02498 0.0285 -0.180
ER 0.709 -0.08307 -0.204 -0.04426 -0.164
UTILOUT5 0.653 -0.03512 0.370 -0.382 -0.000133
SN1 0.594 -0.132 0.389 -0.386 0.116
ATT5 0.559 0.0741 -0.286 0.326 0.196
SN2 0.515 -0.154 0.590 0.167 0.184
SN3 0.435 -0.05272 0.610 0.133 0.02926
ARV 0.235 -0.09343 -0.02292 0.05945 0.789
UBLOUTl 0.177 -.0128 0.300 0.742 -0.302
PBC4 -0.09159 0.544 0.03296 0.315 0.174
PBC1 -0.102 0.824 0.166 -0.08523 -0.244
PBC2 -0.214 0.839 0.140 -0.127 -0.124
PBC3 -0.262 0.571 0.239 0.08817 0.286
(extraction method: principal component analysis, 5 components extracted)
Source: field work
From the above matrix it becomes clear that the factor loadings of habit indicate 
that this predictor variable is the only one able to represent the entire factor. As 
habit will be difficult to influence during this research, fiirther analysis of the 
variables seems warranted. For fiirther interpretation of the factors, factor rotation 
was applied. The oblique rotation method was used, as this is considered more 
realistic than the orthogonal rotation, and the theoretically important underlying 
dimensions are not assumed to be un-collerated with each other. The selected 
technique is still subject to controversy because it is not considered to be as well 
developed analytically as the techniques of orthogonal rotation. However, this is 
not expected to limit its use for the interpretation of the baseline study variables.
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Figure 14 Component plot of the baseline data in rotated space:
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All variables of the attitude construct, except Utilitarian Outcomes 1 (UTILOUT1), 
are part of a cluster with ATT5 and ARV at some distance. Physicians seem to 
agree that less expensive medicines are less effective drugs (see the results ofPBC, 
section 6.4.3, Table 55), but they do not consider that this will lead to them to 
prescribe less effective drugs. In these circumstances they refuse to let cost 
considerations over-ride their desire to prescribe the most effective therapy. This 
element seems to have blurred the influence of their behavioural beliefs and 
outcome evaluation on their cost consciousness during prescribing. It seems 
therefore that Utilitarian Outcomes 1 should be deleted from further analysis. 
Attitude 5 contains an element of perceived behavioural control as it concerns an 
obligation to prescribe cost-effectively and should therefore been removed from 
further elaboration. The remaining variables of the attitude construct are closely 
connected. Subjective Norms 2 and 3 form a cluster, while Subjective Norm 1,
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which concerns the influence of the patient on the prescription behavioural intention 
of the physician, is part of the attitude cluster. This normative construct should 
therefore remain decomposed during further analysis.
Multiple regression analysis was used as an objective means of assessing the 
individual predictive power of each of the independent variables on behavioural 
intention and to assess the degree and character of the relationship between 
behavioural intention and each independent variable. The relative importance of 
each independent variable in the prediction of the dependent variable was used to 
objectively assess the magnitude, positive or negative, of each independent variable. 
First, the concept of a summated scale is used in order to measure error inherent to 
all measured variables. The results of regression analysis of multiple variables will 
be compared with results of single variables of the same construct. The aim is to 
find the most influencing independent variable which influences behavioural 
intention without violating its representative power.
Multiple regression analysis is thus used to analyse the relationship between a 
single dependent variable and several independent variables. The regression 
variate will thus enable a determination of the relative importance of each 
independent variable in the prediction of behavioural intention and/or overt 
behaviour. It seems therefore also suited to investigate the effect of manipulating 
individual factors influencing non-fully volitional behaviour in the second part of 
the study. A limiting factor, however, is that the multiple regression analysis can 
only be used if the independent variables are not, or are only slightly, correlated 
with each other. This is because it is almost impossible to separate the effect of 
each independent variable on behavioural intention and behaviour if multi- 
collinearity exists (Drury, 1994, p.651). This is due to the fact that there is a lack 
of independence among the independent variables, which limits the availability of 
sufficient information to enable the regression coefficients to be determined. 
Attitude, subjective norm, and beliefs might be, to a certain extent, correlated with 
each other and thus blur the individual coefficient estimates. Therefore at the 
beginning of the study period the multi-collinearity was verified by measuring the
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correlation between the independent variables. The correlation between several 
independent variables such as habit and attitude proved to be high and significant. 
However, if past relationships between the independent variables are maintained 
during the study period, there is no need to abandon the multiple regression 
analysis method (Drury, 1994, p.651). Therefore, changes in correlation between 
the independent variables at baseline and at the end of the study was analysed.
Table 64 Estimation of the linear relationship between behavioural
intention and the independent variables:
Variables entered r R2 F %
ATT 1, ATT2, ATT3, ATT 4, ATT 5 0.768 0.590 111.575 <0.001
ATT1,ATT2,ATT3,ATT4 0.768 0.590 140.443 <0.001
ATT, ER, ARV, HABIT, SN, UTILOUTC, PBC 0.711 0.506 52.179 <0.001
ATT,UTILOUT C 0.706 0.498 187.415 <0.001
ATT,ER, ARV 0.706 0.498 126.287 <0.001
ATT,ARV 0.704 0.493 189.512 <0.001
ATT,ER 0.701 0.492 187.468 <0.001
ATT 0.698 0.487 371.272 <0.001
ATT, SN 0.697 0.485 178.569 <0.001
ATT,SN,PBC 0.691 0.477 113.308 <0.001
HABIT 0.646 0.417 279.113 <0.001
UTILOUT1, UTILOUT2,UTILOUT3,UTILOUT 4 0.625 0.391 48.445 <0.001
UTILOUTC 0.530 0.281 148.799 <0.001
(behavioural beliefs x outcome evaluation)
ER 0.515 0.265 140.681 <0.001
SN1, SN2, SN3 0.331 0.110 15.679 <0.001
PBC 1 ,PBC2,PBC3,PBC4 0.259 0.067 6.856 <0.001
Source: field work
Multiple regression of the entire attitude construct turned out to be the most 
important determinant of behavioural intention. The decomposed attitude construct 
on behavioural intention revealed a significant contribution of all attitudinal 
determinants except ARV and ATT5.
The influence ofPBC is much lower than might be expected with this non-fully- 
volitional behaviour. Multiple regression analysis revealed no significant 
influence ofPBC on behavioural intention. The exclusion of PBC4 does not
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change the outcome of the multiple regression analysis ofPBC on behavioural 
intention. This finding did not confirm the importance of Perceived Behavioural 
Control in the prediction of behaviour in domains in which volitional control was 
thought to be incomplete (Giles & Cairns, 1995; Van der Geer & Kangis, 2000). 
Analysis of the PBC results by a group of non-participating physicians, see 
section 6.4.4 of this thesis, indicated that the pressure of sick funds on doctors to 
prescribe economically is still limited. Greek physicians might thus be still rather 
volitional in their prescription choice. However, this may change before long as 
the Greek Minister of Health, Alekos Papadopoulos, has announced tighter 
regulations in terms of operations and expenditure of the Greek private healthcare 
market, one of the largest in Europe counting for 48% of the total healthcare 
expenditure in Greece (Scrip, 2000e, 2001a, 2001b).
Behavioural beliefs x Outcome evaluation (UTILOUTC) was shown to be the 
second most important determinant of behavioural intention. Some support for a 
multidimensional representation of this belief-based measure of attitude was 
provided.
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Homogeneity was calculated by HOMALS, version 0.6 developed by the 
Department of Data Theory of the University of Leiden, in the Netherlands.
Figure 15 Object scores of baseline data.
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Figure 16 Category quantifications of baseline data.
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The category quantification of Utilitarian Outcomes confirmed the findings of the 
component plot in rotated space, see Figure 14, that Utilitarian outcomes 1 does 
not fit in this belief construct and should therefore be deleted from further 
analysis.
6.6. Development of the external stimuli
Factor analysis (see Table 61) indicated that HABIT could best be used to represent 
all other independent variables during further research. However, habit is very 
resistant to change and an external stimulus based on past behaviour is therefore
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thought not to be suitable for this research. Factor analysis indicated that attitude 
construct was the second best factor, and Attitude 1 emerged as the best factor from 
the decomposed construct. Common factor analysis indicated that the subjective 
norm (SN) variable could also be used as a starting point for the development of the 
external stimulus. However, this was rejected as literature on the relationship 
between intention and behaviour for both attitudinally and normatively controlled 
people and attitudinally and normatively controlled behaviour suggests that the 
method is more predictive for intentions based on attitudes than intentions based on 
subjective norms (Sheeran et al., 1999, pp.403-406).
Multiple regression of the independent variables on behavioural intention, see Table 
64, showed that the attitude construct had the highest influence of all independent 
variables on behavioural intention. In order to develop an external stimulus, which 
is expected to influence the prescription behavioural intention and behaviour most, 
the attitude construct was therefore decomposed for fiirther analysis. Attitude 5 and 
Anticipated Regret Variables (ARV) were rejected for further analysis as they had 
no significant influence on behavioural intention (see Table 64 of this thesis). 
Attitude 1 emerged as the most suited independent variable of the attitude construct 
during the stepwise enter regression method. As the internal consistency of the 
attitude construct was high, it was not considered a problem to use only Attitude 1 
to represent the entire attitude construct.
The Attitude 1 question reads as follows:
Taking the Daily Therapy Cost into account every time that I prescribe an 
antihypertension medicine is :
Of high Important Not very Indifferent Without
importance important importance
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Pharmaceutical companies often use a comparison of the daily treatment costs of 
their and competing pharmaceutical products as a promotional tool. Using 
information about daily treatment costs is therefore not considered to be new or 
additional information. What is new is the direct link between the (positive) 
attitude of the prescribing physician towards cost-conscious prescribing and 
information about the daily treatment costs of the product and its competition. It 
was therefore considered that an external stimulus based on the Attitude 1 
question could be constructed.
Features of the source of the external stimuli, the message itself, and the audience 
can all have an effect upon persuasion. Two influential theories, Chaiken’s 
heuristic-systemic persuasion model and Petty and Cacioppo’s elaboration 
likelihood model, have tried to specify the conditions under which people will be 
more influenced by message content and those under which they will be influenced 
by superficial characteristics of the message. Both theories state that, under certain 
conditions, people are motivated to pay attention to and to elaborate on the facts in a 
message. This is called the central route of persuasion. Central route persuasion is 
elaboration-based, persuasion ultimately depends on carefiil scrutiny of the 
persuasive message. The favourability of thoughts is determined by the strength of 
the message. Strong messages, which are supported by more arguments or 
arguments which are perceived as being more logical by the receiver, are thought to 
be more convincing than weak arguments. Thus message qualities take precedence 
over other factors. Under other conditions, people are not motivated to pay 
attention to the facts a message presents and only attend to superficial 
characteristics. In this case, people are said to be influenced by the peripheral route 
of persuasion. This route is therefore characterised by low elaboration of the 
message, and depends on message-irrelevant qualities.
Attitude change might be obtained because of “cues” in the persuasive context, such 
as an attractive source, the sheer number of arguments presented, or the listener 
being in a good mood. Because peripheral cues are message irrelevant, persuasion 
does not depend on the strength of the message. Attitude change as a result of
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central route persuasion is therefore more persistent and resistant than the peripheral 
route. As the interest of this research is to look for possibilities to influence 
prescription behaviour persistently, persuasion via the central route was chosen. 
However, the audience’s motivation and ability also influence the route by which 
they will be most influenced. Petty et al. (1981) asked students to listen to a 
persuasive message advocating a senior exam. Personal relevance was manipulated 
by saying that the exam was considered for the next year (high relevance) or for 10 
years hence (low relevance). Also, the message contained either strong or weak 
arguments and was presented by either a high- or a low-prestige source. They 
found that with high relevance, people were more influenced by strong than weak 
arguments, regardless of the prestige of the source. With low relevance, however, 
people were influenced by the prestige of the speaker more than by the quality of 
the arguments. Thus, motivation to pay attention to arguments depends on the 
personal relevance of a message, and consequently the message to be developed 
should be relevant to the physician and devoid of complexity. The daily treatment 
costs of a medication should fulfil these requirements in an environment in which 
increasing attention is paid to the rise of healthcare costs.
The phrase developed was:
Original phrase in Greek:
Eivcn noXv aqpavTiKÔ yiaxps, va Mpsxe mr’dr|nv aaç t o  r||ispf)oio k ô o t o ç  
Oeparcsiaç t o u  TtpoïôvTOç Trou GKOTueueTS va ouvTayoypacpfjasTe. To Fisiotens/ 
Dumyrox/ Femaston s%£i éva avTayœvraTiKÔ qpepqoio k ô o t o ç , ysyoroôç Trou 
aTtoTeXef éva STrurXéov Xoyo yiaxpé yia va t o  ouvTayoypacpfjosTs.
Translation into English:
It is very important, doctor, that you take into account the daily therapy cost of the 
product that you intend to prescribe. Fisiotens / Dumyrox / Femaston has a 
competitive daily cost, which is one extra reason for you, doctor, to prescribe it.
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Every month for six months, the first group of physicians was confronted with the 
normal promotional message by the pharmaceutical industry representative to 
which the external stimulus developed above was added. The second group of 
physicians was confronted with the normal message to which an external stimulus 
was added which was expected to have almost no influence on the prescription 
behavioural intention or behaviour (see below). The third group of physicians 
received the regular promotional message only. See Figure 12 for a representation 
of the research design over time.
The external stimulus presented to the second group of physicians, which was 
expected to have almost no influence on their prescription behavioural intention or 
behaviour, was developed as follows:
Habit and the attitude construct were excluded because of their expected important 
influence on behavioural intention. Utilitarian outcomes, being behavioural beliefs 
multiplied by outcome evaluation, were also excluded, as they are strongly 
correlated to attitude and habit. Subjective norm, being normative beliefs 
multiplied by motivation to comply, and perceived behavioural control (PBC) both 
have a low significant correlation to behavioural intention and could therefore be 
used. Multiple regression analysis did not reveal major differences between these 
variables; both have a low influence on behavioural intention with PBC the lower. 
The internal consistency of the PBC construct indicated that the seriousness of the 
indication or the patient’s impression of the efficacy of low-priced products should 
be included. The oblique rotation of the results of factor analysis showed that the 
entire PBC construct is situated near the other independent variables while 
subjective norms 2 and 3 are outside the cluster. PBC based on the seriousness of 
the indication was also rejected, in order to prevent possible bias because of a 
different interpretation of the seriousness of illnesses to be treated. This fact might 
appear in particular while discussing a preventive treatment such as the symptoms 
of menopause. It was therefore decided to develop an external stimulus based on 
perceived behavioural control 4 covering the patient’s impression. The question 
covering this independent variable is:
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Does the patients’ belief that expensive medicines are better medicines prevent me 
from taking the Daily Therapy Cost into account every time that I prescribe an anti­
hypertension medicine?
Always : Often
cases
In50%ofthe Sometimes Never
The phrase developed is as follows:
Oi aoGsvslç auvriGœç maieuonv on xa aKpipâ (pappaxa sivai KaXuxepa anô m  
cpBrjvd. Anxf) r\ yeviKT) svxuTixoari xcov aoGsvév Ôsv 6a Tcpéjcsiva aaç aTtoxpéjcsi 
yiaxps ajcô xo va aovxayoypacpsixs xo Fisiotens/Dumyrox/Femaston, 87tsiôf| Ttépa 
anô avxayœviaxiKÔ TiXeovéKxripa xon xaprjXou xipepfjaiou KÔaxoua Gepaîtsiaç Ttou 
TiapÉxst, sivai STnarjç éva aTtoxsXsapaxiKÔ Kai aacpaXéç Ttpoïôv.
Patients usually beheve that expensive medicines are better than low-prices 
medicines. This general impression that patients have, should not prevent you, 
doctor, from prescribing Fisiotens / Dumyrox / Femaston, because apart from the 
competitive advantage of the low daily therapy cost that it offers, it is also an 
effective and safe product.
As already indicated above, pharmaceutical companies are used to presenting to 
physicians a comparison of daily treatment costs of their and competing 
pharmaceutical products as a promotional tool. Using information about daily 
treatment costs is therefore not considered to be new or additional information.
Also the remark about efficacy and tolerance should not be considered new 
information, as these are the two basic product properties on which promotional 
claims are built. What is new is the direct link between the hindrance the physician 
feels because of the negative impression the patients may have about the efficacy of 
low-priced products and the physician’s willingness to take cost into consideration 
when prescribing. It was therefore considered that an external stimulus based on 
PBC 4 question could be constructed.
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Research on the attitude-behaviour relation suggests that the accessibility of an 
attitude from memory is critical to the process by which attitudes guide behaviour 
(Snyder, 1982; Fazio et al., 1983). If an attitude is to influence subsequent 
behaviour, it first must be accessed from memory when the individual encounters 
the attitude object. Individuals with relatively accessible attitudes, as indicated by 
relatively fast latencies of response to the attitudinal inquiry, displayed greater 
selective perception as a function of those attitudes and greater attitude-behaviour 
consistency than individuals with less accessible attitudes (Fazio & Williams, 1986, 
p.511). Powell and Fazio (1984) proved that conceptualizing an attitude as a simple 
association between the attitude object and a given evaluation should be sufficient. 
Therefore, while preparing external stimuli, careful attention was paid to including 
a clear direct link between the attitude object and the physician’s evaluation, i.e. the 
link between the positive attitude towards cost- conscious prescribing and the low 
daily treatment costs of the proposed medication in the first stimulus and the 
impression of the patients that low-priced products have a low efficacy and the 
efficacy profile of the proposed product in the second.
However, although message content may be the most important determinant of 
persuasion under some circumstances, in other circumstances non-content 
manipulation such as source credibility, attractiveness, and so forth, have been 
reported to be even more important (Petty et al., 1981). When a persuasive message 
concerns an issue of high personal relevance for the receiver, the effectiveness of 
the appeal is reported to be more a function of the cogency of the arguments 
presented in the message than of peripheral cues such as the expertise of the 
message source. On the other hand, when a message concerns an issue of relatively 
low personal relevance, the effectiveness of the persuasive attempt seems to be 
more a function of peripheral cues than of the arguments presented. An increase in 
the involvement of the receiver might be associated with an increase in the 
importance of message arguments in producing persuasion. Firstly because, as the 
personal implications of the message for the recipient increase, it becomes more 
important to form a reasoned and honest opinion. An attitude based on a careful 
examination of issue-relevant arguments will usually prove to be more adaptive and
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should be easier to defend. Repeated discussions of the argument are therefore 
believed to improve the degree to which individuals are able to retrieve rapidly 
beliefs about the attitude object from memory. Discussing the argument should also 
increase the likelihood that the subjects will be motivated and able to engage in the 
task of evaluating the message arguments and thus obtain more accessible attitudes 
and become more responsive to persuasive messages (Fazio & Williams, 1986, 
p.513). Consistent with this reasoning, the arguments presented were discussed 
with the physicians during all six subsequent visits, using open questions to involve 
the physician in active discussion.
The phrases were developed so as to avoid possible differences in argument 
strength. Petty et al. (1981, p.850) called argument strength “argument quality” and 
described it as the inherent strength, plausibility, or believability of an argument. 
They described strong arguments as messages containing persuasive evidence such 
as statistics, data, etc., while weak arguments are messages containing quotations, 
personal opinions, and examples. Argument quality seems important because 
research on persuasion indicated that a set of “strong” arguments ascribed more 
desirable attributes to the attitude object than a set of “weak” arguments. The 
“quality of the arguments” expressed in the two phrases used in the present research 
are thought to be similar; physicians who asked for the source of the opinions 
expressed in either phrase were informed that they were taken from “unpublished 
research performed in Greece in 1999 by researchers from the University of 
Surrey”.
Eight physicians, comprising three general practitioners, two cardiologists, two 
psychiatrists and one gynaecologist, all with practices in Athens, were contacted in 
the last week of January 2000, in order to ensure that the meaning of both phrases 
was well understood..
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6.7.
6.7.1.
Final data 
Return rates
During the final stage of the study, 396 questionnaires were distributed to the 
selected physicians. In total, 392 completed questionnaires were returned. In the 
group confronted with the first external stimulus, one cardiologist had stopped 
practising and another refused participation, while in the group confronted with the 
second external stimulus, one general practitioner refused to fill in the questionnaire 
and data on the actual prescription behaviour of one general practitioner could not 
be counted. In the control group one general practitioner refused to fill in the 
questionnaire and data on the actual prescription behaviour of one psychiatrist could 
not be counted. The return rate of completed questionnaires was as follows:
Table 65 Return rates of the completed questionnaires at the end of the 
study period:
Distributed Completed questionnaire 
returned
% returns
General practitioner 140 138 98.6
Psychyatrist/ 77 77 100.0
neurologist
Cardiologist 90 88 97.8
Gynaecologist 89 89 100.0
Total 396 392 99.0
Source: field work
The distribution of the non-responders over the research groups is presented in 
Table 66.
Table 66 Distribution of the non-responders over the research groups:
Gen.
pract.
Psych/
neur.
Cardiol Gynaecol Total
Group receiving message 1 - - 2 2
Group receiving message 2 1 - - 1
Control group 1 - - 1
Source: field work
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The percentage of non-responders (1.0 %) was low and distributed over all the 
specialties and groups studied. It was therefore concluded that there was no 
response rate bias. Actual prescription behaviour could be evaluated for 393 of the 
396 physicians (99.2%). Prescription data was missing for one psychiatrist in the 
control group and one general practitioner in the group receiving message 2.
6.7.2. Missing data
The number of data items missing on the questionnaires was low, 1.11%, and well 
distributed over the questions. No question was unanswered on more than seven 
questionnaires. The creation of a sub-sample of cases that had completed every 
item in the questionnaire, was therefore considered unnecessary as there is always 
the possibility of introducing an inadvertent bias (Oppenheim, 1997, p.281).
6.7.3. Application of the external stimuli
Data on the reports of the administration of the external stimulus (see Table 26) 
showed that 369 selected physicians were visited with the required six visits. One 
cardiologist in group 1 was visited twice only, nine physicians (two in group 1; 
three in group 2 and four in group 3), were visited seven times and six physicians 
(three in group 1 ; one in group 2 and two in group 3) were visited eight times while 
nine physicians (two in group 1 ; five in group 2 and two in group 3) were visited 
nine times. It was decided that the external stimulus had been presented with 
acceptable frequency, as a deviation from protocol was only recorded in 6.8% of 
cases. The small variations from the original plan should not have influenced the 
outcome of the study.
6.7.4. Statistical evaluation of the final data
The means of the independent variables at the beginning and at the end of the study 
period were compared. First a comparison was made for all physicians in each 
group studied, followed by a comparison per specialty. Tables with the complete 
results can be found in the Annexes J-X.
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The first external stimulus was based on the first element of the Attitude construct. 
It was hypothesised that activating ATT 1 of the Attitude construct would influence 
behavioural intention and thus behaviour. This stimulus was used for physicians of 
group 1.
Comparisons of the means of all independent variables at the beginning and at the 
end of the study period for all physicians of group 1, see Appendix J for a complete 
listing, showed that there was a significant difference for the following elements:
Table 67 Means of the variables of all physicians of group 1 that changed 
significantly during the study period:
Variable Mean at baseline Mean at the end of the 
study
t df P
BI 3.2687 3.6364 -3.429 131 0.001
ATT1 3.1654 3.3939 -2.266 130 0.025
HABIT 2.4733 2.9545 -3.495 128 0.001
Bb5 1.8462 1.6565 2.340 126 0.021
Mc3 2.2424 2.7803 -4.271 129 <0.001
Oe3 3.7308 3.9697 -2.596 127 0.011
Source: field work
The Behavioural intention (BI) to take cost into consideration when prescribing 
increased significantly during the study period, while the attitude towards cost- 
conscious prescribing became significantly more positive (ATT1). It was expected 
that, except for ARV, the other elements of the Attitude construct (ATT 2, ATT3, 
ATT4, ATT5, and ER) would also change significantly during the study period as 
their intercorrelations are significant.
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Table 68 Correlations of the elements of the attitude construct at the end 
of the study period:
Variable ATT2 ATT3 ATT4 ATT5 ER ARV
ATT1 Correlation 0.486 0.523 0.391 0.314 0.493 0.098
Sig (2 tailed) <0.001 <0.001 <0.001 <0.001 <0.001 0.265
N 132 132 132 132 132 132
Source: field work
It appears that, although significantly intercorrelated, the components can be 
affected individually, and consequently the decomposition of the attitude construct 
(ATTITUDE) is necessary if the influence of each element is to be recognised. 
Presentation of an external stimulus based on ATT1 of the attitude construct seems 
also to influence some elements of the belief construct, such as behavioural beliefs, 
outcome evaluation, and the motivation to comply. The belief of the physician that 
cost-conscious prescribing will result in better patient compliance due to the lower 
costs of the product (Bb5) increased significantly during the study period. At the 
end of the study, the physicians considered it more positive when their cost- 
conscious prescribing led to a financial benefit for the sick funds (Oe3). They were 
also more willing to comply with the wishes of the representative of the 
pharmaceutical industry that they should prescribe in a cost-conscious way (Mc3). 
The data of the different specialties were also analysed separately to elucidate any 
differences between them.
Table 69 Means of the variables of the general practitioners of group 1 
that changed significantly during the study period:
Variable Mean at baseline Mean at the end of the 
study
t df P
BI 3.1944 3.7222 -2.440 35 0.020
ATT1 3.0571 3.5000 -2.472 34 0.019
HABIT 2.3939 3.0556 -2.261 32 0.031
Mc3 2.1111 2.7778 -3.347 35 0.002
Oe3 3.4167 3.8056 -2.497 35 0.017
Source: field work
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The scores for the general practitioners were identical to the scores for the entire 
group of physicians except for behavioural beliefs. The belief of the general 
practitioners in the assumed improved patient compliance due to the lower costs of 
products (Bb5) prescribed by the cost conscious physician did not change 
significantly. This is in line with the correlation between ATT1 and Bb5, which 
was not significant (0.265; p  0.119). The other independent variables that changed 
significantly such as HABIT, Mc3 and Oe3 were significantly correlated with 
ATT1 (0.759; 0.562 and 0.446; p  < 0.001;/? < 0.001 andp  0.006). The other 
variables of the same constructs e.g. Mcl and Mc2 were not significantly correlated 
with ATT1 (0.263 and 0.262; p  0.121 andp  0.123).
Table 70 Means of the variables of the cardiologists of group 1 that 
changed significantly during the study period:
Variable Mean at baseline Mean at the end of the 
study
t Df P
BI 3.3784 3.7714 -2.079 34 0.045
ATT1 3.1081 3.4857 -2.171 34 0.037
ATT5 2.6486 3.2000 -2.071 34 0.046
HABIT 2.4054 3.0571 -2.691 34 0.011
Mc3 2.3333 3.0857 -2.982 33 0.005
Oe4 4.4118 3.9143 -2.301 31 0.028
Source: field work
Two elements of the Attitude construct were significantly influenced by the use of 
the external stimulus. They were influenced independently as the correlation 
between the two variables was not significant (0.237; p  0.171). ATT1 was 
significantly correlated with BI (0.410; p  0.014) and ATT5 with HABIT (0.508; p  
0.002) which in turn was again highly correlated with BI (0.445; p  0.007). It was 
not unexpected that the external stimulus would influence ATT1 and ATT5 
independently, as they differ only slightly in wording. The differences between 
ATT1 and some other elements of the attitude construct such as ER and ARV are 
more important and their simultaneous activating is therefore less anticipated. The 
general practitioner assumed a financial benefit for the sick funds (Oe3) while the 
cardiologists’ expectations about an improved cost/benefit ratio diminished (Oe4).
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The representative of the pharmaceutical industry, by presenting the stimulus, 
improved the motivation of the physician to comply with the wishes to be cost 
conscious notably further. However, it seems that at the same moment the 
cardiologists beheve that the benefits of the therapy prescribed will diminish 
significantly. The therapeutic profile of the product presented might have too low 
an image. This finding is important for the pharmaceutical industry and they should 
have a carefiil look at the way the therapeutic features are presented.
The means of the psychiatrists was calculated likewise and resulted in the 
subsequent results:
Table 71 Means of the variables of the psychiatrists of group 1 that 
changed significantly during the study period:
Variable Mean at baseline Mean at the end of the 
study
t df P
BI 3.3704 3.9259 -2.155 26 0.041
ER 3.0385 3.4444 -2.101 25 0.046
HABIT 2.7407 3.4074 -2.360 26 0.026
Mc3 2.2593 3.0370 -2.267 26 0.032
Oe3 3.7778 4.2222 -2.473 26 0.020
Source: field work
The external stimulus did not change the attitude determinant on which the external 
stimulus was built significantly, but the emotional element of the construct (ER) 
was significantly influenced. This might be due to the significant correlation 
between ATT1 and ER (0.411 ; p  0.033). A strong correlation between ER and 
HABIT was also seen (0.574; p  0.002). An influence of the representative of the 
pharmaceutical industry on the motivation of the physician to comply (Mc3) was 
observed with the psychiatrists, analogous to the cardiologists. The external 
stimulus and the representative only have an influence on the second element of the 
behavioural and normative beliefs. Motivation to comply with the wishes of the 
representative (Mc3) increased significantly, however, the normative belief (Nb3) 
that the representative wants the physician to be cost-conscious did not change 
significantly, and an identical situation appeared with Bb3 and Oe3. The
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behavioural and normative belief elements seem to have been formed in the past 
and to be less influenced by a new external stimulus. Its presentation by the 
representative of the pharmaceutical industry, however, is a new element and seems 
to have contributed to a change.
The analysis of the mean of the gynaecologists of group 1 showed quite a different 
picture:
Table 72 Means of the variables of the gynaecologists of group 1 that
changed significantly during the study period:
Variable Mean at baseline Mean at the end of the 
study
t df P
Bb5 2.0000 1.6061 2.396 31 0.023
PBC3 3.6176 4.1818 -2.484 32 0.018
Nb2 3.8710 3.5294 -2.402 30 0.023
Source: field work
The analysis of the mean of the gynaecologists of group 1 showed quite a different 
picture (see Table 72). During the study period, the belief of the gynaecologists that 
prescribing lower-priced products will increase the compliance of the patient with 
the prescribed therapy (Bb5) decreased significantly. Their belief that the 
seriousness of the illness to be treated limits their ability to prescribe in a cost- 
conscious way (PBC3) increased significantly, while the belief that the sick funds 
want them to prescribe cost-consciously (Nb2) decreased significantly. It can 
therefore be concluded that the low therapeutic profile of the lower-priced products 
hinders them from becoming more cost-conscious.
It is striking that the external stimulus developed to influence ATT 1 did change 
elements of the attitude construct of general practitioners, cardiologists, and 
psychiatrists in group 1, but not of the gynaecologists. When the magnitude of the 
attitude construct changed, changes in past behaviour, as reported by the physician 
(HABIT) were also noted. With the gynaecologists, where no element of the 
attitude construct changed due to the presentation of the external stimulus, the
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reported HABIT did not change. Should ATT1 have changed, then a change in 
HABIT would be expected, as their correlation was significant (0.509; p  0.002).
The external stimulus increased the motivation of the general practitioners, 
cardiologists, and psychiatrists to comply with the wishes of the representative of 
the pharmaceutical industry to prescribe cost consciously (Mc3). An influence of 
the expressed normative beliefs of the representative (Nb3) was not noted. It can be 
concluded that external stimuli developed to influence the attitude construct 
(ATTITUDE) can be successful but that their influence is not limited to influencing 
the attitude construct only. The person presenting the external stimulus was shown 
also to influence the motivation of the physician to comply (Me) with the expressed 
wishes and this resulted also in a significant change in the past behaviour reported 
by the physician.
The data on the gynaecologists showed that the lower therapeutic profile of lower- 
priced products hinders them from prescribing cost-consciously, as does their belief 
that the patient will comply less well with their recommendations for lower-priced 
products. It can therefore be concluded that gynaecologists assume that lower- 
priced products are therapeutically inferior to higher-priced products. Analysis of 
the actual prescriptions of the gynaecologists should disclose whether they classify 
the researched product Femaston as a therapeutically inferior or superior product.
The second external stimulus was based on the physicians’ assumed impression that 
patients think that higher-priced products have greater efficacy or fewer side-effects 
than lower-priced products. It was anticipated that such a stimulus would not 
influence behavioural intention and real behaviour of physicians. This stimulus was 
used with the physicians in group 2.
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Analysis of the means of the whole group of physicians revealed the following 
significant alterations during the study period:
Table 73 Means of the variables of all physicians of group 2 that changed 
significantly during the study period:
Variable Mean at baseline Mean at the end of the 
study
t df P
HABIT 2.3077 3.0615 -11.734 128 <0.001
Nb3 3.4275 2.9308 7.617 129 <0.001
Source: field work
Perceived behavioural control (PBC4) was not influenced by the external stimulus, 
as anticipated; nor was there any significant influence of the external stimulus on 
behavioural intention. However, the presentation of the external stimulus did 
decrease significantly the belief of the physician that the representative wants the 
physician to be cost-conscious. It can thus be concluded that drawing the attention 
of the physician to the wishes of the patient decreases the influence of the belief of 
the physician about the preferences of the representative with respect to cost- 
conscious prescribing. Discussing cost-consciousness was able to increase 
significantly the reported cost-conscious behaviour (HABIT) of the physician. 
However, this was not influenced by PBC4 as there was no significant correlation 
between these independent variables (-0.028; p  0.754). PBC4 had no significant 
correlation with the other independent variables except PBC2 (0.272; p  0.002). 
PBC4 had a significant negative influence on the dependent variable Behavioural 
Intention (-0.247; p  0.005).
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Detailed analysis o f the different specialties showed the following picture:
Table 74 Means of the variables of the general practitioners of group 2
that changed significantly during the study period:
Variable Mean at baseline Mean at the end of the 
study
t df P
HABIT 2.4600 3.3000 -12.231 48 <0 .0 0 1
Nb3 3.2157 2.7200 4.045 49 <0 .0 0 1
Source: field work
Table 75 Means of the variables of the psychiatrists of group 2 that 
changed significantly during the study period:
Variable Mean at baseline Mean at the end of the 
study
t df P
HABIT 2.6296 3.1852 -2.575 26 0.016
Nb3 3.6667 3.2222 2.726 26 0 .0 1 1
Source: field work
Table 76 Means of the variables of the cardiologists of group 2 that 
changed significantly during the study period:
Variable Mean at baseline Mean at the end of the 
study
t df P
HABIT 2 . 0 0 0 0 2.8519 -7.359 26 <0 .0 0 1
Nb3 3.3333 2.8519 4.914 26 <0 .0 0 1
Source: field work
Table 77 Means of the variables of the gynaecologists of group 2 that
changed significantly during the study period:
Variable Mean at baseline Mean at the end of the 
study
t df P
HABIT 2 . 0 0 0 0 2.6923 -5.195 25 <0 . 0 0 1
Nb3 3.6923 3.1154 5.091 25 <0 . 0 0 1
Source: field work
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Separate analysis of the data from the general practitioners, cardiologists, 
psychiatrists and gynaecologists, did not disclose any different influence of being 
exposed to the external stimulus among the different specialties. The normative 
belief (Nb3) that the representative of the pharmaceutical industry wants the 
physician to be cost conscious when prescribing, diminished significantly with both 
the general practitioners and the specialists. The assumed self-reported cost- 
consciousness when prescribing increased with all physicians. The reason for the 
change in HABIT is unclear as none of the other independent variables, except NB3 
and HABIT, changed significantly during the study period. The correlation 
between HABIT and Nb3 with PBC4 was not significant (-0.075; p  0.396 and -  
0.028; p  0.754). It can thus be concluded that the alteration of HABIT during the 
study period was not due to the presentation of the external stimulus to the 
physicians. Analysis of actual prescription data should show whether this reported 
change in HABIT was real or not.
The physicians in Group 3 (the control group) were not confronted with an external 
stimulus based on cost-conscious prescribing. Neither the dependent variable nor 
any of the independent variables of this group showed a significant change during 
the study period.
Data for the Greek prescription market as a whole were analysed at the beginning 
and end of the study period in order to be able to compare the prescription 
behaviour of the selected physicians with that of Greek physicians in general. Data 
published by IMS (International Medical Statistics, 1999,2000) were taken as the 
source of information on actual prescription behaviour in this comparison. The 
moving annual totals (MATs) of prescription data in October 1999 were taken as 
baseline data as these were the latest figures available at the start of the field 
research period. Corresponding data in October 2000 were taken at the end of the 
research period.
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The total number of prescriptions written by Greek physicians in the period 1 
November 1998 up to and including 31 October 1999 for the studied products and 
their competitors, were as follows:
Table 78 Moving annual total of the prescriptions at baseline for the 
researched and their class of products:
Total number o f prescriptions per year per specialty at baseline in Greece
Fisiotens Dumyrox Femaston
General practitioner 79,948 14,345 0
Specialist 39,511 91,866 1 1 ,8 6 6
Antihypertensives Antidepressants H.R.T.
General practitioner 6,412,872 319,254 0
Specialist 3,756,004 1,126,622 329,953
Total 10,168,876 1,445,876 329,953
Entire Greek market 11,588,973 1,827,926 329,953
% covered by research 87.7 79.1 1 0 0 .0
(IMS, October 1999)
The products included in this research covered almost 8 8 % of the total number of 
prescriptions written for antihypertensives in Greece in the period November 1998 
to October 1999. This was considered sufficient to prevent bias. The percentage of 
antidepressants was 79.1% which, while lower, was still considered adequate 
because of particularities of this market segment. Dumyrox, the researched product, 
belongs to the class of serotonin re-uptake inhibitors, whose market segment was 
entirely covered by this research. Not all antidepressants from other product classes 
were fully covered by this research, as the number of prescriptions written for some 
of them is very limited, and these products were not monitored for practical reasons. 
All prescriptions written for HRT products were covered by this research.
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Table 79 Moving annual total of the prescriptions at the end of the study 
period for the researched and their class of products:
Number ofprescriptions per year per specialism in Greece at end o f study period
Fisiotens Dumyrox Femaston
General practitioner 136,516 12,039 0
Specialist 52,090 118,136 11,800
Antihypertensives Antidepressants H.R.T.
General practitioner 7,389,274 438,238 0
Specialist 4,100,245 1,229,236 378,400
Total 11,489,519 1,667,474 378,400
Entire Greek market 12,836,257 2,311,607 378,400
% covered by research 89.5 72.1 1 0 0 .0
Source: IMS, October 2000
Data at the end of the study period showed that the products included in this 
research accounted for almost 90% of prescriptions written for antihypertensives in 
Greece in the period November 1999 to October 2000. For antidepressants this 
figure was 72.1% and for the HRT products 100%. It was unnecessary to take any 
corrective measures as no major differences from the percentages at the beginning 
of the research period were recorded.
The average number of prescriptions written per week in Greece for the researched 
products and their selected competitors at the beginning and at the end of the 
research period was as follows:
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Table 80 Weekly average number of prescriptions issued by all Greek
physicians at baseline and at the end of the study period for the 
researched and their class of products:
Average number ofprescriptions per week per specialist at baseline in Greece
Fisiotens Dumyrox Femaston
Baseline End Baseline End Baseline End
General practitioner 0.169 0.289 0.030 0.025 0.000 0.000
Specialist 0.418 0.551 1.197 1.539 0.115 0.114
Antihypertensives Antidepressants H.R.T.
Baseline End Baseline End Baseline End
General practitioner 13.57 15.63 0.675 0.927 0 .0 0  0 .0 0
Specialist 39.75 43.40 14.68 16.02 3.19 3.65
Total 53.32 59.03 15.35 16.94 3.19 3.65
Source: I.M.S., October 1999; October 2000
The prescription data for the whole Greek market show that antihypertensives, anti­
depressants are, for the major part, prescribed by specialists. Products for the 
treatment of the symptoms of menopause are prescribed by specialists only and not 
by general practitioners. During the research period the number of prescriptions for 
antihypertensives written by all Greek general practitioners increased by 15.2 % and 
for antidepressants by 37.3 %. Prescriptions for the antihypertensive Fisiotens 
increased in the same period by 71.0 % and decreased for the antidepressant 
Dumyrox by 16.7 %. Greek cardiologists increased their prescriptions for anti­
hypertensives in general during the research period by 9.2 % and for Fisiotens by 
31.8%. Greek psychiatrists increased their number of prescriptions for anti­
depressants during the research period by 9.1 % and for Dumyrox by 28.6 %. The 
gynaecologists increased their prescriptions for products for the treatment of the 
symptoms of menopause by 14.4 % while the number of prescriptions for Femoston 
remained stable (-0 . 8  %).
These market data were compared with the prescriptions written by the participating 
physicians in order to confirm that the group of physicians studied was 
representative of the total population of general practitioners, cardiologists, 
psychiatrists and gynaecologists in Greece (see page 289).
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The number of prescriptions written for the researched products and their 
competitors at the beginning and at the end of the research period by the 
participating physicians was as follows:
Table 81 Weekly average number of prescriptions issued by the selected 
physicians at baseline and at the end of the study period for the 
researched and their class of products:
Number ofprescriptions per week per specialist at baseline o f the selected physicians
Fisiotens Dumyrox Femaston
Baseline End Baseline End Baseline End
General 0.140 0.4531 0.000 0.3000 0.000 0.000
practitioner
Specialist 0.378 0.9551 1.130 1.6447 0.079 0.0899
Antihypertensives Antidepressants H.R.T.
Baseline End Baseline End Baseline End
General 13.66 15.4922 1.90 4.6000 0 .0 0 0 .0 0
practitioner
Specialist 40.44 38.9551 14.61 12.5395 3.13 3.53
Total 54.10 54.44 16.51 17.14 3.13 3.53
Source: field work
The analysis of the changes of the number of prescriptions written by the three 
groups of physicians for the three researched products gave the following picture:
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Table 82 Weekly average number of prescriptions issued by the selected 
general practitioners at baseline and at the end of the study 
period for Fisiotens and other antihypertensives:
Entire group Group 1 Group 2 Group 3
Fisiotens Mean at 0.1395 0.05882 0.2143 0.1321
baseline
Mean at end 0.4531** 0.8824** 0.4146* 0.2075
df 127 33 40 52
P <0 .0 0 1 <0 .0 0 1 0.037 0.252
Anti­ Mean at 13.6589 12.9412 13.5476 14.2075
hypertensives baseline
Mean at end 15.4922* 14.5294 15.4390* 16.1509
df 127 33 40 52
P 0.015 0.106 0.017 0.228
Source: field work
The analysis of the changes of the number of prescriptions written by the three 
groups of physicians for the three researched products (Table 82) showed that the 
general practitioners of group 1 issued significantly more prescriptions for Fisiotens 
at the end of the study period compared with the beginning (means 0.0588 and 
0.8824, respectively, <0.001) while the prescriptions for antihypertensives, 
including Fisiotens, did not increase significantly (means 12.9412 and 14.9412,/? 
0.106). Significantly more prescriptions were also issued by the general 
practitioners in group 2 for antihypertensives in general, as well as for Fisiotens 
(13.5476 and 15.4390; p  0.017 and means 0.2143 and 0.4146; p  0.037). In order to 
clarify whether the increase for Fisiotens was comparable with the increase for the 
entire group of antihypertensives, a /-test for independent samples was performed 
on the data for Fisiotens and for the total market without Fisiotens at the beginning 
and at the end of the study period. Both groups showed a significant dependence (p 
0.037 andp  0.028).
In addition, the Pearson product moment of volume against a time series for 
Fisiotens and for the entire group of antihypertensives was calculated. The 
correlation coefficient for Fisiotens was 0.178 (/? 0.267) and for antihypertensives
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0.875 {p <0.001). This shows that the distribution of the data for antihypertensives 
is close to a straight line while the distribution of the data for Fisiotens clearly 
deviates. The mean of the total market without Fisiotens was 12.7% higher at the 
end of the study period than at the beginning (means 13.3333 and 15.0244; s.d. 
9.4968 and 7.6239, respectively). The means for Fisiotens, however, changed even 
more markedly, namely by 93.5% (means 0.2143 and 0.4146, s.d. 0.4153 and 
0.5906, respectively). It was therefore concluded that the increase of prescriptions 
for Fisiotens was significantly higher than the increase of the total market.
The physicians in group 3 did not show any significant alteration in prescription 
behaviour during the study period, either for Fisiotens or for antihypertensives in 
general.
The change in prescriptions for antihypertensives of the general practitioners in the 
three groups was also compared with the overall figures of the market for 
antihypertensives. Greek general practitioners prescribed 15.2% more 
antihypertensives at the end compared with the beginning of the study period. An 
identical increase was found with participating general practitioners (13.4%) as well 
with the individual groups studied who prescribed 12.3% (group 1), 14.0% (group 
2) and 13.7% (group 3) more antihypertensives, respectively. Greek general 
practitioners prescribed 71.0% more Fisiotens, compared with 224.8% for 
participating general practitioners. However, the percentage increases for Fisiotens 
in groups 2 and 3 were 93.5% and 57.1%, respectively, while the increase of 
prescriptions in group 1 was 1400.7%.
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Table 83 Weekly average number of prescriptions issued by the selected 
cardiologists for Fisiotens and other antihypertensives at 
baseline and at the end of the study period:
Entire group Group 1 Group 2 Group 3
Fisiotens Mean at 
baseline
0.3778 0.3514 0.2963 0.5000
Mean at end 0.9551 1.6667 0.3704 0.5769
df 8 8 35 26 25
P <0 .0 0 1 < 0 .0 0 1 0.327 0.603
All
antihypertensives, 
including Fisiotens
Mean at 
baseline
35.1889 39.2432 29.5926 35.2308
Mean at end 38.9551 43.9167 31.4815 39.8462
df 8 8 35 26 25
P 0.007 0.017 0.461 0.137
Source: field work
Cardiologists from group 1 increased their prescriptions for Fisiotens significantly 
during the study period (means 0.3514 and 1.6667;p  <0.001). The total number of 
prescriptions for all antihypertensives, including Fisiotens, also increased 
significantly (means 39.2432 and 43.9167;p  0.017). In order to analyse both 
increases further, Pearson correlations were calculated for Fisiotens and for the 
antihypertensives without Fisiotens. The correlation for Fisiotens was 0.477 and for 
the rest of the antihypertensives 0.944, both statistically highly significant (p 0.003 
and < 0.001). The t test for independent samples showed that only Fisiotens 
exhibited a highly significant independence (p < 0.001). This was not the case for 
antihypertensives without Fisiotens (p 0.079). It can thus be concluded that the 
number of prescriptions for Fisiotens issued by cardiologists in group 1 increased 
significantly while the total number of prescriptions for other antihypertensives did 
not show a significant change. The cardiologists from groups 2 and 3 did not show 
any significant change in their prescription behaviour, either in the total number of 
prescriptions for Fisiotens or for antihypertensives in general.
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The increase of prescriptions written for antihypertensives by cardiologists of the 
entire market was 9.2% while the percentages for the participating cardiologists, 
either as a group (10.7%) or as individual groups (11.9% for group 1, 6.4% for 
group 2 and 13.1% for group 3), did not differ substantially. The prescriptions of 
all Greek cardiologists for Fisiotens increased by 31.8% during the study period 
while among the participating cardiologists the increase was 152.8%. The increases 
in the prescription behaviour of group 2 and 3 (25.0% and 15.4%) were somewhat 
lower than the market while the increase in group 1 was much higher (374.3%).
Table 84 Weekly average number of prescriptions issued by the selected 
psychiatrists for Dumyrox and other antidepressants at 
baseline and at the end of the study period:
Entire
group
Group 1 Group 2 Group S
Dumyrox Mean at 1.1299 1 .2 2 2 2 1.1852 0.9545
baseline
mean at end 1.6447 2.1852 1.4815 1.1818
df 75 26 26 2 1
P 0.005 0.016 0.223 0.411
All antidepressants, Mean at 11.5325 11.6296 8.8148 15.0000
including Dumyrox baseline
Mean at end 12.5395 12.5926 9.6296 16.0455
Df 75 26 26 2 1
P 0.125 0.539 0.092 0.161
Source: field work
Significantly more prescriptions for Dumyrox were issued per week at the end 
compared with at the beginning of the study period by psychiatrists from group 1 
(means 1.2222 and 2.1852,/? 0.016). This was not a result of an overall increase of 
prescriptions for antidepressants as the total number of prescriptions for 
antidepressants did not show a significant difference (means 11.6296 and 12.5926, 
p  0.539). There were no significant changes in the number of prescriptions issued 
by psychiatrists for Dumyrox or for the entire class of antidepressants. It can thus 
be concluded that the presentation of the second external stimulus to the second 
group of psychiatrists did not have any influence on their prescription behaviour.
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At the end of the study period Greek psychiatrists prescribed approximately 9.1% 
more antidepressants than at the beginning. The participating psychiatrists of all 
three groups together increased their prescriptions for antidepressants by a similar 
percentage of 8.7%. The increases in the separate groups were 8.3, 9.2, and 7.0% 
for groups 1,2, and 3, respectively. The total number of prescriptions for Dumyrox 
issued by psychiatrists increased by 28.6% in Greece while the increase among the 
participating psychiatrists was 45.6%. This higher increase was not caused by the 
psychiatrists of group 2 and 3 (25.0 and 23.8 %, respectively). However, the 
psychiatrists of group 1 increased their prescriptions for Dumyrox by 78.8% during 
the same period.
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Table 85 Weekly average number of prescriptions issued by the selected 
gynaecologists for Femaston and other products for the 
treatment of the symptoms of menopause at baseline and at the 
end of the study period:
Entire
group
Group 1 Group 2 Group 3
Femaston Mean at 
baseline
0.07865 0.1176 0.03846 0.06897
Mean at end 0.08989 0.1176 0.1154 0.03448
df 8 8 33 25 28
P 0.810 1.000 0.327 0.573
All products for the 
treatment of the 
symptoms of 
menopause, 
including Femaston
Mean at 
baseline
3.1348 4.8529 2.2308 1.9310
Mean at end 3.5281 5.3529 2.7308 2.1034
df 8 8 33 25 28
P 0.108 0.379 0.206 0.096
Source: field work
Gynaecologists in the first and second groups who were confronted by the external 
stimuli did not change their prescription behaviour significantly (means 0.1176;
0.1176 and 0.03846; 0.1154; p  1.000 and 0.327). The mean of the prescriptions for 
Femaston at the beginning and at the end of the study period was identical, however 
the standard deviation diminished from 0.4093 to 0.3270. It seems that the 
presentation of the external stimuli to the gynaecologists did not have any 
significant influence on their prescription behaviour. The Greek gynaecologists 
issued 14.4% more prescriptions for the treatment of symptoms of menopause 
during the period of the study, quite similar to the percentage for gynaecologists 
who participated in the study (12.5%). The percentage increases for the individual 
groups did not show a different pattern and were 10.3% for group 1, 22.4% for 
group 2, and 8.9% for group 3. Gynaecologists in general issued 0.8% fewer 
prescriptions for Femaston at the end of the study period while the participating 
gynaecologists issued 14.3% more prescriptions. Those percentages were 0 for 
group 1 ; + 200.1% for group 2 and -50.0% for group 3. The low number of
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prescriptions for Femaston at the beginning and at the end of the study period 
precluded drawing any conclusions (7 and 8  prescriptions, respectively).
The changes in the number of prescriptions issued by the participating physicians in 
comparison with the prescriptions issued by all physicians of the same specialties 
for the selected indications, showed the same pattern. The total number of 
prescriptions issued by all Greek general practitioners for antihypertensives 
increased by 15.2% in the study period compared with 13.4% for the general 
practitioners participating in the study. Similarly, the prescriptions of the 
participating cardiologists increased by 10.7% while the market grew by 9.2%, and 
participating psychiatrists issued 8.7% more prescriptions for antidepressants 
compared with 9.1% more by all Greek psychiatrists. The increases in prescriptions 
for HRT issued by the participating gynaecologists increased by 14.3%, which was 
very similar to the overall increase seen in the market. It can therefore be 
concluded that the prescription behaviour of the selected physicians reflects the 
prescription behaviour of the entire specialties for the selected treatments.
Significant changes in actual prescription behaviour for the researched products 
during the research period were noticed with the general practitioners, cardiologists 
and psychiatrists confronted with the first external stimulus, developed on the 
independent variable ATT1. No significant changes were found in the prescription 
behaviour of gynaecologists confronted with the same external stimulus. This 
influence on actual prescription behaviour was expected, as significant changes of 
the independent variable behavioural intention (BI) were noticed for the general 
practitioners, cardiologists, and psychiatrists but not for the gynaecologists. The 
means of behavioural intention (BI), past behaviour (HABIT) and motivation to 
comply (Mc3) of general practitioners, cardiologists and psychiatrists of group 1, 
changed significantly (see Tables 69, 70 and 71). The mean of past behaviour 
(HABIT) of the general practitioners changed significantly from 2.3939 to 3.0556 
(p 0.031). A similar situation was found with cardiologists where the mean 
changed significantly from 2.4054 to 3.0571 (p 0.011) and with psychiatrists (from 
2.7407 to 3.4074; p  0.026). The mean of past behaviour (HABIT) was expected to
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change because of the significant correlation between behavioural intention (BI) 
and HABIT, which could be noticed with general practitioners, cardiologists, and 
psychiatrists. The Pearson correlation between BI and HABIT at the beginning of 
the study period was 0.543,0.662, and 0.793 (p 0.001, < 0.001, and < 0.001), while 
at the end of the study period it was 0.616,0.445, and 0.766 ip < 0.001, 0.007, and 
< 0 .0 0 1 ) for general practitioners, cardiologists, and psychiatrists, respectively.
At the beginning of the study, the motivation of the general practitioners, 
cardiologists and psychiatrists of group 1 to comply with the wishes of the 
representative to take cost into consideration each time they prescribe, was 
significantly below the probable mean of physicians who are neutral about 
responding to the representative’s wishes (means o f2.1111,2.3322, and 2.2593 
versus 3.000;p  < 0.001, 0.001, and 0.002, respectively). The mean increased 
significantly in all groups during the study period although it was still not 
significantly higher than the probable mean of physicians who are neutral about 
responding to the representative’s wishes at the end of the study (means o f2.7778, 
3.0857, and 3.0370, versus 3.0000,p  0.282,0.585, and 0.861, respectively). It was 
therefore concluded that motivation to comply (Mc3) was not responsible for the 
significant change of behavioural intention and behaviour.
Correlation at the end of the study period between ATT1 and BI was significant 
with general practitioners, cardiologists, psychiatrists, and gynaecologists of group 
1 (0.805, 0.410, 0.700, and 0.525;/? < 0.001,0.014, < 0.001, and 0.001, 
respectively). It was concluded that the significant change of BI and B was due to 
the change of the independent variable ATT1, alone or in combination with 
HABIT, and not of Mc3 which did not have a significant influence on BI and B.
Of the physicians of group 2, confronted with the second external stimulus based on 
PBC4, only the general practitioners showed a significant change in their 
prescription behaviour in favour of the researched product. The independent 
variables that changed significantly during the study period showed a consistent 
pattern, however, with significant changes in HABIT and Nb3 in all physicians in
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group 2. Nb3 was based on the belief that the physicians think that the 
representative of the pharmaceutical industry wants the physician to be cost- 
conscious while prescribing. Behavioural intention (BI) did not change significantly 
under influence of the significant changes of Nb3 as there was no motivation to 
comply.
The means of motivation to comply should be above 3.000 in order to allow 
normative beliefs to have any positive influence on behavioural intention. The 
mean of Mc3 of the GPs, cardiologists, psychiatrists and gynaecologists of group 2 
were 2.1400,2.1852,2.3333, and 2.5385, respectively, at the end of the study 
period, still significantly below 3.000 (p < 0.001, < 0.001, 0.004,0.049). HABIT 
could influence behaviour directly without the mediation of behavioural intention 
(BI). Thus Nb3 might have had an influence on actual prescription behaviour if it 
were significantly correlated with HABIT. However, no significant correlation 
could be demonstrated between Nb3 and HABIT for general practitioners, 
cardiologists, psychiatrists and gynaecologists (0.054; - 0.139; -0.216; and 0.054; p  
0.794; 0.488; 0.280; and 0.794 respectively) and thus it can be concluded that the 
significant changes of the independent variable Nb3 did not influence the 
prescription behaviour of the physicians in group 2 .
Significant changes of the independent variable HABIT were noticed with general 
practitioners and all other specialties in group 2. It seems that the presentation of 
the external stimulus based on PBC4 and the related discussion of the representative 
with the physician about cost-conscious prescribing did change past behaviour 
significantly, as reported by the physician. The change in prescription behaviour, 
seen with general practitioners in group 2 , was not influenced by behavioural 
intention. It was concluded that the actual prescription behaviour of general 
practitioners changes significantly because of a direct influence of HABIT on B. 
Significant changes, however, were also seen in the mean of HABIT of 
cardiologists, psychiatrists and gynaecologists. It is not clear why their actual 
prescription behaviour did not change under the direct influence of the change of 
HABIT as it did with the general practitioners.
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Further research on the role of HABIT in influencing prescription behaviour of 
physicians directly, without the mediation of behavioural intention, is needed.
No significant changes were found in the prescription behaviour of the physicians 
of group 3, who were confronted with the usual promotional message where no 
additional external stimulus had been added.
6 .8 . Discussion
Prescriptions for the selected products for the treatment of hypertension, 
depression and the symptoms of menopause were compared with the total number 
of prescriptions written for those indications. This analysis showed that the 
selected products are representative of the entire market.
The prescription behaviour of the selected physicians did not differ significantly 
from their colleagues at baseline. The prices of the researched products and their 
reimbursement status did not change during the research period. One new 
antihypertensive and one new antidepressant were launched during the research 
period. The influences of those launches on the prescriptions for the researched 
products are considered to have been limited and would be exerted on all products 
involved. The return rates of the questionnaires at baseline and at the end of the 
study period were good and the analysis of the non-responders did not raise 
concern about possible non-responder bias. The number of missing answers was 
low, both at baseline and at the end of the research period. Actual prescription 
data could be collected from an appropriate percentage of the selected physicians. 
The appropriateness of using a parametric statistical technique was established by 
analysing the skewness of the data, the probability and detrended normal 
probability plots, and by applying the Kolmogorov-Smirnov statistic, with a 
Lilliefors significance level for testing normality.
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The data resulting from the questionnaires at baseline were statistically treated in 
order to identify the influence of the individual independent variables on 
behavioural intention and possible different influences of specialty, gender and 
age group of the participating physicians. Descriptive statistics and correlation 
matrixes were analysed and an opinion of the collected baseline data was sought 
from a group of independent physicians, who did not participate in the study. The 
initial unrotated factor matrix was computed to explore the structure of the set of 
predictor variables. Common factor analysis was selected as the exploratory 
approach. The Barlett test of spheriticy and the Kaiser-Meyer-Olkin measure of 
sampling confirmed the correctness of the use of the common factor analysis 
method. The principal component correlation matrix and Scree test were analysed 
to identify the minimum number of factors needed to account for the maximum 
portion of variance represented in the original set of variables. For further 
interpretation of the factors, factor rotation has been applied. Multiple regression 
analysis was used as a means of assessing the individual predictive power of each 
of the independent variables on behavioural intention of physicians. The choice 
of the statistical tests was based on frequently used conventions which are 
generally accepted. Conventions in behavioural science are not unique and 
therefore more statistics were needed to bring the analysis of the findings to a 
common vocabulary.
Two independent variables were selected on which the external stimuli used 
during the research, are based. The first one selected was ATT1 as it is expected 
that it would be able to most influence the prescription behavioural intention of 
physicians in a cost-conscious environment. PBC4 was chosen as the second 
independent variable; this variable was expected to influence the behavioural 
intention only marginally.
The development of the external stimuli has been described and the wording of 
the phrases to be used tested in order to confirm their suitability. The records of 
the application of the external stimuli have been controlled. The desired
293
frequency was obtained with all selected physicians, although slight deviations 
from the original timetable was noted. The research period was 34 weeks instead 
of 24 weeks as the selected physicians could not be visited more frequently than 
once every five to six weeks on average. The influence of the extended study 
period on the final results is considered insignificant. The final data resulting 
from the questionnaires were compared with baseline data and significant changes 
noted. Actual prescription behaviour at the end of the study period was compared 
with initial prescribing behaviour and significant changes reported for the selected 
products as well as per research group. No significant abnormalities in the 
development of the external stimuli and its use could be detected; suitable 
methods of analysis seem to have been used and thus the results of the analysis of 
the data should be a proper basis for drawing conclusions.
6.9. Conclusion
Regardless of whether one is using attitudes or behavioural intentions to forecast 
behaviour, the accuracy of such forecasts will depend on the degree of measurement 
correspondence between what is being measured and what is being predicted (Engel 
et al, 1995, p.393). Measurement correspondence refers to how well a measure 
captures the action, target, time, and/or contextual elements that constitute the 
behaviour to be predicted. Greater correspondence leads to more accurate 
predictions. Action should refer to a specific action. In this research, the behaviour 
is clearly specified as prescribing a pharmaceutical product for the treatment of 
hypertension, depression or the symptoms of menopause. The target element is also 
very specific because it is defined as prescribing the pharmaceutical products 
mentioned on the ‘detail aids’. The time focuses on the time frame in which the 
behaviour is to occur. The period in which the behaviour of the participating 
physicians is measured at the start and at the end of the study is clearly defined as 
the week after the baseline questionnaires are filled in and the week after the sixth 
and last time the promotional message was presented to the physician. The 
remaining element, context, refers to the setting in which the behaviour is to occur. 
The prescriptions issued by the participating physicians are counted at the pharmacy
294
in which at least 70% of them are filled. Therefore also the fourth and last factor of 
measurement correspondence has been met. Hence it can be concluded that, in this 
research, measurement correspondence should have been adequate. On this basis 
we can proceed to drawing conclusions and expressing their implication in 
Chapter 7.
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CHAPTER 7 Conclusions and implications
7.1. Introduction
This chapter summarises the results of the study, as presented in Chapter 6 , in terms 
of the hypotheses developed in Chapter 2, and discusses them within the contexts of 
this and prior research (reviewed in Chapter 2). The extent to which the results of 
the research further our understanding of the subject area are explored. This chapter 
incorporates qualitative findings about the research problem developed during the 
course of the study. The theoretical implication of the findings are considered, and 
the practical implications for private sector managers and public sector analysts and 
managers are covered in sections 7.5.1 and 2, respectively. Limitations, other than 
those already mentioned in section 1 .6 , which became apparent during the progress 
of the research, are presented. There follows a discussion of the implications of the 
findings of this research for further research, and the chapter concludes with a 
summary of three publications written on the basis of data collected during the 
research programme.
7.2. Conclusion about each research question and hypothesis
The first hypothesis states that
i f  the composite attitude behaviour model according to Eagly and Chaiken is used 
instead o f the model o f the theory ofplanned behaviour according to Ajzen, then a 
greater number o f determinants o f non-volitional behaviour will be reveiled.
It should thus be demonstrated that the predictive power of the model of the 
combined attitude behaviour model is superior to the model of planned behaviour. 
Regression analyses were performed on Behavioural Intention (BI) and the 
components of both models in order to prove the above hypothesis.
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The following determinants were analysed from the model of the theory of planned
behaviour:
• ATTITUDE: Behavioural beliefs x Outcome evaluations, which are in this 
research abridged as UTILOUT1, UIÏLOUT2, UTILOUT3, UTILOUT4, 
UTILOUT5.
• Perceived Behavioural Control: in this research called PBC1, PBC2, PBC3, 
PBC4.
• Subjective Norm: Normative beliefs (Nb) x Motivation (Me) to comply 
labelled: SN1, SN2, SN3.
For the composite attitude behavioural model, the following items were added to
the above-mentioned construct:
• to the attitude construct: Anticipated Regret Variables called ARV and 
Emotional Reaction called ER,
and
• Past behaviour called HABIT.
Table 86 The regression of independent variables on BI of the
researched models of expectancy value theories:
R R2 F Sig.
Theory of
planned
behaviour
UTILOUT1, UTILOUT2, 
UTILOUT3, UTILOUT4, 
UTILOUT5, PBC1, 
PBC2, PBC3, PBC4,
SN1, SN2, SN3
0.659 0.435 22.876 <0 .0 0 1
Composite
attitude
behaviour
model
UTILOUT1, UTILOUT2, 
UTILOUT3, UTILOUT4, 
UTILOUT5, PBC1, 
PBC2, PBC3, PBC4,
SN1, SN2, SN3, ARV, 
ER, HABIT
0.743 0.553 28.756 <0 . 0 0 1
Source: present author
The composite attitude behaviour model covered the determinants of behavioural 
intention far better than the model of the theory of planned behaviour, as shown 
by the residual sum of squares which decreased from 275.703 to 214.324 with the
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composite model, while the predictive power went up from 43.5% to 55.3%. This 
percentage is higher than expected, as only the cost element of a therapy was 
covered by this research and not biomedical aspects such as the expected efficacy 
of the therapy, its side-effect profile, and/or daily dosage. These biomedical 
aspects are known to be more important determinants of physicians’ prescribing 
decision process than cost (Denig, 1993, p.920). (See Table 3 in section 2.2.5 of 
this thesis for further details.) It is recommended to use the adjusted coefficient 
of determination when comparing the outcomes of two regressions performed 
with a different number of independent variables (Hair et al., 1998, p. 142). The 
adjusted R square of the combined attitude behaviour model was 0.534, compared 
with 0.416 for the model of the theory of planned behaviour, thus confirming the 
outcome of the R square statistic.
A comparison was made of two validity coefficients X 2 and X 3 with the same 
third variable Xi, namely the variables of the model of the theory of planned 
behaviour and the variables of the composite attitude behaviour model with 
behavioural intention, while the sample was composed of the same physicians for 
the two validity coefficients. As two predictor-test variables might be correlated 
with the same criterion, the comparison of r  s calls for special treatment. For this 
particular kind of problem. Hotelling (1940) has developed a t test that takes into 
account the correlation between rn and r^.
The inter-correlation r 23 was calculated and turned out to be 0.891, while the 
validity coefficients r \2 and r 13 were 0.743 and 0.659, respectively. The resulting 
computation became 5.104424. The t test of Hotelling thus detects that the 
composite attitude behaviour model fits the determinants of intention significantly 
better than the model of the theory of planned behaviour. The calculation is shown 
in detail in Appendix AA.
An alternative hypothesis has also been considered, namely that the r \2 represents 
a genuinely higher correlation than the r 13; and thus a one-tail test was used. As 
for large A’s, the z is interchangeable with t for hypothesis-testing purposes, the
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t needed for a 0.5 level of significance is 1.64. Accordingly, the hypothesis being 
tested (that the true difference in correlation is either zero or negative) could be 
rejected.
The current study compared the ability of the theory of planned behaviour (TPB) 
and the composite attitude behaviour model to predict physicians’ prescribing 
intentions. For behaviours that are not fully volitional, Ajzen (1985) hypothesized 
that the model of the theory of planned behaviour (TPB) would predict behavioural 
intention sufficiently. This research confirmed that the composite attitude 
behaviour model has a superior predictive power, as it demonstrated a stronger 
association between the determinants of behaviour and behavioural intention. The 
null hypothesis could therefore be rejected.
The second hypothesis assumes that
i f  the most salient determinants o f non-volitional behaviour are exposed to 
promotional expressions then they will alter in magnitude.
The method used to select the most salient independent variables of BI was 
described in section 6.5 of this thesis. It was decided that HABIT could best be 
used to represent all other independent variables during further research, see Table 
62. However, habit is very resistant to change and an external stimulus based on 
past behaviour was therefore thought not to be suitable for this research. The 
attitude construct was the second best factor, and ATT 1 emerged as the most 
important factor from the decomposed construct. It was assumed that stimulating 
ATT 1 of the attitude construct would increase its influence on behavioural 
intention. Behavioural intention (BI) to take cost into consideration when 
prescribing increased significantly during the study period with the group of 
physicians who were confronted with the external stimulus based on ATT1 (3.2687 
and 3.6364,/? 0.001), see Table 67 for more details. The physicians’ attitude 
(ATT1) towards cost-conscious prescribing became significantly more positive 
(3.1654 and 3.3939,/? 0.025). Presentation of an external stimulus based on ATT1
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proved also to influence some elements of the belief construct, such as behavioural 
belief (Bb5) (1.8462 and 1.6565,p  0.021), outcome evaluation (Oe3) (3.7308 and 
3.9697,0.011) and motivation to comply (Mc3) (2.2424 and 2.7803,/? <0.001). 
The belief of the physician that cost-conscious prescribing would result in better 
patient compliance due to the lower costs of the product (Bb5) decreased 
significantly during the study term. At the end of the study, the physicians 
considered it more positive when their cost-conscious prescribing led to a financial 
benefit for the sick funds (Oe3). They were also more willing to comply with the 
wishes of the representative of the pharmaceutical industry to prescribe in a cost- 
conscious way (Mc3). The influence of the external stimulus on ATT1 was 
confirmed by the finding that, in neither the group of physicians confronted with an 
external stimulus based on PBC4 nor the control group, did ATT1 change 
significantly. It was therefore concluded that the most salient determinants of non- 
volitional behaviour will alter in magnitude when they are exposed to promotional 
expressions. The null hypothesis could consequently be rejected.
It was noticed that, apart from ATT1, the external stimulus also changed some other 
independent variables significantly, such as HABIT, Bb3, Mc3 and Oe3, see Table 
67. As HABIT might have an influence on actual behaviour without the mediation 
of behavioural intention, regression analysis was performed on the independent 
variables on BI at baseline and at the end of the study period. The R2of ATT1 at 
baseline was 0.0557 while at the end of the study period it became 0.442,/? <0.01. 
Also the R2 ‘s of habit, Bb5, Mc3 and Oe3 at baseline and at the end of the study 
period did not increase or only slightly (0.438 and 0.386; 0.098 and 0.056; 0.039 
and 0.163; 0.099 and 0.068 respectively). It was consequently concluded that the 
significant change of actual behaviour as shown in the Tables 82, 83 and 84, was 
not only due to the significant change of behavioural intention during the study 
period but also to the direct influence of HABIT on actual behaviour. This finding 
supports the finding of Conner et al. (2000) that past behaviour contributes to 
predictions of behaviour over and above the contribution from intentions. It was 
concluded that HABIT was influenced indirectly by the external stimulus via ATT1 
as the correlation between ATT1 and HABIT was significant and strong (0.725,
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p  < 0.001). Eagly and Chaiken (1993) suggested that habits in their composite 
attitude behaviour model should be understood in Triandis (1977,1980) terms as 
sequences of behaviour that have become relatively automatic in the sense that they 
occur without cognitive processes. The correlation between ATT1 and HABIT at 
the end of the study period should hence be less marked than at baseline. This was 
confirmed during the study as the correlations between ATT1 and HABIT were 
significant both at baseline and the end of the study, but were lower at the end of the 
study (r = 0.725 and r  = 0.536, respectively).
The third hypothesis stated that
i f  promotional tools influence the most salient determinant o f non-volitional 
behaviour then they also change actual customer behaviour.
In order to prove this hypothesis, a correlation between the change of the 
independent variable due to its manipulation by the external stimulus and the 
change of actual behaviour should be demonstrated. In section 6.7.4 of this thesis it 
was reported that significant changes in prescription behaviour were noticed with 
the general practitioners, cardiologists and psychiatrists confronted with the first 
external stimulus, developed on the basis of the independent variable ATT1 (see 
also Table 82), although no significant changes were found in the prescription 
behaviour of the gynaecologists confronted with the same external stimulus. It was 
suggested that this influence on actual prescription behaviour could be anticipated, 
as significant changes were noticed in the independent variable behavioural 
intention (BI) of the general practitioners, cardiologists, and psychiatrists but not of 
the gynaecologists. Correlations between ATT1 and BI at the end of the study 
period were significant with general practitioners, cardiologists, psychiatrists, and 
gynaecologists in group 1 (0.805, 0.410, 0.700, and 0.525; p  < 0.001,0.014,
< 0.001, and 0.001, respectively). It was concluded that the significant change of 
BI and B was due to the change of the independent variable ATT1, alone or in 
combination with HABIT.
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Of the physicians confronted with the second external stimulus, based on PBC4, 
only the prescription behaviour of general practitioners changed; no changes were 
seen with the other physicians in group 2. The independent variables of group 2 
that did change significantly during the study period showed, however, a consistent 
pattern with significant changes in HABIT and Nb3 for all physicians and not in 
PBC4 on which the external stimulus was based. Nb3 was based on the belief that 
the physicians think that the pharmaceutical industry representative wants the 
physician to be cost-conscious while prescribing. Behavioural intention (BI) did 
not change significantly under the influence of the significant changes of Nb3, as 
there was no motivation to comply (Mc3). Significant changes of the independent 
variable HABIT were noticed with all the physicians in group 2. It seems that the 
presentation of the external stimulus based on PBC4 and the related discussion of 
the representative with the physician about cost-conscious prescribing did change 
prescribing habits significantly, as reported by the physician. The change in 
prescription behaviour seen with the general practitioners in group 2, was not, 
however, influenced by behavioural intention. It was consequently concluded that 
the actual prescription behaviour of general practitioners changed significantly 
under the direct influence of HABIT on Behaviour (B). However, this was not due 
to the presentation of the external stimulus but to the fact that the subject of cost- 
conscious prescribing was discussed with the physicians.
No significant changes were noticed in the prescription behaviour of the physicians 
in group 3, who were confronted with the usual promotional message without an 
additional external stimulus. Only in the first group could it be demonstrated that 
actual behaviour was significantly influenced by changes of the independent 
variable influenced by the external stimulus. It was therefore concluded that the 
third null hypothesis could be rejected.
7.3. Conclusion about the research problem
The results of the first field study, which investigated how volitional physicians’ 
prescription behaviour is in a cost-conscious environment, led to the conclusion that 
the physicians in the sample, although claiming that they are not willing to succumb
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to pressure from sick funds, are willing to be cost-conscious when their patients ask 
them to be and when patients pay for the medicine themselves. This study has 
shown that, if an analysis of behavioural intention and behaviour is to be 
undertaken, it is important to separate beliefs from the physician’s motivation to 
comply with the assumed wishes of a number of reference groups. As in the case of 
attitudes and subjective norms, it was found that perceived behavioural control was 
related to an underlying set of salient beliefs. Although all beliefs scored positively, 
there were important differences between them. Further, they provide useful 
information about other influences on non-fully-volitional behaviour. The influence 
of subjective norms on behavioural intention, the improvement in prediction of this 
intention by the addition of perceived behavioural control, and the significant 
influence of the control factor, lead to the conclusion that the prescribing behaviour 
of physicians is not fully volitional. This finding is important, particularly in an 
environment in which cost containment plays an increasingly important role as 
healthcare funds and governments become demonstrably more aware of the huge 
increases in health budgets. Research into the influence of cost-containment 
measures on prescription behaviour is important as these measures may not only 
interfere with physicians’ wishes and inclination to prescribe what they deem to be 
the most appropriate therapy for their patients, but they may also reduce the 
influence of clinical product characteristics, such as efficacy and tolerance, on what 
is being prescribed. Ultimately, patients may not receive the best treatment if the 
prescribing physician is somehow coerced into prescribing the least costly 
alternative. Communications from pharmaceutical companies reacting to this 
changing environment and thus concentrating on the cost element in their 
promotional messages, may be less successful than anticipated because of the lack 
of volition of physicians’ prescription behaviour.
The purpose of the second part of this study was to identify the determinants 
leading to prescription behavioural intention and actual behaviour of physicians. 
More specifically, it was important to establish if a set of behavioural intention 
factors covered by the model of the theory of planned behaviour, and the composite 
attitude behaviour model of Eagly and Chaiken can be used to predict the
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behavioural intention of physicians in a cost-conscious environment. This study 
specified and tested the determinants of this behaviour and compared the predictive 
power of the two models.
As predicted by theory, physicians in the sample had the intention to prescribe 
economically. From the three determinants identified by Ajzen in the theory of 
planned behaviour, only attitude towards the act influenced significantly the 
intentions of physicians. Subjective Norms had a low influence on behavioural 
intention, while the influence of Perceived Behavioural Control was non­
significant. Habit, although less pronounced than the attitude construct, was found 
to be an important factor influencing intentions. It should be included in 
expectancy-value models to improve their predictive abilities. De-composing 
Subjective Norms into Normative beliefs and Motivation to comply, and de­
composing the Attitude construct into Emotional Reaction, Anticipated Regret 
Variables and Behavioural beliefs multiplied by Outcome evaluation, proved to be 
important in revealing the contribution of each factor. Perceived Behavioural 
Control did not show a significant influence on behavioural intention. It may thus 
be concluded that the physician does not perceive being under many constraints in 
terms of costs when prescribing. The prescription behaviour of Greek physicians in 
the sample can therefore be classified as being still quite volitional where it 
concerns cost containment.
This conclusion deviates from the conclusion drawn from the results of the first 
study into how volitional the prescription behaviour of physicians is, see Chapter 3 
of this thesis. During that study, Perceived Behaviour Control was shown to 
influence behavioural intention. It seems therefore that the influence of both 
elements of Perceived Behavioural Control (perceived power and control beliefs) 
alter when circumstances differ. In the first study, perceived power was measured, 
namely how successfully the individual can, or cannot, perform the activity of 
prescribing in a cost-conscious way, while during the second study control beliefs 
were measured, namely, whether the person’s motivation is influenced by how 
difficult the intended behaviour was perceived to be. The apparent discrepancy
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between the findings of the two studies therefore supports the statement of Sparks et 
al. (1997) that considerable care needs to be taken when constructing measures of 
personal evaluation of the difficulty in performing the intended behaviour. 
Furthermore, it confirms their recommendation that perceived difficulty to carry out 
the behavioural intention and perceived behavioural control should be assessed 
separately, as they load onto different components of the behavioural decision­
making process.
Subjective Norm is determined by the physician’s normative beliefs that others 
important to them think that he or she should or should not perform the behaviour, 
coupled with motivation to comply with its referents. Thus, physicians feel the 
pressure of sick funds to be cost-conscious while prescribing, and the wishes of the 
sick funds regarding prescription behaviour are important to them. However, 
motivation to comply with the wishes of the sick funds turned out to be low. For 
sick funds it will be interesting to understand why physicians, who feel the pressure 
to be cost-conscious, show a low willingness to comply, and why, except those over 
the age of 60, they claim to become less cost-conscious with age. Further research 
is needed to see whether different practice characteristics, such as demographics of 
the patients, might help explain this observation.
For pharmaceutical companies it is interesting to know that emotional reaction in 
cost conscious prescribing is much stronger in males than in females. Regression 
analysis showed that physicians are most easily persuaded by informational, 
utilitarian, external stimuli for products, towards which they have cognitively based 
attitudes, than by value or social-identity-laden external stimuli for products, 
towards which they have affectively based attitudes. However, value-expressive 
external stimuli might be a valuable complement to persuasive campaigns, in 
particular where they are addressed at male physicians.
Habit forming was much lower with females than with males. Since a physician’s 
prescription habit is rather difficult to change (Hellerstein, 1994), pharmaceutical 
companies might consider presenting external stimuli aiming at changing
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prescribing habits predominantly to female physicians. Inviting female physicians 
to have their patients participate in clinical studies with the pharmaceutical product 
involved might, according to the priming hypothesis discussed in Chapter 2, alter 
memory and raise the behaviour’s accessibility in memory and consequently have a 
direct effect upon the corresponding behavioural intent on future behaviours 
(Trafimow & Borrie, 1999).
The parameters for the model of the theory of planned behaviour and the composite 
attitude behaviour model were evaluated. This evaluation showed that the more 
complex model fits the data better. Decomposing the normative and behavioural 
belief constructs generated additional information which was important for the 
understanding of each factor’s influence on behavioural intention and actual 
behaviour. The use of the decomposed composite attitude behaviour model is 
preferable to the model of the theory of planned behaviour, although there still seem 
to be factors influencing behavioural intention and actual behaviour which are not 
covered by the model.
The most nested models of the expectancy-value theory were evaluated for their 
ability to predict behavioural intention and actual behaviour. The composite 
attitude behaviour model (which is a combination of the expectancy-value models 
of the theories of reasoned action extended by Rentier and Speckart, planned 
behaviour and interpersonal behaviour) proved to have the highest predictive 
power concerning prescription behaviour of physicians in a cost conscious 
environment.
Multiple regression analysis showed that ATTITUDE was the most important 
determinant of physicians’ behavioural intention, while HABIT was the second 
most important independent variable. Perceived Behavioural Control (PBC), 
although proposed by Ajzen as independent variable to be added to the model of the 
theory of reasoned action in order to improve its predictive power with behaviours 
which are not fully under volitional control, did not contribute significantly.
Detailed analysis of the PBC construct showed that the pressure from sick funds on
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physicians to prescribe economically is still rather limited. It was therefore 
concluded that the behaviour of the physicians in the research sample was still 
rather volitional as far as cost-conscious prescribing is concerned.
In addition to raising questions about the kinds of attitudes, beliefs or control factors 
that are likely to be susceptible to persuasion, considerations of the role of 
accessibility highlight an important issue concerning the objectives of influence 
strategies. The confrontation of physicians with external stimuli based on the cost 
advantages of certain pharmaceutical products showed that the significance of the 
stimuli for the physician is important for its effect. If the strength of the external 
stimulus was weak it was unable to induce any change in the attitude construct. The 
general practitioners, cardiologists, and psychiatrists significantly changed their 
attitude after being informed of the daily treatment costs of the researched products 
and their competitors. The gynaecologists did not change their attitude towards cost 
conscious prescribing, however, presumably because the cost advantage offered did 
not seem to be great enough. This finding confirms the conclusion of De Bono and 
Hamish (1988) that it is not only the manipulation of the functional relevance of a 
message but also the quality of the arguments supporting the new attitude position 
that indicate whether or not the attitude changes and, if it does change, how 
important these changes may be.
Several researchers have argued that intentions to perform behaviours can be 
predicted not only from attitudes and subjective norms as Fishbein (1980) 
suggested, but also from previous behaviours. It has been further argued that the 
path from previous behaviour to future intention is independent of attitude and 
subjective norm. However, this has never been demonstrated experimentally, only 
through correlational paradigms. In addition, the reason for the relationship 
between previous behaviour and future intention has not been determined, thereby 
leading some researchers to conclude that including previous behaviour in a causal 
model of behaviour has no explanatory value. In the literature there is an 
abundance of support for the hypothesis that some rather stable characteristics of 
the individual influence his or her intention to behave in the future. However,
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during this research it could be demonstrated that changes of HABIT do not always 
lead to a change of behavioural intention. All physicians to whom the external 
stimulus based on PBC4 was presented changed their HABIT significantly, but no 
significant changes of behavioural intentions were noted. As the actual prescription 
behaviour of the general practitioners did change, it can be concluded that HABIT 
influenced the actual prescription behaviour of the general practitioners without the 
mediation of behavioural intention. The actual prescription behaviour of the 
cardiologists, psychiatrists and gynaecologists did not change significantly, in spite 
of the fact that similar changes of the independent variables were seen as with the 
general practitioners. The hypothesis that their prescribing behaviour might have 
been different as a fimction of patient-specific situations rather than being 
influenced by past behaviour or subjective norms was rejected, as the same 
argumentation should be valid for the specialists of group 1. The mean of HABIT 
of general practitioners was significantly higher than that of the specialists and it 
may have been this difference in strength that caused the variation.
Discussing cost-consciousness had a significant influence on the normative belief 
of physicians in the group confronted with the external stimulus based on the 
control element. As expected, the presentation had no significant effect on the 
mean of Perceived Behavioural Control. It was concluded that either its 
accessibility was too limited or that the accessibility of the normative belief 
component was much more pronounced. It is therefore important in research also 
to measure the possible influence of the vehicle of the presentation of the external 
stimulus. The significant changes of the normative component did not lead to 
significant changes of behavioural intention or behaviour, as the motivation to 
comply with the belief element did not change significantly. The part of the 
normative belief construct that changed concerned the physicians’ beliefs about 
the wishes of the representative that the physicians should take cost into 
consideration when prescribing. As it was the same representative who discussed 
the subject of cost-consciousness with the physicians, this could be a result of 
social desirability distortion. The method of presenting the external stimulus to 
the physicians of all three groups was identical and should therefore have had a
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similar effect on this particular normative belief element. However, with 
physicians of group 1 and the control group no significant influences on this 
independent variable were found. It was therefore concluded that the significant 
changes were not due to social desirability bias.
Decomposing the independent variable constructs into their individual elements in 
order to allow an analysis of their individual influence on behavioural intention and 
behaviour proved to be necessary to understand the behaviour fully.
Cardiologists of the group confronted with the first external stimulus became more 
positive about the assumed wishes of the representatives to prescribe cost 
consciously, while also showing a significantly lower expectation about the 
costbenefit ratio. Decomposing the attitude construct into behavioural beliefs and 
outcome evaluation, shows that the benefits of the lower-priced product were not 
sufficiently understood by the cardiologists. Decomposing the control factor into its 
component factors showed that the gynaecologists assume that lower-priced 
products for the treatment of the symptoms of menopause have a low therapeutic 
profile. Results of comparative clinical studies between the pharmaceutical 
products used for this indication could be of help in correcting any false 
impressions about the efficacy and tolerance of the products concerned. During the 
study it was found that drawing the attention of the physician to the wishes of the 
patient decreased the influence of the assumed belief of the physician regarding the 
preference of the representative for the physician to be cost conscious. De­
composing the behavioural and normative belief structures into their individual 
building blocks thus allows us to determine the influence of the external stimuli on 
independent variables other than the one targeted. Corrective measures, if needed, 
can then be prepared and taken.
7.4. Contributions to behaviour theory
Expectancy value theories provide the framework to study attitudes toward 
behaviours. According to these theories, the most important determinant of a 
person’s behaviour is personal intent. The widely referenced theory of reasoned
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action suggests that the individual’s intention to perform a behaviour is a 
combination of attitude toward performing the behaviour and subjective norm. The 
individual’s attitude toward the behaviour includes behavioural belief and 
evaluations of behavioural outcome, while subjective norm includes normative 
beliefs and the motivation to comply.
The theory of reasoned action works most successfully when applied to behaviours 
under volitional control. If behaviours are not fully under volitional control, even 
though a person may be highly motivated by his or her own attitudes and subjective 
norms, the intended behaviour might actually not be performed due to intervening 
environmental conditions. The theory of planned behaviour was developed to 
predict behaviours in which individuals have incomplete volitional control. The 
major difference between the theory of reasoned action and the theory of planned 
behaviour is the addition of a third determinant of behavioural intention in the form 
of perceived behavioural control. This control construct is determined by two 
factors, control beliefs and perceived power. In other words, a person’s motivation 
is influenced by how difficult the behaviours are perceived to be, as well as by the 
perception of how successfully the individual can, or cannot, perform the activity. 
The inclusion of the perceived behaviour control variable leads to significant 
improvements in R2 for behaviours perceived to be low in control.
Despite the obvious success of the theory of planned behaviour in certain domains, 
there are several aspects of the theory that warrant scrutiny. Several studies have 
been carried out on the role of repeated behaviour and have demonstrated that the 
prediction of behaviour could be inlproved by adding habit as an independent 
variable, influencing behaviour both directly, and indirectly via behavioural 
intention.
Eagly and Chaiken proposed the composite attitude behaviour model in order to 
improve the prediction of real behaviour. This research was the first study to 
explore the value of the composite attitude behaviour model for the prediction of 
non-fully volitional behaviour. The significant superiority of the composite attitude
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behaviour model over the model of the theory of planned behaviour was 
demonstrated and should lead to push aside the theory of planned behaviour for the 
prediction of non fully volitional behaviours. The composite attitude model should 
therefore become the model of first choice for research into non-fully volitional 
behaviour. There are no fundamental objections to the basic framework, types of 
methods and objectives of Fishbein and Ajzen, in other words, the perspectives 
from which the theory of planned behaviour departed, are shared with the theory 
leading to the composite attitude behaviour model and there is common conception 
of the independent variables. What has been demonstrated in this research is that 
the construction of a unipolar measurement of attitude, as presented by the theory of 
planned behaviour, is controversial. Other attitudinal factors such as affective ones 
or anticipated regret variables proved also to be influential in the formation of 
intentions.
Fishbein and Ajzen (1975) do not deny that attitudes may be more complex than 
their model suggests, they believe though that, as far as predicting behaviour is 
concerned, the only relevant aspect of attitude is its evaluative dimension. They 
believe that fragmentation of attitude and subjective norm into context-specific 
beliefs and statistical evaluation of their importance for the forming of behavioural 
intention is only relevant from an operational point of view and does not add 
anything to the theoretical underpinning of the model.
Adopting a functional approach, however, is essential when studying persuasion for 
which external stimuli are used. The persuasion settings necessary for successful 
alteration of behaviour may indeed need to be very different for different people. 
That is, people may have different motivational bases for maintaining their 
attitudes. The composite attitude behaviour model comprises more independent 
variables that may prove to be important for the development of persuasive 
messages which aim to alter behaviour, than the model of planned behaviour.
Research into behavioural change should include measurement of isolated 
fundamental prepositional attitudes such as the most salient behavioural beliefs,
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emotional reaction, and anticipated regret variables, as well as the measurement of 
the building blocks of subjective norm such as the isolated salient normative beliefs 
and the motivation to comply. The separate determination of perceived behavioural 
control factors should be added. Separation will allow the appropriate examination 
of the magnitude of the influence of each independent variable on behavioural 
intention and behaviour. Also the composite attitude behaviour model may be 
criticised for not reveiling the component elements of the attitude, normative or 
control constructs. The decomposed model used in this study proved capable of 
revelling elements of each construct necessary for the understanding of the 
formation of those constructs. The decomposed construct showed that, while 
subjective norm might seem to be unaltered, the individual elements of the 
construct may have changed dramatically. Similarly, the normative belief variable 
might have become much more pronounced while the motivation to comply 
changed in such a way that the overall influence of subjective norms on behavioural 
intention remained unchanged. Knowledge of these changes allows us to develop 
external stimuli aimed specifically at altering that particular element of the 
independent variable construct. These results highlight the utility of investigating 
the isolated elements of the constructs which influence behaviour when developing 
persuasive strategies, and encourage us to discard the theory of planned behaviour.
7.5. Implications for policy and managers
7.5.1. Practical implications for private sector managers
Successful prediction does not necessarily mean successful alteration of behaviour. 
Frequently it is thought that the central route to persuasion is the route which should 
be adopted when dealing with physicians, as they are expected to be motivated to 
pay attention to and elaborate on the facts in a message. However, this study 
demonstrated that the peripheral route to persuasion can also be important. 
Physicians are not always motivated to pay attention to the facts a message presents 
and frequently focus on superficial characteristics such as who delivers the message 
and how is it presented. This phenomenon is especially important with male
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physicians as their behavioural intention proved to be significantly more influenced 
by emotional reaction than that of their female colleagues. External stimuli which 
include an emotional component might therefore be especially useful for the 
persuasion of males.
Everyday we are bombarded with countless persuasive messages, particularly 
advertising messages from mass media. However, it is doubtful how many of them 
effectively persuade a consumer or affect a consumer’s decision making. The focus 
of advertising agencies has traditionally been on the retention of communication 
content. The retention of a communication message was thought to play an 
important role in changing a communication recipient’s attitude. The more a 
recipient retains a communication content, the more persuasive a message is 
deemed to be. However, Greenwald already indicated in 1968 that the effectiveness 
of persuasive messages should be measured by the acceptance of content, rather 
than by its retention. Furthermore, the person to be persuaded should be motivated 
to elaborate on the message of the external stimulus, while the personal relevance of 
the message influences motivation.
The present study confirmed that the amount of persuasion increased when the 
message was relevant to the physician. An external stimulus based on the most 
important independent variable of behavioural intention was shown to influence 
actual prescription behaviour to a significantly greater extent than an external 
stimulus based on a less relevant independent variable. Attempts to change 
physicians’ prescription behaviour should therefore be directed at influencing those 
elements of attitudinal, normative or control constructs that have the most influence 
on behavioural intention. Private sector managers should direct their research 
towards identifying these independent variables, which should become the basis for 
the development of external stimuli rather than the features of their products or 
assumptions about the attitudes of their customers, even if these are long-held 
beliefs. This research has demonstrated that such assumptions may be wrong and 
misleading.
314
Habit forming is generally believed to become stronger with age. However, the 
results of the present study demonstrated that habit was much stronger with younger 
physicians. As habit is difficult to change, external stimuli might therefore have 
more effect when addressed to somewhat older physicians.
Both private and public sector managers should take into consideration that the 
vehicle used to present the external stimulus may also have a significant influence 
on its effect. This influence may either support or hamper the adoption of the 
behavioural change intended to result from the external stimulus. Determination of 
the effect of the external stimulus should therefore be extended to cover its 
influence on other independent variables which may have a significant influence on 
behaviour. Attitude, in particular, proved to be a powerful determinant of 
evaluative responses to the source and content of influence attempts.
7.5.2. Practical implications for public sector analysts and managers
Most European countries have tried to limit the increasing costs of healthcare using 
a multiplicity of instruments (Kobelt, 1996) such as imposed price reductions of 
pharmaceuticals, patient co-payment, and the limitation of the freedom of 
physicians to prescribe any product desired. Sick funds have published so-called 
‘positive’ lists of products which will be reimbursed, or negative lists of products 
excluded from reimbursement. This study has demonstrated that these cost- 
containment measures are not very effective in influencing prescribing behaviour. 
Physicians feel the pressure to prescribe cost-consciously but their motivation to 
comply with this normative belief remained low. The current attempts of sick funds 
to increase the pressure on physicians to take cost into consideration are therefore 
unlikely to be successful. Governmental bodies and sick funds should try to 
influence the motivation of the physician to comply with their wishes to prescribe in 
an economical way, as simply increasing the pressure on physicians may turn out to 
be a waste of time and money. Instead, they should look at the reasons why 
physicians do not comply with cost-containment recommendations and then 
develop external stimuli aiming at improving the physicians’ motivation to comply.
315
Governments, by removing free market mechanisms from the pharmaceutical 
sector, have taken a huge responsibility upon themselves. The decision to 
rationalise in this sector, and to take responsibility for limiting and allocating public 
resources, are political decisions. Such decisions cannot be delegated to a scientific 
organisation, but should be the result of a consensus between medical experts and 
interest groups, and must take into account considerations of common justice and 
social acceptability.
The complexity of the available systems of rationalising healthcare, principally 
based on the exclusion of certain interventions, groups of pharmaceutical products, 
or treatments for segments of the population, have triggered the proposal of many 
alternative solutions. Whatever the system of rationalisation, however, restrictions 
in available healthcare increase the anxiety of the population, both with regard to 
their confidence in healthcare management and the ability of the system to fulfil 
their healthcare needs. This study has demonstrated that some rationalisation of 
healthcare costs can be achieved by the development of prescribing guidelines, as 
long as these guidelines are based on the independent variables that have the most 
significant influence on physicians’ prescription behaviour. The development of an 
external stimulus based on a particular element of the attitude construct proved 
capable of changing physicians’ prescription behaviour significantly. Governments 
and sick funds could follow a similar procedure. The current strategy of increasing 
the pressure on physicians to prescribe in a cost-conscious way may increase the 
magnitude of the normative belief but its effect will be limited as long as the 
motivation to comply remains low. The motivation to comply should be measured, 
in addition to other independent variables of prescription behaviour, and corrective 
persuasive strategies developed to alter prescription behaviour if needed.
The preoccupation of governments with the increases in healthcare costs may be 
justified, but free market mechanisms (the allocation of resources on the basis of 
price competition and the interaction between supply and demand) may have been 
abolished too easily. Cost-containment measures in the healthcare sector based on
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political decisions are dangerous, as such measures should also take medical 
considerations into account.
This research has shown that attention should also be paid to the position of 
physicians who may find themselves in a situation where, because of cost- 
containment measures, they will be obliged to prescribe products which are not the 
best for the treatment of their patients. The physician treating the patient is the only 
one who is able to decide which treatment is best for that patient. Cost-containment 
measures taken by governmental bodies or sick funds will not function properly if 
they limit the physician in the execution of his or her profession and may thus have 
a negative effect on the health and/or recovery of patients. External stimuli based 
on independent variables which influence prescription behaviour may be a more 
effective and appropriate way to achieve cost-containment in the health sector, with 
respect to the prescription of pharmaceutical products.
7.6. Limitations
The cost-containment measures taken by governments in more developed countries 
vary, as do the environments in which the physicians operate. Pressure by patients 
on physicians to prescribe in a cost-conscious way may be stronger in countries 
where co-payment by patients has been introduced, while in other countries the 
pressure of sick funds may be more pronounced. This research was carried out in a 
country where cost-containment measures have included the introduction of a so- 
called positive list, a list of pharmaceutical products which are reimbursed by the 
sick funds. However, Greek physicians frequently do not obey the list and prescribe 
products for the account of sick funds, which are not re-imbursed. This 
phenomenon was confirmed by the present research, which showed that the 
prescription behaviour of Greek physicians was still rather volitional.
Confirmation of this conclusion was obtained by analysing the determinants of 
behavioural intention. It was discovered that, although the pressure of sick funds on 
physicians to prescribe economically was felt (Normative belief), the motivation to
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comply was low. In other countries, the motivation of physicians, voluntary or not, 
might be much higher. Therefore, the results of this research are only fully 
applicable to the market place and specialists investigated. However, there are 
reasons to assume that the findings of this research might also apply in other 
settings. For example, the conclusions should also apply to physicians from the 
same specialties who were not themselves included in this research, as the study 
sample selected was shown to be representative. Physicians from other specialties 
might also be covered, as the cost-containment measures of the government, 
hospitals and sick funds apply to all specialties. The findings of this research might 
even be valid outside the country in which this research took place. Increasingly, 
scientific knowledge is distributed internationally. Many Greek physicians obtained 
their degrees in foreign countries, visit international congresses, and read 
international literature, both as hard copy and via the Internet. This rapid exchange 
of information and ideas might lead to independent variables of prescription 
behaviour of physicians in different countries becoming quite similar. Further 
research should provide confirmation of these assumptions.
7.7. Further research
This is the first study known to have used an attitude behaviour model which takes 
into account the activation of habits, attitudes toward targets, and three classes of 
anticipated outcomes of behaviour (utilitarian, normative and self-identity). The 
resulting composite attitude behaviour model proved capable of predicting the 
prescription behaviour of physicians significantly better than the reference model of 
the theory of planned behaviour. Further research is needed to confirm the 
superiority of the composite attitude model, also in other domains and settings.
The actual prescription behaviour of physicians proved to be sensitive to change 
when physicians were confronted with external stimuli based on independent 
variables which had been found to influence behavioural intention significantly.
The research was performed using products for the treatment of hypertension, 
depression and the treatment of the symptoms of menopause. It will be interesting
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to see whether similar results are obtained for other, more-or-less life-threatening 
indications. This research was carried out in Greece, a country in which the 
prescription behaviour of physicians proved to be still rather volitional. Further 
research is needed to investigate the value of the composite attitude behaviour 
model in market places where behaviour is less volitional.
The presentation of the external stimulus proved capable of changing behavioural 
intention significantly. At the same time, an influence of the person presenting the 
external stimulus was also noted. Further research into the influence of the vehicle 
used to present the external stimulus seems warranted, as this may be an important 
tool in behavioural alteration.
Bentler and Speckart (1979) included past behaviour in their expectancy-value 
model. Using multiple regression techniques, the model has been tested in several 
studies and was found to fare well, although it did not predict behavioural intentions 
consistently significantly better than the model of planned behaviour (Brinberg, 
1979; Davidson et al., 1976). The contribution of Habit changed significantly 
during this research when external stimuli were used which had an important 
influence on behavioural intention. It seems that habit contributed over and above 
behavioural intention, although its overall importance for the prediction of actual 
behaviour remained unclear and needs to be investigated further.
7.8. Academic contributions
• Kangis P. and Van der Geer L.A.M. (1996). Pharmaco-economic information 
and its effect on prescriptions. Journal o f management in Medicine, volume 10, 
number 5, pp. 66-74.
The influence of the efficacy of a product on the decision-making process of 60 
prescribers was examined, together with two other biomedical parameters; the 
safety of a product and the convenience it offers to the patient, such as one daily 
dose or a pack which is easy to take on travels. The relative importance attributed
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by the sample to three price proxies and also to the reimbursement status of the 
product was measured. The study showed that additional information of a 
pharmaco-economic nature was associated with a change in the nature of the 
proposed prescription. It was concluded that a paradigm shiâ would not be an 
unrealistic consequence of this additional information.
• Van der Geer L, and Kangis P. (2000). What influences prescriptions by 
physicians? A study of subjective norm, perceived behavioural control and 
volition. Internationaljournal o f medical marketing, volume 1, number 1, pp. 
66-73.
Understanding how medical practitioners reach a decision on what to prescribe has 
been one of the more interesting areas of research for some time. Yet the accessible 
literature in this area is rather limited. Of particular interest is the assessment of the 
extent to which behaviour is entirely volitional and thus completely under the 
physician’s control. This would determine the extent to which external stimuli, 
such as communications from the pharmaceutical industry and the media, have an 
influence or not. On the basis of a small-scale study with 38 physicians in Greece, 
the importance of isolating normative beliefs and the motivation to comply has been 
identified as a key factor to understanding the decision process for prescriptions.
The evidence shows that prediction of intended prescription behaviour increases 
significantly when behavioural control is added to the measurements of attitude and 
subjective norm. In circumstances of high behavioural control, the theory of 
planned behaviour seems to collapse in favour of the theory of reasoned action.
• Van der Geer L, and Kangis P. (in press). The influence of cost on 
prescriptions: a comparison of the theory of planned behaviour and the 
composite attitude behaviour model.
This paper is aiming to establish if a set of behavioural intention factors from the 
model of the theory ofplanned behaviour, and the composite attitude behaviour 
model proposed by Eagly and Chaiken, can help predict prescription behavioural
320
intention of physicians in a cost conscious environment. This study specified and 
tested the determinants and compared the predictive power of both models on a 
sample of 396 general practitioners and medical specialists in Greece. It was 
concluded that attitude towards economic prescribing and habit were the most 
important factors influencing behavioural intention. Given that perceived 
behavioural control did not show a significant influence on behavioural intention, it 
was concluded that cost of treatment is not considered as an important constraint 
when prescribing. Of the specialists, cardiologists feel the strongest pressure of the 
sick funds to be cost conscious. However, their willingness to comply with this 
pressure is limited.
External stimuli based on emotional reactions might have more effect when 
presented to male physicians, as emotional reaction towards cost conscious 
prescribing proved stronger with males than with females. Since habit forming was 
much lower with females than with males, prescription behaviour of females might 
therefore be more easily influenced.
Parameters for the model of the theory of planned behaviour and the composite 
attitude behaviour models were estimated. Comparison between the models 
showed that the most complex of the models fits the data most adequately. 
Decomposing the constructs of normative and behavioural beliefs helped generate 
additional information towards understanding each factor’s influence on 
behavioural intention and behaviour. The decomposed composite attitude 
behaviour model is more helpful than that based on the theory of planned 
behaviour, although it is suspected that there are further factors influencing 
behavioural intention and behaviour, which are not covered by either model. These 
findings have important policy implications for pharmaceutical companies and for 
sick funds.
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Appendixes 
Appendix A Copy of the original Greek questionnaire used during the 
study of volition
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t o  k ô g t o ç  tcov T a j i s ic o v  Y y s i a ç ,  y s y o v ô ç  tcou s i v a i
3 2 1 0  -1 -2 -3
aafmavTOErjuaviiKo
E p6T T |G T | 6
Y T toX oy iÇ ovT aç  t o  r u i e p f jo i o  k ô g t o ç  0 8 p a 7 c s ia ç  p i a ç  a v m > 7 re p T a o iK r |ç  a y c o y fiç , 
K d 0 s  (p o p d  ttod G K éîT T opai v a  aX X dÇ œ  t o  (p d p p aK O  T too G U V T ayoypacpœ , 0 a  
p s iœ G S i T a  é Ç o ô a  tcov aG 0 8 v cb v , y s y o v ô ç  ttod s i v a i
0  . ' " 2  '  " 3 acnijiavT OBlim-nicô
Epd)Tr|Gr| 7
Y T to X o y iÇ o v T aç  t o  r ip 8 p f |G io  k ô g t o ç  0 s p a 7 i8 ia ç  p i a ç  avT i'üT rspT aG iK fjç  a y œ y f iç ,  
K d 0 e  (p o p d  ttod G K S îiT o p a i v a  aXXdÇco t o  (p d p p a K O  ttod o u v T a y o y p a c p m , 0 a  p s  
p o r |0 f |G 8 i  g t o  v a  X a p P d v o )  OTi’ôxpiv  p o o  t o  k ô g t o ç  0 s p a 7 r s ( a ç  g t t |v  id iv iK H  
T ipaK T iK fj, y s y o v ô ç  T too s i v a i
SîlfiavTucô
EpcoTT|Gr| 8
Y T to lo y iÇ o v T a ç  t o  T |p sp f)G io  k ô g t o ç  0 s p a 7 i s ( a ç  p i a ç  av T ii)7 tsp T aG iK r|ç  a y c o y fjç ,
K d 0 s  (p o p d  T too G K ST tT opai v a  aXXdÇco t o  (p d p p aK O  T too o o v T a y o y p a q x b ,  0 a  
p s lT i to G s i  tt |v  svTÔTtcoGri tcov a o 0 s v c o v  y i a  p s v a ,  y s y o v ô ç  T too s i v a i
3 2 1 0 - 1 - 2 - 3
acrnjJiavTOSrmavxiKO
E p d )T r|G rj 9
Y îto X o y iÇ o v T a ç  t o  r |p s p f |G io  k ô g t o ç  0 s p a T ts ia ç  p i a ç  av T iO T tsp T ao iK tiç  a y c o y fiç ,
K d 0 s  (p o p d  T too G K ST tT opai v a  aÀ ld Ç c o  t o  (p d p p aK O  T too o o v T a y o y p a c p c b , 0 a  
psX,TicÔGsi tt |v  svTOTtcoGTj t o o  T a p s i o o  Y y s i a ç  y i a  p s v a ,  y s y o v ô ç  Ttoo s i v a i
3 . 2  1 0 -1 , -2 -3
, s > amîpavTOSrmavxiKO
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Epd)Tr|(jr| 10
Ô  D 7to>uoyiG pôç t o i) T ip s p f ja io i)  k ô g t o d ç  O s p a ju s ia ç  p i a ç  avT iD T rspT aG ncnç a y œ y f iç ,
K àO s tp o p à  t t o d  GKSTUTopai v a  aXkâfyd t o  (p â p p a K O  t t o d  o u v T a y o y p a tp é ,  6 a  p s i m o s i  
t o  k ô g t o ç  tc o v  T a j i s ic o v  Y y s i a ç
3 . 2  1 0  -1 -2 -3
E%eôôv : 2%e§ôv ttoté
n a v r a
EpœTT|GT| 11
O  D T ioX oy iG pôç t o d  T)pspT|GiOD k ô g t o d ç  O spaT tsC aç p i a ç  avT iD 7iG pTaG iK r|ç a y c o y f |ç ,
K àO s tp o p à  TtoD G K ST tT opai v a  a À ld Ç c o  t o  cp àp p aK O  ttod G U V T ayoypacpœ , 6 a  
p s iœ G s i  T a  s Ç o ô a  tcov a o O sv c o v
Exsôôv 3 2 1 0 -1 -2 -3
7t“ VTCt : E% sôôv tuoté
Epœ TÎIG Tl 1 2
O DTtoXoyiapôç t o d  ripsprjcnoD k ô g t o d ç  OspaTtsCaç p iaç avTiDTtspTaGiKnç aycoyf|ç, 
KaOs cpopd ttod GKSTtTopai va aXXdÇœ t o  (pdppaKO ttod oDVTayoypatpd), 6 a  p s  
pOT|6f|GSl GTO va XapPdvCO DTt’ÔXl/lV POD TO KÔGTOÇ OspaTlEiaÇ GTT|V KllVlKT) 
TtpaKTlKTI
Ep6TT|GT| 13
O DTtoXoyiopôç t o d  T|pspf|GioD k ô g t o d ç  OspaTtsiaç p iaç avTiDTtspTaGiKnç aycoyf|ç,
KdOs (popd ttod GKSTtTopai v a  aXXdÇco t o  (pdppaKO ttod cmvTayoypatpcb, 6 a  
pslT im G si TT|v y v o p i)  Toov aGOsvmv y id  p sv a
Exsôôv 3 2 1 0 -1 -2 -3
mb™ Z%E86v%OTé
EpG)TT|Gr| 14
O  D îto À o y iG p ô ç  t o d  T |pspT |G ioD  k ô g t o d ç  G s p a î t s i a ç  p i a ç  avT iD TtspT aG iK T|ç a y c o y fjç ,
KdOs (popd ttod GKSTtTopai v a  aXMfyd  to (pdppaKO ttod GüVTayoypa(pœ, 0a  
psX nœ asi TT|v yvcbpri tcov T apsiœ v y ia  p sva
E%eôôv 3 , 2  1 0 -1 -2 -3
n a v r a  E x g ô ô v  tu o ts
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EpcbTrjari 15
0  (papjiaKOTioiôç tt |ç rcepioxnç pou maxsuei o n  0a ênpsm  va ujtoloyiÇco t o  
rjpspfiaio k ô o t o ç  Gepajceiaç piaç avnujrspTaoncnç ayœyfiç, k ô Gs  tpopà tcou 
OKSTtTopai va aXXâÇto t o  tpàppaKO tcou ouvTayoypacpcb
Z%e56v 3 2 1 0 : -1 -2 -3 '
Ttavra E%sôôv îroré
Epronjori 16
01 ouvàôsXcpoi pou tc ig tsu o u v  on  0a éîcpsTcs va uîcoXoyCÇco t o  rjpspfioio k ô o t o ç  
Gspaîcsiaç piaç avnuîcspTaoncnç aycoyf|ç, Kà0s tpopà tcou oKSTCTopai va aXlàÇto 
t o  tpàppaKO tcou ouvTayo-ypatpœ
îtavra
Epmnion 17
Ta Tapeia Yysiaç Tcioxsuouv on  0a éTcpsTcs va uîcoXoyiÇto t o  rjpspfjoio k ô o t o ç  
0spaTcsiaç piaç avnuTcspTaoucrjç ayœyfjç, Kà0s tpopà tcou OKSTCTopai va aXXàÇto 
t o  tpàppaKO tcou ouvTayo-ypatpœ
3 2 1 0  -1 -2 -3
: Zxdüvîtoré
EpmTT|OT| 18
Oi aoGsvsiç pou tc io tsu o u v  on  0a éîcpsTcs va UTCoXoyiÇœ t o  rjpspfjoio k ô o t o ç  
0spaTcsiaç piaç avnuTcspTaoncfjç aytoyfiç, Kà0s tpopà tcou OKSTCTopai va aXXàÇœ 
t o  tpàppaKO tcou ouvTayo-ypatpd)
3 2 1 ; 0 - 1 - 2  -3
7C“VTa Z%6Ôov îroré
E ptonjori 19
Oi «ÔiapoptptoTÉç yvœprjç» tc io tsu o u v  o n  0a stcpstcs va uTcoXoyiÇœ t o  T|pspf|oio 
k ô o t o ç  0spaTcsiaç piaç avnuTcspTaoïKrjç aytoyfjç, Kà0s tpopà tcou OKSTCTopai va 
aX-XàÇto t o  tpàppaKO tcou ouvxayoypatpfb
Hxeôôv 3 2 1 0 - 1 - 2  -3
rcàvra \ 2%e8ôv îroré
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E ptoT T jo ri 2 0
F sv ik c i, OeX-œ v a  kolvcd a u r o  ttod o  (p a p p a K O T to iô ç  ttiç T rep io x fiç  p o i)  T n a ie u e i ,  ôrjX,. 
ô t i  6 a  STipsTre v a  DTroXoyiÇœ t o  r |p e p f |m o  k ô o t o ç  O s p a jc s ia ç  p i a ç  a v T u m e p T a o iic r iç  
a y to y f iç ,  K aO e (p o p à  ttoo oKETUTopai v a  aXXàÇco t o  (p d p p aK O  ttoo o o v T a y o y p a tp d )
s SxeÔôv 3 2 1 0 -1 -2 -3
7r<*VTa E%e56v Tracé
EpcoTriari 21
E e v iK d , OéXa) v a  K d v œ  a o r o  ttod o i  o u v d ô sX x p o i p o o  t h o t c u o o v , ô î |X. ô t i  9 a  STEpsTts 
v a  oTtoXoyiÇcù to  r i p s p f i a i o  k ô o t o ç  O s p a T ts ia ç  p i a ç  a v T u m s p T a a iK r jç  a y c o y f |ç , K dO s 
(p o p d  T too O K ST tT opai v a  aX X àÇ œ  t o  (p d p p aK O  T too o o v T a y o y p a c p m
2 x6Ô6v 3 2 1 0 -1 -2 -3
7r®VTa 5 Exeôôv Ttoré
E pd)T r|O T | 2 2
EsviKd, OsXœ va Kdvœ aoTÔ Ttoo t o  Tapsio Yysiaç t h o t s o e i , ôr|X,. ô t i  0a STtpsTts va 
OTtoXoyiÇœ t o  îipspfioio k ô o t o ç  OspaTtsiaç piaç avTioTtspTaoncnç ayœyf|ç, KdOs 
(popd Ttoo OKSTtTopai va akXatpa t o  (pdppaKO Ttoo oovTayoypaçœ
Hxe5ôv 3 , 2  1 0 -1 -2 -3
7t“VTa Exsôôv Ttoré
E p œ T r |o r i  2 3
EsviKd, OsXœ va Kdvœ aoTÔ Ttoo oi aoOsvsiç poo t u o t s ô o o v , Ôî|X. ô t i  ôa STtpsTts va 
oîtoXoyiÇœ t o  ripspfjoio k ô o t o ç  OspaTtsiaç piaç avTioTtspTaoncriç ayœyfjç, KdOs 
(popd Ttoo OKSTtTopai va aXXdÇœ t o  (pdppaKO Ttoo oovTayoypa(pœ
Zxe56v 3 2 1 0  -1 -2 -3
7c“VTa ExsSov Ttoré
E p œ T T jo ri 2 4
EsviKd, OéZœ va Kdvœ aoTÔ Ttoo oi «ôiapopq>œTSç yvœpriç»TtioTSOoov, ôr|X. ô t i  Ôa 
STtpsTts va OTtoXoyiÇœ t o  r|pspf|oio k ô o t o ç  OspaTtsiaç piaç avTioTtspTaoncriç 
ayœyfjç, KdOs (popd Ttoo OKSTtTopai va aÀldÇœ t o  (pdppaKO Ttoo oovTayoypa(pœ
ExeSôv 3 2 1 0 -1 -2 -3
îr®VTCt g HxcGov Ttoré
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EpœTr|ar| 25
O D7roXoyia|iôç tou  T||i8pf)mou kôotouç GspaTteiaç, kciGs (popd to u  mcsTtTopai va  
aXkâEcù (pdppaKO, ae pia avTiuTOpTacmcfi ayœyfj, sivai
' ' 3
E v k o Xoç
Aiko [iou 0épa 
E^apidiai anô 
jxéva
2 1 0 -1
ôtimcoXoç 
ô x i  ô ik ô  O ép a  
E^apraxai 
aîto dXXovç 
avOptoîcouç r\ 
ysyovôxa
EpmTr|OT| 26
O uTOÀoyiapôç tou rjpepfiaiou kôotouç GspaTteiaç, mGe (popd tou OKSTtTopai v a  
aXXdÇco (pdppaKO, o s  pia avTiuTtspTaoncn aymyf), ps K àveiva aioGdvopai
3
EXeùOepa 
Avsxa 
Euxâpioxa
2 1 ; 0 - 1 - 2  -3
KaxamsaxiKd
aîiéxOeta
ôuaapeaxa
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Appendix B Translation into English of Appendix A
Question 1
I estimate the daily therapy cost of an anti-hypertension treatment every time I believe
that I have to change the medicine that I prescribe.
. Almost 3 ’ 2 1 0 - 1 - 2  -3 Almost
always never
Question 2
The estimate of the daily therapy cost of an anti-hypertension treatment every time I 
believe that I have to change the medicine that I prescribe, is to me
r 3 2 I 0 -1 -2 -3
: Amusing ; Boring
Wise ' ' Silly
Proper Wrong
Pleasant Unpleasant
Good Bad
Useful ' , Damaging
Moral Immoral
Question 3
Many of the people whose opinion I value think that I
3 2 1 0 , - 1  -2 -3
Should Should not
estimate the daily therapy cost of an anti-hypertension treatment every time I believe that 
I have to change the medicine that I prescribe
Question 4
I feel that it is my social duty to reduce the cost of the anti-hypertension medicines that I 
will prescribe from now on
3 2 1 0 -1 -2 -3
I agree i  I disagree
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Question 5
My estimating of the daily therapy cost of an anti-hypertension treatment every time that 
I consider changing the medicine that I prescribe, will reduce the cost for the Sick Funds, 
which is
Significant
3 Insignificant
Question 6
My estimating of the daily therapy cost of an anti-hypertension treatment every time I 
consider changing the medicine that I prescribe, will reduce the expenses of the patients, 
which is
_i
■ '
Significant
Insignificant
Question 7
My estimating of the daily therapy cost of an anti-hypertension treatment every time that 
I consider changing the medicine that I prescribe, will help me to take into account the 
therapy cost in my clinical practice, which is
-1 -3
Significant
Insignificant
Question 8
My estimating of the daily therapy cost of an anti-hypertension treatment every time that 
I consider changing the medicine that I prescribe, will improve my patients’ opinion 
about me, which is
. . .  4 Insignificant
Significant
Question 9
My estimating of the daily therapy cost of an anti-hypertension treatment every time that 
I consider changing the medicine that I prescribe, will improve the Sick Fund’s opinion 
about me, which is
3 2 1 0  -1 -2 -3
i i Insignificant
Significant 
Question 10
The estimate of the daily therapy cost of an anti-hypertension treatment every time that I 
consider changing the medicine that I prescribe, will reduce the cost for the Sick Funds
Almost 3 2 1 0  -1 -2 -3 Almost
always ; never
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Question 11
The estimate of the daily therapy cost of an anti-hypertension treatment every time that I 
consider changing the medicine that I prescribe, will reduce the expenses of the patients
Almost 3 2 i ’ 0 -1 , -2 -3 ' Almost
always never
Question 12
The estimate of the daily therapy cost of an anti-hypertension treatment every time that I 
consider changing the medicine that I prescribe, will help me take into account the 
therapy cost in my clinical practice
Almost 3 2 1 0 - 1 - 2  r -3 Almost
always never
Question 13
The estimate of the daily therapy cost of an anti-hypertension treatment every time that I 
consider changing the medicine that I prescribe, will improve my patients’ opinion about 
me
Almost 3 2 1 0 . -2 -3 f ' Almost
always never
Question 14
The estimate of the daily therapy cost of an anti-hypertension treatment every time that I 
consider changing the medicine that I prescribe, will improve the Sick Funds’ opinion 
about me
Almost 3 2 : 1 0 - 1 - 2  -3 Almost
always . never
Question 15
The pharmacist in my area feels that I should estimate the daily therapy cost of an anti­
hypertension treatment every time that I consider changing the medicine that I prescribe
Almost 3 2 1 0 -1 -2 -3 Almost
always never
Question 16
My colleagues feel that I should estimate the daily therapy cost of an anti-hypertension 
treatment every time that I consider changing the medicine that I prescribe
Almost 3 2 1 0 -1 - 2 - 3  Almost
always never
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Question 17
The Sick Funds feel that I should estimate the daily therapy cost of an anti-hypertension 
treatment every time that I consider changing the medicine that I prescribe
Almost 3 2 1 0 -1 -2 -3 Almost
always never
Question 18
My patients feel that I should estimate the daily therapy cost of an anti-hypertension 
treatment every time that I consider changing the medicine that I prescribe
Almost 3 2 1 0 -1 -2 ’ -3 ' Almost
always never
Question 19
“Opinion leaders” feel that I should estimate the daily therapy cost of an anti­
hypertension treatment every time that I consider changing the medicine that I prescribe
Almost 3 2 1 0 - 1 - 2  -3 Almost
always never
Question 20
In general, I want to do what the pharmacist of my area feels that I should do, that is to 
estimate the daily therapy cost of an anti-hypertension treatment every time that I 
consider changing the medicine that I prescribe
Imosl
Question 21
In general, I want to do what my colleagues feel that I should do, that is to estimate the 
daily therapy cost of an anti-hypertension treatment every time that I consider changing 
the medicine that I prescribe
Almost 3 ' 2 1 0 - 1 - 2  -3 Almost
always never
Question 22
In general, I want to do what the Sick Fund feels that I should do, that is to estimate the 
daily therapy cost of an anti-hypertension treatment every time that I consider changing 
the medicine that I prescribe
Almost 3 2 1 0  - 1 - 2  -3 Almost
always never
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Question 23
In general, I want to do what my patients feel that I should do, that is to estimate the daily 
therapy cost of an anti-hypertension treatment every time that I consider changing the 
medicine that I prescribe
“  1 2 : : 1 -■ -2 -3 "
■ always ever
Question 24
In general, I want to do what “opinion leaders” feel that I should do, that is to estimate the 
daily therapy cost of an anti-hypertension treatment every time that I consider changing 
the medicine that I prescribe
Almost 3 2 1 0 -1 -2 -3 Almost
-Jim .y j  L.;. .;. L . .1 j t LI,:. . ; :L, f
always never
Question 25
The estimate of the daily therapy cost of an anti-hypertension treatment every time that I 
consider changing the medicine that I prescribe,
Is easy 3 2 1 0  -1 -2 -3 Is difficult
Is my choice Is not my choice
Depends on me Depends on other
people or incidents
Question 26
The estimate of the daily therapy cost of an anti-hypertension treatment every time that I 
consider changing the medicine that I prescribe, makes me feel
3 2 1 0 -1 -2 -3
Free 
Comfortably 
Pleasantly
Oppressed
Abhorrence
Unpleasantly
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Appendix C Range of measurements before aggregation of the study 
of volition
BI question 1 ATT 1 ATT 2 ATT 3 ATT 4
question2a question2b question 2c question 2d
MEAN 0.132 -0.263 L289 0.763 0.105
S.D. 1.891 1.309 1.228 2.006 1.410
ATT 5 ATT 6 ATT 7 Norm 1 Norm 2
question 2e question 2 f question 2g question 3 question 4
MEAN 0.658 1.816 1.289 1.579 1.447
STANDARD 1.649 1.270 1.609 1.671 1.329
DEVIATION
_ _ _ _ _ _ _  EL3 Ei4 Ei5 ......
question 5 question 6 question 7 question 8 question 9
MEAN 1.395 2.000 1.632 0.737 0.079
STANDARD DEVIATION 1.911 1.816 1.303 2.114 2.097
Bil B!2 Bi3 B!4 Bi5
question 10 question 11 question 12 question 13 question 14
MEAN 1.263 2.079 1.395 -0.105 -0.605
STANDARD DEVIATION 1.501 0.818 1.104 1.783 1.868
Nbjl Nbj2 Nbj3 Nbj4 Nbj5
question 15 question 16 question 17 question 18 question 19
MEAN -0.526 -0.421 2.368 -0.158 0.763
STANDARD DEVIATION 2.215 1.840 1.364 1.853 1.951
Mcjl Mcj2 Mcj3 Mcj4 Mcj5
question 20 question 21 question 22 question 23 question 24 
MEAN -1.289 -0.526 -0.105 0.763 0.763
STANDARD DEVIATION 1.523 1.955 2.178 1.792 2.336
PBC1 PBC2 PBC3 ER1 ER2 ER3
question 25a question 25b question 25c question 26a question 26b question 26c 
MEAN 0.184 1.579 1.842 -0.868 0.237 -0.211
S.D  1.753 1.954 1.263 1.989 1.762 1.473
Source: field work
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Appendix D Original questionnaire used during the research
IlapaKaXtb cyvpîTXqptboTE sva pôvo Tcrpàytoyo yia KâOe cptomcm
v
1. Tqv £7TÔ|i£VT| cpopâ ttov 6a avvTayoypatptjao) éva avriim spT acnK Ô  6a lapm  V7r’ôx|/iv 
to K ôcttoç Hpspqaïaç deparaïaç
07tG)GÔf|7t0T£ IIiGavÔTaTa Aôiâcpopo pâXXov 6%i aiyoupa ô%i
2. To va Xâfko vjrôxinv to K ôcttoç Hp£pfjaiaç ÔEpajreiaç K à0£ tpopâ ttou
auvTayoypaqxo éva avriwrspTaaiKÔ sivai :
I§iau£pr|ç ZripavTiKÔ : piKpfjç rnipaoiaç Aôiàçopo %(Opiç aripaoia
aripaoiaç
3 . To va >udp(9 V7rÔYj/iv t o  K ô c tto ç  Hpepqauiç 6£pa7T€iaç kô6£ cpopâ tto v  
cruvTayoypacpd) éva avTiUTrepTacriKÔ Etvai :
HoXô koXô arcM KaXô Aôiâcpopo kœkô ttoà.ô kuko
4 . To va Zapto uttoxj/iv t o  K ô c tto ç  Hpeptiaiaç 0£pa7r£iaç K â0£ cpopâ ttoi) 
crovTayoypacpca éva avTiwrspTaciKÔ etvai :
0£TIKÔ pâXXoV 0£TIKÔ AÔlâ(pOpO pâXXoV apvrjTlKÔ
apVTjTlKÔ
5. To v a  Xâfkd i)7rôv}/iv t o  K ô c tto ç  Hpcpqcriaç 0£pa7T£iaç Kâ0£ cpopâ tto u  
cruvTayoypacpcb é v a  avriUTrspTaaiKÔ e tv a i  :
aTtapaiTnxo MâXlov Aôiâcpopo
aîiaparaixo
pdXXov pr| Ka0ôÀ.oi)
aTiapaiTnio a7rapatrr|TO
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6. To va là  (ko dttoxj/iv to Kôotoç Hg£pf|aiaç OspaTreiaç KàOs <popà ttov 
cruvTayoypacptb éva avriVTrcpTaaiKÔ civai :
VTtoxpecoTiKÔ M â llo v  AÔiâtpopo p â llo v  pr| Kaôôlov
BTCOXpSCOTlKÔ V7tOXp£G)TlKÔ D7[0%p£(DTlKÔ
7. To va lap® i)7r6x}nv to Kôcttoç HpspfjCTiaç 0£pa7T£iaç KàOc cpopà ttov 
CTVVTayoypatpto éva avriOTTEpTaaiKÔ sivai :
KaGôlov 6%i Ttolô aôiâ(popo pâllov teoIô
; £VOxlî|TlKÔ EVOXlrjTtKÔ £VOxll]TlK0 £VO%lriTlKÔ
8 . H ôcto  CTuyva é la ^ a  xm9 oijnv t o  K ô c tto ç  Hpspfjoiaç OcpŒTrciaç KâOs <popâ tto v  
CTDVTayoypà(pi]CTa éva avritmspraCTiKÔ t t ] v  jieoaauévn ellôouâôa:
o£Kà0£ ctto7 5 % t(ov CTTO 50 % Tmv oto2 5 % tcov ge Kaptà
7t£pUtT0)(Tr| : 7t£pi7tTti)CT£Q)V 7t£pi7tT(ÙCJ£COV TCEplOiaTlKtoV 7r£pi7tTCÔCTr|
9. 'Orav lappàvco dtt’ oxj/iv to Kôcttoç Hp£pi]CTiaç 0£pa^£iaç koOe tpopà ttov
CTDVTayoypatpto éva avrivrapTaCTiKO KaTaXijyco cte lôiOCTKevàCTpaTa piKpÔT£pî]ç 
a7rOT£l£CTpŒTlKÔTÎ]TaÇ ;
sd v ta  ouxvà aro 50 % tojv nepiKéç <popéç tcoté
,tCpi!tT(h(7C(.)V
10. 'Orav lapPàvco vit9 ôi|nv t o  K ô c tto ç  HpEpfjCTiaç OspaTreiaç kôGe cpopà tto v  
CTDVTayoypacpcb éva avrioTrcpTaCTiKO airro éy£i œç aTtoTélsapa t o  oiKovopiKÔ 
ôcpsloç yia t o v  aoBEvrj ;
nàvxa CTU%và ctto 50 % tcov pEpiKéç cpopéç tcote
, TtEplTETtoCTECOV
11. "Orav lappavco d t t ’ ovpiv t o  K ô c tto ç  H ji£pi]oiaç OEparaïaç kôOe cpopà tto v  
CTDVTayoypacpcb éva avrioTTEpTaCTiKÔ a o rô  é / s i  coç aTTOTÉlEopa t o  oiKovopiKÔ 
ôcpEloç y ia  t o v  aCTcpalicmKÔ opyaviopô (TapEio);
nàvxa auxvà oxo 50 % xcov ; pEpiKéç cpopéç
TtEplTETtoCTECOV
TtOTE
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12 'Orov lagpavco vît’ 6vj/iv to  Kôcttoç H iispfjoiaç 0Ep«7t£iaç k«0£ cpopà Ttou 
CTDVTayoypacpcb éva avriojŒpTaCTiKÔ aorô £%£i coç aTTOTéXcopa éva koXdtepo 
lôyo kôcttovçZ a7TOT£>uéCTpaTOç;
! nàvxa avyvà oxo 50 % xcov pspiKéç cpopéç noré
7t8pl7tX(bG8CÛV
13 "Orav lappavco d î t ’ ô\j/iv t o  K ô c tto ç  H p£prjaiaç ÔcpaTrciaç Kà0£ cpopà tto d  
CTDVTayoypacpcb éva avxiDTrcpxaCTiKÔ airro é/ei coç aTTOTÉlccrpa t î ] v  KalDrcpi] 
CTVppÔpCpCOCTn TOD ttCT0£VODÇ lÔyCO TOD %apï|lÔT£pOD KÔCTTODÇ ;
: Hàvxa CTD%và oxo 50 %  xcov pepiKéç cpopéç Ttoxé
TtepiTtXCOCTECOV
14 H xap ultj ajcoT£l£CTpaTiKÔTi|Ta tcov cp0qvcbv epappâKeov p£ ajroTpéTTEi anô to  va  
l à  (ko dtt’ ôvj/iv to  K ôcttoç H p£pi]oiaç 0£pa^£iaç Kà0£ cpopà ttod CTDVTayoypacpcb 
éva avTiojtEpTaaiKÔ ;
i n àv x a  ZDyvà oxo 50 % xcov pepucéç cpopéç Ttoxé
; TtspiTtxœascov
15 To Jtpocpil TCOV ttV£7tl0ÔpT|TCOV EVEpyEMOV TCOV Cp0T]VCOV CpappàKCOV p£ aJtOTpéTTEl 
aîto to  va lâpco dtt’ ô\jnv to  K ôcttoç Hp£pf|CTiaç 0£pa7t£iaç Kà0£ cpopà ttod 
CTDVTayoypacpcb éva avriOTtEpTaaiKÔ ;
n àv x a  GDxvà oxo 50 % xcov , pspucéç cpopéç Ttoxé
TtSplTtXCÛGSCOV
16 H  CTofkcpôxrjTa rqç ao0év£iaç p£ aTtoxpénet aîiô to  va lâpco dtt’ ovpiv to  
K ôcttoç Hp£pfjoiaç 0£pa7t£iaç kô0£ cpopâ ttod CTDVTayoypacpcb éva 
OVTlDTtEpTaCTlKÔ ;
n àv x a  ooyvà . oxo 50 % xcov psptKéç cpopéç Ttoxé
Tt£plTtXtoG£C0V
17 H  âno\\n\ tcov ao0£vcbv Jtcoç Ta anpipà cpàppana £ivai KalDTEpa p£ ajroTpértEi 
aîto to  va  lâpco dît’ ô\|/iv to  K ôcttoç HpEprjoiaç 0£paTt£caç Kâ0£ cpopâ ttod 
CTDVTayoypacpcb éva avxiDTtEpxaoïKÔ ;
n àv x a  GD%và oxo 50 % xcov . pEpiKéç cpopéç Ttoxé
i TteptTtxœoECOV
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18 O ctoOEvrjç OéÀ£i va la^pavm  vtt’ ô\|nv to  kootoç KâGs cpopd ttov 
crvvTayoypatpto éva avTiDTtepraaiKÔ ;
nàvxa oD%và axo 50 % xtov (lepiKsç cpopéç ; Troie
7ISpi7tTffl(J£©V
19 Ta aacpaXKTTiKà x a p s i a  e ttiO dpodv ottcoç X appavc»  d tt’ôij/iv t o  k ô c tto ç  kôG e 
tp o p â  tto d  CTüvrayoypatpto é v a  avTiOTrepTatriKÔ ;
nâvTa Eo/yâ axo 50 % xtov pspiKéç cpopéç Ttoxé
TtepiTtxrooetov
2 0  O  laxpiK Ô ç ETtKTKéTrxqç EJtiGupEi v a  X ap p âv to  DTt’ovj/iv t o  k ô c tto ç  kô G s tp o p â  
tto d  tTDvrayoypatpto é v a  avTiDTtepxaaiKÔ ;
nâvxa Eo^vâ oxo 50 % xcov pspucéç cpopéç Ttoxé
TtSplTtTtoOStoV ’
21 O  aoGsvrjç p s  sTrqpsâÇsi c tto  v a  Xâp® DJt’oxpiv t o  k ô c tto ç  ( k o t ô  t o  Ttotrotrro tto d  
sy to  K pivto) kô G s tp o p â  tto d  oD vrayoypatp to  é v a  avTiDTtspTacriKÔ ;
ï- nâvxa Euyyâ oxo 50 % xcov pspiKéç cpopéç Ttoxé
TtSpiTtXtoOSCDV
2 2  Ta aotpaXioxiKâ xapsia ps EjrqpsâÇoDV c tto  va lâpto d tt’ôvj/iv t o  k ô c tto ç  (KttTâ 
TO TtOCTOCTTÔ TTOD Syto KptVto) KÔGs CpOptt TTOD CTDVTttyOyptttpto ÔVtt 
avxiDTtspxacTiKÔ ;
nâvxa Eu%vâ oxo 50 % xcov pspiKéç cpopéç Ttoxé
TtSplTtXCOOSCOV
2 3  O  laxpiK Ô ç ETTKTKéTrrqç p s  srrqpsâÇ E i c tto  v a  X ajko DTt’ôvj/iv t o  k ô c tto ç  (Kaxâ t o  
TtocTocTTÔ TtOD syto  Kpivco) kôGs tp o p â  TtOD CTDVTayoypatpto é v a  avTiDTtspTacriKÔ ;
; nâvxa Euyyâ oxo 50 % xcov pspucéç cpopéç Ttoxé
TtSplTtTtoOStoV
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24 H  <n)VTayoypd(pi]ffn cvog liyÔTEpo «jrorsX^opaTiKOü avnwrspraoiKov Xôyco 
VTToXoyicrpov tov Kootoç HpspTjoiaç GspaTisiaç sivai koti to :
Holv koXô KaXô ASidcpopo kœkô teoXv  kœkô
25 Av VTrdp/ci oiKovopiKÔ ôtpcloç yia tov aoGsvfj pov ôtov Xappavco vjr’ôxj/iv to
Kootoç Hpvpfjoiaç GepaTrciaç KdGc (popd ttov ovvrayoypaqxo éva 
avTivTrcpTaoïKÔ, avTÔ sivai :
IIoXv koXô kœZô aôidtpopo KaKÔ ttoXv  k o k o
26 Av vjrdp/si oiKovopiKÔ ôcpsloç yia Ta aotpalioriKd xapsia orav Xappdvto
vjr’ôxiav to Kootoç Hpspfjoiaç Ospajrsiaç KdGs cpopd ttov ovvxayoypaqxb éva 
avTiVTrspxaoïKÔ, avrô sivai :
noM K a).ô  KOXÔ : aStâfopo
27 Av TrpoKUTTTSi svaç KaXvTEpoç Xôyoç KÔOTOUçZaTroTsXéopaTOç orav lappavo
VTr’ôxj/iv to Kootoç Hpspfjoiaç Gspajrsiaç KdGs cpopd ttov ouvxayoypacpcb éva 
avTivTrspxaoïKÔ, avrô sivai :
Holv koXô kœXô aôiacpopo KaKÔ nokb k o k ô
28. Av ETriTuy/âvErai Kalvxspî] ovppôpcpraoi) tov aoGsvovç Xoyco xaprjlorspov 
kootovç ôtov lappavco vtt’ôvj/iv to Kootoç Hpspfjoiaç Gspajrsiaç KdGs cpopd 
jrov ovvrayoypacpcb éva avTivjrspraoïKd, avrô sivai :
H o l v  koXô K a lô  aô iacp o p o  KaKÔ  T io lv  kœkô
29. ©a orsvo/copiiGcb orav ovvTayoypacpfjoco éva liydrspo ajroxslsopaxiKO
avTivjrspTaoïKÔ, sjrsiôfj sipai vjroypscopsvoç va Zdpco vjt’ oipiv to i)pspfjoio 
kootoç Gspajrsiaç
Evpcpcovto
ajrolVTCDÇ
Evpcpcovd) pov sivai Aiacpcovcb
aôiacpopo
ôiacpcovco
xslsicoç
30. FeviKEç IDiTtpotpopfeç
ElSlKÔTTlTa IlaGoXÔYOC
KaoSioXÔYoc
Xœpoç epyaàiaç NoaoKopsio
Iômotikti kXivikti
laxpsio
OvXo FvvaiKa
Àvôpaç
Evpoç r|Xiidaç -40
41-50
51-60
60 +
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Appendix E Translation into English of Appendix D
Please, chose only one answer for each Question
v
1. Next time that I prescribe an anti-hypertension medicine I will take the Daily 
Therapy Cost into account
Definitely Possibly Indifferent Probably not Definitely not
2. Taking the Daily Therapy Cost into account every time that I prescribe an 
anti-hypertension medicine is :
O f high Important Not very Indifferent Without
importance important importance
3. Taking the Daily Therapy Cost into account every time that I prescribe an anti­
hypertension medicine is :
Very good Just good Indifferent Bad Very bad
4. Taking the Daily Therapy Cost into account every time that I prescribe an anti­
hypertension medicine is :
Positive Rather positive Indifferent Rather negative Negative
5. Taking the Daily Therapy Cost into account every time that I prescribe an anti­
hypertension medicine is :
Necessary Rather necessary Indifferent ' Rather , Not necessary
, unecessary s at all
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6. Taking the Daily Therapy Cost into account every time that I prescribe an anti­
hypertension medicine is :
: Obligatory Rather Indifferent Rather not Not obligatory
obligatory obligatory ; at all
7. Taking the Daily Therapy Cost into account every time that I prescribe an anti­
hypertension medicine is :
Not annoying at Not very Indifferent Rather annoying Very annoying
; all ; annoying
8. How often did I take the Daily Therapy Cost into account every time that I 
prescribed an anti-hypertension medicine last week :
; In every case In 75% o f the In 50% of the In 25% of the In any case
cases cases cases
9. When I take the Daily Therapy Cost into account every time that I prescribe an 
anti-hypertension medicine, do I end up prescribing proprietary medicines of 
lower effectiveness?
I Always Often In 50% o f the Some times Never
i cases
10. Does my taking the Daily Therapy Cost into account every time that I prescribe 
an anti-hypertension medicine have a financial benefit for the patient?
Always : Often
-
50 % of the Sometimes
.....cases
11. Does my taking the Daily Therapy Cost into account every time that I prescribe 
an anti-hypertension medicine have a financial benefit for the sick fund?
Always ’ Often In 50 % of the 
cases
Some times Never
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12. Does my taking the Daily Therapy Cost into account every time that I prescribe
an anti-hypertension medicine have as a result a better ratio of cost / result?
Always Often In 50 % of the Some times Never
: cases
13. Does my taking the Daily Therapy Cost into account every time that I prescribe 
an anti- hypertension medicine have as a result the better compliance of the 
patient because of the lower cost?
14. Does the lower effectiveness of low-priced medicines prevent me from taking the 
Daily Therapy Cost into account every time that I prescribe an anti­
hypertension medicine?
Always Often In 50 % of the Some times Never
cases
15 Does the profile of the undesirable effects of low-priced medicines prevent me 
from taking the Daily Therapy Cost into account every time that I prescribe an 
anti-hypertension medicine?
Always Often In 50 % of the Some times Never
cases
16 Does the seriousness of the disease prevent me from taking the Daily Therapy
Cost into account every time that I prescribe an anti-hypertension medicine?
Always Often In 50 % o
cases
Never
17 Does the patients’ belief that expensive medicines are better medicines prevent 
me from taking the Daily Therapy Cost into account every time that I prescribe 
an anti-hypertension medicine?
Always Often In 50 % of the 
cases
Some times - Never
342
18 Does the patient wish that I take the cost into account every time that I 
prescribe an anti-hypertension medicine?
i Always ; Often In 50 % of the Some times Never
cases
19 Do the sick funds wish that I take into account the cost every time that I 
prescribe an anti-hypertension medicine?
Always 50% of the SometimesOften
......
ever
::v,;:.y4'
20 Does the medical representative wish that I take into account the cost every 
time that I prescribe an anti-hypertension medicine?
In 50% of the Some times Never
y #
21 Does the patient influence me in taking the cost into account (to the rate that I 
think it is appropriate) every time that I prescribe an anti-hypertension 
medicine?
In 50% o f the Sometimes
. cases
Never
22 Do the sick funds influence me in taking the cost into account (to the rate that I 
think it is appropriate) every time that I prescribe an anti-hypertension 
medicine?
Always Often In 50 % of the Some times
cases
Never
23 Does the medical representative influence me in taking the cost into account (to 
the rate that I think it is appropriate) every time that I prescribe an anti­
hypertension medicine?
Always I Often i In 50 % of the Some times Never
; , cases ;
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X24 The prescription of a less effective anti-hypertension medicine because of the
estimate of the Daily Therapy Cost is :
Very good Good Indifferent Bad Very bad
25 If there is a financial benefit for my patient when I take the Daily Therapy Cost
into account every time that I prescribe an anti-hypertension medicine, it is :
Very good Good Indifferent Bad Very bad
26 If there is a financial benefit for the sick funds when I take the Daily Therapy
Cost into account every time that I prescribe an anti-hypertension medicine, it 
is :
Very good Good Indifferent Bad Very bad
27 If a better ratio of cost / result results from my taking the Daily Therapy Cost
into account every time that I prescribe an anti-hypertension medicine, it is :
Very good Good Indifferent Bad Very bad
28. If a better compliance of the patient is achieved because of the lower cost when I 
take the Daily Therapy Cost into account every time that I prescribe an anti­
hypertension medicine, it is :
Very good Good Indifferent Bad Very bad
29. I will be troubled if I prescribe a less effective anti-hypertension medicine
because I have to take the daily therapy cost into account
I totally agree Ï agree It makes no I disagree I totally
difference to me disagree
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30. General Information
Specialization Pathologist
Cardiologist
Work place Hospital
Private Clinic
Doctor’s Office
Sex Female
Male
Age -40
41-50
51-60
60 +
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Appendix I Survey with means of answers at baseline presented to
non participating physicians, which was used by the 
group for analysis.
Gp Card Gyn Psych Males Females <40 41-50 51-60 >60
Qi BI 3.43 3.31 3.20 3.25 3.33 3.23 3.45 3.30 3.09 3.56
Q2 ATT! 3.16 3.18 3.08 3.38 3.20 3.11 3.31 3.17 2.94 3.60
Q3 ATT2 3.78 3.89 3.85 3.96 3.88 3.76 3.97 3.75 3.81 4.36
Q4 ATT3 3.96 3.73 3.75 3.77 3.87 3.58 3.90 3.78 3.73 4.12
Q5 ATT4 3.42 3.51 3.38 3.45 3.46 3.35 3.47 3.43 3.40 3.56
Q6 ATT5 2.81 2.89 2.81 3.04 2.88 2.85 3.12 2.85 2.62 2.84
Q7 ER 3.37 3.64 3.43 3.13 3.49 2.94 3.40 3.34 3.42 3.84
Q8 HABIT 2.44 2.46 2.39 2.53 2.52 2.11 2.64 2.44 2.04 3.00
Q9 Bbl 1.78 1.83 1.57 1.48 1.70 1.65 1.78 1.77 1.41 1.60
Q10 Bb2 2.80 3.18 2.86 3.26 3.07 2.57 3.29 2.81 2.99 3.08
QH Bb3 3.13 3.20 2.92 3.38 3.22 2.81 3.76 3.18 2.20 3.20
Q12 Bb4 2.99 2.94 2.87 3.26 2.98 3.16 3.23 2.93 2.73 3.54
Q13 Bb5 1.79 1.69 2.00 1.83 1.80 1.95 1.84 1.87 1.61 2.04
Q14 PBC1 3.14 2.99 3.42 2.78 3.15 2.84 2.60 3.10 3.65 3.42
Q15 PBC2 3.24 2.86 3.52 3.18 3.21 3.23 2.72 3.31 3.52 3.54
Q16 PBC3 3.74 4.28 3.60 3.64 3.86 3.52 3.80 3.82 3.97 3.29
Q17 PBC4 1.69 1.60 1.60 1.42 1.56 1.76 1.30 1.74 1.68 1.40
Q18 Nbl 2.16 2.31 2.45 2.52 2,27 2.68 2.60 2.38 1.96 2.04
Q19 Nb2 3.40 4.36 3.87 3.71 3,78 3.82 4.44 3.76 2.90 4.08
Q20 Nb3 3.10 3.42 3.45 3.63 3.38 3.21 3.38 3.52 3.19 2.42
Q21 Mcl 1.82 1.78 1.92 192 1.83 1.97 2.18 1.75 1.77 1.52
Q22 Mc2 2.35 2.56 2.27 2.22 2.28 2.76 2.82 2.41 1.77 1.78
Q23 Mc3 2.15 2.34 2.40 2.29 2.20 2.65 2.56 2.27 2.05 1.80
Q24 Oel 1.79 1.84 1.66 1.55 1.68 1.92 1.68 1.82 1.65 1.40
Q25 Oe2 3.65 3.99 3.94 3.82 3.90 3.44 3.98 3.67 3.83 4.36
Q26 Oe3 3.46 4.02 3.81 3.82 3.75 3.61 3.94 3.62 3.69 3.88
Q27 Oe4 4:16 4.31 4.07 4.13 4.23 3.80 4.42 4.06 4.06 4.24
Q28 Oe5 3.60 3.93 3.92 3.94 3.88 3.47 4.23 3.71 3.46 3.96
Q29 ARV 4.20 4.64 4.46 4.43 4.46 4.11 4.49 4.49 4.26 3.88
Source: field work
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Appendix J Baseline and final means of independent and dependent
variables of behaviour of group 1
Group 1 : All physicians
Variable Mean Mean t df Sig.
baseline final
BI 3.2687 3.6364 -3.429 131 0.001
ATT1 3.1654 3.3939 -2.266 130 0.025
ATT2 3.8271 3.8712 -0.533 130 0.595
ATT3 3.7744 3.8258 -0.675 130 0.501
ATT4 3.4286 3.4545 -0.160 130 0.873
ATT5 2.8788 2.9848 -0.839 129 0.403
ER 3.3231 3.1894 0.950 127 0.344
HABIT 2.4733 2.9545 -3.495 128 0.001
Bbl 1.6846 1.5152 1.678 127 0.096
Bb2 3.0076 2.8450 0.749 123 0.455
Bb3 3.0394 3.2273 -1.550 124 0.124
Bb4 2.9449 2.6894 1.419 124 0.158
Bb5 1.8462 1.6565 2.340 126 0.021
PBC1 3.1417 2.9070 1.141 122 0.256
PBC2 3.1984 3.1667 -0.300 123 0.764
PBC3 3.7652 3.9771 -1.392 128 0.166
PBC4 1.5802 1.6489 -0.567 128 0.572
Nbl 2.3030 2.5606 -1.865 129 0.064
Nb2 3/7717 3.7727 -0.064 124 0.949
Nb3 3.2769 3.2576 -0.192 127 0.848
Mcl 1.8931 1.9773 -0.553 128 0.581
Mc2 2.3411 2.1061 1.701 126 0.091
Mc3 2.2424 2.7803 -4.271 129 0.000
Oel 1.7077 1.8636 -1.257 127 0.211
Oe2 3.8125 3.9318 -1.352 125 0.179
Oe3 3.7308 3.9697 -2.596 127 0.011
Oe4 4.2500 4.1527 1.146 124 0.254
Oe5 3.8828 3.8485 0.751 125 0.454
ARV 4.4615 4.5076 -0.456 127 0.649
Valid N 106 124
(listwise)_______
Source: field work
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Appendix K Baseline and final means of independent and dependent
variables of behaviour of group 2
Group 2 : All physicians
Variable Mean Mean t df Sig.
baseline Final
BI 3.2672 3.3154 -1.178 129 0.241
ATT1 3.2137 3.2231 0.000 129 1.000
ATT2 3.8015 3.7462 0.985 129 0.327
ATT3 3.7786 3.7615 0.403 129 0.687
ATT4 3.4504 3.3846 1.289 129 0.200
ATT5 2.8154 2.8077 0.194 128 0.847
ER 3.3511 3.3231 0.673 129 0.502
HABIT 2.3077 3.0615 -11.734 128 0.000
Bbl 1.6565 1.7615 -1.823 129 0.071
Bb2 2.8550 2.7692 1.837 129 0.069
Bb3 3.1985 3.1538 0.896 129 0.372
Bb4 3.0382 2.9692 1.490 129 0.139
Bb5 1.7710 1.8308 -1.152 129 0.251
PBC1 3.1069 3.1769 -1.044 129 0.299
PBC2 3.2846 3.3000 -0.145 128 0.885
PBC3 3.9542 4.000 -0.807 129 0.421
PBC4 1.5267 1.6077 -1.340 129 0.182
Nbl 2.2519 2.2385 0.427 129 0.670
Nb2 3.8140 3.7615 0.948 127 0.345
Nb3 3.4275 2.9308 7.617 129 0.000
Mcl 1.8015 1.7769 0.564 129 0.574
Mc2 2.2901 2.2077 1.181 129 0.240
Mc3 2.3206 2.2692 1.021 129 0.309
Oel 1.6794 1.7692 -1.825 129 0.070
Oe2 3.8244 3.8692 -0.904 129 0.368
Oe3 3.6565 3.6846 -0.142 129 0.887
Oe4 4.1679 4.1462 0.506 129 0.614
Oe5 3.8321 3.8846 -0.927 129 0.356
ARV 4.3664 4.3231 1.092 129 0.277
Valid N 128 130
(listwise)_______
Source: field work
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Appendix L Baseline and final means of independent and dependent
variables of behaviour of the control group
Group 3: All physicians
Variable Mean Mean t df Sig.
baseline Final
BI 3.4122 3.4077 0.446 129 0.656
ATT1 3.1832 3.2308 -0.749 129 0.455
ATT2 3.9466 3.9077 0.639 129 0.524
ATT3 3.9237 3.8915 0.647 128 0.519
ATT4 3.4427 3.4615 -0.137 129 0.891
ATT5 2.9237 2.9615 -0.373 129 0.709
ER 3.5267 3.5154 0.253 129 0.801
HABIT 2.5725 2.5462 0.436 129 0.663
Bbl 1.7252 1.7385 -0.588 129 0.557
Bb2 3.1069 3.0538 0.970 129 0.334
Bb3 3.1985 3.1318 1.040 128 0.301
Bb4 3.0382 3.1000 -1.089 129 0.287
Bb5 1.8473 1.8615 -0.436 129 0.663
PBC1 3.0458 3.0538 -0.242 129 0.809
PBC2 3.1450 3.1615 -0.537 129 0.592
PBC3 3.7099 3.6538 0.584 129 0.560
PBC4 1.6718 1.7077 -0.780 129 0.437
Nbl 2.4427 2.4154 0.506 129 0.614
Nb2 3.7710 3.7231 0.773 129 0.441
Nb3 3.3511 3.3462 0.000 129 1.000
Mcl 1.8626 1.9077 -0.973 129 0.332
Mc2 2.4351 2.3923 0.685 129 0.494
Mc3 2.2595 2.2308 0.427 129 0.670
Oel 1.7786 1.7923 -0.257 129 0.797
Oe2 3.8397 3.8308 0.164 129 0.870
Oe3 3.8092 3.7846 0.467 129 0.641
Oe4 4.0840 4.0769 0.145 129 0.885
Oe5 3.7252 3.6923 0.728 129 0.468
ARV 4.3893 4.3692 0.506 129 0.614
Valid N 131 128
(listwise)_______
Source: field work
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Appendix M Baseline and final means of independent and dependent
variables of behaviour of general practitioners of
group 1
Group 1 : General practitioners
Variable Mean Mean t df Sig.
baseline Final
BI 3.1944 3.7222 -2.440 35 0.020
ATT1 3.0571 3.5000 -2.472 34 0.019
ATT2 3.6857 3.7778 -0.572 34 0.571
ATT3 3.8857 3.7222 1.000 34 0.324
ATT4 3.3429 3.4444 -0.475 34 0.638
ATT5 2.9118 2.7778 0.845 33 0.404
ER 3.2424 2.8611 1.459 32 0.154
HABIT 2.3939 3.0556 -2.261 32 0.031
Bbl 1.8857 1.6667 1.190 34 0.242
Bb2 2.7714 2.8333 -0.325 34 0.747
Bb3 3.0571 3.0000 0.236 34 0.815
Bb4 3.0000 2.9444 0.223 34 0.825
Bb5 1.6667 1.7778 -1.071 35 0.291
PBC1 3.2857 3.1212 1.000 32 0.325
PBC2 3.3824 3.5000 -0.828 33 0.414
PBC3 3.7778 3.8611 -0.347 35 0.731
PBC4 1.7778 1.8889 -0.644 35 0.524
Nbl 2.0556 2.3333 -1.405 35 0.169
Nb2 3.3824 3.2778 0.845 33 0.404
Nb3 2.9722 2.9722 0.000 35 1.000
Mcl 1.7714 1.9167 -0.682 34 0.500
Mc2 2.3889 2.4167 -0.112 35 0.911
Mc3 2.1111 2.7778 -3.347 35 0.002
Oel 1.8611 2.0278 -0.712 35 0.481
Oe2 3.6571 3.5833 0.683 34 0.499
Oe3 3.4167 3.8056 -2.497 35 0.017
Oe4 4.2000 4.2778 -0.320 34 0.751
Oe5 3.6286 3.8611 -1.096 34 0.281
ARV 4.2059 4.4444 -1.178 33 0.247
Valid N 28 33
(listwise)
Source: field work
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Appendix N Baseline and final means of independent and dependent
variables of behaviour of the general practitioners of
group 2
Group 2 : General practitioners
Variable Mean Mean t df Sig.
baseline Final
BI 3.4706 3.5200 -1.000 49 0.322
ATT1 3.2549 3.3000 -0.299 49 0.766
ATT2 3.8431 3.8600 0.000 49 1.000
ATT3 4.0980 4.0200 1.941 49 0.058
ATT4 3.4902 3.4800 0.299 49 0.766
ATT5 2.8200 2.8200 0.155 48 0.878
ER 3.4118 3.4200 0.256 49 0.799
HABIT 2.4600 3.3000 -12.231 48 0.000
Bbl 1.9020 2.0200 -1.181 49 0.243
Bb2 2.8824 2.8200 1.000 49 0.322
Bb3 3.2157 3.3200 -0.893 49 0.376
Bb4 2.9804 2.9600 0.622 49 0.537
Bb5 1.8039 1.8000 0.444 49 0.659
PBC1 3.1569 3.1600 0.704 49 0.485
PBC2 3.3400 3.3400 0.573 48 0.569
PBC3 3.9804 4.0400 -0.850 49 0.399
PBC4 1.5098 1.6000 -0.781 49 0.438
Nbl 2.1373 2.2000 -0.468 49 0.642
Nb2 3.6122 3.6000 0.000 47 1.000
Nb3 3.2157 2.7200 4.045 49 0.000
Mcl 1.8824 1.8600 0.389 49 0.699
Mc2 2.3333 2.3200 -0.629 49 0.533
Mc3 2.1765 2.1400 0.704 49 0.485
Oel 1.6667 1.7200 -.0685 49 0.497
Oe2 3.7647 3.8200 -0.771 49 0.444
Oe3 3.4510 3.5000 0.000 49 1.000
Oe4 4.1765 4.2200 -0.573 49 0.569
Oe5 3.6078 3.6600 -0.573 49 0.569
ARV 4.1961 4.1600 0.330 49 0.743
Valid N 48 50
(listwise)_______
Source: field work
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Appendix O Baseline and final means of independent and dependent
variables of behaviour of the general practitioners of the
control group
Group 3 : General practitioners
Variable Mean Mean t df Sig.
baseline Final
BI 3.5472 3.5577 0.375 51 0.709
ATT1 3.1321 3.1538 -0.299 51 0.766
ATT2 3.7925 3.7692 0.198 51 0.844
ATT3 3.8868 3.8462 0.468 51 0.642
ATT4 3.4151 3.4231 0.207 51 0.837
ATT5 2.7358 2.7692 -0.139 51 0.890
ER 3.4151 3.4038 0.207 51 0.837
HABIT 2.4528 2.4231 0.375 51 0.709
Bbl 1.6038 1.5769 -0.240 51 0.811
Bb2 2.7358 2.6731 0.782 51 0.438
Bb3 3.0943 3.1176 -0.275 50 0.785
Bb4 3.0000 3.0385 -0.496 51 0.622
Bb5 1.8491 1.8077 0.275 51 0.785
PBC1 3.0189 2.9808 0.198 51 0.844
PBC2 3.0566 3.0577 -0.330 51 0.742
PBC3 3.4906 3.5000 -0.256 51 0.799
PBC4 1.7925 1.8077 -0.216 51 0.830
Nbl 2.2642 2.2692 -0.299 51 0.766
Nb2 3.2075 3.1731 0.299 51 0.766
Nb3 3.0755 3.0769 -0.227 51 0.821
Mcl 1.7925 1.8077 -0,275 51 0.785
Mc2 2.3396 2.3462 -0.216 51 0.830
Mc3 2.1509 2.1731 -0.531 51 0.598
Oel 1.8491 1.8269 0.207 51 0.837
Oe2 3.5472 3.5769 -0.496 51 0.622
Oe3 3.4906 3.4615 0.275 51 0.785
Oe4 4.1132 4.1154 0.000 51 1.000
Oe5 3.5849 3.5769 0.444 51 0.659
ARV 4.2075 4.2308 -0.299 51 0.766
Valid N 53 51
(listwise)_______
Source: field work
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Appendix P Baseline and final means of independent and dependent
variables of behaviour of the cardiologists of group 1
Group 1 : Cardiologists
Variable Mean Mean t df Sig.
baseline Final
BI 3.3784 3.7714 -2.079 34 0.045
ATT1 3.1081 3.4857 -2.171 34 0.037
ATT2 3.8919 3.8857 -0.154 34 0.879
ATT3 3.7027 3.8857 -0.925 34 0.361
ATT4 3.4865 3.2286 0.865 34 0.393
ATT5 2.6486 3.2000 -2.071 34 0.046
ER 3.5676 3.4000 0.596 34 0.555
HABIT 2.4054 3.0571 -2.691 34 0.011
Bbl 1.7222 1.5714 0.379 33 0.707
Bb2 3.1429 2.5588 1.531 31 0.136
Bb3 3.0303 3.2286 -0.677 30 0.504
Bb4 2.7059 2.5429 0.577 31 0.568
Bb5 1.7941 1.5714 0.924 31 0.363
PBC1 2.9394 3.0571 -0.557 30 0.582
PBC2 2.6667 2.8571 -0.756 30 0.456
PBC3 4.2857 3.8571 1.302 32 0.202
PBC4 1.5294 1.5882 0.000 30 1.000
Nbl 2.3056 2.8571 -1.912 33 0.065
Nb2 4.2778 4.2571 0.000 33 1.000
Nb3 3.3889 3.4000 0.180 33 0.858
Mcl 1.8056 2.0571 -1.178 33 0.247
Mc2 2.5556 2.2286 1.055 33 0.299
Mc3 2.3333 3.0857 -2.982 33 0.005
Oel 1.7714 1.7714 -0.138 32 0.891
Oe2 4.0000 4.1429 -0.924 31 0.363
Oe3 4.0588 4.0571 -0.361 31 0.720
Oe4 4.4118 3.9143 2.301 31 0.028
Oe5 4.0294 3.9429 0.166 31 0.869
ARV 4.6111 4.7143 -0.812 33 0.422
Valid N 32 34
(listwise)
Source: field work
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Appendix Q Baseline and final means of independent and dependent
variables of behaviour of the cardiologists of group 2
Group 2 : Cardiologists
Variable Mean Mean t df Sig.
baseline Final
BI 3.0370 3.2222 -1.991 26 0.057
ATT1 3.0000 3.0741 -0.811 26 0.425
ATT2 3.6667 3.7407 -0.493 26 0.626
ATT3 3.4444 3.5926 -1.000 26 0.327
ATT4 3.3704 3.3704 0.000 26 1.000
ATT5 2.7407 2.7037 0.182 26 0.857
ER 3.3704 3.4444 -0.625 26 0.537
HABIT 2.0000 2.8519 -7.359 26 0.000
Bbl 1.4444 1.3704 0.700 26 0.490
Bb2 2.7037 2.6296 0.811 26 0.425
Bb3 2.7778 2.7407 0.440 26 0.663
Bb4 2.8148 2.7407 0.570 26 0.574
Bb5 1.6667 1.7407 -1.000 26 0.327
PBC1 2.9630 3.0741 -0.769 26 0.449
PBC2 3.0741 3.0000 0.465 26 0.646
PBC3 4.3704 4.2963 1.442 26 0.161
PBC4 1.6296 1.6667 -0.372 26 0.713
Nbl 2.1111 2.0370 0.527 26 0.602
Nb2 4.1852 4.0370 1.000 26 0.327
Nb3 3.3333 2.8519 4.914 26 0.000
Mcl 1.4815 1.4815 0.000 26 1.000
Mc2 2.1852 2.0370 1.000 26 0.327
Mc3 2.1111 2.1852 -0.700 26 0.490
Oel 1.5926 1.7037 -1.803 26 0.083
Oe2 3.7407 3.7407 0.000 26 1.000
Oe3 3.7407 3.8519 -0.827 26 0.416
Oe4 4.0741 4.0000 0.700 26 0.490
Oe5 3,5926 3.8148 -1.537 26 0.136
ARV 4.7037 4.6296 1.000 26 0.327
Valid N 27 27
(listwise)
Source: field work
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Appendix R Baseline and final means of independent and dependent
variables of behaviour of the cardiologists of the control
group
Group 3 : Cardiologists
Variable Mean Mean t df Sig.
baseline Final
BI 3.5000 3.4615 0.440 25 0.664
ATT1 3.4615 3.5000 -0.225 25 0.824
ATT2 4.1154 4.0769 0.328 25 0.746
ATT3 4.0769 4.0000 0.625 25 0.538
ATT4 3.6923 3.6538 0.372 25 0.713
ATT5 3.3846 3.4231 -0.272 25 0.788
ER 4.0385 4.0000 0.254 25 0.802
HABIT 3.0000 2.9231 0.493 25 0.627
Bbl 2.3846 2.4231 -0.372 25 0.713
Bb2 3.7308 3.6923 0.205 25 0.840
Bb3 3.8462 3.6923 0.750 25 0.461
Bb4 3.3846 3.5000 -0.618 25 0.542
Bb5 1.5769 1.6154 -0.328 25 0.746
PBC1 3.0769 3.1154 -0.238 25 0.814
PBC2 2.8846 3.0000 -0.827 25 0.416
PBC3 4.1923 4.0769 0.768 25 0.449
PBC4 1.6538 1.6154 0.440 25 0.664
Nbl 2.5385 2.4615 0.625 25 0.538
Nb2 4.6538 4.5385 0.618 25 0.542
Nb3 3.5385 3.5000 0.238 25 0.814
Mcl 2.0385 2.0769 -0.328 25 0.746
Mc2 2.9615 2.8462 0.721 25 0.478
Mc3 2.5769 2.4615 1.140 25 0.265
Oel 2.1923 2.1923 0.000 25 1.000
Oe2 4.2308 4.1923 0.328 25 0.746
Oe3 4.2692 4.2308 0.440 25 0.664
Oe4 4.4231 4.4231 0.000 25 1.000
Oe5 4.1538 4.0385 0.681 25 0.502
ARV 4.6154 4.5385 0.625 25 0.538
Valid N 26 26
(listwise)_______
Source: field work
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Appendix S Baseline and final means of independent and dependent
variables of behaviour of the psychiatrists of group 1
Group 1 : Psychiatrists
Variable Mean Mean t d f Sig.
baseline Final
BI 3.3704 3.9259 -2.155 26 0.041
ATT1 3.5185 3.6296 -0.414 26 0.683
ATT2 3.9630 3.8148 0.750 26 0.460
ATT3 3.8519 3.7407 0.473 26 0.640
ATT4 3.5926 3.5185 0.328 26 0.746
ATT5 3.1481 3.0000 0.596 26 0.556
ER 3.0385 3.4444 -2.101 25 0.046
HABIT 2.7407 3.4074 -2.360 26 0.026
Bbl 1.4444 1.2593 1.727 26 0.096
Bb2 3.2593 3.2000 -0.112 24 0.912
Bb3 3.2593 3.7037 -1.345 26 0.190
Bb4 3.4231 2.7407 1.758 25 0.091
Bb5 1.9630 1.6667 1.093 26 0.285
PBC1 2.8846 2.1111 1.891 25 0.070
PBC2 3.2692 2.6667 1.412 25 0.170
PBC3 3.2593 4.0370 -1.876 26 0.072
PBC4 1.4444 1.5185 -0.348 26 0.731
Nbl 2.4815 2.9259 -1.100 26 0.282
Nb2 3.4615 4.1111 -1.966 25 0.060
Nb3 3.5000 3.3704 0.570 25 0.574
Mcl 2.1481 2.1852 -0.103 26 0.919
Mc2 2.2222 1.9630 0.753 26 0.548
Mc3 2.2593 3.0370 -2.267 26 0.032
Oel 1.5185 1.7037 -1.546 26 0.134
Oe2 3.7778 3.9259 -0.700 26 0.490
Oe3 3.7778 4.2222 -2.473 26 0.020
Oe4 4.2593 4.0741 1.308 26 0.202
Oe5 4.0370 3.7037 1.561 26 0.131
ARV 4.5769 4.2963 0.893 25 0.381
Valid N 20 25
(listwise)_______
Source: field work
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Appendix T Baseline and final means of independent and dependent
variables of behaviour of the psychiatrists of group 2
Group 2 : Psychiatrists
Variable Mean Mean t df Sig.
baseline Final
BI 3.2963 3.3333 -0.328 26 0.746
ATT1 3.5926 3.5185 0.625 26 0.537
ATT2 4.0000 3.7778 1.442 26 0.161
ATT3 3.7407 3.6667 0.465 26 0.646
ATT4 3.5556 3.3704 1.224 26 0.232
ATT5 3.0000 3.0741 -0.372 26 0.713
ER 3.1852 3.0370 0.891 26 0.381
HABIT 2.6296 3.1852 -2.575 26 0.016
Bbl 1.4815 1.6296 -1.072 26 0.294
Bb2 3.5556 3.4074 1.072 26 0.294
Bb3 3.7037 3.4815 1.537 26 0.136
Bb4 3.5185 3.3333 1.412 26 0.170
Bb5 1.8519 1.8519 0.000 26 1.000
PBC1 2.7778 2.8519 -0.700 26 0.490
PBC2 3.0741 3.1481 -.0465 26 0.646
PBC3 3.6296 3.6296 0.000 26 1.000
PBC4 1.4444 1.4815 -0.328 26 0.746
Nbl 2.5556 2.4074 1.162 26 0.256
Nb2 3.7407 3.7778 -0.440 26 0.663
Nb3 3.6667 3.2222 2.726 26 0.011
Mcl 2.0741 1.9259 1.162 26 0.256
Mc2 2.5185 2.3704 1.280 26 0.212
Mc3 2.4444 2.3333 0.827 26 0.416
Oel 1.6667 1.8519 -1.224 26 0.232
Oe2 3.9630 3.9630 0.000 26 1.000
Oe3 3.9259 3.8889 0.254 26 0.802
Oe4 4.2963 4.1111 1.727 26 0.096
Oe5 4.2963 4.2222 0.625 26 0.537
ARV 4.2593 4.1852 1.000 26 0.327
Valid N 27
(listwise)______
Source: field work
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Appendix U Baseline and final means of independent and dependent
variables of behaviour of the psychiatrists of the control
group
Group 3 : Psychiatrists
Variable Mean Mean t df Sig.
baseline final
BI 3.0435 3.0870 -0.569 22 0.575
ATT1 2.9565 3.0000 -0.204 22 0.840
ATT2 3.9130 3.9565 -0.272 22 0.788
ATT3 3.6957 3.7391 -0.371 22 0.714
ATT4 3.1739 3.2174 -0.272 22 0.788
ATT5 2.9565 3.0000 -0.161 22 0.874
ER 3.1739 3.2174 -0.569 22 0.575
HABIT 2.1739 2.2174 -0.238 22 0.814
Bbl 1.5217 1.5652 -0.371 22 0.714
Bb2 2.9130 2.8696 0.295 22 0.770
Bb3 3.1304 3.0870 0.371 22 0.714
Bb4 2.7826 2.7391 0.327 22 0.747
Bb5 1.6522 1.6957 -0.371 22 0.714
PBC1 2.6522 2.6957 -0.214 22 0.833
PBC2 3.2174 3.2609 -0.439 22 0.665
PBC3 4.0870 4.0435 0.105 22 0.917
PBC4 1.3478 1.3913 -0.439 22 0.665
Nbl 2.5217 2.4783 0.569 22 0.575
Nb2 3.9565 3.9130 0.196 22 0.847
Nb3 3.7391 3.6957 0.371 22 0.714
Mcl 1.4783 1.5217 -0.439 22 0.665
Mc2 1.8696 1.8261 0.569 22 0.575
Mc3 2.1304 2.0870 0.204 22 0.840
Oel 1.4348 1.4783 -0.327 22 0.747
Oe2 3.6957 3.6522 0.371 22 0.714
Oe3 3.7391 3.7391 0.000 22 1.000
Oe4 3.7826 3.7826 0.000 22 1.000
Oe5 3.3913 3.4348 -0.439 22 0.665
ARV 4.4783 4.4348 1.000 22 0.328
Valid N 23 23
(listwise)_______
Source: field work
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Appendix V Baseline and final means of independent and dependent
variables of behaviour of the gynaecologists of group 1
Group 1 : Gynaecologists
Variable Mean Mean t df Sig.
baseline final
BI 3.1471 3.1765 -0.135 33 0.893
ATT1 3.0588 3.0000 0.264 33 0.794
ATT2 3.7941 4.0000 -1.125 33 0.269
ATT3 3.6765 3.9412 -1.327 33 0.193
ATT4 3.3235 3.6471 -1.771 33 0.086
ATT5 2.8824 2.9706 -0.463 33 0.646
ER 3.3529 3.1176 0.840 33 0.407
HABIT 2.4118 2.3824 0.102 33 0.919
Bbl 1.6250 1.5000 0.796 31 0.432
Bb2 2.9032 2.8824 -0.130 30 0.897
Bb3 2.8437 3.0882 -1.137 31 0.264
Bb4 2.7500 2.5294 0.469 31 0.643
Bb5 2.0000 1.6061 2.396 31 0.023
PBC1 3.3939 3.1765 0.435 32 0.667
PBC2 3.4848 3.5294 -0.431 32 0.669
PBC3 3.6176 4.1818 -2.484 32 0.018
PBC4 1.5294 1.5588 -0.126 33 0.900
Nbl 2.4242 2.2059 1.179 32 0.247
Nb2 3.8710 3.5294 2.402 30 0.023
Nb3 3.3125 3.3235 -0.538 31 0.594
Mcl 1.9091 1.7941 0.702 32 0.488
Mc2 2.1333 1.7647 1.775 29 0.086
Mc3 2.2727 2.2647 -0.130 32 0.897
Oel 1.6250 1.9118 -0.725 31 0.474
Oe2 3.8125 4.0882 -1.438 31 0.161
Oe3 3.6970 3.8529 -0.796 32 0.432
Oe4 4.1250 4.3333 -1.315 30 0.198
Oe5 3.8750 3.8529 0.442 31 0.662
ARV 4.4706 4.5294 -0.349 33 0.729
Valid N 26 32
(listwise)_______
Source: field work
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Appendix W Baseline and final means of independent van dependent
variables of behaviour of the gynaecologists of group 2
Group 2: Gynaecologists
Variable Mean Mean t df Sig.
baseline final
BI 3.0769 3.0000 0.811 25 0.425
ATT1 2.9615 2.9231 0.440 25 0.664
ATT2 3.6538 3.5000 1.072 25 0.294
ATT3 3.5385 3.5385 0.000 25 1.000
ATT4 3.3462 3.2308 0.721 25 0.478
ATT5 2.6923 2.6154 0.700 25 0.490
ER 3.3846 3.3077 0.625 25 0.538
HABIT 2.0000 2.6923 -5.195 25 0.000
Bbl 1.5769 1.8077 -1.806 25 0.083
Bb2 2.2308 2.1538 0.811 25 0.425
Bb3 3.0769 2.9231 0.891 25 0.381
Bb4 2.8846 2.8462 0.372 25 0.713
Bb5 1.7308 1.9615 -1.656 25 0.110
PBC1 3.5000 3.6538 -1.072 25 0.294
PBC2 3.6154 3.6923 -0.700 25 0.490
PBC3 3.8077 4.0000 -0.926 25 0.363
PBC4 1.5385 1.6923 -1.072 25 0.294
Nbl 2.3077 2.3462 -0.440 25 0.664
Nb2 3.8846 3.7692 0.827 25 0.416
Nb3 3.6923 3.1154 5.091 25 0.000
Mcl 1.6923 1.7692 -0.811 25 0.425
Mc2 2.0769 2.0000 0.625 25 0.538
Mc3 2.6923 2.5385 0.941 25 0.356
Oel 1.8077 1.8462 -0.440 25 0.664
Oe2 3.8846 4.0000 -0.901 25 0.376
Oe3 3.6923 3.6538 0.440 25 0.664
Oe4 4.1154 4.1923 -0.811 25 0.425
Oe5 4.0385 4.0385 0.000 25 1.000
ARV 4.4615 4.4615 0.000 25 1.000
Valid N 26 26
(listwise) _____
Source: field work
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Appendix X Baseline and final means of independent and dependent
variables of behaviour of the gynaecologists of the control
group
Group 3 : Gynaecologists
Variable Mean Mean t df Sig.
baseline final
BI 3.3793 3.3448 0.441 28 0.663
ATT1 3.2069 3.3103 -0.902 28 0.375
ATT2 4.1034 3.9655 1.072 28 0.293
ATT3 4.0345 4.000 0.570 27 0.573
ATT4 3.4828 3.5517 -0.626 28 0.537
ATT5 2.8276 2.8621 -0.273 28 0.787
ER 3.5517 3.5172 0.215 28 0.832
HABIT 2.7241 2.6897 0.372 28 0.712
Bbl 1.5172 1.5517 -0.254 28 0.801
Bb2 3.3793 3.3103 0.701 28 0.489
Bb3 2.8621 2.6897 0.961 28 0.345
Bb4 3.0000 3.1379 -1.684 28 0.103
Bb5 2.2414 2.3103 -0.465 28 0.646
PBC1 3.3793 3.4138 -0.441 28 0.663
PBC2 3.4828 3.4138 1.000 28 0.326
PBC3 3.3793 3.2414 0.779 28 0.442
PBC4 1.7241 1.8621 -1.279 28 0.212
Nbl 2.6207 2.5862 0.297 28 0.769
Nb2 3.8621 3.8276 1.000 28 0.326
Nb3 3.3793 3.4138 -0.328 28 0.745
Mcl 2.1379 2.2414 -0.902 28 0.375
Mc2 2.5862 2.5172 0.571 28 0.573
Mc3 2.2759 2.2414 0.441 28 0.663
Oel 1.5517 1.6207 -0.701 28 0.489
Oe2 4.1379 4.1034 0.441 28 0.663
Oe3 4.0345 4.0000 0.000 28 1.000
Oe4 3.9655 3.9310 0.000 28 1.000
Oe5 3.8621 3.7931 0.254 28 0.801
ARV 4.4483 4.4138 0.000 28 1.000
Valid N 29 28
(listwise)_______
Source: field work
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Appendix Y Descriptive statistics of the baseline data
N Mean Skewness Kurtosis
Statistics statistics statistics std. error statistic std. error
BI 396 3.3157 -0.539 0.123 -0.696 0.245
HABIT 392 2.4515 0.416 0.123 -1.196 0.246
UHLOUTC 383 47.7050 0.322 0.125 -0.694 0.249
ER 392 3.4005 -0.191 0.123 -1.074 0.246
ARV 392 4.4056 -2.261 0.123 5.064 0.246
PBC1 389 3.0977 -0.085 0.124 -1.610 0.247
PBC2 387 3.2093 -0.180 0.124 -1.482 0.247
PBC3 394 3.8096 -0.862 0.123 -0.905 0.245
PBC4 393 1.5929 1.954 0.123 3.150 0.246
SN 385 22.7766 1.018 0.124 0.548 0.248
Source: field work
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Appendix Z Normal probability and detrended normal probability 
plots
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Appendix AA Hotelling’s t test
Hotelling’s t test can be computed by the formula:
 (N-3)(l+r,J)____________ s
2  (I - r 232- r n - r u 2 + 2  r 23 r l2r u)
The inter-correlation r 23 was calculated and turned out to be 0.891 the validity 
coefficients r 12 and r 13 were calculated before, they are 0.743 and 0.659 
respectively. The resulting computation is
(366-3)(l+ 0.8905673")
t dl = (0.743-0.659) I  /  2 ( 1 - 0 .793] 101 -  0.552049- 0.434281 + 0.8721094)
(684.38536)
té , = (0.084) \  I  2(0.0926693)
(0.084) (60.766946 = 5.104424
Appendix AB Descriptive statistics of low cost-conscious preservers
(BI = 1 or 2)
N minimum maximum mean s.d.
BI 107 1.00 2.00 1.6822 0.4678
ER 106 1.00 5.00 2.6509 0.8842
HABIT 107 1.00 3.00 1.4673 0.7047
ARV 107 1.00 5.00 4.2523 1.2445
ATTITUDE 107 5.00 20.00 13.3738 3.4737
Bb 105 5.00 18.00 9.9333 4.4317
PBC 103 4.00 20.00 12.2913 4.2395
Nb 107 3.00 15.00 8.4953 2.7656
Me 107 3.00 12.00 5.3458 2.6390
Oe 106 6.00 23.00 15.8868 3.6627
SN 107 3.00 48.00 16.4860 11.7082
valid N (listwise) 101
Source: field work
Appendix AC Descriptive statistics of high cost-conscious prescril
(BI = 4 and 5)
N Minimum Maximum Mean S.d.
BI 222 4.00 5.00 4.1982 0.3995
ER 219 1.00 5.00 4.0137 1.0857
HABIT 218 1.00 5.00 3.3119 1.1890
ARV 218 1.00 5.00 4.4266 0.8515
ATTITUDE 219 11.00 25.00 19.7717 3.3909
Bb 218 7.00 22.00 14.7982 3.5019
PBC 217 4.00 19.00 11.6452 3.8476
Nb 214 3.00 15.00 10.0327 2.4655
Me 218 3.00 15.00 7.1560 3.0319
Oe 218 10.00 22.00 18.1193 2.5875
SN 213 4.00 75.00 26.3662 16.0458
valid N (listwise) 202
Source: field work
389
Appendix AD Calculation of the difference between the behavioural
beliefs of specialists and general practitioners.
r e (N ij-E ij)2 
1=1 M  E ij
(23-22.52)3 (16-16.48)3 (14-10.79)2 (5-8.03)2 (4-7.51)2 (9-5.49)2
X2 — —— — — + -       + ————— +-------- —— + ———-—— + —--------- —
22.52 16.48 10.79 8.03 7.51 5.4 9
X2 = 0.010 + 0.014 + 0.955 +1.1433 +1.640 + 2.244 = 6.01
Appendix AE Calculation of the difference between the normative
beliefs of specialists and general practitioners.
r c (N ij-E ij)2
X2-X 2  ----------
1=1 f=l E ij
(14-12.87)2 (10-11.13)2 (12-11.26)2 (9-9.74)2 (11-12.87)2 (13-11.13)2
X2 — ——— ——— + ------------- + —————— + — —— + ——— —— + -------------
12.87 11.13 11.26 9.74 12.87 11.13
0.992 + 0.1147 + 0.0486 + 0.0562 + 0.2717 + 0.3142 = 0.90
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